data_2jz2_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jz2 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 109.347 -0.612 . . . . 75.22 109.347 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -135.27 161.71 61.79 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.605 -0.27 . . . . 75.25 110.295 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.86 117.55 4.32 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.274 1.983 . . . . 74.14 111.191 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.85 1.36 24.15 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.892 -0.67 . . . . 63.42 111.897 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.33 141.72 32.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.93 0.395 . . . . 61.42 110.948 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -82.55 129.96 35.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 71.14 110.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.45 HG22 HD12 ' A' ' 52' ' ' LEU . 16.4 m -132.36 153.02 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 73.13 111.565 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -117.13 137.04 52.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.515 -0.766 . . . . 73.52 109.969 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.4 t -80.42 115.26 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 71.31 110.353 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.49 18.52 22.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.212 -0.449 . . . . 75.43 112.21 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -89.82 113.9 25.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.177 -0.675 . . . . 62.3 109.177 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.11 -28.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.767 -0.651 . . . . 70.43 111.976 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -93.07 23.54 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 65.54 110.791 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.72 160.96 18.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.791 -0.568 . . . . 55.0 110.527 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -71.06 -32.09 68.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 71.02 111.173 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.65 ' HH ' ' HD3' ' A' ' 43' ' ' LYS . 71.6 m-85 -96.85 25.45 5.29 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.886 0.328 . . . . 72.4 111.886 -175.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -59.23 131.32 50.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.537 -0.301 . . . . 73.44 110.198 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 78.23 -16.84 0.62 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.885 0.874 . . . . 75.34 111.577 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -75.25 157.46 34.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 73.21 110.686 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.61 139.63 50.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.859 -0.609 . . . . 71.43 110.854 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 179.88 18.46 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.785 -0.643 . . . . 41.04 111.506 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.2 tp -119.0 123.23 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.311 -0.255 . . . . 63.53 110.311 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.93 116.81 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.845 -0.428 . . . . 74.3 109.845 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -90.49 -33.65 15.88 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.938 -0.574 . . . . 71.11 110.914 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -169.84 154.02 5.11 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.764 -0.653 . . . . 63.44 110.177 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.16 124.74 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.097 -0.956 . . . . 70.53 109.115 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -120.2 98.84 6.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.992 0.425 . . . . 75.54 111.179 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 54.29 39.45 30.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.356 -0.838 . . . . 74.21 112.178 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.47 -11.72 65.0 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.642 -0.789 . . . . 62.54 112.569 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 99.0 mttt -99.13 177.61 5.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.113 -0.329 . . . . 75.14 110.113 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.99 126.18 40.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 70.52 110.604 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.821 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -83.58 107.52 16.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.291 -0.413 . . . . 74.4 109.957 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.12 124.02 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.137 -0.483 . . . . 73.23 110.822 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -99.13 126.51 44.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.821 -0.627 . . . . 74.31 110.511 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -103.59 136.46 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.535 -0.913 . . . . 71.12 108.535 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.83 133.22 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.807 -0.442 . . . . 72.11 109.807 -172.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -129.11 21.78 5.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.196 0.522 . . . . 74.41 111.09 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.13 9.26 54.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.643 -0.789 . . . . 50.34 112.951 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 169.34 -46.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.087 -0.709 . . . . 73.42 109.087 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -80.25 138.69 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.501 -0.772 . . . . 74.23 109.894 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -154.8 163.21 40.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.736 -0.665 . . . . 60.32 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.65 ' HD3' ' HH ' ' A' ' 17' ' ' TYR . 87.4 tttt -165.39 106.79 0.78 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.242 -0.89 . . . . 72.13 109.462 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 33' ' ' ALA . 8.7 tt -77.52 119.25 20.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 61.3 109.649 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.15 124.26 62.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.861 -0.422 . . . . 75.53 109.861 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -84.09 129.2 34.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.225 0.536 . . . . 75.14 110.729 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 95.7 m-85 -124.73 178.45 5.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.454 -0.793 . . . . 74.11 109.182 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.934 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 49.7 mtt180 -87.08 163.02 17.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.296 -0.631 . . . . 64.54 109.296 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.37 -31.24 69.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.724 -0.843 . . . . 71.31 108.724 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 p -67.82 -21.34 65.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 114.933 -1.03 . . . . 61.32 110.466 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.934 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 41.2 mm-40 -87.95 -7.9 56.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.501 -0.48 . . . . 65.23 111.254 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 8' ' ' VAL . 49.9 mt -122.88 156.63 34.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.973 0.416 . . . . 74.33 111.719 -173.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -129.22 147.24 51.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.114 -0.698 . . . . 52.14 109.114 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.94 132.33 36.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 74.3 111.127 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 177.969 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.665 HD11 HD23 ' A' ' 49' ' ' LEU . 52.3 mt . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.145 -0.317 . . . . 73.44 110.145 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.47 143.46 30.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.249 -0.432 . . . . 72.05 110.762 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.85 134.6 44.23 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.675 2.25 . . . . 63.24 111.544 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.83 -5.01 50.23 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.991 -0.624 . . . . 70.24 112.331 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.7 161.07 13.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.831 0.348 . . . . 75.23 110.695 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -99.69 131.79 45.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.264 -0.425 . . . . 75.13 110.234 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.617 HG21 HD11 ' A' ' 52' ' ' LEU . 25.9 m -125.7 155.52 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.163 -0.471 . . . . 72.44 110.206 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -109.47 143.07 39.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.669 -0.493 . . . . 44.44 109.669 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.16 113.96 16.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.032 -0.359 . . . . 71.42 110.032 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -89.69 -19.02 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 73.44 111.142 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.03 106.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 74.42 110.5 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.15 -30.42 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 71.55 111.132 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.66 -26.55 68.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 71.44 111.125 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.16 155.37 25.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 63.23 110.647 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 -27.5 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.002 -0.545 . . . . 73.11 110.945 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.43 22.66 2.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.276 -0.42 . . . . 74.55 111.489 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 35.6 t80 -63.32 134.61 56.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.239 -0.437 . . . . 74.41 110.332 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.7 mtp180 76.17 1.82 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.761 0.825 . . . . 74.55 112.293 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -85.35 150.51 24.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 75.25 110.212 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 125.25 53.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 74.52 109.744 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -125.72 155.27 18.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.586 -0.816 . . . . 41.33 111.85 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.66 116.48 28.98 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 110.252 -0.277 . . . . 75.41 110.252 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.01 106.34 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.85 -0.426 . . . . 61.31 109.85 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -79.37 -34.5 41.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.101 0.477 . . . . 72.31 110.521 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -167.03 143.72 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.695 -0.684 . . . . 70.14 109.65 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.18 136.14 25.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.431 -0.804 . . . . 72.52 109.276 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 m -127.03 93.75 3.84 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.264 -0.273 . . . . 74.02 110.264 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.92 -76.82 0.06 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.298 -0.864 . . . . 65.13 111.085 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -140.76 11.73 2.9 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.332 -1.304 . . . . 44.31 111.132 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 47.4 mtmt -114.6 165.95 12.23 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.115 -0.543 . . . . 74.22 109.55 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.98 133.4 37.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.681 0.277 . . . . 71.14 110.5 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -83.74 99.6 10.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.18 -0.674 . . . . 54.11 109.18 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.526 ' CG1' ' HA3' ' A' ' 22' ' ' GLY . 55.4 t -91.78 118.09 36.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 64.1 110.793 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.8 tp -94.6 122.59 37.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.781 -0.645 . . . . 74.4 110.509 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 92.3 m-85 -99.95 146.77 26.3 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.957 -0.757 . . . . 71.41 108.957 174.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 30.8 tt0 -129.55 -56.06 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.669 -0.412 . . . . 60.31 111.805 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 64.64 -66.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.825 0.45 . . . . 74.02 111.523 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 41' ' ' TRP . . . -168.73 93.5 0.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.334 -0.706 . . . . 52.05 111.334 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 8.6 t30 72.59 -36.79 0.37 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.492 0.717 . . . . 74.12 111.743 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 48.1 t90 -57.41 155.38 9.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 75.23 110.789 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.0 p-10 -148.54 153.45 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 71.41 110.301 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -169.45 110.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.362 -0.836 . . . . 73.13 109.378 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.522 HD12 ' HB3' ' A' ' 33' ' ' ALA . 37.8 tp -90.91 105.98 18.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.066 -0.516 . . . . 73.13 110.067 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -118.0 118.09 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 110.004 -0.369 . . . . 73.4 110.004 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 m -79.27 129.6 34.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.08 0.467 . . . . 73.33 110.583 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -124.84 178.41 5.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.613 -0.721 . . . . 65.44 109.119 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.936 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 62.8 mmt-85 -90.17 162.85 15.07 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.959 -0.756 . . . . 74.13 108.959 175.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.665 HD23 HD11 ' A' ' 2' ' ' ILE . 87.0 mt -79.36 -22.31 44.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.27 0.557 . . . . 71.32 109.882 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 p -75.21 -15.12 60.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.399 -0.819 . . . . 73.3 110.003 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.936 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 13.4 mm-40 -91.89 -13.17 31.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.732 -0.667 . . . . 63.54 110.604 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 8' ' ' VAL . 62.9 mt -115.56 161.54 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.73 . . . . 74.15 111.01 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.64 128.99 48.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.802 -0.636 . . . . 75.13 109.549 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.581 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -79.93 108.74 13.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 72.34 110.71 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 108.837 -0.801 . . . . 72.14 108.837 176.878 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.007 -0.738 . . . . 74.25 109.007 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -149.62 144.27 17.63 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.887 -0.412 . . . . 74.22 109.887 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.36 131.57 44.08 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.71 2.273 . . . . 53.12 111.857 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.2 -13.26 48.52 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.985 -0.626 . . . . 38.23 111.883 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 164.39 13.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.877 0.37 . . . . 38.23 110.561 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -97.36 134.42 40.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.902 -0.59 . . . . 72.51 110.085 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.79 148.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.991 0.425 . . . . 72.42 111.008 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 22.2 ttt180 -104.92 122.23 45.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.66 -0.7 . . . . 73.43 109.504 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 52' ' ' LEU . 41.2 t -70.82 103.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.1 0.476 . . . . 64.42 110.16 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -108.88 23.94 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.799 -0.637 . . . . 75.32 111.572 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -72.87 106.43 4.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.876 -0.787 . . . . 72.33 108.876 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.41 -25.47 38.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.179 0.514 . . . . 73.34 111.178 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.08 -23.26 26.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.308 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.79 155.8 18.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 73.31 110.905 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 18' ' ' TYR . 88.9 m -78.94 -23.4 44.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 54.12 111.822 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -76.91 11.77 1.62 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 74.32 111.28 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 64.9 t80 -71.33 78.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.516 -0.765 . . . . 75.23 110.055 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 14.8 ptt180 168.9 -20.38 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.182 -0.917 . . . . 74.33 109.629 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.12 148.07 23.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.305 0.574 . . . . 74.14 111.408 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 41.5 mt-10 -125.91 118.12 24.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.246 -1.02 . . . . 74.11 108.246 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.76 176.81 17.86 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.132 -1.032 . . . . 64.12 113.148 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -93.67 140.4 29.68 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.553 0.216 . . . . 71.11 110.632 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.27 117.33 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.254 -0.43 . . . . 72.33 110.667 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.9 -37.71 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 72.02 110.108 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -170.67 141.06 1.79 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.798 -0.637 . . . . 64.25 110.615 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.75 108.25 21.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.264 -0.88 . . . . 63.22 108.788 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -88.92 41.71 1.04 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.523 -0.308 . . . . 62.13 110.955 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 63.5 88.93 0.09 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.317 -0.856 . . . . 71.21 111.143 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.24 -30.55 9.66 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.656 -0.702 . . . . 60.5 112.448 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -120.65 162.66 19.29 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.214 0.206 . . . . 73.44 110.491 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.94 140.7 28.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.519 0.2 . . . . 73.23 111.019 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.619 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -93.02 116.57 29.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.51 -0.552 . . . . 71.01 109.51 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 127.21 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.398 -0.364 . . . . 74.44 110.66 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.0 tp -88.72 125.88 35.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.454 . . . . 72.32 110.889 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.593 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 91.4 m-85 -102.91 142.22 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.766 -0.652 . . . . 71.23 109.445 173.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -143.3 119.7 10.95 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.65 -0.5 . . . . 75.22 109.65 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.455 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 55.5 t30 -137.92 91.36 2.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 54.11 110.62 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.19 -91.76 0.83 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.747 -0.66 . . . . 64.0 112.473 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -114.49 -11.61 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 75.41 110.385 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.455 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 63.8 t90 -89.01 139.15 30.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 74.41 111.39 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.74 154.4 46.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.303 -0.862 . . . . 72.44 109.784 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -163.5 121.34 1.89 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.679 -0.691 . . . . 71.35 110.503 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 33' ' ' ALA . 9.1 tt -91.03 113.76 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.244 -0.65 . . . . 74.44 109.244 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.593 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 44.3 t -123.14 129.05 75.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.364 . . . . 74.54 110.636 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.8 m -84.37 132.62 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.991 0.424 . . . . 72.43 110.585 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -128.44 -176.61 3.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.911 -0.586 . . . . 74.1 110.053 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 25.2 mtp180 -100.47 157.01 16.95 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.298 -0.631 . . . . 74.22 109.298 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.5 -23.04 50.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.059 0.457 . . . . 72.22 110.424 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -74.47 -18.04 60.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.667 -0.697 . . . . 65.34 110.315 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.545 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp0 -99.0 -4.63 32.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.58 . . . . 74.2 111.294 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 10' ' ' VAL . 84.0 mt -120.18 130.18 54.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.458 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.95 135.34 45.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.104 -0.702 . . . . 75.03 109.104 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 128.9 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.085 -0.507 . . . . 73.41 110.579 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.32 -0.689 0 N-CA-C 108.6 -0.889 . . . . 70.52 108.6 177.149 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.927 -0.397 . . . . 74.22 109.927 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -149.4 167.48 12.94 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.678 -0.692 . . . . 75.23 110.028 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.804 ' HG3' ' HA ' ' A' ' 26' ' ' ARG . 51.6 Cg_exo -53.83 124.33 15.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.696 2.264 . . . . 64.15 112.061 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.27 -16.3 35.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.129 -0.558 . . . . 73.2 112.036 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.26 155.27 30.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 71.02 110.792 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -98.39 130.37 45.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.341 -0.39 . . . . 62.44 110.401 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.48 157.45 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.435 . . . . 62.43 110.459 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -133.98 135.7 43.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.061 -0.518 . . . . 71.02 110.365 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.77 120.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 75.33 110.678 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.9 p -100.1 5.88 44.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 61.23 111.817 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.3 t30 -80.86 108.48 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 64.13 109.616 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.3 t -71.17 -28.14 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 74.01 111.528 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.45 -6.5 57.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 74.32 110.933 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.471 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 8.8 t70 -94.24 160.64 14.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.756 0.312 . . . . 74.05 110.306 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -82.92 -19.71 36.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.708 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.45 19.61 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 71.33 110.351 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.56 128.63 36.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.683 -0.69 . . . . 75.42 111.145 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 70.05 7.44 6.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.245 -0.889 . . . . 75.51 112.512 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.74 145.29 32.97 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.168 -0.678 . . . . 74.24 109.168 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -113.19 129.92 56.37 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.5 -0.773 . . . . 71.22 109.804 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.75 164.67 25.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.444 -0.884 . . . . 71.54 112.047 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.03 129.95 44.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 110.283 -0.266 . . . . 74.53 110.283 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.05 112.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 64.42 109.845 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -71.25 -37.68 71.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 74.11 109.524 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.804 ' HA ' ' HG3' ' A' ' 4' ' ' PRO . 33.0 ptt180 -174.78 150.22 1.27 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.086 -0.961 . . . . 72.25 109.011 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.18 128.57 45.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.552 -0.749 . . . . 74.11 109.414 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -124.94 78.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.877 -0.416 . . . . 72.52 109.877 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.3 t70 49.56 82.86 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.29 -0.868 . . . . 72.44 112.416 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 -12.39 19.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.98 -0.628 . . . . 63.31 113.209 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 59.1 mtpt -115.38 158.27 22.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.567 0.223 . . . . 71.15 110.513 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.62 131.46 27.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.475 -0.329 . . . . 71.3 110.361 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.63 105.43 14.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.413 -0.588 . . . . 72.15 109.413 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -92.26 121.01 42.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.265 -0.425 . . . . 62.02 110.812 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.3 tp -97.88 108.55 21.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.754 -0.461 . . . . 75.13 109.754 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -82.42 134.42 35.23 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.038 -0.727 . . . . 73.32 109.038 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.34 -54.92 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.555 . . . . 70.31 111.165 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.647 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 24.4 t-20 68.89 -48.22 0.58 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.971 0.508 . . . . 73.23 111.971 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.9 -48.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.203 -0.523 . . . . 62.15 111.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -132.25 4.93 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.585 1.183 . . . . 72.45 108.985 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.647 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 26.4 t90 -103.12 172.7 6.67 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.725 -1.58 . . . . 64.41 109.828 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 3.3 p30 -154.08 153.79 32.5 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.272 -0.27 . . . . 75.02 110.272 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.51 ' HE2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -175.52 109.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.531 -0.759 . . . . 62.4 110.237 175.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.9 tp -97.68 109.97 22.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.176 -0.305 . . . . 72.24 110.176 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.3 t -134.76 129.64 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 70.12 109.932 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -90.13 135.14 33.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.251 0.548 . . . . 63.42 110.683 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -130.38 -176.36 3.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.701 -0.851 . . . . 64.25 108.701 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.083 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 68.4 mtt180 -87.48 168.43 13.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.455 -0.572 . . . . 74.45 109.455 174.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.36 -24.07 42.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.135 -0.691 . . . . 75.01 109.135 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -80.46 -20.42 43.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.171 -0.922 . . . . 75.33 110.58 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 1.083 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 10.4 mm-40 -85.83 -14.39 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.363 0.601 . . . . 71.35 110.409 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.0 mt -115.42 155.7 26.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.567 -0.742 . . . . 74.32 110.151 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.87 133.58 52.7 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.409 -0.589 . . . . 72.13 109.409 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.3 120.59 22.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.233 -0.44 . . . . 41.34 109.845 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 109.447 -0.575 . . . . 74.43 109.447 -179.731 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.4 mt . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.775 0.322 . . . . 75.52 110.451 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.69 159.92 69.77 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 115.898 -0.592 . . . . 73.25 109.751 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.84 127.76 23.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.504 2.136 . . . . 73.04 111.782 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.37 -5.68 52.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 71.05 112.618 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.7 146.28 26.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.63 0.253 . . . . 51.25 111.253 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 124.78 32.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.115 -0.493 . . . . 71.41 110.083 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.683 HG21 HD11 ' A' ' 52' ' ' LEU . 16.5 m -128.39 144.52 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 72.54 111.37 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.735 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 11.5 ttt85 -100.89 130.12 46.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.659 -0.701 . . . . 65.34 110.174 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.31 111.9 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.054 -0.721 . . . . 72.13 109.054 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -112.58 10.78 19.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.121 0.486 . . . . 64.43 111.806 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -82.35 112.73 19.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.784 -0.821 . . . . 65.33 108.784 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -66.56 -21.47 28.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.645 . . . . 71.11 111.431 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.81 -31.0 68.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.969 -0.56 . . . . 73.22 111.415 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.22 161.57 17.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 75.23 111.077 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 m -77.87 -23.29 48.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 75.54 111.53 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -88.63 20.41 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.654 0.264 . . . . 74.52 111.57 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -71.2 77.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 62.34 110.876 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 166.67 -30.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.02 -0.991 . . . . 70.44 109.675 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -78.38 151.21 32.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.678 -0.692 . . . . 74.45 111.539 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.735 ' HG2' ' HB2' ' A' ' 9' ' ' ARG . 29.3 mt-10 -125.38 122.95 38.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.094 -0.957 . . . . 74.22 109.509 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.77 -178.68 15.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.75 . . . . 72.35 112.472 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.07 135.94 42.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.764 0.316 . . . . 74.03 111.191 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.66 111.09 11.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.937 0.399 . . . . 71.35 110.04 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.84 -41.39 64.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.659 0.742 . . . . 62.3 109.669 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -164.95 138.53 4.81 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.575 -1.193 . . . . 73.31 109.569 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.501 HG11 HD23 ' A' ' 49' ' ' LEU . 60.3 t -95.21 139.77 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.396 -0.82 . . . . 55.34 109.77 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 6.0 t -130.43 63.29 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.475 -0.565 . . . . 62.53 109.475 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 16.25 81.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.291 1.436 . . . . 71.31 113.386 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.99 -41.83 1.87 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.673 -1.149 . . . . 71.05 110.672 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 51.7 mmtt -109.78 167.35 10.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.76 0.424 . . . . 71.34 110.195 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.4 139.06 9.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.211 -0.45 . . . . 51.13 110.147 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -90.9 114.57 27.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.942 -0.392 . . . . 65.03 109.942 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 52' ' ' LEU . 42.2 t -99.21 120.29 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 74.21 110.819 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.9 tp -97.65 114.52 26.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.566 -0.531 . . . . 62.04 109.566 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.4 141.97 30.46 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.95 -0.568 . . . . 73.1 109.925 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.49 113.94 11.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 72.2 109.648 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -142.39 79.71 1.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.062 0.458 . . . . 74.13 110.936 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.42 -104.04 2.12 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.848 -0.615 . . . . 71.24 112.656 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -96.78 -16.58 20.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.665 0.745 . . . . 64.12 109.625 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -95.04 141.17 29.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.211 -0.904 . . . . 75.23 111.239 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -153.39 150.91 29.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.88 -1.055 . . . . 75.31 109.527 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HE2' ' CG2' ' A' ' 45' ' ' VAL . 87.3 tttt -158.09 131.31 7.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.058 -0.519 . . . . 72.22 110.27 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' A' ' 33' ' ' ALA . 56.9 tp -99.81 110.7 23.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.358 -0.383 . . . . 71.13 110.3 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.447 ' CG2' ' HE2' ' A' ' 43' ' ' LYS . 40.2 t -124.27 120.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.981 0.419 . . . . 64.53 110.425 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.2 m -75.88 130.01 37.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.206 0.527 . . . . 73.4 110.493 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -125.28 -171.06 2.28 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.504 -0.771 . . . . 73.22 108.979 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.7 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 19.9 mtm180 -99.33 171.04 8.23 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.466 -0.568 . . . . 74.11 109.466 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.501 HD23 HG11 ' A' ' 27' ' ' VAL . 75.3 mt -76.6 -30.99 57.18 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.014 0.435 . . . . 64.22 110.039 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 p -71.58 -12.78 61.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.718 -0.674 . . . . 72.23 110.345 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.7 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 4.8 mm-40 -86.67 -14.68 41.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 73.3 110.744 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.683 HD11 HG21 ' A' ' 8' ' ' VAL . 79.7 mt -110.74 130.67 55.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.283 0.563 . . . . 74.3 112.403 -168.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -109.89 116.0 30.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.35 -0.841 . . . . 75.31 109.081 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 131.35 50.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.343 . . . . 74.35 110.485 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 109.245 -0.65 . . . . 72.12 109.245 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.575 HG12 ' HB3' ' A' ' 54' ' ' ALA . 48.1 mt . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 109.796 -0.446 . . . . 71.01 109.796 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -119.64 153.08 54.14 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.056 -0.52 . . . . 75.02 110.753 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.17 130.81 28.28 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.619 2.213 . . . . 74.32 111.463 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 103.39 -13.1 54.8 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 74.03 112.16 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 150.63 24.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 64.0 111.232 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -87.24 130.27 34.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.716 -0.674 . . . . 72.0 109.882 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 54' ' ' ALA . 22.9 m -128.93 152.29 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.898 0.38 . . . . 75.21 110.601 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HD2' ' OE2' ' A' ' 53' ' ' GLU . 44.7 ttm180 -110.46 138.05 47.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.246 -0.65 . . . . 73.12 109.246 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.5 t -76.25 113.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.907 0.384 . . . . 70.54 110.818 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -96.87 2.32 51.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 74.4 110.577 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.8 115.26 11.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.528 -0.76 . . . . 65.02 110.32 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.77 -8.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.422 0.63 . . . . 71.42 110.471 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.37 -37.81 88.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 64.35 110.637 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.468 ' OD2' ' HD2' ' A' ' 17' ' ' TYR . 13.6 t70 -103.45 173.47 6.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 72.23 109.877 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -88.94 -12.1 42.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.713 0.264 . . . . 73.31 111.713 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 58.4 m-85 -79.27 30.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 73.41 112.068 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 86.2 t80 -70.54 138.31 50.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 75.4 109.432 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 41.3 mtt180 70.59 18.96 6.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.506 0.504 . . . . 74.44 112.049 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -93.73 150.74 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 72.41 110.522 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -103.57 121.52 43.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.221 -0.9 . . . . 73.11 109.341 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.84 162.84 23.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.508 -0.853 . . . . 63.11 112.318 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.435 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.6 tt -116.74 123.69 47.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.703 -0.48 . . . . 65.44 109.703 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' A' ' 32' ' ' ALA . 75.6 t -65.74 114.85 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 72.24 110.954 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -79.21 -35.46 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.366 0.603 . . . . 63.45 110.145 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -165.68 154.47 11.66 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.136 -0.938 . . . . 72.42 108.923 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.75 126.36 68.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.535 -0.757 . . . . 72.13 109.305 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.7 t -125.43 84.98 2.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.55 -0.296 . . . . 71.02 110.8 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 40.59 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.263 0.977 . . . . 52.05 112.969 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.09 -29.9 9.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.586 -0.816 . . . . 71.34 112.804 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HB3' HG23 ' A' ' 46' ' ' THR . 41.4 mttt -109.71 163.82 13.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.995 0.426 . . . . 71.24 111.379 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 24' ' ' VAL . . . -143.7 137.14 27.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 71.32 109.93 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -83.82 105.34 14.64 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.961 -0.385 . . . . 71.13 109.961 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.77 118.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.18 -0.463 . . . . 72.31 110.925 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.34 118.79 31.71 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.638 -0.504 . . . . 73.42 109.638 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -86.76 147.35 25.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.941 -0.572 . . . . 74.24 109.93 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -135.54 119.99 18.03 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 71.23 108.988 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -138.97 42.26 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.565 0.697 . . . . 72.22 110.046 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.18 -102.54 2.42 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 44.45 111.671 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -93.29 -32.87 14.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.211 0.529 . . . . 72.41 109.793 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -74.96 140.63 43.81 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.491 -0.777 . . . . 73.32 111.007 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.9 165.62 27.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.66 -1.155 . . . . 74.04 108.77 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -164.7 137.93 4.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.144 -0.317 . . . . 72.31 110.144 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 33' ' ' ALA . 47.8 tp -109.16 109.24 20.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.809 0.338 . . . . 73.1 110.178 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -124.44 124.06 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.064 0.459 . . . . 74.0 110.265 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -87.33 111.13 20.76 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.393 0.616 . . . . 73.22 110.796 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.78 178.1 4.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.245 -0.889 . . . . 70.43 109.455 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.731 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 54.0 mtt85 -88.9 159.19 17.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.706 -0.479 . . . . 71.12 109.706 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.0 mt -71.45 -26.91 62.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.343 0.592 . . . . 74.11 109.792 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 p -80.0 -12.03 59.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.289 -0.869 . . . . 71.41 109.994 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.731 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.5 mt-10 -98.93 3.08 47.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.838 -0.619 . . . . 74.5 110.558 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.01 153.55 46.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 71.43 110.361 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 9' ' ' ARG . 11.7 pt-20 -118.28 123.14 44.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 74.22 109.28 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.717 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -78.5 123.86 27.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.319 -0.4 . . . . 73.33 110.03 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 108.899 -0.778 . . . . 63.31 108.899 177.825 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.487 HG12 ' HB1' ' A' ' 54' ' ' ALA . 41.1 mt . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.234 0.54 . . . . 73.44 111.444 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -130.77 154.64 81.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 75.41 109.714 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.82 119.15 6.11 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.354 2.036 . . . . 75.43 111.425 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.24 -3.83 31.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 43.43 111.949 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.15 153.77 19.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 73.02 110.811 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -91.82 132.44 36.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.564 . . . . 72.42 110.29 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.64 160.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.0 0.428 . . . . 64.31 110.828 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -124.81 130.59 52.69 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.884 -0.784 . . . . 72.23 108.884 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.2 t -68.73 108.81 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.155 0.503 . . . . 65.33 110.767 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -88.13 -17.98 29.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.484 -0.78 . . . . 72.11 110.416 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 42.7 t30 -66.85 106.99 2.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 71.22 110.573 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.22 -24.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 74.14 110.54 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.01 -27.09 67.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.362 -0.835 . . . . 71.14 111.189 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.474 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 11.2 t70 -85.86 164.94 17.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.2 -0.455 . . . . 63.01 110.766 -176.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -82.65 -23.77 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.346 -0.388 . . . . 72.33 110.705 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.38 21.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.949 0.404 . . . . 72.21 111.026 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 29.9 t80 -63.19 133.04 53.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.032 -0.531 . . . . 73.33 110.268 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 62.8 mtt180 76.66 3.23 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.621 0.768 . . . . 72.34 112.22 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.5 157.21 21.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.885 0.374 . . . . 75.35 110.251 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -118.05 141.94 47.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 72.32 110.122 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.55 165.19 33.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.551 -0.833 . . . . 54.42 111.793 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -104.43 131.52 51.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 110.26 -0.274 . . . . 73.23 110.26 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 27' ' ' VAL . 59.9 t -70.46 117.08 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.023 -0.535 . . . . 74.02 110.199 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 29.3 mm-40 -83.33 -31.7 26.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.496 0.665 . . . . 75.34 110.279 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -158.18 128.55 6.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.96 -1.018 . . . . 73.33 110.373 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 24' ' ' VAL . 57.8 t -98.38 120.14 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.572 -0.74 . . . . 75.42 110.036 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.5 m -102.09 -178.86 3.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.053 -0.721 . . . . 74.31 109.053 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.18 81.93 3.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.342 0.592 . . . . 70.22 110.069 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 121.84 -31.24 5.04 Favored Glycine 0 C--N 1.318 -0.444 0 CA-C-N 115.364 -0.834 . . . . 74.11 112.447 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -120.28 159.79 24.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.868 0.366 . . . . 52.35 111.262 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.0 135.92 36.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.047 -0.524 . . . . 75.51 109.812 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -89.19 109.36 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.909 0.385 . . . . 37.46 110.263 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.0 126.58 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 64.43 110.423 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 34.4 tp -90.79 123.61 34.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 74.54 110.666 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 88.6 m-85 -107.85 134.0 51.41 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.55 -0.907 . . . . 74.11 108.55 171.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -143.05 128.69 19.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.972 0.415 . . . . 72.12 110.392 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -134.31 74.9 1.56 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.415 -0.587 . . . . 60.44 109.415 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.34 -97.82 0.35 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.684 -0.689 . . . . 40.01 112.554 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.55 -22.5 24.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.266 0.555 . . . . 71.21 110.201 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.447 ' HZ2' ' HD2' ' A' ' 43' ' ' LYS . 87.1 t90 -91.75 146.93 23.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 74.04 110.983 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -150.27 159.07 44.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.442 -0.799 . . . . 63.15 110.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 11.9 mttm -163.88 133.49 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.688 -0.687 . . . . 63.45 110.828 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.7 tp -106.3 104.12 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.523 . . . . 71.24 109.587 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.433 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 29.0 t -113.53 118.04 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.071 0.463 . . . . 74.44 110.411 -176.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.4 m -82.81 130.28 35.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.875 -0.602 . . . . 64.14 110.469 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.468 ' HB2' HD11 ' A' ' 52' ' ' LEU . 91.2 m-85 -123.13 178.97 4.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.607 -0.724 . . . . 61.24 109.062 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 57.7 mtp180 -96.63 162.83 13.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.048 0.451 . . . . 72.54 110.563 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.408 HD22 HD11 ' A' ' 2' ' ' ILE . 94.4 mt -76.3 -22.92 54.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.929 -0.578 . . . . 55.24 110.41 -173.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 p -85.76 -8.26 58.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 70.15 109.92 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.7 mt-10 -98.89 -8.31 25.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 64.42 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 10' ' ' VAL . 57.1 mt -124.15 151.61 43.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.85 -0.614 . . . . 71.14 110.45 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 147.97 37.17 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.203 -0.665 . . . . 74.44 109.203 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB1' HG12 ' A' ' 2' ' ' ILE . . . -89.27 126.9 35.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.043 0.449 . . . . 61.21 110.937 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.321 -0.638 0 N-CA-C 108.018 -1.105 . . . . 71.53 108.018 175.541 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--O 1.232 0.165 0 N-CA-C 109.946 -0.39 . . . . 74.33 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -133.94 152.65 78.96 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.193 -0.458 . . . . 73.04 110.726 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HG3' ' H ' ' A' ' 27' ' ' VAL . 24.1 Cg_exo -64.4 123.1 11.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.73 2.287 . . . . 73.45 111.565 176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.58 -0.81 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.017 -0.611 . . . . 60.41 112.089 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.88 145.41 32.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.848 0.356 . . . . 70.04 111.043 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -84.93 131.18 34.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.757 -0.656 . . . . 73.21 110.021 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 54' ' ' ALA . 32.7 m -129.46 150.85 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.778 0.323 . . . . 62.14 110.832 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 9' ' ' ARG . 17.3 ttt85 -104.33 134.83 46.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.856 -0.424 . . . . 62.43 109.856 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 52' ' ' LEU . 49.0 t -60.9 114.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.284 -0.416 . . . . 75.13 110.131 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -98.05 -9.73 25.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.39 0.614 . . . . 73.4 110.184 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 36.0 t30 -74.25 113.89 11.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 74.24 110.556 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.46 -26.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 60.13 110.889 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.64 -30.25 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 62.42 111.408 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -75.37 158.49 32.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 65.23 111.418 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -90.42 -12.31 37.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.817 -0.628 . . . . 71.44 110.938 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -98.51 21.4 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 72.25 110.169 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 48.1 t80 -66.63 80.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.7 . . . . 64.13 111.3 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 12.7 ptm180 165.22 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.728 -1.124 . . . . 75.35 109.206 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -76.73 152.44 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.491 0.662 . . . . 75.25 111.854 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -119.42 109.78 16.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.856 -1.065 . . . . 74.34 109.232 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.05 174.89 15.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.726 -0.75 . . . . 44.44 112.565 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 23' ' ' LEU . 1.2 tm? -102.38 126.54 49.43 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.592 -0.521 . . . . 54.42 109.592 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.0 t -78.3 112.44 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.263 -0.273 . . . . 75.44 110.263 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -79.11 -34.39 43.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.956 0.407 . . . . 74.24 110.551 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -164.01 134.63 4.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.899 -0.591 . . . . 74.12 110.41 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.429 ' H ' ' HG3' ' A' ' 4' ' ' PRO . 96.9 t -91.58 123.3 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.386 -0.825 . . . . 75.22 109.096 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.6 t -126.91 91.36 3.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.702 0.286 . . . . 64.1 110.765 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 49.94 75.88 0.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 53.42 112.586 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.33 -20.99 6.42 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.06 -0.59 . . . . 43.11 113.404 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.563 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 55.8 mtpt -110.48 165.48 11.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.767 -0.255 . . . . 73.2 110.607 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB3' HD23 ' A' ' 49' ' ' LEU . . . -142.79 141.25 31.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 72.03 110.48 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.14 107.8 19.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.578 -0.527 . . . . 70.11 109.578 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.8 t -102.85 118.87 50.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.974 -0.557 . . . . 74.11 110.897 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.68 119.28 31.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.837 -0.619 . . . . 64.4 110.74 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 47.3 m-85 -89.59 134.12 34.28 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.594 -1.262 . . . . 71.55 107.594 169.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -149.38 124.39 10.02 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.934 -0.395 . . . . 72.12 109.934 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.12 86.09 1.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 74.2 110.667 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.7 -93.73 0.94 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.625 -0.716 . . . . 75.04 113.516 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -91.63 -21.97 20.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.869 0.366 . . . . 72.0 111.217 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t90 -111.07 143.5 41.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.315 0.578 . . . . 73.04 111.857 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 4.2 p-10 -147.99 153.06 38.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.664 -1.153 . . . . 74.14 109.176 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HG3' HG21 ' A' ' 45' ' ' VAL . 57.1 tptt -160.39 111.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.169 -0.469 . . . . 73.42 110.594 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -92.09 104.71 17.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 71.51 110.082 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.404 HG21 ' HG3' ' A' ' 43' ' ' LYS . 21.1 t -117.88 125.74 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 55.45 109.958 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.458 HG23 ' HE2' ' A' ' 31' ' ' LYS . 4.4 m -85.03 130.83 34.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.076 -0.511 . . . . 64.43 110.607 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HB2' HD12 ' A' ' 52' ' ' LEU . 88.1 m-85 -126.53 -175.27 3.34 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.684 -0.689 . . . . 70.23 109.772 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.873 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 15.8 mmt180 -88.91 161.33 16.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.445 . . . . 73.55 109.8 174.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 32' ' ' ALA . 94.0 mt -83.41 -27.03 29.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.56 0.695 . . . . 74.52 109.343 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -76.45 -10.17 59.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.066 -0.97 . . . . 74.55 110.8 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.873 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 19.1 pt-20 -117.22 16.57 14.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.367 -0.533 . . . . 74.43 111.278 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.716 HD12 ' HB2' ' A' ' 47' ' ' PHE . 95.8 mt -131.86 154.35 49.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.857 -0.611 . . . . 71.3 109.97 175.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -149.06 141.37 24.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.624 -0.51 . . . . 73.52 109.624 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.3 138.34 51.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 64.35 111.594 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.544 -0.753 . . . . 64.14 109.057 177.555 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.281 0.563 . . . . 73.11 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -95.19 139.78 22.16 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 75.13 110.752 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.67 137.94 43.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.636 2.224 . . . . 73.52 111.458 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.22 4.37 64.58 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.844 -0.694 . . . . 72.21 111.799 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.44 161.68 13.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.617 0.246 . . . . 72.33 110.446 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -87.43 131.26 34.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.091 -0.504 . . . . 75.14 110.239 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.69 150.29 34.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 73.43 111.055 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.9 ttp180 -117.41 142.22 47.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.754 -0.657 . . . . 73.24 109.366 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.8 t -77.86 105.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.742 -0.466 . . . . 72.43 109.742 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -89.52 -4.21 58.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 72.33 111.053 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.607 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 58.0 t30 -69.38 102.86 1.85 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.7 -0.482 . . . . 73.31 109.7 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.505 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 22.4 t -63.03 -35.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.73 . . . . 54.21 112.14 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.96 -10.94 59.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.027 0.441 . . . . 71.01 111.597 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.607 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 5.6 t70 -84.4 160.37 20.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.012 -0.43 . . . . 72.24 110.7 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 m -71.06 -32.37 69.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 74.31 110.507 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 91.2 m-85 -87.86 21.13 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 73.32 111.25 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.505 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 32.9 t80 -59.27 132.25 53.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.02 0.438 . . . . 75.52 111.146 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 74.81 -3.8 2.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.924 -1.034 . . . . 65.33 111.917 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -77.78 149.87 34.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 75.34 109.652 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 37.1 mt-10 -125.34 136.2 53.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.55 . . . . 70.04 110.726 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.12 -171.24 17.62 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.009 -0.836 . . . . 73.34 111.009 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.9 mp -112.85 150.8 31.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.431 0.616 . . . . 71.3 110.923 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.01 115.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 75.34 110.231 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -79.58 -28.24 41.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 75.21 110.71 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -170.28 133.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 72.42 110.665 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.536 HG12 HD23 ' A' ' 49' ' ' LEU . 58.0 t -93.88 135.4 28.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.318 -0.855 . . . . 72.24 109.786 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t -107.34 -159.94 0.71 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.929 -0.397 . . . . 75.3 109.929 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.8 -33.83 72.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.525 0.678 . . . . 71.32 111.709 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.16 -12.46 0.06 OUTLIER Glycine 0 C--N 1.31 -0.865 0 CA-C-N 114.791 -1.095 . . . . 54.43 112.319 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 63.8 mttp -104.27 172.09 6.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.844 0.354 . . . . 71.35 111.255 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.11 140.87 21.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 73.53 110.03 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.61 111.73 22.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.692 -0.484 . . . . 73.52 109.692 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 40.1 t -104.17 122.77 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 63.44 111.067 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.46 121.59 31.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.131 -0.486 . . . . 75.22 110.269 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.452 ' CE2' ' HE2' ' A' ' 47' ' ' PHE . 96.4 m-85 -101.41 151.96 21.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.993 -0.549 . . . . 71.43 110.244 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -122.32 -63.46 1.28 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.891 -0.595 . . . . 75.44 110.168 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.08 -57.32 0.42 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.538 0.735 . . . . 73.45 111.525 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . 158.35 102.55 0.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.904 -0.878 . . . . 72.13 110.904 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 24.9 t30 75.09 -40.59 0.44 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.422 0.689 . . . . 74.33 110.623 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.437 ' H ' ' C ' ' A' ' 39' ' ' GLY . 43.5 t90 -64.26 154.68 34.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.521 -0.763 . . . . 70.22 110.7 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -152.62 143.7 23.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.099 0.476 . . . . 74.34 109.882 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -168.22 125.25 1.08 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.568 -0.742 . . . . 74.11 109.904 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -100.09 102.55 13.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.3 -0.63 . . . . 71.41 109.3 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.35 120.04 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.061 -0.518 . . . . 53.21 110.609 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.23 129.25 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.942 -0.572 . . . . 72.4 110.269 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HE2' ' CE2' ' A' ' 36' ' ' PHE . 45.2 m-85 -126.99 -174.37 3.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.938 -0.574 . . . . 72.23 109.542 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 33.5 mtt180 -103.93 162.13 13.39 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.462 -0.57 . . . . 72.15 109.462 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.536 HD23 HG12 ' A' ' 27' ' ' VAL . 90.4 mt -73.06 -33.8 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.261 -0.427 . . . . 71.54 110.508 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -73.44 -16.08 61.32 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.751 -0.659 . . . . 70.43 110.579 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 3.5 mp0 -89.95 -8.85 50.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.827 -0.624 . . . . 74.04 111.387 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.88 157.39 25.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.341 -0.391 . . . . 74.51 111.391 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.54 148.42 52.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.045 -0.724 . . . . 74.01 109.045 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.37 121.73 21.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.995 0.426 . . . . 71.35 110.067 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.194 -0.669 . . . . 72.41 109.194 177.776 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.439 ' O ' HG21 ' A' ' 27' ' ' VAL . 48.8 mt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.341 -0.614 . . . . 74.45 109.341 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -115.79 149.24 42.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.595 0.236 . . . . 74.42 110.98 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.13 142.79 93.33 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.607 2.205 . . . . 64.25 111.744 176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.58 -7.85 65.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.975 -0.631 . . . . 54.22 112.128 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 143.6 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.929 0.395 . . . . 75.15 110.864 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -80.59 125.03 29.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 74.12 109.907 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 54' ' ' ALA . 17.6 m -130.1 148.22 33.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.314 0.578 . . . . 63.42 111.349 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -111.76 133.85 53.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.285 -0.87 . . . . 63.32 109.3 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.3 t -80.08 101.17 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.576 -0.527 . . . . 75.42 109.576 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -103.31 13.7 33.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.895 -0.593 . . . . 64.45 110.526 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.9 t30 -61.6 107.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.533 -0.914 . . . . 71.43 108.533 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.84 -47.04 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 74.12 112.298 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.58 40.57 1.18 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.363 0.602 . . . . 71.53 110.537 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 6.1 t70 -110.44 161.13 15.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.129 -0.487 . . . . 74.41 110.111 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -81.14 -23.17 38.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.591 . . . . 70.31 110.104 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CD1' ' HZ ' ' A' ' 47' ' ' PHE . 73.7 m-85 -98.66 24.72 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 75.32 110.848 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 46.0 t80 -62.44 127.88 33.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.954 -0.566 . . . . 74.35 110.023 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 17.4 mtp180 76.12 10.54 3.09 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.057 0.848 . . . . 72.02 112.308 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -87.66 148.26 24.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.425 -0.583 . . . . 71.55 109.425 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -128.73 142.48 50.99 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.702 -0.681 . . . . 73.04 110.401 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -166.96 -169.03 30.03 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.82 -0.705 . . . . 53.41 111.709 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.77 136.66 52.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.716 0.293 . . . . 72.22 110.914 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.36 122.91 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 62.33 109.654 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.403 ' HG3' HD12 ' A' ' 44' ' ' LEU . 31.2 mm-40 -89.4 -33.09 16.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.285 0.564 . . . . 71.14 110.177 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -169.03 136.55 1.88 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.289 -0.869 . . . . 74.45 110.204 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 29' ' ' ASP . 43.7 t -103.35 142.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.485 -0.78 . . . . 74.23 109.689 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 t -121.91 34.8 5.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.078 0.466 . . . . 73.55 109.868 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.601 ' H ' HG12 ' A' ' 27' ' ' VAL . 24.4 m-20 50.04 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.953 -1.021 . . . . 73.51 111.533 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.29 -46.26 1.19 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.842 -0.903 . . . . 53.11 110.842 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 30.5 mtpp -112.28 161.02 17.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.844 -0.428 . . . . 75.0 109.844 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.55 142.63 21.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.751 -0.204 . . . . 51.44 110.556 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -91.67 115.48 28.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 75.23 109.593 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.637 HG21 HD23 ' A' ' 52' ' ' LEU . 18.3 t -100.67 124.79 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.119 -0.491 . . . . 73.52 110.594 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.6 tp -94.92 107.29 19.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 73.2 109.579 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.488 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 81.4 m-85 -86.63 142.33 28.33 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.16 -0.682 . . . . 71.5 109.16 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -140.1 131.32 26.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.96 0.41 . . . . 71.51 110.449 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.47 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 3.2 t-20 -141.14 91.07 2.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 72.12 108.951 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.66 -114.61 4.04 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.651 -0.704 . . . . 71.0 111.774 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -89.87 -30.24 18.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.622 0.725 . . . . 71.35 109.079 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.47 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 65.8 t90 -72.27 138.9 47.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.994 -1.003 . . . . 75.24 111.556 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.14 155.17 44.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.824 -1.08 . . . . 65.03 109.181 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.439 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 76.4 tttt -153.97 120.18 5.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.458 -0.337 . . . . 71.44 110.516 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 33' ' ' ALA . 62.6 tp -93.88 110.4 22.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 73.13 110.566 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.488 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 25.3 t -126.2 127.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.014 -0.539 . . . . 71.24 109.799 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.5 m -83.26 133.0 35.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.247 0.546 . . . . 63.52 110.826 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.461 ' HZ ' ' CD1' ' A' ' 17' ' ' TYR . 55.7 m-85 -131.83 -160.15 1.02 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.425 -0.807 . . . . 70.1 109.656 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.784 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 63.7 mtm180 -109.08 173.66 6.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.77 -0.455 . . . . 75.34 109.77 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 HG11 ' A' ' 27' ' ' VAL . 95.5 mt -81.45 -28.56 34.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.116 0.484 . . . . 72.41 109.912 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 p -68.9 -17.86 64.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.675 -0.693 . . . . 55.22 110.178 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.784 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.3 mm-40 -86.62 -13.07 46.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.865 -0.607 . . . . 73.11 110.622 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.637 HD23 HG21 ' A' ' 34' ' ' VAL . 87.5 mt -112.73 140.93 47.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 73.21 112.144 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -117.0 112.8 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.699 -0.682 . . . . 63.34 109.714 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.416 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -65.78 134.26 52.76 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.865 -0.421 . . . . 55.11 109.865 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 109.586 -0.524 . . . . 52.54 109.586 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.581 HD12 HD22 ' A' ' 49' ' ' LEU . 72.7 mt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 74.41 110.18 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -131.16 146.09 60.55 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.309 -0.405 . . . . 73.31 110.639 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.77 125.6 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.54 2.16 . . . . 73.44 111.207 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.12 -3.0 47.57 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.051 -0.595 . . . . 62.31 112.026 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.38 154.94 18.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.74 0.305 . . . . 75.44 110.825 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -88.43 134.79 33.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.765 -0.652 . . . . 71.41 110.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.478 HG21 HD13 ' A' ' 52' ' ' LEU . 16.3 m -124.22 153.56 30.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.426 . . . . 72.54 110.702 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HD3' ' OE2' ' A' ' 53' ' ' GLU . 53.8 ttt180 -110.98 119.87 40.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.699 -0.682 . . . . 74.41 109.73 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 25.8 t -76.15 98.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.005 0.431 . . . . 63.41 110.249 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -105.8 13.83 29.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.313 -0.403 . . . . 72.41 111.273 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 54.3 t30 -62.8 112.65 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 63.45 109.671 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.518 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 23.5 t -69.54 -27.92 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 74.53 111.411 -172.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -100.39 40.36 1.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.817 0.818 . . . . 71.34 109.395 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 3.7 t70 -119.47 -174.53 2.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.511 -0.768 . . . . 73.33 110.671 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -109.59 -28.85 8.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.967 -0.56 . . . . 75.41 110.241 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 92.6 m-85 -101.07 38.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.098 -0.501 . . . . 72.21 111.151 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.671 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 10.1 t80 -59.35 126.3 27.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.742 -0.663 . . . . 75.41 110.263 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.671 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 87.1 mtt180 80.09 4.05 1.93 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.097 0.959 . . . . 72.51 112.681 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -83.71 149.09 26.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.46 . . . . 71.22 110.153 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.29 125.46 43.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.606 -0.724 . . . . 71.41 110.221 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.61 171.67 23.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.844 -0.693 . . . . 61.45 111.754 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.21 124.88 46.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.867 0.365 . . . . 74.51 110.976 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.03 119.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.88 -0.6 . . . . 73.13 110.313 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -77.86 -36.71 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.3 0.571 . . . . 74.21 109.854 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -170.03 143.0 2.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.063 -0.971 . . . . 72.21 109.408 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.22 92.85 2.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.605 -0.725 . . . . 75.22 109.373 174.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -103.54 114.12 28.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.277 -0.42 . . . . 64.24 111.12 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 61.67 37.68 15.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.427 -0.806 . . . . 64.12 111.624 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.44 6.14 89.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.609 -0.805 . . . . 53.54 112.772 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -117.4 144.74 44.65 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.305 -0.628 . . . . 62.22 109.305 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 124.25 51.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.764 0.316 . . . . 75.12 111.113 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -81.93 101.09 10.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.241 -0.652 . . . . 64.12 109.241 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.97 121.36 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 71.13 110.874 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.33 126.74 36.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.8 -0.636 . . . . 71.32 110.493 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.11 143.7 39.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 74.51 110.409 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.78 129.19 27.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.395 -0.821 . . . . 74.54 109.126 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -135.86 87.53 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.717 0.294 . . . . 71.13 110.291 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.18 -77.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.962 -0.563 . . . . 71.41 112.576 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -128.39 -4.79 5.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.78 . . . . 54.24 109.17 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -89.98 138.25 31.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 73.21 111.022 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.33 146.23 49.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.067 -0.969 . . . . 64.34 109.787 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -166.28 136.49 3.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.049 0.452 . . . . 72.22 111.156 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 33' ' ' ALA . 54.0 tp -106.48 109.49 21.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 75.35 110.128 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.25 117.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.913 0.387 . . . . 72.24 110.293 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.3 m -78.6 127.94 32.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 74.44 110.643 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.64 179.01 4.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.772 -0.649 . . . . 73.42 110.173 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HD3' ' HG2' ' A' ' 51' ' ' GLU . 2.2 mpt_? -98.77 154.83 17.7 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.66 -0.867 . . . . 74.32 108.66 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 2' ' ' ILE . 84.5 mt -72.82 -32.86 65.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.45 0.643 . . . . 73.44 109.388 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 p -71.03 -12.21 61.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.994 -1.003 . . . . 61.44 110.764 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 2.9 mp0 -108.02 7.15 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.791 -0.641 . . . . 73.34 111.589 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 8' ' ' VAL . 93.0 mt -121.97 146.22 47.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.111 0.481 . . . . 73.14 111.591 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.476 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 40.0 tt0 -102.48 108.43 19.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.838 -0.801 . . . . 40.34 108.838 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.11 22.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.181 -0.463 . . . . 65.23 110.015 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.234 -0.439 . . . . 65.52 109.827 -178.99 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.439 HD12 HD23 ' A' ' 49' ' ' LEU . 54.3 mt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.342 -0.614 . . . . 74.32 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.08 146.62 51.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.438 0.161 . . . . 74.5 110.609 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.97 127.79 27.53 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.762 2.308 . . . . 75.55 111.902 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.84 0.29 39.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.834 -0.698 . . . . 55.42 112.187 -176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.41 135.38 34.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.649 0.262 . . . . 64.33 110.48 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -83.12 125.07 31.1 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.591 -0.522 . . . . 64.12 109.591 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 54' ' ' ALA . 17.0 m -122.18 143.39 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.221 -0.445 . . . . 71.33 111.014 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -98.77 129.54 45.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.005 -0.543 . . . . 72.41 109.702 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.84 120.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.078 -0.341 . . . . 74.45 110.078 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -116.29 8.85 14.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 71.34 110.303 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -74.21 106.83 6.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.749 -0.834 . . . . 74.41 108.749 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.76 -21.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 112.846 0.684 . . . . 75.41 112.846 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.14 -32.12 21.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.442 . . . . 72.31 110.612 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.19 158.24 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 71.23 111.824 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -81.43 -24.19 37.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.46 -0.791 . . . . 74.33 111.279 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -92.68 21.2 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 74.24 110.61 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.526 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 42.9 t80 -70.49 77.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 74.51 111.293 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.526 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 9.7 ptp85 163.58 -22.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.59 1.156 . . . . 74.51 108.633 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -77.98 154.73 31.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.35 -0.841 . . . . 74.45 111.224 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -125.02 127.85 47.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.2 -0.909 . . . . 63.51 109.298 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.96 168.17 21.43 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.529 -0.843 . . . . 73.41 112.228 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.47 126.37 41.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.639 0.257 . . . . 73.5 110.473 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.494 HG11 HG23 ' A' ' 27' ' ' VAL . 59.1 t -67.96 119.8 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 74.21 110.132 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.05 -30.38 22.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.828 -0.623 . . . . 62.41 110.578 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -164.31 143.15 7.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 75.23 109.63 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 24' ' ' VAL . 40.0 t -114.69 142.33 27.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.214 -0.903 . . . . 71.32 110.369 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 p -132.42 -175.56 3.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.658 -0.497 . . . . 63.14 109.658 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.74 75.35 4.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 72.4 110.517 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.43 -27.16 5.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.536 -0.756 . . . . 72.23 112.586 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 47.7 mtmt -120.11 162.23 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.693 0.282 . . . . 74.11 111.34 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.04 143.78 21.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 72.11 110.561 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.83 115.37 27.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.83 -0.433 . . . . 64.11 109.83 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.88 128.99 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 71.34 110.814 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.2 tp -102.34 120.06 39.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 73.43 110.934 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -104.9 146.37 29.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.841 -0.618 . . . . 73.52 109.532 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -149.27 127.41 12.03 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.28 -0.267 . . . . 71.34 110.28 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.72 85.71 1.9 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 54.22 109.666 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.0 -105.11 1.54 Allowed Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.602 -0.727 . . . . 62.2 112.159 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -87.56 -32.17 19.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.204 0.525 . . . . 73.1 110.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -75.93 138.53 41.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.592 -0.731 . . . . 73.31 111.272 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.11 155.99 44.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.824 -1.08 . . . . 71.45 108.813 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.577 ' HG3' HG23 ' A' ' 45' ' ' VAL . 41.9 tptt -155.94 108.8 2.66 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.664 -0.415 . . . . 73.54 111.247 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.23 109.57 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.389 -0.597 . . . . 71.43 109.389 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 43' ' ' LYS . 46.1 t -130.28 131.99 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 72.4 110.247 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -83.29 126.54 32.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.067 0.46 . . . . 71.23 110.682 177.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -123.25 -170.34 2.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.765 -0.828 . . . . 74.51 108.765 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 1.024 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mtt180 -95.03 176.96 6.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.325 -0.621 . . . . 73.42 109.325 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.474 HD21 HG11 ' A' ' 27' ' ' VAL . 97.3 mt -84.1 -32.01 24.98 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.038 -0.727 . . . . 71.51 109.038 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 p -71.21 -19.63 62.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.087 -0.96 . . . . 62.15 110.862 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 1.024 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.0 mm-40 -85.54 -7.84 58.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 72.52 110.81 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.58 HD13 HG22 ' A' ' 8' ' ' VAL . 73.4 mt -116.85 138.47 51.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.094 0.473 . . . . 73.11 111.751 -172.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.68 104.46 16.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.094 -1.076 . . . . 64.33 108.094 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.789 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.08 107.86 3.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.25 -0.432 . . . . 63.11 110.838 -176.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.63 0 N-CA-C 108.877 -0.786 . . . . 72.1 108.877 177.695 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.936 -0.394 . . . . 74.23 109.936 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -117.72 141.21 28.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.512 -0.313 . . . . 74.31 110.864 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.6 137.2 62.8 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.492 2.128 . . . . 51.4 110.975 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 74.44 112.018 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.82 165.76 12.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.881 0.372 . . . . 72.34 110.706 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -93.31 138.95 31.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.092 -0.504 . . . . 74.4 110.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 52' ' ' LEU . 6.7 m -130.65 148.06 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 65.43 111.083 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.629 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 34.2 ttm180 -109.97 141.81 42.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.838 -0.619 . . . . 71.52 109.483 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 55.4 t -79.54 110.56 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 64.23 110.019 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -91.29 -11.78 37.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.718 -0.674 . . . . 74.42 111.159 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.23 106.33 1.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.182 -0.463 . . . . 74.21 109.808 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.34 -24.16 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 75.23 111.375 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.98 -8.13 52.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.867 -0.606 . . . . 72.32 110.759 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.05 165.22 16.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.919 0.39 . . . . 61.13 110.445 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 m -72.16 -35.96 69.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 72.32 111.893 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.498 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -94.97 27.97 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 74.01 111.689 -172.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 45.5 t80 -61.86 130.97 48.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 64.44 110.038 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.6 mtm180 77.82 6.04 2.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.827 0.851 . . . . 72.14 111.833 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -96.33 148.29 22.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.832 -0.433 . . . . 71.4 109.832 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.629 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 33.5 mt-10 -127.92 128.15 44.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 74.05 110.245 -175.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.49 -177.11 14.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.939 -0.648 . . . . 72.42 112.335 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.89 132.48 49.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.491 0.186 . . . . 75.21 110.555 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.74 111.85 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.153 -0.314 . . . . 75.52 110.153 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -78.08 -34.98 49.95 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.192 -0.67 . . . . 74.43 109.192 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.28 136.59 0.37 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.325 -0.852 . . . . 65.23 110.16 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.9 108.56 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.645 -0.872 . . . . 71.21 108.645 172.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 t -152.47 142.62 22.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.523 -0.308 . . . . 53.42 111.056 -172.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.79 18.95 10.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.457 -0.792 . . . . 63.11 111.386 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 -1.15 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.927 -0.654 . . . . 72.33 112.81 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 26.2 mtmt -124.09 174.28 7.74 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.629 0.372 . . . . 72.45 110.118 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.07 129.92 28.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.622 0.249 . . . . 65.21 110.446 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -86.52 115.01 23.73 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.705 -0.48 . . . . 51.33 109.705 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.422 HG23 HD23 ' A' ' 52' ' ' LEU . 55.9 t -98.53 119.09 46.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.285 0.564 . . . . 73.54 110.648 -177.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.6 tp -89.81 118.78 29.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.546 -0.752 . . . . 74.21 110.072 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.77 137.43 33.87 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.929 -0.767 . . . . 72.44 108.929 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -156.41 108.59 2.53 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.71 -0.848 . . . . 74.33 108.71 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -136.89 100.88 4.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 64.05 110.84 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.96 -77.81 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.583 -0.735 . . . . 72.21 112.471 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -127.27 -17.41 4.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.205 0.526 . . . . 73.44 110.385 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -88.76 138.24 31.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.786 -0.643 . . . . 75.15 111.683 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.9 143.6 47.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.712 -1.131 . . . . 64.44 109.741 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -167.61 120.45 0.92 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.919 0.39 . . . . 73.53 110.631 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.18 109.72 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.304 -0.407 . . . . 71.54 110.032 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.19 120.74 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 74.25 109.97 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.8 m -78.19 130.73 36.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.206 0.527 . . . . 74.3 109.673 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -123.17 180.0 4.49 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.477 -0.783 . . . . 75.51 109.746 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.49 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 73.4 mtp180 -94.62 161.65 14.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.738 -0.665 . . . . 75.12 109.565 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.44 -26.44 63.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.108 -0.496 . . . . 64.53 110.064 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 m -76.2 -11.32 59.9 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.687 -0.688 . . . . 65.55 110.726 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.49 ' OE2' ' HD3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -85.02 -23.4 28.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 74.31 111.116 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 8' ' ' VAL . 62.1 mt -115.79 144.7 43.61 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.331 0.493 . . . . 74.32 112.331 -168.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -111.85 140.92 46.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.783 -0.821 . . . . 75.54 108.783 167.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.49 115.43 17.25 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.145 -0.317 . . . . 54.24 110.145 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 10.3 t . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.139 -0.689 . . . . 73.53 109.139 179.22 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--O 1.233 0.2 0 N-CA-C 110.068 -0.345 . . . . 74.2 110.068 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -126.92 158.68 67.82 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 72.22 110.507 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.71 128.79 18.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.543 2.162 . . . . 73.21 111.241 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 23' ' ' LEU . . . 94.11 27.2 12.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.555 -0.831 . . . . 70.41 111.646 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.83 144.34 48.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 72.11 110.778 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -82.72 130.2 35.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 72.3 110.574 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.78 162.37 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 62.12 110.846 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.578 ' HB3' ' OE2' ' A' ' 53' ' ' GLU . 41.5 ttp180 -119.88 124.0 44.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.397 -0.819 . . . . 73.51 109.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.484 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 t -66.4 113.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.373 . . . . 73.41 110.65 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.24 -11.41 26.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.961 -0.563 . . . . 73.13 111.007 -176.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 41.7 t30 -65.93 113.12 4.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.472 . . . . 63.1 110.288 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.98 -39.07 76.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 74.13 111.532 -174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.59 34.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.903 0.859 . . . . 64.43 109.66 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.534 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 7.1 t70 -116.42 159.17 22.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.447 -0.797 . . . . 71.44 110.269 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -75.76 -31.31 59.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.191 0.519 . . . . 74.12 110.325 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -99.72 25.02 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.859 -0.609 . . . . 74.23 111.089 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 18.4 t80 -58.39 128.88 39.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.651 . . . . 64.01 111.126 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 74.2 mtp180 77.14 -8.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.138 0.975 . . . . 71.21 112.376 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.39 158.03 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.018 0.437 . . . . 72.32 110.809 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -104.91 138.76 40.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.688 -0.687 . . . . 75.12 110.445 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.36 171.83 26.31 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.552 -0.619 . . . . 70.3 111.552 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 5' ' ' GLY . 4.4 tt -120.08 122.54 41.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.062 0.431 . . . . 41.24 109.889 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.539 HG13 HG23 ' A' ' 27' ' ' VAL . 39.5 t -69.21 122.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 75.04 110.762 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.401 ' NE2' HD21 ' A' ' 23' ' ' LEU . 27.4 mm-40 -98.61 -30.78 12.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.914 -0.585 . . . . 75.44 110.752 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 26' ' ' ARG . 19.0 ttt180 -146.61 118.92 8.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 74.33 109.903 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.539 HG23 HG13 ' A' ' 24' ' ' VAL . 59.4 t -103.64 128.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 75.13 110.888 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.9 t -106.42 -179.35 3.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.903 -0.777 . . . . 74.43 108.903 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.61 29.91 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 73.34 111.099 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.0 -29.64 0.17 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.956 -0.566 . . . . 64.41 111.777 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.06 164.92 11.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.58 0.229 . . . . 63.11 110.44 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.49 137.9 19.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.586 -0.279 . . . . 62.54 110.405 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -101.06 110.73 22.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.893 -0.41 . . . . 73.24 109.893 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -100.26 129.39 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 55.44 110.858 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 tp -95.19 129.15 42.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.681 -0.69 . . . . 64.55 110.399 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.74 136.91 48.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.469 -0.567 . . . . 74.41 109.469 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.85 116.82 25.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.085 -0.507 . . . . 70.13 111.059 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 17.2 t30 -110.2 -10.9 14.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.706 . . . . 70.22 110.295 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.58 -71.98 0.22 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.899 -0.667 . . . . 53.5 111.545 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.16 -18.89 24.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.602 0.715 . . . . 72.45 109.935 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 73.7 t90 -112.92 135.14 54.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 65.44 111.022 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.43 149.06 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.039 -0.982 . . . . 71.25 109.256 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HE2' HG21 ' A' ' 45' ' ' VAL . 88.5 tttt -165.14 119.06 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.934 0.397 . . . . 75.02 110.865 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.6 tp -92.7 108.36 19.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.675 -0.693 . . . . 64.25 109.562 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.576 HG21 ' HE2' ' A' ' 43' ' ' LYS . 10.8 t -108.51 125.43 65.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.427 -0.351 . . . . 74.35 110.766 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -85.17 130.76 34.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.405 0.621 . . . . 72.13 110.679 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -125.56 -164.55 1.31 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.252 -0.885 . . . . 64.03 108.838 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.816 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 86.6 mtm180 -106.37 162.6 13.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.285 -0.635 . . . . 70.53 109.285 171.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.41 -25.15 60.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.101 0.477 . . . . 74.33 109.941 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 p -82.48 -9.19 59.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 73.33 110.432 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.816 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 7.7 mm-40 -88.17 -12.96 42.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.274 0.559 . . . . 71.34 110.929 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 10' ' ' VAL . 27.2 mt -126.59 167.28 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.611 -0.722 . . . . 71.12 110.732 -173.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.578 ' OE2' ' HB3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -151.27 148.77 28.6 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.993 -0.743 . . . . 71.3 108.993 167.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.44 141.31 34.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.682 0.277 . . . . 71.05 110.631 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.784 -0.821 . . . . 74.01 108.784 177.282 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 49' ' ' LEU . 48.9 mt . . . . . 0 C--O 1.233 0.202 0 N-CA-C 109.552 -0.536 . . . . 55.15 109.552 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.13 147.19 37.3 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.719 0.295 . . . . 62.32 111.173 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.97 151.66 73.48 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.738 2.292 . . . . 64.2 111.438 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.48 2.54 90.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.843 -0.694 . . . . 50.31 112.004 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.91 153.02 20.24 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.773 0.32 . . . . 74.33 110.496 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -89.56 129.91 35.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.556 . . . . 72.21 110.649 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 52' ' ' LEU . 17.3 m -124.34 158.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.908 -0.587 . . . . 72.43 110.023 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -118.59 126.53 52.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.907 -0.405 . . . . 74.15 109.907 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.27 115.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 75.15 110.941 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 m -100.36 -3.68 30.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 64.12 110.6 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.602 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 27.0 t-20 -64.94 113.67 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 63.23 110.042 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.08 -13.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 72.41 111.54 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.59 -48.89 17.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.967 0.358 . . . . 74.25 111.967 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.98 161.43 25.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.063 0.458 . . . . 71.42 110.97 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.92 -30.49 71.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.502 -0.772 . . . . 64.02 112.605 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -80.91 24.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.286 0.476 . . . . 73.42 112.286 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 50.7 t80 -64.99 127.88 33.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 74.22 109.795 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 35.7 mtm180 74.72 27.15 1.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.288 0.635 . . . . 70.43 111.892 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.42 152.87 24.11 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.954 -0.387 . . . . 73.5 109.954 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -102.96 142.18 34.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.581 -0.526 . . . . 73.42 109.581 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -144.24 170.0 26.15 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.719 -0.753 . . . . 73.25 112.067 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.8 tp -109.91 123.04 48.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.647 0.26 . . . . 73.32 110.577 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 27' ' ' VAL . 52.2 t -68.32 115.42 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.535 -0.302 . . . . 64.41 110.52 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -81.48 -33.08 32.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 75.3 110.463 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.414 ' HD2' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -169.38 143.6 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.643 -0.873 . . . . 74.43 108.643 177.444 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.411 HG23 HG12 ' A' ' 24' ' ' VAL . 23.6 t -99.14 135.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.69 -0.686 . . . . 63.01 110.332 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 8.5 t -104.89 -176.19 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.695 -0.854 . . . . 73.35 108.695 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.39 77.69 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.495 0.664 . . . . 71.21 110.081 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 3.24 39.64 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.039 -0.982 . . . . 73.22 111.84 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG2' HG23 ' A' ' 46' ' ' THR . 27.7 ttmt -141.5 172.88 12.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.903 -0.777 . . . . 72.15 108.903 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.8 143.73 6.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.479 0.18 . . . . 54.3 110.887 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.19 119.07 32.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 72.14 110.276 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.45 HG21 HD23 ' A' ' 52' ' ' LEU . 39.9 t -100.82 124.65 54.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 62.34 111.028 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.5 tp -96.44 121.59 38.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.129 -0.487 . . . . 73.03 110.295 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.75 137.23 36.14 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.655 -0.869 . . . . 74.54 108.655 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.47 114.51 8.61 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.823 -0.436 . . . . 64.31 109.823 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -137.04 90.31 2.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.215 0.531 . . . . 75.2 111.157 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.13 -90.7 0.52 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.46 -0.791 . . . . 62.03 112.833 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.0 -16.23 11.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 75.32 109.943 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -94.28 144.07 25.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 75.23 110.682 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.2 158.29 43.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.368 -0.833 . . . . 72.23 110.018 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.58 132.11 6.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.957 -0.565 . . . . 74.15 110.132 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.0 tp -103.92 109.44 21.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.311 -0.404 . . . . 62.33 110.301 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.59 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 62.51 110.307 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.3 m -81.12 132.65 35.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.267 0.556 . . . . 53.43 110.755 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -129.61 177.89 6.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.82 -0.808 . . . . 73.24 108.82 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -97.61 178.11 5.28 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.816 -0.354 . . . . 64.34 110.265 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 2' ' ' ILE . 68.8 mt -78.56 -25.96 45.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.195 0.521 . . . . 64.14 110.02 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 p -76.3 -17.5 59.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 75.3 109.996 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -86.44 -18.84 30.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.1 -0.955 . . . . 72.13 110.835 -178.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.45 HD23 HG21 ' A' ' 34' ' ' VAL . 55.6 mt -122.65 122.63 39.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.957 -0.565 . . . . 73.41 111.202 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.34 118.26 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.114 -0.698 . . . . 73.21 109.114 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 8' ' ' VAL . . . -75.11 106.29 6.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.977 -0.556 . . . . 71.54 109.967 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 74.35 110.107 -177.674 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.472 HD11 HD22 ' A' ' 49' ' ' LEU . 57.9 mt . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.585 -0.895 . . . . 72.35 108.585 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.85 145.55 55.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.75 0.31 . . . . 71.44 111.281 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.86 142.91 99.49 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.092 2.528 . . . . 64.23 112.313 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.25 6.08 63.23 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.846 -0.692 . . . . 74.41 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.669 0.271 . . . . 53.01 110.305 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -92.03 130.55 37.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.399 . . . . 74.54 110.45 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 54' ' ' ALA . 11.3 m -123.63 142.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.074 -0.512 . . . . 75.21 110.154 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -102.18 125.44 48.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.954 -0.566 . . . . 72.14 110.047 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.64 115.85 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.684 -0.689 . . . . 64.54 110.406 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -105.69 10.52 32.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 73.14 110.319 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.0 109.71 0.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.93 -0.577 . . . . 71.41 109.979 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.37 -35.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.011 -0.54 . . . . 75.12 112.141 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.89 -2.61 34.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.394 0.616 . . . . 63.45 111.018 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.98 165.61 16.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.256 -0.429 . . . . 72.54 110.263 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.82 -27.29 26.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.268 -0.424 . . . . 72.24 110.84 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -87.95 24.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.085 0.469 . . . . 73.3 111.16 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 53.6 t80 -63.12 136.81 57.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 72.54 110.027 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 40.3 mtm180 82.44 -10.91 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.802 0.841 . . . . 63.23 112.251 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -72.92 150.64 42.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 73.42 110.398 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -117.62 133.38 56.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.13 -0.486 . . . . 73.44 110.235 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.68 172.97 21.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.583 -0.818 . . . . 73.23 112.484 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.47 125.96 48.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.422 -0.214 . . . . 74.02 110.422 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.87 115.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.133 -0.321 . . . . 75.12 110.133 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.438 ' HG3' HD13 ' A' ' 44' ' ' LEU . 27.6 mm-40 -87.35 -35.81 18.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.959 -0.564 . . . . 74.5 110.418 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -166.81 148.87 6.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.692 -0.686 . . . . 74.53 109.574 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 2' ' ' ILE . 44.4 t -105.4 140.93 21.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.334 -0.848 . . . . 73.31 109.755 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -129.3 -162.27 1.19 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.859 -0.423 . . . . 72.42 109.859 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.42 86.85 1.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.541 . . . . 75.23 110.139 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.64 5.67 86.32 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 114.739 -1.119 . . . . 73.01 111.854 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -129.41 166.25 19.93 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 122.625 0.37 . . . . 73.34 110.637 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 141.88 24.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.268 -0.423 . . . . 62.22 110.242 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -89.71 108.48 19.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.971 -0.381 . . . . 73.25 109.971 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.6 122.42 47.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.609 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.0 tp -96.63 120.09 36.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 75.23 110.553 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.647 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 95.9 m-85 -93.44 141.62 28.25 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.82 -0.807 . . . . 73.12 108.82 171.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -140.72 133.21 28.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.263 -0.426 . . . . 64.1 110.028 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -147.44 70.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.172 0.51 . . . . 71.21 110.127 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.54 -88.02 1.22 Allowed Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.653 -0.703 . . . . 54.15 112.441 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -104.53 -20.81 13.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.394 0.616 . . . . 51.43 109.878 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -81.69 132.01 35.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.261 -0.881 . . . . 75.51 111.394 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -128.93 152.57 48.42 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.458 -1.246 . . . . 72.54 109.346 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 54.5 tttp -157.73 100.92 1.79 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.517 -0.311 . . . . 62.42 110.224 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 33' ' ' ALA . 56.5 tp -95.15 106.32 18.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.387 -0.369 . . . . 74.34 110.324 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.51 HG21 ' HG2' ' A' ' 43' ' ' LYS . 54.8 t -126.33 126.46 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.195 -0.457 . . . . 63.44 110.487 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.1 m -77.65 131.8 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 73.25 110.347 177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -124.44 -174.59 3.05 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.134 -0.691 . . . . 70.13 109.134 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.57 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 9.4 mtt180 -102.28 164.1 11.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.723 0.297 . . . . 60.14 110.31 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.472 HD22 HD11 ' A' ' 2' ' ' ILE . 91.7 mt -78.64 -20.89 49.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.269 0.556 . . . . 75.15 110.378 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 p -88.53 -16.49 32.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.65 -0.704 . . . . 54.44 110.102 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 12.3 mm-40 -93.55 -4.18 51.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.561 -0.745 . . . . 63.03 110.347 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -121.58 158.74 27.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 72.02 110.768 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -139.63 123.84 17.92 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.457 -0.572 . . . . 62.22 109.457 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . 0.416 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -62.37 132.04 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 63.53 110.697 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.166 -177.619 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.665 HD13 HD22 ' A' ' 49' ' ' LEU . 56.8 mt . . . . . 0 C--O 1.231 0.103 0 N-CA-C 109.703 -0.48 . . . . 70.01 109.703 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.36 147.82 66.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.308 -0.405 . . . . 65.25 110.519 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.6 129.77 30.73 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.613 2.209 . . . . 73.12 111.209 175.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.18 27.67 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.115 -0.564 . . . . 61.53 111.829 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 147.27 24.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.612 0.244 . . . . 64.44 110.617 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -89.31 132.71 34.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 75.35 110.381 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.636 HG21 HD13 ' A' ' 52' ' ' LEU . 12.0 m -133.61 149.27 30.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.935 0.398 . . . . 73.13 111.552 -176.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -114.96 135.83 53.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.776 -0.647 . . . . 72.12 109.695 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -75.2 106.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 64.14 109.927 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -90.97 -5.97 54.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.756 0.312 . . . . 72.2 111.48 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -65.68 111.37 3.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.309 -0.626 . . . . 73.34 109.309 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 3.0 t -80.78 -1.14 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.395 0.617 . . . . 54.32 111.033 -173.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -101.35 -22.99 14.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.99 -0.55 . . . . 73.21 110.673 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.72 158.03 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.528 0.68 . . . . 74.23 111.964 -170.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.1 m -65.31 -32.6 74.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.979 -1.009 . . . . 72.12 111.555 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -101.4 30.62 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 71.41 111.232 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 25.0 t80 -55.37 138.16 46.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 75.54 111.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 56.08 18.3 3.11 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.239 1.416 . . . . 73.23 113.276 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.27 151.27 24.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.786 -0.82 . . . . 74.42 108.786 167.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.19 130.16 53.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.006 -0.543 . . . . 72.44 110.067 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.16 -174.67 16.62 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.522 -0.847 . . . . 38.41 112.384 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.1 tp -113.1 132.81 55.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.336 -0.246 . . . . 75.11 110.336 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.51 114.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 74.35 110.043 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.405 ' HG3' HD13 ' A' ' 44' ' ' LEU . 28.6 mm-40 -79.11 -35.3 42.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.145 0.498 . . . . 73.51 110.366 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -172.24 146.24 1.84 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.366 -0.834 . . . . 74.23 109.259 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.327 -0.851 . . . . 75.52 110.17 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 t -106.63 67.87 0.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.492 -0.558 . . . . 73.12 109.492 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 68.85 -72.34 0.1 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.9 -1.046 . . . . 74.31 112.531 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.55 -9.76 20.73 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 115.257 -0.883 . . . . 38.41 113.022 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -124.28 170.35 10.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 110.2 -0.296 . . . . 61.31 110.2 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.72 149.1 30.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.532 0.206 . . . . 65.1 110.973 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -96.16 117.07 30.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.731 -0.47 . . . . 53.42 109.731 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.2 t -100.36 120.94 50.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 65.44 110.85 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.69 115.72 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 75.23 109.912 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -91.75 144.73 25.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 72.1 109.508 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.87 112.37 7.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.693 -0.484 . . . . 74.04 109.693 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -130.73 79.68 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.106 -0.497 . . . . 52.14 110.262 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.49 -90.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.055 -0.52 . . . . 73.33 112.672 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -100.73 -22.38 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 74.53 110.1 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.9 t90 -92.16 144.49 25.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.401 -0.818 . . . . 74.24 110.978 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -149.69 153.59 37.2 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.076 -0.965 . . . . 71.43 109.266 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -162.53 128.43 3.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.409 -0.359 . . . . 72.14 110.82 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 33' ' ' ALA . 63.8 tp -98.12 112.03 24.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 74.01 109.959 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.53 125.81 67.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.839 0.352 . . . . 74.11 110.483 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.5 m -73.68 140.4 46.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.189 0.519 . . . . 71.54 110.844 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.0 -176.06 4.25 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 72.44 109.262 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.827 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 98.9 mtt180 -91.39 -179.28 5.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.099 -0.704 . . . . 72.31 109.099 170.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.665 HD22 HD13 ' A' ' 2' ' ' ILE . 87.0 mt -87.25 -33.03 19.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.951 -0.759 . . . . 74.41 108.951 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.8 m -70.63 -14.41 62.47 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.57 -0.741 . . . . 75.42 111.106 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.827 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 11.1 mm-40 -80.53 -18.71 47.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.204 0.526 . . . . 74.34 110.591 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.636 HD13 HG21 ' A' ' 8' ' ' VAL . 38.8 mt -115.68 157.38 24.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 74.5 111.325 -172.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.84 146.6 49.19 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.7 -0.852 . . . . 74.15 108.7 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.87 123.57 26.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.761 0.315 . . . . 52.12 110.238 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 108.947 -0.76 . . . . 74.11 108.947 177.166 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 121.44 0.638 . . . . 74.21 110.421 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -146.17 162.56 34.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.177 -0.92 . . . . 71.3 109.533 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.47 113.11 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.181 1.921 . . . . 72.23 111.098 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.11 -9.58 15.51 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.798 -0.715 . . . . 44.42 111.983 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.95 147.12 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 63.34 110.433 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -89.89 132.58 35.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.116 -0.493 . . . . 64.22 110.158 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -127.7 152.59 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.954 0.407 . . . . 70.02 110.736 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.551 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 43.5 ttm180 -110.06 129.28 55.71 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.032 -0.729 . . . . 65.11 109.032 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.36 101.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.085 0.469 . . . . 63.13 110.915 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -79.76 -12.45 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 75.4 109.573 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -68.6 107.42 2.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.28 -0.873 . . . . 71.01 110.125 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -89.94 -13.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 64.43 110.601 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.69 -36.17 82.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.418 -0.81 . . . . 72.5 110.47 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 16' ' ' THR . 11.3 t70 -80.99 -174.91 5.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 75.13 109.874 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.436 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 11.3 m -93.92 -21.13 19.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.085 0.469 . . . . 65.15 110.807 -176.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' OH ' ' HG3' ' A' ' 43' ' ' LYS . 54.2 m-85 -90.25 40.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 74.41 111.329 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.518 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 29.7 t80 -57.65 132.46 53.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.813 -0.631 . . . . 75.23 111.096 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 18' ' ' TYR . 36.2 ptt180 59.84 14.93 4.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.147 1.379 . . . . 71.33 112.77 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.22 156.57 26.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 73.44 110.106 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.73 117.66 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.106 -0.497 . . . . 74.22 109.901 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.6 176.47 17.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.615 -0.803 . . . . 71.1 112.478 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.95 123.18 48.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.232 . . . . 73.04 110.383 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 27' ' ' VAL . 58.0 t -67.56 122.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 74.33 110.007 177.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 24.9 mm-40 -91.49 -27.56 18.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.976 -0.557 . . . . 61.32 111.005 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -168.2 135.5 2.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.389 -0.823 . . . . 73.04 109.938 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 24' ' ' VAL . 42.5 t -104.06 150.36 7.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.256 -0.884 . . . . 62.5 110.086 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.85 -177.63 4.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.3 -0.63 . . . . 72.21 109.3 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.44 80.43 3.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.595 0.712 . . . . 71.14 110.759 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.41 -24.58 9.1 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 114.809 -1.087 . . . . 61.02 112.025 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -118.82 157.83 26.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.556 0.217 . . . . 72.22 111.161 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.06 138.43 22.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.347 -0.388 . . . . 72.2 110.163 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -95.0 112.15 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.125 -0.324 . . . . 72.53 110.125 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.9 124.52 50.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 73.22 110.586 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 33.8 tp -93.53 119.79 33.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.007 -0.542 . . . . 74.42 110.467 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -100.46 141.06 33.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.95 -0.759 . . . . 65.05 108.95 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -139.03 141.08 38.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.549 -0.296 . . . . 73.0 110.37 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -153.8 76.49 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.239 -0.652 . . . . 74.32 109.239 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.94 -110.08 3.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 44.31 111.877 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.37 -15.83 44.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.885 0.374 . . . . 75.24 110.736 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -87.16 142.78 27.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.363 0.602 . . . . 73.44 110.582 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.31 163.35 36.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.919 -1.037 . . . . 72.51 109.45 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HD2' ' CG2' ' A' ' 45' ' ' VAL . 4.3 tmtp? -166.5 109.23 0.73 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 73.41 110.221 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.34 104.05 15.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.764 -0.458 . . . . 75.33 109.764 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.547 ' CG2' ' HD2' ' A' ' 43' ' ' LYS . 17.9 t -111.95 126.37 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 73.44 110.251 -176.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.6 m -85.68 120.28 26.94 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.328 0.585 . . . . 71.45 109.815 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.42 -168.32 1.3 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.402 -0.817 . . . . 74.51 109.106 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.95 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 55.3 mmt-85 -105.63 160.45 15.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.187 -0.672 . . . . 64.41 109.187 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -71.07 -27.86 63.93 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.254 0.549 . . . . 74.04 110.035 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 p -75.43 -22.47 57.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.477 -0.783 . . . . 64.12 110.305 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.95 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 20.6 mm-40 -88.28 -5.38 58.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.0 -0.545 . . . . 70.01 111.378 -173.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.425 HD13 HG21 ' A' ' 8' ' ' VAL . 72.5 mt -120.02 143.04 48.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.059 -0.519 . . . . 71.03 110.263 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HG3' ' HB3' ' A' ' 9' ' ' ARG . 9.7 pt-20 -107.59 130.66 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.183 -0.673 . . . . 74.04 109.183 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.64 24.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.34 -0.391 . . . . 75.21 110.093 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.323 -0.572 0 N-CA-C 108.849 -0.797 . . . . 64.22 108.849 177.547 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.688 ' HB ' HD22 ' A' ' 49' ' ' LEU . 59.7 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.14 0.495 . . . . 72.41 111.856 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -135.83 155.88 77.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.306 -0.861 . . . . 73.12 109.448 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.72 132.38 34.92 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.063 1.842 . . . . 74.25 111.59 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.52 -7.54 58.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.98 -0.628 . . . . 63.33 112.216 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.81 147.31 23.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.312 . . . . 72.11 111.15 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -87.02 126.15 34.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 74.52 110.068 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 m -124.97 148.16 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.211 0.529 . . . . 72.42 110.973 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.501 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 23.5 ttp180 -111.05 132.41 54.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.46 -0.791 . . . . 73.03 109.682 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.08 100.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.133 -0.485 . . . . 74.35 110.362 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 p -102.06 7.26 41.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.216 0.532 . . . . 75.42 111.176 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 48.1 t30 -71.93 100.12 2.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.55 -0.75 . . . . 74.13 109.549 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.95 -30.18 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 72.54 111.984 -171.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.66 -7.43 59.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.438 . . . . 75.4 111.637 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 18.3 t70 -87.92 162.09 17.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.048 -0.408 . . . . 73.2 111.277 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 m -77.05 -26.63 53.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.083 -0.508 . . . . 75.15 111.696 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.479 ' OH ' ' HE2' ' A' ' 43' ' ' LYS . 89.9 m-85 -106.91 28.89 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 73.24 111.265 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 t80 -68.88 82.2 0.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 74.44 110.408 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 25.9 ptt180 169.91 -27.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.376 -0.829 . . . . 73.43 110.421 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.61 158.4 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.291 0.567 . . . . 74.24 112.013 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . 0.501 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 81.4 mt-10 -125.8 134.16 51.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.183 -0.917 . . . . 72.3 108.962 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.61 178.45 21.05 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.373 -0.918 . . . . 73.24 112.335 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.94 129.69 56.09 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.943 0.372 . . . . 61.32 110.388 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.559 HG22 ' CG2' ' A' ' 2' ' ' ILE . 74.4 t -68.31 124.83 24.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.295 -0.412 . . . . 73.14 110.764 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -93.63 -29.17 15.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 73.0 110.82 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -165.3 133.06 3.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.509 -0.769 . . . . 73.33 110.689 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 29' ' ' ASP . 96.5 t -97.4 131.54 44.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.554 -0.748 . . . . 75.33 109.057 173.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -116.06 36.37 4.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.17 0.51 . . . . 72.13 109.996 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 27' ' ' VAL . 10.5 m-20 63.0 99.85 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.032 -0.985 . . . . 71.22 111.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.02 3.87 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.873 -0.603 . . . . 73.44 111.64 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 23.3 ttmt -118.62 165.24 14.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 64.11 109.062 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.97 146.02 18.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.513 -0.312 . . . . 63.22 110.676 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.54 114.34 26.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.823 -0.436 . . . . 74.54 109.823 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.58 125.66 47.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 75.42 110.408 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.0 tp -98.14 110.77 23.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 64.51 110.39 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 78.6 m-85 -91.66 142.87 27.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.66 -0.866 . . . . 73.31 108.66 173.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 3.8 tm-20 -155.77 126.59 6.93 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.168 -0.678 . . . . 73.3 109.168 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -153.56 102.91 2.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.627 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.6 -84.93 1.18 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.823 -0.626 . . . . 63.12 112.398 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -129.39 -4.9 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.509 0.671 . . . . 70.12 109.95 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 43' ' ' LYS . 35.3 t90 -100.38 135.97 41.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.764 -0.653 . . . . 74.43 112.251 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.2 144.12 48.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.764 -1.107 . . . . 74.44 109.154 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 44.9 tptt -146.76 110.39 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.585 0.231 . . . . 70.23 110.431 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -106.74 105.46 15.51 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 73.54 110.087 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.4 HG23 ' HG3' ' A' ' 43' ' ' LYS . 24.7 t -127.98 133.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 71.44 110.018 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -85.07 122.88 29.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 120.972 0.415 . . . . 74.03 111.206 -179.271 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.91 175.67 6.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.765 -0.828 . . . . 74.54 108.765 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.843 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 63.6 mtt180 -89.11 165.11 14.71 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.256 0.55 . . . . 72.32 110.589 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.688 HD22 ' HB ' ' A' ' 2' ' ' ILE . 96.5 mt -79.53 -24.78 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.497 -0.774 . . . . 74.11 110.139 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 t -91.63 -5.98 52.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.603 -0.726 . . . . 64.04 110.101 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.843 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 52.8 mt-10 -92.73 -9.38 40.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.64 -0.424 . . . . 70.34 111.91 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.573 ' HB2' HD13 ' A' ' 2' ' ' ILE . 44.5 mt -120.66 163.78 17.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.559 -0.291 . . . . 73.12 110.694 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -123.57 155.09 38.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.891 -0.411 . . . . 73.03 109.891 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.6 125.06 39.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.863 0.363 . . . . 73.03 110.955 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.8 -0.815 . . . . 74.13 108.8 177.479 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 C--O 1.232 0.156 0 N-CA-C 108.8 -0.815 . . . . 75.32 108.8 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.93 154.83 53.21 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.68 0.276 . . . . 72.31 110.899 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' PRO . . . . . 0.621 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 15.8 Cg_endo -59.82 126.03 19.34 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.366 2.044 . . . . 74.22 111.214 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.563 ' HA2' HD22 ' A' ' 23' ' ' LEU . . . 108.78 -7.48 33.61 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.623 -0.799 . . . . 45.34 111.811 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.57 152.73 19.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 71.0 110.715 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -95.32 130.46 42.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 72.12 110.117 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 52' ' ' LEU . 21.6 m -124.52 155.8 32.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.908 0.385 . . . . 73.14 111.395 -177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 9' ' ' ARG . 19.2 ttt180 -122.8 121.32 35.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 73.31 109.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.99 116.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 54.4 111.238 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -90.74 -28.32 18.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 73.13 111.514 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.031 -0.359 . . . . 75.02 110.031 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.465 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 30.5 t -72.81 -26.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.175 0.512 . . . . 75.5 111.515 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.47 -15.39 55.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 65.34 111.281 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 160.16 29.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.093 0.473 . . . . 54.4 111.3 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -66.88 -38.69 86.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.739 -0.664 . . . . 75.54 111.637 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.61 26.8 5.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.897 0.379 . . . . 73.23 111.345 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.465 ' CG ' ' HA ' ' A' ' 13' ' ' VAL . 37.4 t80 -57.98 140.51 52.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.048 -0.524 . . . . 74.55 110.86 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 73.87 9.5 4.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.405 -0.816 . . . . 75.41 111.485 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -102.58 153.04 20.48 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.896 -0.409 . . . . 74.51 109.896 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.88 139.38 49.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 62.42 110.181 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.53 175.92 23.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.815 -0.707 . . . . 65.33 112.228 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.563 HD22 ' HA2' ' A' ' 5' ' ' GLY . 6.8 tt -112.6 124.95 53.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.112 -0.329 . . . . 74.42 110.112 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.54 117.31 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 62.3 110.804 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -78.09 -36.13 48.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.987 -0.552 . . . . 64.3 110.161 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.621 ' HA ' ' HB3' ' A' ' 4' ' ' PRO . 30.5 ptt180 -170.8 145.98 2.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.695 -0.684 . . . . 62.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.603 HG11 HD22 ' A' ' 49' ' ' LEU . 89.7 t -106.76 121.52 59.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.279 -0.873 . . . . 72.04 109.302 172.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.4 m -155.29 139.31 16.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.726 -0.215 . . . . 65.43 110.873 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 67.67 15.29 9.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.799 -0.637 . . . . 64.21 111.474 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.98 2.7 71.2 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.709 -0.758 . . . . 54.43 111.907 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -115.31 163.05 16.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 110.182 -0.303 . . . . 71.3 110.182 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.25 125.87 25.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.256 -0.429 . . . . 42.45 110.048 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.38 113.12 20.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 71.3 109.891 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.18 119.65 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 71.42 111.238 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.7 tp -94.1 108.79 20.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.945 -0.571 . . . . 74.34 109.685 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 96.6 m-85 -80.36 141.36 35.46 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.284 -0.636 . . . . 72.34 109.284 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -139.24 124.37 18.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.488 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -128.85 86.3 2.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 60.21 109.916 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.81 -95.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.205 -0.758 . . . . 71.52 111.205 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -122.37 87.77 2.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.529 1.156 . . . . 74.42 108.554 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 t90 178.8 138.46 0.09 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.283 -2.235 . . . . 74.54 109.463 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.6 p30 -137.03 152.71 50.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.489 -0.778 . . . . 74.1 110.558 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HG3' HG23 ' A' ' 45' ' ' VAL . 17.1 tppt? -156.56 107.14 2.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 73.42 110.044 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LEU . . . . . 0.659 HD11 ' HB1' ' A' ' 33' ' ' ALA . 57.4 tp -89.21 110.86 21.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.169 -0.469 . . . . 71.2 110.716 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.406 HG23 ' HG3' ' A' ' 43' ' ' LYS . 34.8 t -125.65 120.73 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 65.54 109.213 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.0 m -81.41 130.93 35.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.282 0.563 . . . . 71.44 111.067 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.438 ' HB2' HD12 ' A' ' 52' ' ' LEU . 81.9 m-85 -124.53 -167.27 1.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.19 -0.914 . . . . 74.34 109.038 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.694 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 65.2 mtt-85 -110.24 162.81 14.25 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.885 -0.413 . . . . 65.35 109.885 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.603 HD22 HG11 ' A' ' 27' ' ' VAL . 3.6 mm? -66.4 -33.29 75.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.429 0.633 . . . . 63.25 109.999 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 p -78.16 -6.38 54.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.514 -0.766 . . . . 64.33 110.573 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.694 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 15.4 mm-40 -94.13 -15.57 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 74.3 111.001 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 8' ' ' VAL . 29.4 mt -127.79 150.07 49.98 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.066 -0.515 . . . . 74.11 111.645 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -121.25 143.45 49.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.655 -0.868 . . . . 75.21 108.655 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.18 136.37 37.08 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.958 -0.297 . . . . 53.24 110.246 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.534 -0.543 . . . . 72.43 109.534 179.037 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.858 0.361 . . . . 71.52 110.5 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.0 mt -131.88 142.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.347 -0.612 . . . . 75.22 109.347 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -135.27 161.71 61.79 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.605 -0.27 . . . . 75.25 110.295 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.86 117.55 4.32 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.274 1.983 . . . . 74.14 111.191 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.85 1.36 24.15 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.892 -0.67 . . . . 63.42 111.897 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.33 141.72 32.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.93 0.395 . . . . 61.42 110.948 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -82.55 129.96 35.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 71.14 110.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.45 HG22 HD12 ' A' ' 52' ' ' LEU . 16.4 m -132.36 153.02 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 73.13 111.565 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -117.13 137.04 52.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.515 -0.766 . . . . 73.52 109.969 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.466 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.4 t -80.42 115.26 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 71.31 110.353 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.49 18.52 22.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.212 -0.449 . . . . 75.43 112.21 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -89.82 113.9 25.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.177 -0.675 . . . . 62.3 109.177 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.11 -28.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.767 -0.651 . . . . 70.43 111.976 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -93.07 23.54 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 65.54 110.791 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.72 160.96 18.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.791 -0.568 . . . . 55.0 110.527 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -71.06 -32.09 68.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 71.02 111.173 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.65 ' HH ' ' HD3' ' A' ' 43' ' ' LYS . 71.6 m-85 -96.85 25.45 5.29 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.886 0.328 . . . . 72.4 111.886 -175.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -59.23 131.32 50.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.537 -0.301 . . . . 73.44 110.198 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 78.23 -16.84 0.62 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.885 0.874 . . . . 75.34 111.577 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -75.25 157.46 34.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 73.21 110.686 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.61 139.63 50.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.859 -0.609 . . . . 71.43 110.854 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 179.88 18.46 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.785 -0.643 . . . . 41.04 111.506 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.2 tp -119.0 123.23 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.311 -0.255 . . . . 63.53 110.311 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.93 116.81 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.845 -0.428 . . . . 74.3 109.845 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -90.49 -33.65 15.88 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.938 -0.574 . . . . 71.11 110.914 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -169.84 154.02 5.11 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.764 -0.653 . . . . 63.44 110.177 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.16 124.74 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.097 -0.956 . . . . 70.53 109.115 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -120.2 98.84 6.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.992 0.425 . . . . 75.54 111.179 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 54.29 39.45 30.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.356 -0.838 . . . . 74.21 112.178 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.47 -11.72 65.0 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.642 -0.789 . . . . 62.54 112.569 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.418 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 99.0 mttt -99.13 177.61 5.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.113 -0.329 . . . . 75.14 110.113 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.99 126.18 40.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 70.52 110.604 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.821 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -83.58 107.52 16.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.291 -0.413 . . . . 74.4 109.957 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.12 124.02 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.137 -0.483 . . . . 73.23 110.822 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -99.13 126.51 44.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.821 -0.627 . . . . 74.31 110.511 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -103.59 136.46 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.535 -0.913 . . . . 71.12 108.535 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.83 133.22 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.807 -0.442 . . . . 72.11 109.807 -172.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -129.11 21.78 5.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.196 0.522 . . . . 74.41 111.09 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 98.13 9.26 54.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.643 -0.789 . . . . 50.34 112.951 175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 169.34 -46.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.087 -0.709 . . . . 73.42 109.087 -178.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -80.25 138.69 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.501 -0.772 . . . . 74.23 109.894 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -154.8 163.21 40.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.736 -0.665 . . . . 60.32 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.65 ' HD3' ' HH ' ' A' ' 17' ' ' TYR . 87.4 tttt -165.39 106.79 0.78 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.242 -0.89 . . . . 72.13 109.462 173.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.821 HD21 ' HB3' ' A' ' 33' ' ' ALA . 8.7 tt -77.52 119.25 20.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 61.3 109.649 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.15 124.26 62.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.861 -0.422 . . . . 75.53 109.861 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.526 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -84.09 129.2 34.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.225 0.536 . . . . 75.14 110.729 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.418 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 95.7 m-85 -124.73 178.45 5.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.454 -0.793 . . . . 74.11 109.182 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.934 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 49.7 mtt180 -87.08 163.02 17.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.296 -0.631 . . . . 64.54 109.296 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.37 -31.24 69.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.724 -0.843 . . . . 71.31 108.724 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 p -67.82 -21.34 65.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 114.933 -1.03 . . . . 61.32 110.466 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.934 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 41.2 mm-40 -87.95 -7.9 56.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.501 -0.48 . . . . 65.23 111.254 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.45 HD12 HG22 ' A' ' 8' ' ' VAL . 49.9 mt -122.88 156.63 34.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.973 0.416 . . . . 74.33 111.719 -173.125 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -129.22 147.24 51.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.114 -0.698 . . . . 52.14 109.114 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.94 132.33 36.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 74.3 111.127 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.656 HG11 ' H ' ' A' ' 56' ' ' LYS . 2.7 t -93.88 174.39 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.656 ' H ' HG11 ' A' ' 55' ' ' VAL . 14.5 mptt -90.02 134.52 31.58 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-O 120.63 0.252 . . . . 73.22 110.584 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.44 -168.28 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.939 2.426 . . . . 74.43 111.846 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.764 ' H ' HD11 ' A' ' 58' ' ' ILE . 2.6 mp -67.0 152.36 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.151 -0.685 . . . . 61.25 109.151 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -88.35 82.07 7.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.137 0.494 . . . . 74.31 110.923 -174.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.32 156.13 33.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.628 -0.715 . . . . 53.54 109.938 174.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -97.65 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.689 -0.486 . . . . 75.13 109.689 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -84.43 146.55 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.531 . . . . 73.23 109.568 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -160.7 142.63 12.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.925 0.393 . . . . 74.42 110.839 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -138.02 163.72 30.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.887 -0.783 . . . . 75.22 108.887 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.75 153.92 36.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.895 0.378 . . . . 74.23 110.928 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.192 -0.909 . . . . 74.41 109.239 176.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.875 0.369 . . . . 60.31 110.194 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.665 HD11 HD23 ' A' ' 49' ' ' LEU . 52.3 mt -98.37 144.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.385 -0.37 . . . . 73.44 110.145 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.47 143.46 30.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.249 -0.432 . . . . 72.05 110.762 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.85 134.6 44.23 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.675 2.25 . . . . 63.24 111.544 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.83 -5.01 50.23 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.991 -0.624 . . . . 70.24 112.331 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.7 161.07 13.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.831 0.348 . . . . 75.23 110.695 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -99.69 131.79 45.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.264 -0.425 . . . . 75.13 110.234 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.617 HG21 HD11 ' A' ' 52' ' ' LEU . 25.9 m -125.7 155.52 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.163 -0.471 . . . . 72.44 110.206 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -109.47 143.07 39.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.669 -0.493 . . . . 44.44 109.669 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.16 113.96 16.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.032 -0.359 . . . . 71.42 110.032 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -89.69 -19.02 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 73.44 111.142 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.03 106.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 74.42 110.5 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.15 -30.42 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 71.55 111.132 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.66 -26.55 68.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 71.44 111.125 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.16 155.37 25.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 63.23 110.647 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 -27.5 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.002 -0.545 . . . . 73.11 110.945 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.43 22.66 2.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.276 -0.42 . . . . 74.55 111.489 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.438 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 35.6 t80 -63.32 134.61 56.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.239 -0.437 . . . . 74.41 110.332 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.7 mtp180 76.17 1.82 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.761 0.825 . . . . 74.55 112.293 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -85.35 150.51 24.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 75.25 110.212 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 125.25 53.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 74.52 109.744 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.526 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -125.72 155.27 18.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.586 -0.816 . . . . 41.33 111.85 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.66 116.48 28.98 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 110.252 -0.277 . . . . 75.41 110.252 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.01 106.34 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.85 -0.426 . . . . 61.31 109.85 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -79.37 -34.5 41.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.101 0.477 . . . . 72.31 110.521 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -167.03 143.72 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.695 -0.684 . . . . 70.14 109.65 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.18 136.14 25.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.431 -0.804 . . . . 72.52 109.276 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 m -127.03 93.75 3.84 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.264 -0.273 . . . . 74.02 110.264 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.92 -76.82 0.06 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.298 -0.864 . . . . 65.13 111.085 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.471 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -140.76 11.73 2.9 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.332 -1.304 . . . . 44.31 111.132 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.495 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 47.4 mtmt -114.6 165.95 12.23 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.115 -0.543 . . . . 74.22 109.55 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.98 133.4 37.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.681 0.277 . . . . 71.14 110.5 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.522 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -83.74 99.6 10.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.18 -0.674 . . . . 54.11 109.18 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.526 ' CG1' ' HA3' ' A' ' 22' ' ' GLY . 55.4 t -91.78 118.09 36.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 64.1 110.793 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.8 tp -94.6 122.59 37.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.781 -0.645 . . . . 74.4 110.509 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.452 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 92.3 m-85 -99.95 146.77 26.3 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.957 -0.757 . . . . 71.41 108.957 174.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.478 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 30.8 tt0 -129.55 -56.06 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.669 -0.412 . . . . 60.31 111.805 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 64.64 -66.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.825 0.45 . . . . 74.02 111.523 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.444 ' C ' ' H ' ' A' ' 41' ' ' TRP . . . -168.73 93.5 0.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.334 -0.706 . . . . 52.05 111.334 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.4 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 8.6 t30 72.59 -36.79 0.37 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.492 0.717 . . . . 74.12 111.743 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 48.1 t90 -57.41 155.38 9.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 75.23 110.789 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.452 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.0 p-10 -148.54 153.45 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 71.41 110.301 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -169.45 110.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.362 -0.836 . . . . 73.13 109.378 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.522 HD12 ' HB3' ' A' ' 33' ' ' ALA . 37.8 tp -90.91 105.98 18.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.066 -0.516 . . . . 73.13 110.067 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -118.0 118.09 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 110.004 -0.369 . . . . 73.4 110.004 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 m -79.27 129.6 34.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.08 0.467 . . . . 73.33 110.583 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -124.84 178.41 5.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.613 -0.721 . . . . 65.44 109.119 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.936 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 62.8 mmt-85 -90.17 162.85 15.07 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.959 -0.756 . . . . 74.13 108.959 175.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.665 HD23 HD11 ' A' ' 2' ' ' ILE . 87.0 mt -79.36 -22.31 44.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.27 0.557 . . . . 71.32 109.882 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 p -75.21 -15.12 60.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.399 -0.819 . . . . 73.3 110.003 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.936 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 13.4 mm-40 -91.89 -13.17 31.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.732 -0.667 . . . . 63.54 110.604 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.617 HD11 HG21 ' A' ' 8' ' ' VAL . 62.9 mt -115.56 161.54 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.73 . . . . 74.15 111.01 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.64 128.99 48.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.802 -0.636 . . . . 75.13 109.549 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.581 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -79.93 108.74 13.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 72.34 110.71 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.56 HG11 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -73.63 173.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.837 -0.801 . . . . 72.14 108.837 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.56 ' H ' HG11 ' A' ' 55' ' ' VAL . 19.9 pttp -63.16 134.75 95.93 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.878 0.37 . . . . 70.14 110.626 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 8.5 Cg_exo -72.64 -173.68 1.25 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.964 2.442 . . . . 63.25 111.945 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -79.34 152.0 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.027 -0.731 . . . . 74.34 109.027 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 pp -92.98 150.3 20.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.27 -0.423 . . . . 74.43 111.321 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.81 -78.2 0.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 53.42 108.845 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -156.01 174.95 14.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.189 -0.914 . . . . 72.31 109.375 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -83.71 102.99 12.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 74.42 110.717 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.19 147.62 26.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.762 . . . . 74.25 109.39 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -70.89 115.34 9.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.011 -0.737 . . . . 75.41 109.011 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -73.51 162.17 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.575 -0.739 . . . . 70.35 111.895 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.8 m80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.168 -0.92 . . . . 70.4 109.464 175.931 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptm . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.898 0.38 . . . . 74.14 111.007 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.15 136.5 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.007 -0.738 . . . . 74.25 109.007 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -149.62 144.27 17.63 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.887 -0.412 . . . . 74.22 109.887 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.36 131.57 44.08 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.71 2.273 . . . . 53.12 111.857 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.2 -13.26 48.52 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.985 -0.626 . . . . 38.23 111.883 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 164.39 13.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.877 0.37 . . . . 38.23 110.561 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -97.36 134.42 40.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.902 -0.59 . . . . 72.51 110.085 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.79 148.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.991 0.425 . . . . 72.42 111.008 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.419 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 22.2 ttt180 -104.92 122.23 45.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.66 -0.7 . . . . 73.43 109.504 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 52' ' ' LEU . 41.2 t -70.82 103.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.1 0.476 . . . . 64.42 110.16 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -108.88 23.94 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.799 -0.637 . . . . 75.32 111.572 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -72.87 106.43 4.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.876 -0.787 . . . . 72.33 108.876 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.41 -25.47 38.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.179 0.514 . . . . 73.34 111.178 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.08 -23.26 26.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.168 -0.469 . . . . 73.11 111.308 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.79 155.8 18.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 73.31 110.905 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.409 ' C ' ' H ' ' A' ' 18' ' ' TYR . 88.9 m -78.94 -23.4 44.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 54.12 111.822 -176.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -76.91 11.77 1.62 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 74.32 111.28 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.472 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 64.9 t80 -71.33 78.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.516 -0.765 . . . . 75.23 110.055 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 14.8 ptt180 168.9 -20.38 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.182 -0.917 . . . . 74.33 109.629 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.12 148.07 23.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.305 0.574 . . . . 74.14 111.408 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.419 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 41.5 mt-10 -125.91 118.12 24.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.246 -1.02 . . . . 74.11 108.246 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.76 176.81 17.86 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.132 -1.032 . . . . 64.12 113.148 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -93.67 140.4 29.68 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.553 0.216 . . . . 71.11 110.632 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.27 117.33 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.254 -0.43 . . . . 72.33 110.667 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -75.9 -37.71 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 72.02 110.108 176.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -170.67 141.06 1.79 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.798 -0.637 . . . . 64.25 110.615 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.75 108.25 21.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.264 -0.88 . . . . 63.22 108.788 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -88.92 41.71 1.04 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.523 -0.308 . . . . 62.13 110.955 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 63.5 88.93 0.09 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.317 -0.856 . . . . 71.21 111.143 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.24 -30.55 9.66 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.656 -0.702 . . . . 60.5 112.448 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -120.65 162.66 19.29 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.214 0.206 . . . . 73.44 110.491 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.94 140.7 28.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.519 0.2 . . . . 73.23 111.019 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.619 ' HB3' HD21 ' A' ' 44' ' ' LEU . . . -93.02 116.57 29.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.51 -0.552 . . . . 71.01 109.51 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 127.21 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.398 -0.364 . . . . 74.44 110.66 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.0 tp -88.72 125.88 35.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.454 . . . . 72.32 110.889 176.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.593 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 91.4 m-85 -102.91 142.22 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.766 -0.652 . . . . 71.23 109.445 173.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -143.3 119.7 10.95 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.65 -0.5 . . . . 75.22 109.65 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.455 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 55.5 t30 -137.92 91.36 2.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 54.11 110.62 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.19 -91.76 0.83 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.747 -0.66 . . . . 64.0 112.473 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -114.49 -11.61 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 75.41 110.385 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.455 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 63.8 t90 -89.01 139.15 30.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 74.41 111.39 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.74 154.4 46.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.303 -0.862 . . . . 72.44 109.784 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -163.5 121.34 1.89 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.679 -0.691 . . . . 71.35 110.503 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.619 HD21 ' HB3' ' A' ' 33' ' ' ALA . 9.1 tt -91.03 113.76 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.244 -0.65 . . . . 74.44 109.244 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.593 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 44.3 t -123.14 129.05 75.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.364 . . . . 74.54 110.636 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.474 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.8 m -84.37 132.62 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.991 0.424 . . . . 72.43 110.585 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -128.44 -176.61 3.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.911 -0.586 . . . . 74.1 110.053 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.545 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 25.2 mtp180 -100.47 157.01 16.95 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.298 -0.631 . . . . 74.22 109.298 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.5 -23.04 50.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.059 0.457 . . . . 72.22 110.424 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -74.47 -18.04 60.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.667 -0.697 . . . . 65.34 110.315 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.545 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp0 -99.0 -4.63 32.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.58 . . . . 74.2 111.294 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 10' ' ' VAL . 84.0 mt -120.18 130.18 54.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.199 -0.455 . . . . 74.43 110.458 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.95 135.34 45.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.104 -0.702 . . . . 75.03 109.104 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 128.9 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.085 -0.507 . . . . 73.41 110.579 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.491 HG13 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -102.05 168.34 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.6 -0.889 . . . . 70.52 108.6 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.491 ' H ' HG13 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -104.73 138.28 19.46 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.579 -0.526 . . . . 74.14 109.579 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.87 144.21 67.91 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.716 2.278 . . . . 73.53 111.718 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.774 ' H ' HD12 ' A' ' 58' ' ' ILE . 1.9 mp -60.43 148.22 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.523 -0.547 . . . . 75.25 109.523 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.52 117.91 22.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.819 -0.628 . . . . 70.55 110.021 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.62 144.57 50.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.949 -0.76 . . . . 73.22 108.949 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -128.84 113.67 15.56 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.724 -0.39 . . . . 74.33 110.716 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -65.49 118.06 8.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.374 -0.602 . . . . 75.01 109.374 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -137.13 124.6 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.07 0.462 . . . . 75.41 111.377 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -77.42 143.99 38.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.939 -0.763 . . . . 75.14 108.939 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -59.45 104.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 74.11 111.578 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.398 -0.819 . . . . 72.23 109.143 175.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.847 -0.427 . . . . 75.1 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.2 mt -71.66 131.75 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.927 -0.397 . . . . 74.22 109.927 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 36.9 m-85 -149.4 167.48 12.94 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.678 -0.692 . . . . 75.23 110.028 -177.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.804 ' HG3' ' HA ' ' A' ' 26' ' ' ARG . 51.6 Cg_exo -53.83 124.33 15.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.696 2.264 . . . . 64.15 112.061 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.27 -16.3 35.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.129 -0.558 . . . . 73.2 112.036 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.26 155.27 30.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 71.02 110.792 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -98.39 130.37 45.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.341 -0.39 . . . . 62.44 110.401 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.48 157.45 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.435 . . . . 62.43 110.459 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -133.98 135.7 43.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.061 -0.518 . . . . 71.02 110.365 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.77 120.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 75.33 110.678 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.9 p -100.1 5.88 44.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 61.23 111.817 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.471 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.3 t30 -80.86 108.48 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 64.13 109.616 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.3 t -71.17 -28.14 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 74.01 111.528 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.45 -6.5 57.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 74.32 110.933 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.471 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 8.8 t70 -94.24 160.64 14.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.756 0.312 . . . . 74.05 110.306 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -82.92 -19.71 36.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.23 -0.441 . . . . 73.43 110.708 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.45 19.61 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 71.33 110.351 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.56 128.63 36.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.683 -0.69 . . . . 75.42 111.145 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 70.05 7.44 6.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.245 -0.889 . . . . 75.51 112.512 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.74 145.29 32.97 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.168 -0.678 . . . . 74.24 109.168 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -113.19 129.92 56.37 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.5 -0.773 . . . . 71.22 109.804 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.75 164.67 25.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.444 -0.884 . . . . 71.54 112.047 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.03 129.95 44.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 110.283 -0.266 . . . . 74.53 110.283 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.05 112.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 64.42 109.845 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -71.25 -37.68 71.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 74.11 109.524 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.804 ' HA ' ' HG3' ' A' ' 4' ' ' PRO . 33.0 ptt180 -174.78 150.22 1.27 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.086 -0.961 . . . . 72.25 109.011 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.18 128.57 45.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.552 -0.749 . . . . 74.11 109.414 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -124.94 78.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.877 -0.416 . . . . 72.52 109.877 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.3 t70 49.56 82.86 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.29 -0.868 . . . . 72.44 112.416 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 -12.39 19.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.98 -0.628 . . . . 63.31 113.209 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 59.1 mtpt -115.38 158.27 22.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.567 0.223 . . . . 71.15 110.513 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.62 131.46 27.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.475 -0.329 . . . . 71.3 110.361 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -83.63 105.43 14.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.413 -0.588 . . . . 72.15 109.413 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -92.26 121.01 42.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.265 -0.425 . . . . 62.02 110.812 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.3 tp -97.88 108.55 21.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.754 -0.461 . . . . 75.13 109.754 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -82.42 134.42 35.23 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.038 -0.727 . . . . 73.32 109.038 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.34 -54.92 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.555 . . . . 70.31 111.165 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.647 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 24.4 t-20 68.89 -48.22 0.58 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.971 0.508 . . . . 73.23 111.971 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.9 -48.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.203 -0.523 . . . . 62.15 111.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -132.25 4.93 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.585 1.183 . . . . 72.45 108.985 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.647 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 26.4 t90 -103.12 172.7 6.67 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.725 -1.58 . . . . 64.41 109.828 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.51 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 3.3 p30 -154.08 153.79 32.5 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.272 -0.27 . . . . 75.02 110.272 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.51 ' HE2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -175.52 109.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.531 -0.759 . . . . 62.4 110.237 175.192 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.9 tp -97.68 109.97 22.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.176 -0.305 . . . . 72.24 110.176 175.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.3 t -134.76 129.64 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 70.12 109.932 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -90.13 135.14 33.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.251 0.548 . . . . 63.42 110.683 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -130.38 -176.36 3.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.701 -0.851 . . . . 64.25 108.701 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.083 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 68.4 mtt180 -87.48 168.43 13.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.455 -0.572 . . . . 74.45 109.455 174.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.36 -24.07 42.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.135 -0.691 . . . . 75.01 109.135 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -80.46 -20.42 43.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.171 -0.922 . . . . 75.33 110.58 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 1.083 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 10.4 mm-40 -85.83 -14.39 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.363 0.601 . . . . 71.35 110.409 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.0 mt -115.42 155.7 26.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.567 -0.742 . . . . 74.32 110.151 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.87 133.58 52.7 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.409 -0.589 . . . . 72.13 109.409 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.3 120.59 22.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.233 -0.44 . . . . 41.34 109.845 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.524 HG11 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -80.85 166.6 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.447 -0.575 . . . . 74.43 109.447 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.524 ' H ' HG11 ' A' ' 55' ' ' VAL . 98.0 mttt -99.04 154.97 37.06 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.475 -0.329 . . . . 74.03 110.739 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.09 145.79 97.62 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.505 2.137 . . . . 72.2 111.425 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.77 ' H ' HD12 ' A' ' 58' ' ' ILE . 2.2 mp -67.34 153.03 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.123 0.487 . . . . 74.33 110.563 -175.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.4 118.72 31.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.487 -0.779 . . . . 72.54 109.847 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 72.04 130.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.043 0.839 . . . . 54.53 111.105 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -82.46 115.84 21.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.981 -0.554 . . . . 74.21 110.56 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.53 94.34 0.97 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.134 -1.062 . . . . 73.44 108.134 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -71.13 -19.38 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.332 0.864 . . . . 73.31 113.332 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 60.11 -152.8 0.39 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.791 -0.448 . . . . 74.43 109.791 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -123.41 116.03 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.312 -0.625 . . . . 52.1 109.312 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.577 -0.725 . . . . 65.04 110.358 -177.539 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.749 ' HA ' ' HE1' ' A' ' 1' ' ' MET . 1.7 tpt . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.793 0.33 . . . . 63.22 110.151 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 32.4 mt -77.92 136.51 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 75.52 110.451 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.69 159.92 69.77 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 115.898 -0.592 . . . . 73.25 109.751 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.84 127.76 23.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.504 2.136 . . . . 73.04 111.782 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.37 -5.68 52.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 71.05 112.618 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.7 146.28 26.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.63 0.253 . . . . 51.25 111.253 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 124.78 32.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.115 -0.493 . . . . 71.41 110.083 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.683 HG21 HD11 ' A' ' 52' ' ' LEU . 16.5 m -128.39 144.52 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 72.54 111.37 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.735 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 11.5 ttt85 -100.89 130.12 46.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.659 -0.701 . . . . 65.34 110.174 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.0 t -68.31 111.9 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.054 -0.721 . . . . 72.13 109.054 176.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -112.58 10.78 19.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.121 0.486 . . . . 64.43 111.806 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -82.35 112.73 19.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.784 -0.821 . . . . 65.33 108.784 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -66.56 -21.47 28.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.645 . . . . 71.11 111.431 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.81 -31.0 68.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.969 -0.56 . . . . 73.22 111.415 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.22 161.57 17.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 75.23 111.077 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 m -77.87 -23.29 48.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 75.54 111.53 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.6 m-85 -88.63 20.41 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.654 0.264 . . . . 74.52 111.57 -177.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -71.2 77.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 62.34 110.876 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 166.67 -30.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.02 -0.991 . . . . 70.44 109.675 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -78.38 151.21 32.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.678 -0.692 . . . . 74.45 111.539 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.735 ' HG2' ' HB2' ' A' ' 9' ' ' ARG . 29.3 mt-10 -125.38 122.95 38.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.094 -0.957 . . . . 74.22 109.509 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.77 -178.68 15.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.75 . . . . 72.35 112.472 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.07 135.94 42.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.764 0.316 . . . . 74.03 111.191 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.66 111.09 11.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.937 0.399 . . . . 71.35 110.04 175.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.84 -41.39 64.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.659 0.742 . . . . 62.3 109.669 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -164.95 138.53 4.81 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.575 -1.193 . . . . 73.31 109.569 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.501 HG11 HD23 ' A' ' 49' ' ' LEU . 60.3 t -95.21 139.77 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.396 -0.82 . . . . 55.34 109.77 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.525 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 6.0 t -130.43 63.29 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.475 -0.565 . . . . 62.53 109.475 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 16.25 81.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.291 1.436 . . . . 71.31 113.386 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.99 -41.83 1.87 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.673 -1.149 . . . . 71.05 110.672 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.578 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 51.7 mmtt -109.78 167.35 10.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.76 0.424 . . . . 71.34 110.195 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.4 139.06 9.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.211 -0.45 . . . . 51.13 110.147 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -90.9 114.57 27.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.942 -0.392 . . . . 65.03 109.942 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.471 HG22 HD22 ' A' ' 52' ' ' LEU . 42.2 t -99.21 120.29 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 74.21 110.819 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.9 tp -97.65 114.52 26.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.566 -0.531 . . . . 62.04 109.566 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.4 141.97 30.46 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.95 -0.568 . . . . 73.1 109.925 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.49 113.94 11.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 72.2 109.648 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -142.39 79.71 1.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.062 0.458 . . . . 74.13 110.936 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.42 -104.04 2.12 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.848 -0.615 . . . . 71.24 112.656 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -96.78 -16.58 20.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.665 0.745 . . . . 64.12 109.625 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -95.04 141.17 29.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.211 -0.904 . . . . 75.23 111.239 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -153.39 150.91 29.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.88 -1.055 . . . . 75.31 109.527 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HE2' ' CG2' ' A' ' 45' ' ' VAL . 87.3 tttt -158.09 131.31 7.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.058 -0.519 . . . . 72.22 110.27 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.458 HD13 ' HB2' ' A' ' 33' ' ' ALA . 56.9 tp -99.81 110.7 23.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.358 -0.383 . . . . 71.13 110.3 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.447 ' CG2' ' HE2' ' A' ' 43' ' ' LYS . 40.2 t -124.27 120.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.981 0.419 . . . . 64.53 110.425 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.557 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.2 m -75.88 130.01 37.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.206 0.527 . . . . 73.4 110.493 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -125.28 -171.06 2.28 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.504 -0.771 . . . . 73.22 108.979 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.7 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 19.9 mtm180 -99.33 171.04 8.23 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.466 -0.568 . . . . 74.11 109.466 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.501 HD23 HG11 ' A' ' 27' ' ' VAL . 75.3 mt -76.6 -30.99 57.18 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.014 0.435 . . . . 64.22 110.039 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 p -71.58 -12.78 61.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.718 -0.674 . . . . 72.23 110.345 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.7 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 4.8 mm-40 -86.67 -14.68 41.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 73.3 110.744 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.683 HD11 HG21 ' A' ' 8' ' ' VAL . 79.7 mt -110.74 130.67 55.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.283 0.563 . . . . 74.3 112.403 -168.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -109.89 116.0 30.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.35 -0.841 . . . . 75.31 109.081 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 131.35 50.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.343 . . . . 74.35 110.485 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.57 HG13 ' H ' ' A' ' 56' ' ' LYS . 2.7 t -80.54 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.245 -0.65 . . . . 72.12 109.245 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.57 ' H ' HG13 ' A' ' 55' ' ' VAL . 62.9 pttt -67.17 142.53 97.05 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 110.076 -0.342 . . . . 62.51 110.076 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.17 154.11 54.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.407 2.071 . . . . 72.34 111.103 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.719 ' H ' HD11 ' A' ' 58' ' ' ILE . 1.8 mp -58.26 147.47 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 75.14 109.926 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.765 ' H ' HD22 ' A' ' 59' ' ' LEU . 1.6 pt? -85.06 102.44 13.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.556 -0.747 . . . . 72.2 110.665 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.414 ' HB2' ' H ' ' A' ' 61' ' ' HIS . 30.7 mt-10 -111.27 -82.95 0.58 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.818 -0.628 . . . . 70.31 109.683 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' H ' ' HB2' ' A' ' 60' ' ' GLU . 81.2 m-70 -145.43 138.56 26.28 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 74.44 109.535 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.74 91.2 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.933 -0.395 . . . . 74.24 109.933 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -68.58 142.62 55.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.057 -0.719 . . . . 73.42 109.057 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -72.41 159.83 33.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.986 0.422 . . . . 63.22 111.459 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -68.97 169.74 11.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.507 -0.769 . . . . 73.2 111.924 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.0 t60 . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.044 -0.98 . . . . 74.32 110.208 176.479 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.963 0.411 . . . . 75.24 110.342 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.575 HG12 ' HB3' ' A' ' 54' ' ' ALA . 48.1 mt -122.33 138.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.976 -0.557 . . . . 71.01 109.796 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -119.64 153.08 54.14 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.056 -0.52 . . . . 75.02 110.753 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.17 130.81 28.28 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.619 2.213 . . . . 74.32 111.463 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.435 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 103.39 -13.1 54.8 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 74.03 112.16 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 150.63 24.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 64.0 111.232 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -87.24 130.27 34.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.716 -0.674 . . . . 72.0 109.882 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 54' ' ' ALA . 22.9 m -128.93 152.29 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.898 0.38 . . . . 75.21 110.601 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.426 ' HD2' ' OE2' ' A' ' 53' ' ' GLU . 44.7 ttm180 -110.46 138.05 47.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.246 -0.65 . . . . 73.12 109.246 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.404 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.5 t -76.25 113.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.907 0.384 . . . . 70.54 110.818 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -96.87 2.32 51.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 74.4 110.577 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.8 115.26 11.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.528 -0.76 . . . . 65.02 110.32 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.77 -8.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.422 0.63 . . . . 71.42 110.471 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.37 -37.81 88.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 64.35 110.637 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.468 ' OD2' ' HD2' ' A' ' 17' ' ' TYR . 13.6 t70 -103.45 173.47 6.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 72.23 109.877 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -88.94 -12.1 42.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.713 0.264 . . . . 73.31 111.713 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.468 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 58.4 m-85 -79.27 30.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 73.41 112.068 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.432 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 86.2 t80 -70.54 138.31 50.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 75.4 109.432 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.432 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 41.3 mtt180 70.59 18.96 6.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.506 0.504 . . . . 74.44 112.049 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -93.73 150.74 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 72.41 110.522 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -103.57 121.52 43.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.221 -0.9 . . . . 73.11 109.341 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.84 162.84 23.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.508 -0.853 . . . . 63.11 112.318 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.435 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.6 tt -116.74 123.69 47.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.703 -0.48 . . . . 65.44 109.703 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.455 HG11 ' HB1' ' A' ' 32' ' ' ALA . 75.6 t -65.74 114.85 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 72.24 110.954 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -79.21 -35.46 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.366 0.603 . . . . 63.45 110.145 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -165.68 154.47 11.66 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.136 -0.938 . . . . 72.42 108.923 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.75 126.36 68.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.535 -0.757 . . . . 72.13 109.305 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.7 t -125.43 84.98 2.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.55 -0.296 . . . . 71.02 110.8 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 40.59 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.263 0.977 . . . . 52.05 112.969 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.09 -29.9 9.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.586 -0.816 . . . . 71.34 112.804 177.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.412 ' HB3' HG23 ' A' ' 46' ' ' THR . 41.4 mttt -109.71 163.82 13.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.995 0.426 . . . . 71.24 111.379 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB1' HG11 ' A' ' 24' ' ' VAL . . . -143.7 137.14 27.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 71.32 109.93 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.572 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -83.82 105.34 14.64 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.961 -0.385 . . . . 71.13 109.961 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.77 118.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.18 -0.463 . . . . 72.31 110.925 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.34 118.79 31.71 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.638 -0.504 . . . . 73.42 109.638 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -86.76 147.35 25.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.941 -0.572 . . . . 74.24 109.93 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -135.54 119.99 18.03 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 71.23 108.988 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -138.97 42.26 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.565 0.697 . . . . 72.22 110.046 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.18 -102.54 2.42 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 44.45 111.671 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -93.29 -32.87 14.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.211 0.529 . . . . 72.41 109.793 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -74.96 140.63 43.81 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.491 -0.777 . . . . 73.32 111.007 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.9 165.62 27.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.66 -1.155 . . . . 74.04 108.77 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -164.7 137.93 4.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.144 -0.317 . . . . 72.31 110.144 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.572 HD11 ' HB3' ' A' ' 33' ' ' ALA . 47.8 tp -109.16 109.24 20.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.809 0.338 . . . . 73.1 110.178 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -124.44 124.06 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.064 0.459 . . . . 74.0 110.265 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.412 HG23 ' HB3' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -87.33 111.13 20.76 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.393 0.616 . . . . 73.22 110.796 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.78 178.1 4.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.245 -0.889 . . . . 70.43 109.455 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.731 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 54.0 mtt85 -88.9 159.19 17.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.706 -0.479 . . . . 71.12 109.706 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 94.0 mt -71.45 -26.91 62.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.343 0.592 . . . . 74.11 109.792 -176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 p -80.0 -12.03 59.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.289 -0.869 . . . . 71.41 109.994 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.731 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.5 mt-10 -98.93 3.08 47.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.838 -0.619 . . . . 74.5 110.558 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.01 153.55 46.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 71.43 110.361 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.426 ' OE2' ' HD2' ' A' ' 9' ' ' ARG . 11.7 pt-20 -118.28 123.14 44.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 74.22 109.28 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.717 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -78.5 123.86 27.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.319 -0.4 . . . . 73.33 110.03 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.548 HG11 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -86.37 164.7 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.899 -0.778 . . . . 63.31 108.899 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.548 ' H ' HG11 ' A' ' 55' ' ' VAL . 34.0 ttpt 63.27 111.4 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 123.906 0.753 . . . . 75.44 110.495 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.07 151.66 64.76 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.436 2.091 . . . . 73.34 111.92 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.759 ' H ' HD11 ' A' ' 58' ' ' ILE . 3.0 mp -63.33 158.96 3.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.602 -0.518 . . . . 74.21 109.602 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.816 ' HG ' ' H ' ' A' ' 60' ' ' GLU . 30.6 tp 73.0 -172.08 0.14 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.763 0.664 . . . . 71.52 109.384 -174.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.816 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 32.2 mt-10 -93.48 150.73 20.22 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.688 -0.486 . . . . 65.42 109.688 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -48.62 126.75 12.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.191 0.519 . . . . 65.32 111.11 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -129.19 165.51 21.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.484 -0.78 . . . . 71.31 110.602 -173.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.21 114.08 13.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.286 -0.415 . . . . 64.45 110.975 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -71.53 173.53 7.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.453 -0.34 . . . . 75.41 110.943 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -64.25 -64.68 0.82 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.299 0.571 . . . . 72.13 109.751 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 C--O 1.249 1.039 0 N-CA-C 108.906 -0.776 . . . . 72.15 108.906 175.41 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptm . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.058 0.456 . . . . 73.45 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.487 HG12 ' HB1' ' A' ' 54' ' ' ALA . 41.1 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.234 0.54 . . . . 73.44 111.444 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -130.77 154.64 81.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 75.41 109.714 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.82 119.15 6.11 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.354 2.036 . . . . 75.43 111.425 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.24 -3.83 31.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 43.43 111.949 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.15 153.77 19.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 73.02 110.811 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -91.82 132.44 36.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.564 . . . . 72.42 110.29 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.64 160.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.0 0.428 . . . . 64.31 110.828 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -124.81 130.59 52.69 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.884 -0.784 . . . . 72.23 108.884 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.2 t -68.73 108.81 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.155 0.503 . . . . 65.33 110.767 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -88.13 -17.98 29.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.484 -0.78 . . . . 72.11 110.416 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.474 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 42.7 t30 -66.85 106.99 2.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 71.22 110.573 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.22 -24.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 74.14 110.54 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.01 -27.09 67.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.362 -0.835 . . . . 71.14 111.189 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.474 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 11.2 t70 -85.86 164.94 17.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.2 -0.455 . . . . 63.01 110.766 -176.221 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -82.65 -23.77 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.346 -0.388 . . . . 72.33 110.705 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.38 21.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.949 0.404 . . . . 72.21 111.026 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.476 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 29.9 t80 -63.19 133.04 53.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.032 -0.531 . . . . 73.33 110.268 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.476 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 62.8 mtt180 76.66 3.23 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.621 0.768 . . . . 72.34 112.22 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.5 157.21 21.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.885 0.374 . . . . 75.35 110.251 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -118.05 141.94 47.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 72.32 110.122 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.55 165.19 33.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.551 -0.833 . . . . 54.42 111.793 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -104.43 131.52 51.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 110.26 -0.274 . . . . 73.23 110.26 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.49 HG13 HG23 ' A' ' 27' ' ' VAL . 59.9 t -70.46 117.08 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.023 -0.535 . . . . 74.02 110.199 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.414 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 29.3 mm-40 -83.33 -31.7 26.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.496 0.665 . . . . 75.34 110.279 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -158.18 128.55 6.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.96 -1.018 . . . . 73.33 110.373 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.49 HG23 HG13 ' A' ' 24' ' ' VAL . 57.8 t -98.38 120.14 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.572 -0.74 . . . . 75.42 110.036 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.5 m -102.09 -178.86 3.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.053 -0.721 . . . . 74.31 109.053 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.18 81.93 3.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.342 0.592 . . . . 70.22 110.069 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.401 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 121.84 -31.24 5.04 Favored Glycine 0 C--N 1.318 -0.444 0 CA-C-N 115.364 -0.834 . . . . 74.11 112.447 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -120.28 159.79 24.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.868 0.366 . . . . 52.35 111.262 -177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.0 135.92 36.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.047 -0.524 . . . . 75.51 109.812 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.579 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -89.19 109.36 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.909 0.385 . . . . 37.46 110.263 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.0 126.58 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 64.43 110.423 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.414 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 34.4 tp -90.79 123.61 34.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 74.54 110.666 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 88.6 m-85 -107.85 134.0 51.41 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.55 -0.907 . . . . 74.11 108.55 171.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -143.05 128.69 19.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.972 0.415 . . . . 72.12 110.392 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -134.31 74.9 1.56 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.415 -0.587 . . . . 60.44 109.415 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.34 -97.82 0.35 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.684 -0.689 . . . . 40.01 112.554 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.55 -22.5 24.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.266 0.555 . . . . 71.21 110.201 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.447 ' HZ2' ' HD2' ' A' ' 43' ' ' LYS . 87.1 t90 -91.75 146.93 23.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 74.04 110.983 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -150.27 159.07 44.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.442 -0.799 . . . . 63.15 110.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 11.9 mttm -163.88 133.49 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.688 -0.687 . . . . 63.45 110.828 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.7 tp -106.3 104.12 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.523 . . . . 71.24 109.587 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.433 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 29.0 t -113.53 118.04 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.071 0.463 . . . . 74.44 110.411 -176.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.579 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.4 m -82.81 130.28 35.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.875 -0.602 . . . . 64.14 110.469 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.468 ' HB2' HD11 ' A' ' 52' ' ' LEU . 91.2 m-85 -123.13 178.97 4.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.607 -0.724 . . . . 61.24 109.062 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.516 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 57.7 mtp180 -96.63 162.83 13.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.048 0.451 . . . . 72.54 110.563 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.408 HD22 HD11 ' A' ' 2' ' ' ILE . 94.4 mt -76.3 -22.92 54.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.929 -0.578 . . . . 55.24 110.41 -173.514 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 p -85.76 -8.26 58.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 70.15 109.92 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.516 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.7 mt-10 -98.89 -8.31 25.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 64.42 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.498 HD23 ' HA ' ' A' ' 10' ' ' VAL . 57.1 mt -124.15 151.61 43.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.85 -0.614 . . . . 71.14 110.45 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 147.97 37.17 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.203 -0.665 . . . . 74.44 109.203 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.487 ' HB1' HG12 ' A' ' 2' ' ' ILE . . . -89.27 126.9 35.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.043 0.449 . . . . 61.21 110.937 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.758 HG11 ' H ' ' A' ' 56' ' ' LYS . 2.9 t -100.38 -175.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.018 -1.105 . . . . 71.53 108.018 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.758 ' H ' HG11 ' A' ' 55' ' ' VAL . 86.5 tttt 70.31 109.29 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 121.322 0.582 . . . . 74.14 110.774 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -61.86 142.37 93.15 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.835 2.357 . . . . 64.03 112.867 -176.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mt -71.7 159.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.823 -0.626 . . . . 73.23 109.52 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -85.71 113.03 21.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.999 0.428 . . . . 72.53 110.281 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.464 ' CD ' ' H ' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -151.21 -171.01 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.269 -1.011 . . . . 70.21 108.269 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.464 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 64.9 m80 -87.49 -72.9 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 74.12 109.451 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -150.65 168.19 25.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.632 -0.713 . . . . 72.33 109.2 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -103.65 157.61 16.94 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.618 -0.512 . . . . 64.24 109.618 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -86.06 156.67 20.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.226 -0.443 . . . . 73.35 110.378 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -65.37 155.28 35.86 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.793 -0.447 . . . . 75.23 109.793 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.7 m170 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.356 -0.831 . . . . 74.42 109.714 -179.101 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.993 0.425 . . . . 61.53 110.353 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.4 mt -126.28 140.79 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.501 . . . . 74.33 109.946 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -133.94 152.65 78.96 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.193 -0.458 . . . . 73.04 110.726 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HG3' ' H ' ' A' ' 27' ' ' VAL . 24.1 Cg_exo -64.4 123.1 11.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.73 2.287 . . . . 73.45 111.565 176.015 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.58 -0.81 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.017 -0.611 . . . . 60.41 112.089 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.88 145.41 32.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.848 0.356 . . . . 70.04 111.043 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -84.93 131.18 34.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.757 -0.656 . . . . 73.21 110.021 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.483 HG12 ' HA ' ' A' ' 54' ' ' ALA . 32.7 m -129.46 150.85 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.778 0.323 . . . . 62.14 110.832 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 9' ' ' ARG . 17.3 ttt85 -104.33 134.83 46.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.856 -0.424 . . . . 62.43 109.856 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.457 ' HA ' HD21 ' A' ' 52' ' ' LEU . 49.0 t -60.9 114.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.284 -0.416 . . . . 75.13 110.131 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -98.05 -9.73 25.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.39 0.614 . . . . 73.4 110.184 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.688 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 36.0 t30 -74.25 113.89 11.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 74.24 110.556 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.46 -26.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 60.13 110.889 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.64 -30.25 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 62.42 111.408 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -75.37 158.49 32.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 65.23 111.418 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -90.42 -12.31 37.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.817 -0.628 . . . . 71.44 110.938 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -98.51 21.4 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 72.25 110.169 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.404 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 48.1 t80 -66.63 80.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.7 . . . . 64.13 111.3 -177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.404 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 12.7 ptm180 165.22 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.728 -1.124 . . . . 75.35 109.206 177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -76.73 152.44 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.491 0.662 . . . . 75.25 111.854 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -119.42 109.78 16.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.856 -1.065 . . . . 74.34 109.232 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.05 174.89 15.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.726 -0.75 . . . . 44.44 112.565 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.4 HD23 ' HA ' ' A' ' 23' ' ' LEU . 1.2 tm? -102.38 126.54 49.43 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.592 -0.521 . . . . 54.42 109.592 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.0 t -78.3 112.44 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.263 -0.273 . . . . 75.44 110.263 176.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -79.11 -34.39 43.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.956 0.407 . . . . 74.24 110.551 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -164.01 134.63 4.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.899 -0.591 . . . . 74.12 110.41 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.429 ' H ' ' HG3' ' A' ' 4' ' ' PRO . 96.9 t -91.58 123.3 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.386 -0.825 . . . . 75.22 109.096 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.6 t -126.91 91.36 3.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.702 0.286 . . . . 64.1 110.765 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 49.94 75.88 0.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 53.42 112.586 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.33 -20.99 6.42 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.06 -0.59 . . . . 43.11 113.404 176.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.563 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 55.8 mtpt -110.48 165.48 11.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.767 -0.255 . . . . 73.2 110.607 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.477 ' HB3' HD23 ' A' ' 49' ' ' LEU . . . -142.79 141.25 31.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 72.03 110.48 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.14 107.8 19.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.578 -0.527 . . . . 70.11 109.578 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.8 t -102.85 118.87 50.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.974 -0.557 . . . . 74.11 110.897 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.68 119.28 31.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.837 -0.619 . . . . 64.4 110.74 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.495 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 47.3 m-85 -89.59 134.12 34.28 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.594 -1.262 . . . . 71.55 107.594 169.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -149.38 124.39 10.02 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.934 -0.395 . . . . 72.12 109.934 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.12 86.09 1.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 74.2 110.667 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.7 -93.73 0.94 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.625 -0.716 . . . . 75.04 113.516 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -91.63 -21.97 20.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.869 0.366 . . . . 72.0 111.217 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t90 -111.07 143.5 41.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.315 0.578 . . . . 73.04 111.857 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.495 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 4.2 p-10 -147.99 153.06 38.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.664 -1.153 . . . . 74.14 109.176 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HG3' HG21 ' A' ' 45' ' ' VAL . 57.1 tptt -160.39 111.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.169 -0.469 . . . . 73.42 110.594 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -92.09 104.71 17.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 71.51 110.082 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.404 HG21 ' HG3' ' A' ' 43' ' ' LYS . 21.1 t -117.88 125.74 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 55.45 109.958 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.458 HG23 ' HE2' ' A' ' 31' ' ' LYS . 4.4 m -85.03 130.83 34.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.076 -0.511 . . . . 64.43 110.607 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.716 ' HB2' HD12 ' A' ' 52' ' ' LEU . 88.1 m-85 -126.53 -175.27 3.34 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.684 -0.689 . . . . 70.23 109.772 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.873 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 15.8 mmt180 -88.91 161.33 16.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.445 . . . . 73.55 109.8 174.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.477 HD23 ' HB3' ' A' ' 32' ' ' ALA . 94.0 mt -83.41 -27.03 29.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.56 0.695 . . . . 74.52 109.343 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -76.45 -10.17 59.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.066 -0.97 . . . . 74.55 110.8 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.873 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 19.1 pt-20 -117.22 16.57 14.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.367 -0.533 . . . . 74.43 111.278 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.716 HD12 ' HB2' ' A' ' 47' ' ' PHE . 95.8 mt -131.86 154.35 49.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.857 -0.611 . . . . 71.3 109.97 175.49 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -149.06 141.37 24.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.624 -0.51 . . . . 73.52 109.624 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.483 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.3 138.34 51.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 64.35 111.594 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.576 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -86.15 171.08 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.544 -0.753 . . . . 64.14 109.057 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.576 ' H ' HG12 ' A' ' 55' ' ' VAL . 93.3 mttt -121.22 158.43 53.08 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 116.685 -0.234 . . . . 73.31 110.457 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.33 131.21 41.63 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.087 1.858 . . . . 70.22 110.016 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.718 ' H ' HD12 ' A' ' 58' ' ' ILE . 3.0 mp -62.84 149.69 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.318 0.58 . . . . 74.33 109.833 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.568 HD21 ' H ' ' A' ' 59' ' ' LEU . 2.0 pt? -111.47 146.3 37.48 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.411 -0.813 . . . . 75.4 109.728 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.15 92.93 1.77 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.311 0.577 . . . . 71.5 109.54 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.12 116.28 22.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.392 -0.822 . . . . 75.53 109.965 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.542 ' O ' ' HD2' ' A' ' 64' ' ' HIS . 11.9 m-70 -95.11 158.53 15.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.768 -0.651 . . . . 74.11 111.164 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.442 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 5.9 p80 -66.23 102.3 0.82 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.302 -0.863 . . . . 75.32 109.623 169.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.542 ' HD2' ' O ' ' A' ' 62' ' ' HIS . 4.2 p80 -142.33 80.46 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.7 0.762 . . . . 75.11 111.595 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -136.84 71.61 1.41 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.934 -0.575 . . . . 74.4 110.607 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.599 -0.715 . . . . 73.51 109.367 177.36 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 111.179 0.066 . . . . 63.45 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.9 mt 69.94 147.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.281 0.563 . . . . 73.11 110.928 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -95.19 139.78 22.16 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 75.13 110.752 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -67.67 137.94 43.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.636 2.224 . . . . 73.52 111.458 177.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.22 4.37 64.58 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.844 -0.694 . . . . 72.21 111.799 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.44 161.68 13.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.617 0.246 . . . . 72.33 110.446 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -87.43 131.26 34.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.091 -0.504 . . . . 75.14 110.239 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.69 150.29 34.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 73.43 111.055 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.437 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.9 ttp180 -117.41 142.22 47.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.754 -0.657 . . . . 73.24 109.366 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.8 t -77.86 105.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.742 -0.466 . . . . 72.43 109.742 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -89.52 -4.21 58.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 72.33 111.053 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.607 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 58.0 t30 -69.38 102.86 1.85 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.7 -0.482 . . . . 73.31 109.7 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.505 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 22.4 t -63.03 -35.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.73 . . . . 54.21 112.14 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.96 -10.94 59.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.027 0.441 . . . . 71.01 111.597 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.607 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 5.6 t70 -84.4 160.37 20.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.012 -0.43 . . . . 72.24 110.7 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 m -71.06 -32.37 69.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 74.31 110.507 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 91.2 m-85 -87.86 21.13 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 73.32 111.25 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.505 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 32.9 t80 -59.27 132.25 53.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.02 0.438 . . . . 75.52 111.146 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 74.81 -3.8 2.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.924 -1.034 . . . . 65.33 111.917 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -77.78 149.87 34.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 75.34 109.652 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.437 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 37.1 mt-10 -125.34 136.2 53.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.55 . . . . 70.04 110.726 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.12 -171.24 17.62 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.009 -0.836 . . . . 73.34 111.009 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.423 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.9 mp -112.85 150.8 31.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.431 0.616 . . . . 71.3 110.923 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.01 115.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 75.34 110.231 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -79.58 -28.24 41.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 75.21 110.71 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -170.28 133.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 72.42 110.665 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.536 HG12 HD23 ' A' ' 49' ' ' LEU . 58.0 t -93.88 135.4 28.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.318 -0.855 . . . . 72.24 109.786 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t -107.34 -159.94 0.71 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.929 -0.397 . . . . 75.3 109.929 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.8 -33.83 72.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.525 0.678 . . . . 71.32 111.709 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -155.16 -12.46 0.06 OUTLIER Glycine 0 C--N 1.31 -0.865 0 CA-C-N 114.791 -1.095 . . . . 54.43 112.319 178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.46 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 63.8 mttp -104.27 172.09 6.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.844 0.354 . . . . 71.35 111.255 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.11 140.87 21.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 73.53 110.03 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.61 111.73 22.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.692 -0.484 . . . . 73.52 109.692 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.423 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 40.1 t -104.17 122.77 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 63.44 111.067 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.46 121.59 31.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.131 -0.486 . . . . 75.22 110.269 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.452 ' CE2' ' HE2' ' A' ' 47' ' ' PHE . 96.4 m-85 -101.41 151.96 21.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.993 -0.549 . . . . 71.43 110.244 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -122.32 -63.46 1.28 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.891 -0.595 . . . . 75.44 110.168 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.08 -57.32 0.42 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.538 0.735 . . . . 73.45 111.525 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . 158.35 102.55 0.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.904 -0.878 . . . . 72.13 110.904 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 24.9 t30 75.09 -40.59 0.44 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.422 0.689 . . . . 74.33 110.623 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.437 ' H ' ' C ' ' A' ' 39' ' ' GLY . 43.5 t90 -64.26 154.68 34.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.521 -0.763 . . . . 70.22 110.7 176.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -152.62 143.7 23.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.099 0.476 . . . . 74.34 109.882 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -168.22 125.25 1.08 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.568 -0.742 . . . . 74.11 109.904 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -100.09 102.55 13.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.3 -0.63 . . . . 71.41 109.3 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.35 120.04 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.061 -0.518 . . . . 53.21 110.609 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.23 129.25 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.942 -0.572 . . . . 72.4 110.269 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.452 ' HE2' ' CE2' ' A' ' 36' ' ' PHE . 45.2 m-85 -126.99 -174.37 3.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.938 -0.574 . . . . 72.23 109.542 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.554 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 33.5 mtt180 -103.93 162.13 13.39 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.462 -0.57 . . . . 72.15 109.462 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.536 HD23 HG12 ' A' ' 27' ' ' VAL . 90.4 mt -73.06 -33.8 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.261 -0.427 . . . . 71.54 110.508 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -73.44 -16.08 61.32 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.751 -0.659 . . . . 70.43 110.579 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 3.5 mp0 -89.95 -8.85 50.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.827 -0.624 . . . . 74.04 111.387 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.88 157.39 25.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.341 -0.391 . . . . 74.51 111.391 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.54 148.42 52.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.045 -0.724 . . . . 74.01 109.045 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.37 121.73 21.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.995 0.426 . . . . 71.35 110.067 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.673 HG11 ' H ' ' A' ' 56' ' ' LYS . 12.4 t -76.05 170.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.194 -0.669 . . . . 72.41 109.194 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.673 ' H ' HG11 ' A' ' 55' ' ' VAL . 1.8 mppt? -107.37 128.98 24.93 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 115.732 -0.667 . . . . 63.44 109.378 -175.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -52.06 138.51 53.12 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.525 2.15 . . . . 65.35 111.362 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.765 ' H ' HD12 ' A' ' 58' ' ' ILE . 1.4 mp -61.85 146.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.508 . . . . 74.03 109.693 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.55 HD13 ' HD2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -148.02 -178.56 6.35 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.419 -0.81 . . . . 71.33 110.944 -170.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.24 115.2 29.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.065 0.459 . . . . 64.41 110.554 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.55 ' HD2' HD13 ' A' ' 59' ' ' LEU . 55.6 m-70 -135.59 120.24 18.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.728 -0.669 . . . . 72.11 109.436 170.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -66.85 130.91 44.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.983 0.42 . . . . 74.34 110.138 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -69.71 160.0 32.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.493 -0.776 . . . . 74.43 111.431 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -46.52 143.13 2.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.075 -0.966 . . . . 73.51 112.01 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -93.9 137.21 33.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.043 -0.526 . . . . 74.13 110.438 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.51 -0.757 . . . . 73.21 110.295 178.604 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.871 0.367 . . . . 70.23 110.599 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.439 ' O ' HG21 ' A' ' 27' ' ' VAL . 48.8 mt -125.34 140.96 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 74.45 109.341 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -115.79 149.24 42.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.595 0.236 . . . . 74.42 110.98 -177.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -62.13 142.79 93.33 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.607 2.205 . . . . 64.25 111.744 176.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.58 -7.85 65.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.975 -0.631 . . . . 54.22 112.128 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 143.6 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.929 0.395 . . . . 75.15 110.864 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -80.59 125.03 29.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 74.12 109.907 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 54' ' ' ALA . 17.6 m -130.1 148.22 33.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.314 0.578 . . . . 63.42 111.349 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -111.76 133.85 53.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.285 -0.87 . . . . 63.32 109.3 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.418 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.3 t -80.08 101.17 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.576 -0.527 . . . . 75.42 109.576 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -103.31 13.7 33.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.895 -0.593 . . . . 64.45 110.526 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.9 t30 -61.6 107.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.533 -0.914 . . . . 71.43 108.533 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.84 -47.04 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 74.12 112.298 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.58 40.57 1.18 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.363 0.602 . . . . 71.53 110.537 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.508 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 6.1 t70 -110.44 161.13 15.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.129 -0.487 . . . . 74.41 110.111 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -81.14 -23.17 38.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.591 . . . . 70.31 110.104 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' CD1' ' HZ ' ' A' ' 47' ' ' PHE . 73.7 m-85 -98.66 24.72 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 75.32 110.848 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 46.0 t80 -62.44 127.88 33.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.954 -0.566 . . . . 74.35 110.023 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 17.4 mtp180 76.12 10.54 3.09 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.057 0.848 . . . . 72.02 112.308 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -87.66 148.26 24.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.425 -0.583 . . . . 71.55 109.425 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -128.73 142.48 50.99 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.702 -0.681 . . . . 73.04 110.401 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -166.96 -169.03 30.03 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.82 -0.705 . . . . 53.41 111.709 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.77 136.66 52.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.716 0.293 . . . . 72.22 110.914 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.36 122.91 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 62.33 109.654 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.403 ' HG3' HD12 ' A' ' 44' ' ' LEU . 31.2 mm-40 -89.4 -33.09 16.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.285 0.564 . . . . 71.14 110.177 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -169.03 136.55 1.88 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.289 -0.869 . . . . 74.45 110.204 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.601 HG12 ' H ' ' A' ' 29' ' ' ASP . 43.7 t -103.35 142.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.485 -0.78 . . . . 74.23 109.689 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 t -121.91 34.8 5.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.078 0.466 . . . . 73.55 109.868 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.601 ' H ' HG12 ' A' ' 27' ' ' VAL . 24.4 m-20 50.04 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.953 -1.021 . . . . 73.51 111.533 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.29 -46.26 1.19 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.842 -0.903 . . . . 53.11 110.842 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 30.5 mtpp -112.28 161.02 17.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.844 -0.428 . . . . 75.0 109.844 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.55 142.63 21.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.751 -0.204 . . . . 51.44 110.556 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.623 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -91.67 115.48 28.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 75.23 109.593 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.637 HG21 HD23 ' A' ' 52' ' ' LEU . 18.3 t -100.67 124.79 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.119 -0.491 . . . . 73.52 110.594 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.6 tp -94.92 107.29 19.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 73.2 109.579 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.488 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 81.4 m-85 -86.63 142.33 28.33 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.16 -0.682 . . . . 71.5 109.16 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -140.1 131.32 26.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.96 0.41 . . . . 71.51 110.449 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.47 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 3.2 t-20 -141.14 91.07 2.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 72.12 108.951 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.66 -114.61 4.04 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.651 -0.704 . . . . 71.0 111.774 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -89.87 -30.24 18.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.622 0.725 . . . . 71.35 109.079 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.47 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 65.8 t90 -72.27 138.9 47.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.994 -1.003 . . . . 75.24 111.556 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.14 155.17 44.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.824 -1.08 . . . . 65.03 109.181 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.439 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 76.4 tttt -153.97 120.18 5.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.458 -0.337 . . . . 71.44 110.516 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.505 HD11 ' HB3' ' A' ' 33' ' ' ALA . 62.6 tp -93.88 110.4 22.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 73.13 110.566 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.488 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 25.3 t -126.2 127.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.014 -0.539 . . . . 71.24 109.799 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.623 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.5 m -83.26 133.0 35.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.247 0.546 . . . . 63.52 110.826 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.461 ' HZ ' ' CD1' ' A' ' 17' ' ' TYR . 55.7 m-85 -131.83 -160.15 1.02 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.425 -0.807 . . . . 70.1 109.656 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.784 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 63.7 mtm180 -109.08 173.66 6.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.77 -0.455 . . . . 75.34 109.77 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.405 HD22 HG11 ' A' ' 27' ' ' VAL . 95.5 mt -81.45 -28.56 34.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.116 0.484 . . . . 72.41 109.912 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 p -68.9 -17.86 64.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.675 -0.693 . . . . 55.22 110.178 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.784 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.3 mm-40 -86.62 -13.07 46.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.865 -0.607 . . . . 73.11 110.622 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.637 HD23 HG21 ' A' ' 34' ' ' VAL . 87.5 mt -112.73 140.93 47.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 73.21 112.144 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -117.0 112.8 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.699 -0.682 . . . . 63.34 109.714 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.416 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -65.78 134.26 52.76 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.865 -0.421 . . . . 55.11 109.865 176.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.537 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 2.1 t -80.3 157.76 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.586 -0.524 . . . . 52.54 109.586 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.537 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 12.9 pttm 55.65 146.88 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.945 1.298 . . . . 73.33 112.739 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.48 157.5 58.81 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.439 2.092 . . . . 73.52 112.021 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mt -64.81 150.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.33 -0.619 . . . . 75.23 109.33 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD11 ' HE2' ' A' ' 56' ' ' LYS . 5.3 mp -103.46 115.16 30.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.57 0.581 . . . . 71.13 112.57 -167.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 59.02 92.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.085 -0.961 . . . . 73.02 113.238 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -139.2 164.3 30.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.061 -0.518 . . . . 74.42 110.147 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -84.3 111.57 19.52 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.154 -0.684 . . . . 75.13 109.154 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -127.26 134.29 50.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.005 -0.543 . . . . 75.41 110.089 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.99 120.02 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 73.54 109.964 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.38 133.76 43.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 74.45 110.957 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.932 -0.766 . . . . 74.34 108.932 174.708 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.421 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 17.3 tpt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.366 0.126 . . . . 72.25 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.581 HD12 HD22 ' A' ' 49' ' ' LEU . 72.7 mt 74.83 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 123.667 0.604 . . . . 74.41 110.18 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -131.16 146.09 60.55 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.309 -0.405 . . . . 73.31 110.639 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.77 125.6 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.54 2.16 . . . . 73.44 111.207 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.12 -3.0 47.57 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.051 -0.595 . . . . 62.31 112.026 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.38 154.94 18.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.74 0.305 . . . . 75.44 110.825 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -88.43 134.79 33.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.765 -0.652 . . . . 71.41 110.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.478 HG21 HD13 ' A' ' 52' ' ' LEU . 16.3 m -124.22 153.56 30.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.426 . . . . 72.54 110.702 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.476 ' HD3' ' OE2' ' A' ' 53' ' ' GLU . 53.8 ttt180 -110.98 119.87 40.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.699 -0.682 . . . . 74.41 109.73 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.436 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 25.8 t -76.15 98.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.005 0.431 . . . . 63.41 110.249 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -105.8 13.83 29.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.313 -0.403 . . . . 72.41 111.273 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.581 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 54.3 t30 -62.8 112.65 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 63.45 109.671 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.518 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 23.5 t -69.54 -27.92 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 74.53 111.411 -172.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -100.39 40.36 1.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.817 0.818 . . . . 71.34 109.395 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.581 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 3.7 t70 -119.47 -174.53 2.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.511 -0.768 . . . . 73.33 110.671 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -109.59 -28.85 8.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.967 -0.56 . . . . 75.41 110.241 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 92.6 m-85 -101.07 38.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.098 -0.501 . . . . 72.21 111.151 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.671 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 10.1 t80 -59.35 126.3 27.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.742 -0.663 . . . . 75.41 110.263 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.671 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 87.1 mtt180 80.09 4.05 1.93 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.097 0.959 . . . . 72.51 112.681 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -83.71 149.09 26.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.46 . . . . 71.22 110.153 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.29 125.46 43.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.606 -0.724 . . . . 71.41 110.221 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.61 171.67 23.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.844 -0.693 . . . . 61.45 111.754 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.21 124.88 46.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.867 0.365 . . . . 74.51 110.976 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.03 119.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.88 -0.6 . . . . 73.13 110.313 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -77.86 -36.71 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.3 0.571 . . . . 74.21 109.854 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -170.03 143.0 2.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.063 -0.971 . . . . 72.21 109.408 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.22 92.85 2.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.605 -0.725 . . . . 75.22 109.373 174.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -103.54 114.12 28.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.277 -0.42 . . . . 64.24 111.12 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 61.67 37.68 15.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.427 -0.806 . . . . 64.12 111.624 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.44 6.14 89.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.609 -0.805 . . . . 53.54 112.772 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -117.4 144.74 44.65 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.305 -0.628 . . . . 62.22 109.305 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 124.25 51.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.764 0.316 . . . . 75.12 111.113 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.477 ' HB3' HD11 ' A' ' 44' ' ' LEU . . . -81.93 101.09 10.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.241 -0.652 . . . . 64.12 109.241 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.97 121.36 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 71.13 110.874 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.33 126.74 36.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.8 -0.636 . . . . 71.32 110.493 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.11 143.7 39.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 74.51 110.409 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.78 129.19 27.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.395 -0.821 . . . . 74.54 109.126 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -135.86 87.53 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.717 0.294 . . . . 71.13 110.291 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.18 -77.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.962 -0.563 . . . . 71.41 112.576 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -128.39 -4.79 5.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.78 . . . . 54.24 109.17 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -89.98 138.25 31.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 73.21 111.022 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.33 146.23 49.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.067 -0.969 . . . . 64.34 109.787 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -166.28 136.49 3.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.049 0.452 . . . . 72.22 111.156 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 33' ' ' ALA . 54.0 tp -106.48 109.49 21.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 75.35 110.128 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.25 117.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.913 0.387 . . . . 72.24 110.293 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.3 m -78.6 127.94 32.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 74.44 110.643 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.64 179.01 4.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.772 -0.649 . . . . 73.42 110.173 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.418 ' HD3' ' HG2' ' A' ' 51' ' ' GLU . 2.2 mpt_? -98.77 154.83 17.7 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.66 -0.867 . . . . 74.32 108.66 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.581 HD22 HD12 ' A' ' 2' ' ' ILE . 84.5 mt -72.82 -32.86 65.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.45 0.643 . . . . 73.44 109.388 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 p -71.03 -12.21 61.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.994 -1.003 . . . . 61.44 110.764 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.418 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 2.9 mp0 -108.02 7.15 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.791 -0.641 . . . . 73.34 111.589 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 8' ' ' VAL . 93.0 mt -121.97 146.22 47.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.111 0.481 . . . . 73.14 111.591 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.476 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 40.0 tt0 -102.48 108.43 19.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.838 -0.801 . . . . 40.34 108.838 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.11 22.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.181 -0.463 . . . . 65.23 110.015 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.589 HG11 ' H ' ' A' ' 56' ' ' LYS . 2.8 t -78.65 170.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.234 -0.439 . . . . 65.52 109.827 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.589 ' H ' HG11 ' A' ' 55' ' ' VAL . 21.6 pttp -73.67 144.88 83.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.998 -0.547 . . . . 72.23 110.339 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.68 130.21 27.29 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.075 1.85 . . . . 73.22 111.415 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.418 HG23 ' N ' ' A' ' 59' ' ' LEU . 9.3 mt -73.54 163.94 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.025 -0.534 . . . . 65.42 109.85 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' N ' HG23 ' A' ' 58' ' ' ILE . 92.5 mt 71.31 39.89 0.9 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.554 0.534 . . . . 72.24 110.75 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.53 119.3 9.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 60.51 109.666 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -73.49 110.18 7.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.597 . . . . 75.23 111.282 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -84.23 103.37 13.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 65.45 110.457 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 55.5 73.07 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.693 0.621 . . . . 74.23 110.621 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.56 103.37 3.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.705 -0.85 . . . . 65.11 108.705 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -74.77 96.94 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.218 -0.446 . . . . 63.32 111.197 -170.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.591 -0.732 . . . . 62.33 109.655 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.885 0.374 . . . . 72.42 110.748 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.439 HD12 HD23 ' A' ' 49' ' ' LEU . 54.3 mt -92.16 148.29 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.817 -0.629 . . . . 74.32 109.342 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.08 146.62 51.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.438 0.161 . . . . 74.5 110.609 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.97 127.79 27.53 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.762 2.308 . . . . 75.55 111.902 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.84 0.29 39.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.834 -0.698 . . . . 55.42 112.187 -176.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.41 135.38 34.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.649 0.262 . . . . 64.33 110.48 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -83.12 125.07 31.1 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.591 -0.522 . . . . 64.12 109.591 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 54' ' ' ALA . 17.0 m -122.18 143.39 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.221 -0.445 . . . . 71.33 111.014 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -98.77 129.54 45.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.005 -0.543 . . . . 72.41 109.702 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.84 120.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.078 -0.341 . . . . 74.45 110.078 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 17.9 m -116.29 8.85 14.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 71.34 110.303 -178.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -74.21 106.83 6.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.749 -0.834 . . . . 74.41 108.749 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.76 -21.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 112.846 0.684 . . . . 75.41 112.846 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.14 -32.12 21.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.442 . . . . 72.31 110.612 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.19 158.24 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 71.23 111.824 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -81.43 -24.19 37.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.46 -0.791 . . . . 74.33 111.279 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -92.68 21.2 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 74.24 110.61 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.526 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 42.9 t80 -70.49 77.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 74.51 111.293 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.526 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 9.7 ptp85 163.58 -22.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.59 1.156 . . . . 74.51 108.633 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -77.98 154.73 31.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.35 -0.841 . . . . 74.45 111.224 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -125.02 127.85 47.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.2 -0.909 . . . . 63.51 109.298 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.96 168.17 21.43 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.529 -0.843 . . . . 73.41 112.228 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.47 126.37 41.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.639 0.257 . . . . 73.5 110.473 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.494 HG11 HG23 ' A' ' 27' ' ' VAL . 59.1 t -67.96 119.8 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 74.21 110.132 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.05 -30.38 22.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.828 -0.623 . . . . 62.41 110.578 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -164.31 143.15 7.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 75.23 109.63 -178.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.494 HG23 HG11 ' A' ' 24' ' ' VAL . 40.0 t -114.69 142.33 27.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.214 -0.903 . . . . 71.32 110.369 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 p -132.42 -175.56 3.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.658 -0.497 . . . . 63.14 109.658 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.74 75.35 4.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 72.4 110.517 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.43 -27.16 5.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.536 -0.756 . . . . 72.23 112.586 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 47.7 mtmt -120.11 162.23 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.693 0.282 . . . . 74.11 111.34 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.04 143.78 21.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 72.11 110.561 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.83 115.37 27.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.83 -0.433 . . . . 64.11 109.83 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.88 128.99 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 71.34 110.814 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.2 tp -102.34 120.06 39.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 73.43 110.934 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -104.9 146.37 29.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.841 -0.618 . . . . 73.52 109.532 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -149.27 127.41 12.03 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.28 -0.267 . . . . 71.34 110.28 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.72 85.71 1.9 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 54.22 109.666 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.0 -105.11 1.54 Allowed Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.602 -0.727 . . . . 62.2 112.159 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -87.56 -32.17 19.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.204 0.525 . . . . 73.1 110.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -75.93 138.53 41.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.592 -0.731 . . . . 73.31 111.272 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.11 155.99 44.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.824 -1.08 . . . . 71.45 108.813 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.577 ' HG3' HG23 ' A' ' 45' ' ' VAL . 41.9 tptt -155.94 108.8 2.66 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.664 -0.415 . . . . 73.54 111.247 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.23 109.57 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.389 -0.597 . . . . 71.43 109.389 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.577 HG23 ' HG3' ' A' ' 43' ' ' LYS . 46.1 t -130.28 131.99 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 72.4 110.247 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -83.29 126.54 32.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.067 0.46 . . . . 71.23 110.682 177.155 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -123.25 -170.34 2.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.765 -0.828 . . . . 74.51 108.765 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 1.024 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mtt180 -95.03 176.96 6.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.325 -0.621 . . . . 73.42 109.325 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.474 HD21 HG11 ' A' ' 27' ' ' VAL . 97.3 mt -84.1 -32.01 24.98 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.038 -0.727 . . . . 71.51 109.038 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 p -71.21 -19.63 62.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.087 -0.96 . . . . 62.15 110.862 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 1.024 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.0 mm-40 -85.54 -7.84 58.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 72.52 110.81 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.58 HD13 HG22 ' A' ' 8' ' ' VAL . 73.4 mt -116.85 138.47 51.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.094 0.473 . . . . 73.11 111.751 -172.087 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.68 104.46 16.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.094 -1.076 . . . . 64.33 108.094 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.789 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.08 107.86 3.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.25 -0.432 . . . . 63.11 110.838 -176.339 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.519 HG11 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -88.48 169.25 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.877 -0.786 . . . . 72.1 108.877 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.519 ' H ' HG11 ' A' ' 55' ' ' VAL . 98.6 mttt -110.13 132.61 21.37 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 116.501 -0.318 . . . . 72.22 110.363 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 31.6 Cg_exo -59.23 143.26 99.82 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.542 2.161 . . . . 43.21 111.179 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 58' ' ' ILE . 1.1 mp -64.33 144.8 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.705 -0.479 . . . . 72.13 109.705 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' O ' HD11 ' A' ' 59' ' ' LEU . 2.7 pp -125.91 148.89 49.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.605 -0.725 . . . . 73.53 110.572 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.17 165.16 12.54 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.643 -0.708 . . . . 73.32 111.493 -174.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -131.68 134.26 45.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 75.3 110.397 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -120.9 167.28 12.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 75.33 109.872 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -135.8 145.63 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.148 -0.316 . . . . 74.12 110.148 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -92.48 132.52 36.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.357 -0.609 . . . . 75.31 109.357 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -59.64 -83.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.859 0.318 . . . . 75.52 111.859 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.653 -0.689 . . . . 71.44 109.857 -178.018 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.928 0.394 . . . . 73.34 110.448 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt -115.72 143.79 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.56 -0.745 . . . . 74.23 109.936 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -117.72 141.21 28.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.512 -0.313 . . . . 74.31 110.864 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.6 137.2 62.8 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.492 2.128 . . . . 51.4 110.975 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 74.44 112.018 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.82 165.76 12.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.881 0.372 . . . . 72.34 110.706 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -93.31 138.95 31.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.092 -0.504 . . . . 74.4 110.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 HG21 HD13 ' A' ' 52' ' ' LEU . 6.7 m -130.65 148.06 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 65.43 111.083 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.629 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 34.2 ttm180 -109.97 141.81 42.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.838 -0.619 . . . . 71.52 109.483 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.498 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 55.4 t -79.54 110.56 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 64.23 110.019 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -91.29 -11.78 37.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.718 -0.674 . . . . 74.42 111.159 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.23 106.33 1.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.182 -0.463 . . . . 74.21 109.808 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.34 -24.16 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 75.23 111.375 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.98 -8.13 52.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.867 -0.606 . . . . 72.32 110.759 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.05 165.22 16.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.919 0.39 . . . . 61.13 110.445 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 m -72.16 -35.96 69.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 72.32 111.893 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.498 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -94.97 27.97 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 74.01 111.689 -172.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 45.5 t80 -61.86 130.97 48.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 64.44 110.038 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.6 mtm180 77.82 6.04 2.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.827 0.851 . . . . 72.14 111.833 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -96.33 148.29 22.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.832 -0.433 . . . . 71.4 109.832 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.629 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 33.5 mt-10 -127.92 128.15 44.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 74.05 110.245 -175.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.49 -177.11 14.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.939 -0.648 . . . . 72.42 112.335 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.89 132.48 49.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.491 0.186 . . . . 75.21 110.555 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.74 111.85 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.153 -0.314 . . . . 75.52 110.153 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -78.08 -34.98 49.95 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.192 -0.67 . . . . 74.43 109.192 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.28 136.59 0.37 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.325 -0.852 . . . . 65.23 110.16 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.9 108.56 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.645 -0.872 . . . . 71.21 108.645 172.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 t -152.47 142.62 22.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.523 -0.308 . . . . 53.42 111.056 -172.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.79 18.95 10.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.457 -0.792 . . . . 63.11 111.386 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 -1.15 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.927 -0.654 . . . . 72.33 112.81 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.416 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 26.2 mtmt -124.09 174.28 7.74 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.629 0.372 . . . . 72.45 110.118 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.07 129.92 28.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.622 0.249 . . . . 65.21 110.446 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.686 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -86.52 115.01 23.73 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.705 -0.48 . . . . 51.33 109.705 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.422 HG23 HD23 ' A' ' 52' ' ' LEU . 55.9 t -98.53 119.09 46.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.285 0.564 . . . . 73.54 110.648 -177.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.6 tp -89.81 118.78 29.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.546 -0.752 . . . . 74.21 110.072 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.77 137.43 33.87 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.929 -0.767 . . . . 72.44 108.929 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -156.41 108.59 2.53 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.71 -0.848 . . . . 74.33 108.71 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -136.89 100.88 4.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 64.05 110.84 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.96 -77.81 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.583 -0.735 . . . . 72.21 112.471 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -127.27 -17.41 4.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.205 0.526 . . . . 73.44 110.385 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -88.76 138.24 31.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.786 -0.643 . . . . 75.15 111.683 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.9 143.6 47.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.712 -1.131 . . . . 64.44 109.741 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -167.61 120.45 0.92 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.919 0.39 . . . . 73.53 110.631 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.18 109.72 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.304 -0.407 . . . . 71.54 110.032 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.19 120.74 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 74.25 109.97 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.686 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.8 m -78.19 130.73 36.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.206 0.527 . . . . 74.3 109.673 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -123.17 180.0 4.49 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.477 -0.783 . . . . 75.51 109.746 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.49 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 73.4 mtp180 -94.62 161.65 14.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.738 -0.665 . . . . 75.12 109.565 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.44 -26.44 63.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.108 -0.496 . . . . 64.53 110.064 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 m -76.2 -11.32 59.9 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.687 -0.688 . . . . 65.55 110.726 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.49 ' OE2' ' HD3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -85.02 -23.4 28.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 74.31 111.116 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 8' ' ' VAL . 62.1 mt -115.79 144.7 43.61 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.331 0.493 . . . . 74.32 112.331 -168.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -111.85 140.92 46.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.783 -0.821 . . . . 75.54 108.783 167.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.49 115.43 17.25 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.145 -0.317 . . . . 54.24 110.145 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 56' ' ' LYS . 10.3 t -70.58 170.98 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.139 -0.689 . . . . 73.53 109.139 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.669 ' H ' HG13 ' A' ' 55' ' ' VAL . 50.2 mttp -82.98 150.44 61.61 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.996 -0.547 . . . . 72.22 110.129 -173.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.78 160.12 22.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.646 2.231 . . . . 74.42 112.42 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 58' ' ' ILE . 3.8 mp -77.38 155.05 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.677 -0.86 . . . . 70.25 108.677 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.79 105.48 16.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.134 0.492 . . . . 74.33 111.179 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -112.14 12.84 20.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.688 0.756 . . . . 72.25 109.685 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -136.59 169.37 17.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.892 -0.595 . . . . 74.0 111.085 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -61.75 138.64 58.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.374 -0.83 . . . . 72.11 110.401 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.26 154.32 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.071 0.462 . . . . 65.15 111.159 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -106.64 170.47 7.92 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.64 . . . . 71.44 109.273 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -98.94 160.52 14.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 75.02 110.761 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.5 m80 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.649 -0.691 . . . . 75.21 109.436 177.701 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.065 0.46 . . . . 72.53 110.767 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt -105.24 140.97 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 74.2 110.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -126.92 158.68 67.82 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 72.22 110.507 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.71 128.79 18.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.543 2.162 . . . . 73.21 111.241 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.493 ' HA2' HD22 ' A' ' 23' ' ' LEU . . . 94.11 27.2 12.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.555 -0.831 . . . . 70.41 111.646 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.83 144.34 48.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 72.11 110.778 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -82.72 130.2 35.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 72.3 110.574 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.78 162.37 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 62.12 110.846 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.578 ' HB3' ' OE2' ' A' ' 53' ' ' GLU . 41.5 ttp180 -119.88 124.0 44.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.397 -0.819 . . . . 73.51 109.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.484 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 t -66.4 113.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.373 . . . . 73.41 110.65 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.24 -11.41 26.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.961 -0.563 . . . . 73.13 111.007 -176.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.534 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 41.7 t30 -65.93 113.12 4.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.472 . . . . 63.1 110.288 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.98 -39.07 76.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 74.13 111.532 -174.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.59 34.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.903 0.859 . . . . 64.43 109.66 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.534 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 7.1 t70 -116.42 159.17 22.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.447 -0.797 . . . . 71.44 110.269 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -75.76 -31.31 59.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.191 0.519 . . . . 74.12 110.325 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -99.72 25.02 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.859 -0.609 . . . . 74.23 111.089 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.414 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 18.4 t80 -58.39 128.88 39.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.651 . . . . 64.01 111.126 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 74.2 mtp180 77.14 -8.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.138 0.975 . . . . 71.21 112.376 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.39 158.03 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.018 0.437 . . . . 72.32 110.809 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -104.91 138.76 40.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.688 -0.687 . . . . 75.12 110.445 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.36 171.83 26.31 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.552 -0.619 . . . . 70.3 111.552 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD22 ' HA2' ' A' ' 5' ' ' GLY . 4.4 tt -120.08 122.54 41.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.062 0.431 . . . . 41.24 109.889 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.539 HG13 HG23 ' A' ' 27' ' ' VAL . 39.5 t -69.21 122.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 75.04 110.762 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.401 ' NE2' HD21 ' A' ' 23' ' ' LEU . 27.4 mm-40 -98.61 -30.78 12.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.914 -0.585 . . . . 75.44 110.752 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 26' ' ' ARG . 19.0 ttt180 -146.61 118.92 8.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 74.33 109.903 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.539 HG23 HG13 ' A' ' 24' ' ' VAL . 59.4 t -103.64 128.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 75.13 110.888 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.9 t -106.42 -179.35 3.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.903 -0.777 . . . . 74.43 108.903 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.61 29.91 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 73.34 111.099 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.0 -29.64 0.17 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.956 -0.566 . . . . 64.41 111.777 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.06 164.92 11.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.58 0.229 . . . . 63.11 110.44 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.49 137.9 19.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.586 -0.279 . . . . 62.54 110.405 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -101.06 110.73 22.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.893 -0.41 . . . . 73.24 109.893 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -100.26 129.39 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 55.44 110.858 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 tp -95.19 129.15 42.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.681 -0.69 . . . . 64.55 110.399 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.74 136.91 48.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.469 -0.567 . . . . 74.41 109.469 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.85 116.82 25.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.085 -0.507 . . . . 70.13 111.059 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.407 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 17.2 t30 -110.2 -10.9 14.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.706 . . . . 70.22 110.295 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.58 -71.98 0.22 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.899 -0.667 . . . . 53.5 111.545 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.16 -18.89 24.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.602 0.715 . . . . 72.45 109.935 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.407 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 73.7 t90 -112.92 135.14 54.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 65.44 111.022 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.43 149.06 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.039 -0.982 . . . . 71.25 109.256 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.576 ' HE2' HG21 ' A' ' 45' ' ' VAL . 88.5 tttt -165.14 119.06 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.934 0.397 . . . . 75.02 110.865 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.6 tp -92.7 108.36 19.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.675 -0.693 . . . . 64.25 109.562 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.576 HG21 ' HE2' ' A' ' 43' ' ' LYS . 10.8 t -108.51 125.43 65.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.427 -0.351 . . . . 74.35 110.766 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.411 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -85.17 130.76 34.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.405 0.621 . . . . 72.13 110.679 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -125.56 -164.55 1.31 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.252 -0.885 . . . . 64.03 108.838 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.816 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 86.6 mtm180 -106.37 162.6 13.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.285 -0.635 . . . . 70.53 109.285 171.747 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.41 -25.15 60.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.101 0.477 . . . . 74.33 109.941 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 p -82.48 -9.19 59.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 73.33 110.432 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.816 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 7.7 mm-40 -88.17 -12.96 42.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.274 0.559 . . . . 71.34 110.929 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 10' ' ' VAL . 27.2 mt -126.59 167.28 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.611 -0.722 . . . . 71.12 110.732 -173.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.578 ' OE2' ' HB3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -151.27 148.77 28.6 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.993 -0.743 . . . . 71.3 108.993 167.894 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.44 141.31 34.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.682 0.277 . . . . 71.05 110.631 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -73.37 169.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.784 -0.821 . . . . 74.01 108.784 177.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.53 ' H ' HG12 ' A' ' 55' ' ' VAL . 29.2 mtpp -75.62 135.07 72.0 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 116.66 -0.246 . . . . 54.13 110.652 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.52 119.58 5.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.165 1.91 . . . . 72.15 109.209 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.627 ' H ' HD12 ' A' ' 58' ' ' ILE . 0.5 OUTLIER -48.39 135.83 4.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.998 0.904 . . . . 63.4 112.726 -164.01 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.56 103.19 11.25 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.827 -1.533 . . . . 73.44 107.194 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -53.13 148.11 8.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.948 0.78 . . . . 73.51 111.367 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -42.73 112.69 0.38 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 124.124 0.89 . . . . 74.41 112.366 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -69.6 148.39 49.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.909 -1.041 . . . . 73.14 110.506 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -77.28 178.07 7.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.573 -0.739 . . . . 74.41 110.757 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -72.14 114.9 10.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.014 -0.736 . . . . 74.01 109.014 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -120.65 169.22 10.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.834 0.349 . . . . 72.44 110.779 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 42.2 m80 . . . . . 0 C--O 1.244 0.766 0 N-CA-C 109.199 -0.667 . . . . 75.4 109.199 176.899 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptp . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.808 0.337 . . . . 75.33 110.661 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.715 HD11 HD21 ' A' ' 49' ' ' LEU . 48.9 mt -112.59 146.61 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.552 -0.536 . . . . 55.15 109.552 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.13 147.19 37.3 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.719 0.295 . . . . 62.32 111.173 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.97 151.66 73.48 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.738 2.292 . . . . 64.2 111.438 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.48 2.54 90.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.843 -0.694 . . . . 50.31 112.004 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.91 153.02 20.24 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.773 0.32 . . . . 74.33 110.496 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -89.56 129.91 35.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.556 . . . . 72.21 110.649 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.433 HG21 HD13 ' A' ' 52' ' ' LEU . 17.3 m -124.34 158.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.908 -0.587 . . . . 72.43 110.023 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 35.7 ttt180 -118.59 126.53 52.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.907 -0.405 . . . . 74.15 109.907 179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.27 115.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 75.15 110.941 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 m -100.36 -3.68 30.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 64.12 110.6 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.602 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 27.0 t-20 -64.94 113.67 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 63.23 110.042 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.08 -13.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 72.41 111.54 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.59 -48.89 17.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.967 0.358 . . . . 74.25 111.967 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.98 161.43 25.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.063 0.458 . . . . 71.42 110.97 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.92 -30.49 71.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.502 -0.772 . . . . 64.02 112.605 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -80.91 24.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.286 0.476 . . . . 73.42 112.286 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 50.7 t80 -64.99 127.88 33.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 74.22 109.795 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 35.7 mtm180 74.72 27.15 1.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.288 0.635 . . . . 70.43 111.892 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.42 152.87 24.11 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.954 -0.387 . . . . 73.5 109.954 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -102.96 142.18 34.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.581 -0.526 . . . . 73.42 109.581 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -144.24 170.0 26.15 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.719 -0.753 . . . . 73.25 112.067 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.8 tp -109.91 123.04 48.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.647 0.26 . . . . 73.32 110.577 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.411 HG12 HG23 ' A' ' 27' ' ' VAL . 52.2 t -68.32 115.42 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.535 -0.302 . . . . 64.41 110.52 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -81.48 -33.08 32.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 75.3 110.463 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.414 ' HD2' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -169.38 143.6 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.643 -0.873 . . . . 74.43 108.643 177.444 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.411 HG23 HG12 ' A' ' 24' ' ' VAL . 23.6 t -99.14 135.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.69 -0.686 . . . . 63.01 110.332 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.497 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 8.5 t -104.89 -176.19 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.695 -0.854 . . . . 73.35 108.695 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.39 77.69 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.495 0.664 . . . . 71.21 110.081 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 3.24 39.64 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.039 -0.982 . . . . 73.22 111.84 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.525 ' HG2' HG23 ' A' ' 46' ' ' THR . 27.7 ttmt -141.5 172.88 12.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.903 -0.777 . . . . 72.15 108.903 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.8 143.73 6.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.479 0.18 . . . . 54.3 110.887 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.618 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.19 119.07 32.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 72.14 110.276 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.45 HG21 HD23 ' A' ' 52' ' ' LEU . 39.9 t -100.82 124.65 54.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 62.34 111.028 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.5 tp -96.44 121.59 38.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.129 -0.487 . . . . 73.03 110.295 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.75 137.23 36.14 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.655 -0.869 . . . . 74.54 108.655 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.47 114.51 8.61 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.823 -0.436 . . . . 64.31 109.823 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 29.4 t-20 -137.04 90.31 2.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.215 0.531 . . . . 75.2 111.157 -178.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.13 -90.7 0.52 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.46 -0.791 . . . . 62.03 112.833 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.0 -16.23 11.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 75.32 109.943 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 66.9 t90 -94.28 144.07 25.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 75.23 110.682 -179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.2 158.29 43.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.368 -0.833 . . . . 72.23 110.018 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.58 132.11 6.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.957 -0.565 . . . . 74.15 110.132 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 56.0 tp -103.92 109.44 21.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.311 -0.404 . . . . 62.33 110.301 178.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.59 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 62.51 110.307 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.618 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.3 m -81.12 132.65 35.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.267 0.556 . . . . 53.43 110.755 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -129.61 177.89 6.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.82 -0.808 . . . . 73.24 108.82 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.534 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -97.61 178.11 5.28 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.816 -0.354 . . . . 64.34 110.265 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.715 HD21 HD11 ' A' ' 2' ' ' ILE . 68.8 mt -78.56 -25.96 45.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.195 0.521 . . . . 64.14 110.02 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 p -76.3 -17.5 59.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 75.3 109.996 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.602 ' HG3' ' HB2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -86.44 -18.84 30.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.1 -0.955 . . . . 72.13 110.835 -178.202 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.45 HD23 HG21 ' A' ' 34' ' ' VAL . 55.6 mt -122.65 122.63 39.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.957 -0.565 . . . . 73.41 111.202 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -88.34 118.26 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.114 -0.698 . . . . 73.21 109.114 172.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.418 ' HA ' HG11 ' A' ' 8' ' ' VAL . . . -75.11 106.29 6.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.977 -0.556 . . . . 71.54 109.967 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.503 HG13 ' H ' ' A' ' 56' ' ' LYS . 2.1 t -74.84 168.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 74.35 110.107 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.503 ' H ' HG13 ' A' ' 55' ' ' VAL . 49.2 pttt -78.13 148.99 75.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.918 -0.583 . . . . 73.33 109.808 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.94 163.97 26.43 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.332 2.021 . . . . 71.42 112.059 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.425 HG21 ' H ' ' A' ' 59' ' ' LEU . 12.4 mm -65.65 165.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.852 . . . . 74.25 108.698 176.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.425 ' H ' HG21 ' A' ' 58' ' ' ILE . 76.2 mt -70.66 75.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 74.42 112.365 -173.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -92.81 130.85 38.29 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.187 -1.042 . . . . 72.31 108.187 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -80.55 65.81 5.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.657 0.741 . . . . 72.35 111.453 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . 0.504 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 18.0 t60 -95.7 162.22 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.589 -1.263 . . . . 73.45 107.589 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.504 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 41.6 m-70 72.36 108.2 0.07 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.074 0.464 . . . . 71.43 109.984 -173.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -83.16 -39.66 20.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.268 -0.424 . . . . 74.25 110.826 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 69.59 138.46 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.998 0.811 . . . . 73.42 110.617 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.278 -0.868 . . . . 55.32 109.958 177.747 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.051 0.453 . . . . 74.0 111.413 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.472 HD11 HD22 ' A' ' 49' ' ' LEU . 57.9 mt -127.16 142.89 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.585 -0.895 . . . . 72.35 108.585 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -127.85 145.55 55.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.75 0.31 . . . . 71.44 111.281 -175.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -59.86 142.91 99.49 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.092 2.528 . . . . 64.23 112.313 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.25 6.08 63.23 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.846 -0.692 . . . . 74.41 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.669 0.271 . . . . 53.01 110.305 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -92.03 130.55 37.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.399 . . . . 74.54 110.45 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.416 HG12 ' HA ' ' A' ' 54' ' ' ALA . 11.3 m -123.63 142.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.074 -0.512 . . . . 75.21 110.154 177.15 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -102.18 125.44 48.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.954 -0.566 . . . . 72.14 110.047 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.64 115.85 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.684 -0.689 . . . . 64.54 110.406 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -105.69 10.52 32.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 73.14 110.319 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.0 109.71 0.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.93 -0.577 . . . . 71.41 109.979 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.37 -35.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.011 -0.54 . . . . 75.12 112.141 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.89 -2.61 34.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.394 0.616 . . . . 63.45 111.018 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.98 165.61 16.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.256 -0.429 . . . . 72.54 110.263 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.82 -27.29 26.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.268 -0.424 . . . . 72.24 110.84 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -87.95 24.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.085 0.469 . . . . 73.3 111.16 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.495 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 53.6 t80 -63.12 136.81 57.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 72.54 110.027 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 40.3 mtm180 82.44 -10.91 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.802 0.841 . . . . 63.23 112.251 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -72.92 150.64 42.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 73.42 110.398 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -117.62 133.38 56.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.13 -0.486 . . . . 73.44 110.235 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.68 172.97 21.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.583 -0.818 . . . . 73.23 112.484 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.47 125.96 48.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.422 -0.214 . . . . 74.02 110.422 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.87 115.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.133 -0.321 . . . . 75.12 110.133 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.438 ' HG3' HD13 ' A' ' 44' ' ' LEU . 27.6 mm-40 -87.35 -35.81 18.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.959 -0.564 . . . . 74.5 110.418 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -166.81 148.87 6.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.692 -0.686 . . . . 74.53 109.574 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.42 HG23 ' O ' ' A' ' 2' ' ' ILE . 44.4 t -105.4 140.93 21.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.334 -0.848 . . . . 73.31 109.755 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -129.3 -162.27 1.19 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.859 -0.423 . . . . 72.42 109.859 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.42 86.85 1.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.541 . . . . 75.23 110.139 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.64 5.67 86.32 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 114.739 -1.119 . . . . 73.01 111.854 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -129.41 166.25 19.93 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 122.625 0.37 . . . . 73.34 110.637 -177.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 141.88 24.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.268 -0.423 . . . . 62.22 110.242 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.456 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -89.71 108.48 19.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.971 -0.381 . . . . 73.25 109.971 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.6 122.42 47.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.126 -0.488 . . . . 74.11 110.609 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.0 tp -96.63 120.09 36.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 75.23 110.553 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.647 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 95.9 m-85 -93.44 141.62 28.25 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.82 -0.807 . . . . 73.12 108.82 171.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -140.72 133.21 28.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.263 -0.426 . . . . 64.1 110.028 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -147.44 70.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.172 0.51 . . . . 71.21 110.127 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.54 -88.02 1.22 Allowed Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.653 -0.703 . . . . 54.15 112.441 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -104.53 -20.81 13.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.394 0.616 . . . . 51.43 109.878 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -81.69 132.01 35.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.261 -0.881 . . . . 75.51 111.394 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -128.93 152.57 48.42 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.458 -1.246 . . . . 72.54 109.346 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.647 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 54.5 tttp -157.73 100.92 1.79 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.517 -0.311 . . . . 62.42 110.224 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.456 HD12 ' HB3' ' A' ' 33' ' ' ALA . 56.5 tp -95.15 106.32 18.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.387 -0.369 . . . . 74.34 110.324 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.51 HG21 ' HG2' ' A' ' 43' ' ' LYS . 54.8 t -126.33 126.46 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.195 -0.457 . . . . 63.44 110.487 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.1 m -77.65 131.8 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 73.25 110.347 177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -124.44 -174.59 3.05 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.134 -0.691 . . . . 70.13 109.134 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.57 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 9.4 mtt180 -102.28 164.1 11.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.723 0.297 . . . . 60.14 110.31 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.472 HD22 HD11 ' A' ' 2' ' ' ILE . 91.7 mt -78.64 -20.89 49.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.269 0.556 . . . . 75.15 110.378 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 p -88.53 -16.49 32.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.65 -0.704 . . . . 54.44 110.102 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 12.3 mm-40 -93.55 -4.18 51.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.561 -0.745 . . . . 63.03 110.347 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -121.58 158.74 27.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 72.02 110.768 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -139.63 123.84 17.92 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.457 -0.572 . . . . 62.22 109.457 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.416 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -62.37 132.04 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 63.53 110.697 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.827 HG13 ' H ' ' A' ' 56' ' ' LYS . 1.8 t -103.15 -169.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.154 -0.476 . . . . 74.31 110.166 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.827 ' H ' HG13 ' A' ' 55' ' ' VAL . 18.5 ptpt -63.48 153.67 81.95 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.712 -0.677 . . . . 70.2 111.929 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.57 164.04 28.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.684 2.256 . . . . 65.11 109.613 163.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.496 ' N ' HD11 ' A' ' 58' ' ' ILE . 3.6 mp -75.65 161.7 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.23 -0.656 . . . . 72.1 109.23 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.868 ' HG ' ' H ' ' A' ' 60' ' ' GLU . 19.4 tp 68.58 -169.83 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.602 0.761 . . . . 72.32 110.157 -174.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.868 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 41.8 tt0 -60.75 113.55 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.508 0.323 . . . . 74.0 110.75 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -80.5 121.29 25.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.482 -0.562 . . . . 71.21 109.482 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -91.44 136.81 32.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.981 -0.554 . . . . 73.54 111.178 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -67.28 151.03 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.372 -0.831 . . . . 72.33 109.84 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.04 146.69 31.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.161 0.505 . . . . 63.24 111.447 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -96.29 -165.94 1.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.517 -0.765 . . . . 75.1 110.999 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.564 -0.731 . . . . 75.42 110.136 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.843 0.354 . . . . 73.0 110.514 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.665 HD13 HD22 ' A' ' 49' ' ' LEU . 56.8 mt -130.24 142.84 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.703 -0.48 . . . . 70.01 109.703 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.36 147.82 66.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.308 -0.405 . . . . 65.25 110.519 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.6 129.77 30.73 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.613 2.209 . . . . 73.12 111.209 175.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.18 27.67 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.115 -0.564 . . . . 61.53 111.829 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 147.27 24.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.612 0.244 . . . . 64.44 110.617 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -89.31 132.71 34.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 75.35 110.381 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.636 HG21 HD13 ' A' ' 52' ' ' LEU . 12.0 m -133.61 149.27 30.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.935 0.398 . . . . 73.13 111.552 -176.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -114.96 135.83 53.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.776 -0.647 . . . . 72.12 109.695 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -75.2 106.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 64.14 109.927 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -90.97 -5.97 54.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.756 0.312 . . . . 72.2 111.48 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -65.68 111.37 3.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.309 -0.626 . . . . 73.34 109.309 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.465 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 3.0 t -80.78 -1.14 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.395 0.617 . . . . 54.32 111.033 -173.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -101.35 -22.99 14.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.99 -0.55 . . . . 73.21 110.673 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.72 158.03 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.528 0.68 . . . . 74.23 111.964 -170.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.1 m -65.31 -32.6 74.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.979 -1.009 . . . . 72.12 111.555 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -101.4 30.62 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 71.41 111.232 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.465 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 25.0 t80 -55.37 138.16 46.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 75.54 111.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 56.08 18.3 3.11 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.239 1.416 . . . . 73.23 113.276 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.27 151.27 24.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.786 -0.82 . . . . 74.42 108.786 167.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.19 130.16 53.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.006 -0.543 . . . . 72.44 110.067 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.16 -174.67 16.62 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.522 -0.847 . . . . 38.41 112.384 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.1 tp -113.1 132.81 55.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.336 -0.246 . . . . 75.11 110.336 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.51 114.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 74.35 110.043 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.405 ' HG3' HD13 ' A' ' 44' ' ' LEU . 28.6 mm-40 -79.11 -35.3 42.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.145 0.498 . . . . 73.51 110.366 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -172.24 146.24 1.84 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.366 -0.834 . . . . 74.23 109.259 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.327 -0.851 . . . . 75.52 110.17 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 t -106.63 67.87 0.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.492 -0.558 . . . . 73.12 109.492 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 68.85 -72.34 0.1 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.9 -1.046 . . . . 74.31 112.531 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.55 -9.76 20.73 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 115.257 -0.883 . . . . 38.41 113.022 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -124.28 170.35 10.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 110.2 -0.296 . . . . 61.31 110.2 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.72 149.1 30.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.532 0.206 . . . . 65.1 110.973 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.523 ' HB3' HD12 ' A' ' 44' ' ' LEU . . . -96.16 117.07 30.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.731 -0.47 . . . . 53.42 109.731 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.2 t -100.36 120.94 50.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 65.44 110.85 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.69 115.72 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 75.23 109.912 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -91.75 144.73 25.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 72.1 109.508 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.87 112.37 7.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.693 -0.484 . . . . 74.04 109.693 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -130.73 79.68 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.106 -0.497 . . . . 52.14 110.262 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.49 -90.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.055 -0.52 . . . . 73.33 112.672 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -100.73 -22.38 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 74.53 110.1 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.9 t90 -92.16 144.49 25.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.401 -0.818 . . . . 74.24 110.978 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -149.69 153.59 37.2 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.076 -0.965 . . . . 71.43 109.266 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.2 tptm -162.53 128.43 3.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.409 -0.359 . . . . 72.14 110.82 -175.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.523 HD12 ' HB3' ' A' ' 33' ' ' ALA . 63.8 tp -98.12 112.03 24.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 74.01 109.959 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 42.0 t -126.53 125.81 67.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.839 0.352 . . . . 74.11 110.483 179.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.508 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.5 m -73.68 140.4 46.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.189 0.519 . . . . 71.54 110.844 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.0 -176.06 4.25 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 72.44 109.262 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.827 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 98.9 mtt180 -91.39 -179.28 5.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.099 -0.704 . . . . 72.31 109.099 170.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.665 HD22 HD13 ' A' ' 2' ' ' ILE . 87.0 mt -87.25 -33.03 19.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.951 -0.759 . . . . 74.41 108.951 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.8 m -70.63 -14.41 62.47 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.57 -0.741 . . . . 75.42 111.106 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.827 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 11.1 mm-40 -80.53 -18.71 47.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.204 0.526 . . . . 74.34 110.591 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.636 HD13 HG21 ' A' ' 8' ' ' VAL . 38.8 mt -115.68 157.38 24.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 74.5 111.325 -172.776 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.84 146.6 49.19 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.7 -0.852 . . . . 74.15 108.7 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.87 123.57 26.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.761 0.315 . . . . 52.12 110.238 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.8 t -79.44 162.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.947 -0.76 . . . . 74.11 108.947 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' H ' HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -102.4 126.17 33.99 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.847 -0.615 . . . . 75.44 109.754 -173.572 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 9.7 Cg_endo -52.96 130.6 38.62 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.666 2.244 . . . . 73.21 111.277 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.09 150.25 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.153 0.501 . . . . 75.42 109.959 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.2 tp -132.45 162.51 30.99 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.425 -0.954 . . . . 73.1 108.425 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.35 66.43 3.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.623 0.725 . . . . 75.12 111.28 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.62 147.77 51.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.943 -1.026 . . . . 72.12 108.787 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -96.96 11.65 35.24 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.812 -0.355 . . . . 71.21 111.158 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.4 ' HB3' ' H ' ' A' ' 64' ' ' HIS . 34.3 m80 55.75 -158.35 0.23 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.559 0.537 . . . . 72.43 110.957 178.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.4 ' H ' ' HB3' ' A' ' 63' ' ' HIS . 3.1 t60 -155.55 90.42 1.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 75.43 109.591 174.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -99.29 158.05 15.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 72.21 111.36 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.8 t60 . . . . . 0 C--N 1.321 -0.674 0 CA-C-O 118.232 -0.889 . . . . 72.24 108.772 172.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 tpt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.357 0.122 . . . . 74.32 111.116 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.3 mt 77.11 133.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.44 0.638 . . . . 74.21 110.421 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -146.17 162.56 34.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.177 -0.92 . . . . 71.3 109.533 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.47 113.11 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.181 1.921 . . . . 72.23 111.098 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.11 -9.58 15.51 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.798 -0.715 . . . . 44.42 111.983 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.95 147.12 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 63.34 110.433 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -89.89 132.58 35.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.116 -0.493 . . . . 64.22 110.158 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -127.7 152.59 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.954 0.407 . . . . 70.02 110.736 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.551 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 43.5 ttm180 -110.06 129.28 55.71 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.032 -0.729 . . . . 65.11 109.032 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.36 101.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.085 0.469 . . . . 63.13 110.915 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -79.76 -12.45 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 75.4 109.573 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -68.6 107.42 2.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.28 -0.873 . . . . 71.01 110.125 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -89.94 -13.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 64.43 110.601 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.69 -36.17 82.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.418 -0.81 . . . . 72.5 110.47 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.436 ' CG ' ' H ' ' A' ' 16' ' ' THR . 11.3 t70 -80.99 -174.91 5.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 75.13 109.874 177.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.436 ' H ' ' CG ' ' A' ' 15' ' ' ASP . 11.3 m -93.92 -21.13 19.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.085 0.469 . . . . 65.15 110.807 -176.045 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' OH ' ' HG3' ' A' ' 43' ' ' LYS . 54.2 m-85 -90.25 40.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 74.41 111.329 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.518 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 29.7 t80 -57.65 132.46 53.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.813 -0.631 . . . . 75.23 111.096 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.518 ' HG2' ' O ' ' A' ' 18' ' ' TYR . 36.2 ptt180 59.84 14.93 4.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.147 1.379 . . . . 71.33 112.77 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.22 156.57 26.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 73.44 110.106 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.73 117.66 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.106 -0.497 . . . . 74.22 109.901 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.6 176.47 17.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.615 -0.803 . . . . 71.1 112.478 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.95 123.18 48.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.232 . . . . 73.04 110.383 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.417 HG13 HG23 ' A' ' 27' ' ' VAL . 58.0 t -67.56 122.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 74.33 110.007 177.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . 0.422 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 24.9 mm-40 -91.49 -27.56 18.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.976 -0.557 . . . . 61.32 111.005 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -168.2 135.5 2.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.389 -0.823 . . . . 73.04 109.938 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.417 HG23 HG13 ' A' ' 24' ' ' VAL . 42.5 t -104.06 150.36 7.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.256 -0.884 . . . . 62.5 110.086 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.85 -177.63 4.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.3 -0.63 . . . . 72.21 109.3 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.44 80.43 3.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.595 0.712 . . . . 71.14 110.759 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.41 -24.58 9.1 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 114.809 -1.087 . . . . 61.02 112.025 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -118.82 157.83 26.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.556 0.217 . . . . 72.22 111.161 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.06 138.43 22.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.347 -0.388 . . . . 72.2 110.163 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.447 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -95.0 112.15 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.125 -0.324 . . . . 72.53 110.125 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.9 124.52 50.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 73.22 110.586 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.422 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 33.8 tp -93.53 119.79 33.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.007 -0.542 . . . . 74.42 110.467 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -100.46 141.06 33.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.95 -0.759 . . . . 65.05 108.95 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -139.03 141.08 38.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.549 -0.296 . . . . 73.0 110.37 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -153.8 76.49 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.239 -0.652 . . . . 74.32 109.239 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.94 -110.08 3.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 44.31 111.877 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.37 -15.83 44.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.885 0.374 . . . . 75.24 110.736 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -87.16 142.78 27.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.363 0.602 . . . . 73.44 110.582 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.31 163.35 36.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.919 -1.037 . . . . 72.51 109.45 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.547 ' HD2' ' CG2' ' A' ' 45' ' ' VAL . 4.3 tmtp? -166.5 109.23 0.73 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 73.41 110.221 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.34 104.05 15.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.764 -0.458 . . . . 75.33 109.764 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.547 ' CG2' ' HD2' ' A' ' 43' ' ' LYS . 17.9 t -111.95 126.37 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 73.44 110.251 -176.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.447 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.6 m -85.68 120.28 26.94 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.328 0.585 . . . . 71.45 109.815 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.42 -168.32 1.3 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.402 -0.817 . . . . 74.51 109.106 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.95 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 55.3 mmt-85 -105.63 160.45 15.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.187 -0.672 . . . . 64.41 109.187 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -71.07 -27.86 63.93 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.254 0.549 . . . . 74.04 110.035 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 p -75.43 -22.47 57.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.477 -0.783 . . . . 64.12 110.305 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.95 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 20.6 mm-40 -88.28 -5.38 58.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.0 -0.545 . . . . 70.01 111.378 -173.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.425 HD13 HG21 ' A' ' 8' ' ' VAL . 72.5 mt -120.02 143.04 48.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.059 -0.519 . . . . 71.03 110.263 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.551 ' HG3' ' HB3' ' A' ' 9' ' ' ARG . 9.7 pt-20 -107.59 130.66 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.183 -0.673 . . . . 74.04 109.183 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.64 24.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.34 -0.391 . . . . 75.21 110.093 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.568 HG13 ' H ' ' A' ' 56' ' ' LYS . 2.9 t -83.01 168.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.849 -0.797 . . . . 64.22 108.849 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.568 ' H ' HG13 ' A' ' 55' ' ' VAL . 11.0 mptt -88.13 132.99 38.0 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.715 -0.476 . . . . 72.0 109.715 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.04 177.97 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.349 2.032 . . . . 72.33 112.015 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.31 152.86 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.257 -0.646 . . . . 74.23 109.257 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.86 104.35 13.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.047 0.451 . . . . 52.53 111.116 -175.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.636 ' HB3' ' HB2' ' A' ' 63' ' ' HIS . 1.2 tm-20 -60.11 121.2 11.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.878 -1.156 . . . . 73.32 107.878 171.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.912 0.708 . . . . 75.44 112.912 -167.124 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -100.27 8.34 43.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.819 0.342 . . . . 75.22 110.778 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.636 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 27.2 t60 -82.58 115.41 21.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.209 -0.45 . . . . 73.11 110.138 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -90.17 176.38 6.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.205 0.526 . . . . 54.31 110.784 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -125.21 162.18 25.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 74.2 109.553 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 C--O 1.246 0.888 0 N-CA-C 109.101 -0.703 . . . . 73.05 109.101 175.195 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.866 -0.42 . . . . 64.23 109.866 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.688 ' HB ' HD22 ' A' ' 49' ' ' LEU . 59.7 mt -87.14 144.28 9.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.14 0.495 . . . . 72.41 111.856 -174.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -135.83 155.88 77.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.306 -0.861 . . . . 73.12 109.448 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.72 132.38 34.92 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.063 1.842 . . . . 74.25 111.59 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.52 -7.54 58.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.98 -0.628 . . . . 63.33 112.216 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.81 147.31 23.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.312 . . . . 72.11 111.15 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -87.02 126.15 34.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 74.52 110.068 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 21.0 m -124.97 148.16 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.211 0.529 . . . . 72.42 110.973 -177.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.501 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 23.5 ttp180 -111.05 132.41 54.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.46 -0.791 . . . . 73.03 109.682 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.08 100.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.133 -0.485 . . . . 74.35 110.362 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 p -102.06 7.26 41.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.216 0.532 . . . . 75.42 111.176 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.449 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 48.1 t30 -71.93 100.12 2.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.55 -0.75 . . . . 74.13 109.549 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.95 -30.18 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 72.54 111.984 -171.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.66 -7.43 59.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.438 . . . . 75.4 111.637 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.449 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 18.3 t70 -87.92 162.09 17.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.048 -0.408 . . . . 73.2 111.277 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 m -77.05 -26.63 53.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.083 -0.508 . . . . 75.15 111.696 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.479 ' OH ' ' HE2' ' A' ' 43' ' ' LYS . 89.9 m-85 -106.91 28.89 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 73.24 111.265 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.429 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 t80 -68.88 82.2 0.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 74.44 110.408 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . 0.429 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 25.9 ptt180 169.91 -27.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.376 -0.829 . . . . 73.43 110.421 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.61 158.4 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.291 0.567 . . . . 74.24 112.013 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . 0.501 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 81.4 mt-10 -125.8 134.16 51.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.183 -0.917 . . . . 72.3 108.962 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.61 178.45 21.05 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.373 -0.918 . . . . 73.24 112.335 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.94 129.69 56.09 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.943 0.372 . . . . 61.32 110.388 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.559 HG22 ' CG2' ' A' ' 2' ' ' ILE . 74.4 t -68.31 124.83 24.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.295 -0.412 . . . . 73.14 110.764 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -93.63 -29.17 15.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 73.0 110.82 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 11.3 ptm180 -165.3 133.06 3.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.509 -0.769 . . . . 73.33 110.689 -174.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.439 HG12 ' H ' ' A' ' 29' ' ' ASP . 96.5 t -97.4 131.54 44.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.554 -0.748 . . . . 75.33 109.057 173.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -116.06 36.37 4.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.17 0.51 . . . . 72.13 109.996 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.439 ' H ' HG12 ' A' ' 27' ' ' VAL . 10.5 m-20 63.0 99.85 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.032 -0.985 . . . . 71.22 111.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.02 3.87 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.873 -0.603 . . . . 73.44 111.64 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.434 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 23.3 ttmt -118.62 165.24 14.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 64.11 109.062 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.97 146.02 18.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.513 -0.312 . . . . 63.22 110.676 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.445 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.54 114.34 26.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.823 -0.436 . . . . 74.54 109.823 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.58 125.66 47.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 75.42 110.408 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.0 tp -98.14 110.77 23.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 64.51 110.39 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.659 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 78.6 m-85 -91.66 142.87 27.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.66 -0.866 . . . . 73.31 108.66 173.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.409 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 3.8 tm-20 -155.77 126.59 6.93 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.168 -0.678 . . . . 73.3 109.168 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -153.56 102.91 2.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.2 -0.454 . . . . 73.04 110.627 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.6 -84.93 1.18 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.823 -0.626 . . . . 63.12 112.398 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -129.39 -4.9 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.509 0.671 . . . . 70.12 109.95 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.464 ' CZ2' ' HB2' ' A' ' 43' ' ' LYS . 35.3 t90 -100.38 135.97 41.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.764 -0.653 . . . . 74.43 112.251 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.2 144.12 48.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.764 -1.107 . . . . 74.44 109.154 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.659 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 44.9 tptt -146.76 110.39 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.585 0.231 . . . . 70.23 110.431 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -106.74 105.46 15.51 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 73.54 110.087 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.4 HG23 ' HG3' ' A' ' 43' ' ' LYS . 24.7 t -127.98 133.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 71.44 110.018 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.445 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -85.07 122.88 29.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 120.972 0.415 . . . . 74.03 111.206 -179.271 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.91 175.67 6.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.765 -0.828 . . . . 74.54 108.765 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.843 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 63.6 mtt180 -89.11 165.11 14.71 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.256 0.55 . . . . 72.32 110.589 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.688 HD22 ' HB ' ' A' ' 2' ' ' ILE . 96.5 mt -79.53 -24.78 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.497 -0.774 . . . . 74.11 110.139 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 t -91.63 -5.98 52.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.603 -0.726 . . . . 64.04 110.101 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.843 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 52.8 mt-10 -92.73 -9.38 40.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.64 -0.424 . . . . 70.34 111.91 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.573 ' HB2' HD13 ' A' ' 2' ' ' ILE . 44.5 mt -120.66 163.78 17.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.559 -0.291 . . . . 73.12 110.694 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -123.57 155.09 38.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.891 -0.411 . . . . 73.03 109.891 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.6 125.06 39.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.863 0.363 . . . . 73.03 110.955 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.534 HG13 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -82.95 170.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.8 -0.815 . . . . 74.13 108.8 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.534 ' H ' HG13 ' A' ' 55' ' ' VAL . 19.1 tptm -103.23 121.68 47.94 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.176 -0.305 . . . . 63.14 110.176 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.3 152.5 45.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.074 2.516 . . . . 52.2 112.394 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.7 mt -63.69 156.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 70.53 110.15 -179.492 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.643 ' H ' HD22 ' A' ' 59' ' ' LEU . 1.9 pt? -110.29 -172.39 2.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.153 -0.476 . . . . 71.32 110.276 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . 0.425 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -98.27 45.59 1.01 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.013 0.375 . . . . 64.11 112.013 -174.306 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 70.42 -1.43 2.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.216 0.607 . . . . 64.4 111.883 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -59.76 -32.22 70.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.856 0.317 . . . . 72.33 111.856 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.91 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.675 0.61 . . . . 74.44 110.589 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -102.48 -66.63 0.92 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.75 -0.38 . . . . 75.25 110.287 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 63.91 113.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.78 0.675 . . . . 73.23 110.541 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.3 p80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.168 -0.92 . . . . 74.24 110.188 -179.506 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.515 0.191 . . . . 73.42 111.515 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt -87.41 139.66 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.8 -0.815 . . . . 75.32 108.8 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.93 154.83 53.21 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.68 0.276 . . . . 72.31 110.899 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.621 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 15.8 Cg_endo -59.82 126.03 19.34 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.366 2.044 . . . . 74.22 111.214 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.563 ' HA2' HD22 ' A' ' 23' ' ' LEU . . . 108.78 -7.48 33.61 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.623 -0.799 . . . . 45.34 111.811 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.57 152.73 19.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 71.0 110.715 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -95.32 130.46 42.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 72.12 110.117 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.449 HG23 HD13 ' A' ' 52' ' ' LEU . 21.6 m -124.52 155.8 32.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.908 0.385 . . . . 73.14 111.395 -177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.423 HH11 ' HD2' ' A' ' 9' ' ' ARG . 19.2 ttt180 -122.8 121.32 35.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 73.31 109.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.99 116.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 54.4 111.238 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -90.74 -28.32 18.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 73.13 111.514 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.031 -0.359 . . . . 75.02 110.031 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.465 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 30.5 t -72.81 -26.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.175 0.512 . . . . 75.5 111.515 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.47 -15.39 55.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 65.34 111.281 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 160.16 29.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.093 0.473 . . . . 54.4 111.3 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -66.88 -38.69 86.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.739 -0.664 . . . . 75.54 111.637 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.61 26.8 5.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.897 0.379 . . . . 73.23 111.345 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.465 ' CG ' ' HA ' ' A' ' 13' ' ' VAL . 37.4 t80 -57.98 140.51 52.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.048 -0.524 . . . . 74.55 110.86 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 73.87 9.5 4.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.405 -0.816 . . . . 75.41 111.485 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -102.58 153.04 20.48 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.896 -0.409 . . . . 74.51 109.896 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.88 139.38 49.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 62.42 110.181 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.53 175.92 23.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.815 -0.707 . . . . 65.33 112.228 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.563 HD22 ' HA2' ' A' ' 5' ' ' GLY . 6.8 tt -112.6 124.95 53.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.112 -0.329 . . . . 74.42 110.112 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.54 117.31 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 62.3 110.804 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -78.09 -36.13 48.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.987 -0.552 . . . . 64.3 110.161 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.621 ' HA ' ' HB3' ' A' ' 4' ' ' PRO . 30.5 ptt180 -170.8 145.98 2.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.695 -0.684 . . . . 62.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.603 HG11 HD22 ' A' ' 49' ' ' LEU . 89.7 t -106.76 121.52 59.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.279 -0.873 . . . . 72.04 109.302 172.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.4 m -155.29 139.31 16.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.726 -0.215 . . . . 65.43 110.873 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 67.67 15.29 9.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.799 -0.637 . . . . 64.21 111.474 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.98 2.7 71.2 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.709 -0.758 . . . . 54.43 111.907 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 61.2 mtpt -115.31 163.05 16.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 110.182 -0.303 . . . . 71.3 110.182 178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.25 125.87 25.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.256 -0.429 . . . . 42.45 110.048 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.659 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.38 113.12 20.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 71.3 109.891 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.18 119.65 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 71.42 111.238 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.7 tp -94.1 108.79 20.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.945 -0.571 . . . . 74.34 109.685 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.456 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 96.6 m-85 -80.36 141.36 35.46 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.284 -0.636 . . . . 72.34 109.284 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -139.24 124.37 18.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.488 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -128.85 86.3 2.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 60.21 109.916 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.81 -95.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.205 -0.758 . . . . 71.52 111.205 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -122.37 87.77 2.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.529 1.156 . . . . 74.42 108.554 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 t90 178.8 138.46 0.09 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.283 -2.235 . . . . 74.54 109.463 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.6 p30 -137.03 152.71 50.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.489 -0.778 . . . . 74.1 110.558 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.406 ' HG3' HG23 ' A' ' 45' ' ' VAL . 17.1 tppt? -156.56 107.14 2.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 73.42 110.044 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LEU . . . . . 0.659 HD11 ' HB1' ' A' ' 33' ' ' ALA . 57.4 tp -89.21 110.86 21.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.169 -0.469 . . . . 71.2 110.716 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.406 HG23 ' HG3' ' A' ' 43' ' ' LYS . 34.8 t -125.65 120.73 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 65.54 109.213 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.586 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.0 m -81.41 130.93 35.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.282 0.563 . . . . 71.44 111.067 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.438 ' HB2' HD12 ' A' ' 52' ' ' LEU . 81.9 m-85 -124.53 -167.27 1.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.19 -0.914 . . . . 74.34 109.038 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.694 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 65.2 mtt-85 -110.24 162.81 14.25 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.885 -0.413 . . . . 65.35 109.885 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.603 HD22 HG11 ' A' ' 27' ' ' VAL . 3.6 mm? -66.4 -33.29 75.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.429 0.633 . . . . 63.25 109.999 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 p -78.16 -6.38 54.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.514 -0.766 . . . . 64.33 110.573 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.694 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 15.4 mm-40 -94.13 -15.57 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 74.3 111.001 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.449 HD13 HG23 ' A' ' 8' ' ' VAL . 29.4 mt -127.79 150.07 49.98 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.066 -0.515 . . . . 74.11 111.645 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -121.25 143.45 49.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.655 -0.868 . . . . 75.21 108.655 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.18 136.37 37.08 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.958 -0.297 . . . . 53.24 110.246 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.566 HG13 ' H ' ' A' ' 56' ' ' LYS . 3.0 t -67.27 164.17 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.534 -0.543 . . . . 72.43 109.534 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . 0.566 ' H ' HG13 ' A' ' 55' ' ' VAL . 87.6 tttt -130.53 137.02 29.89 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.168 -0.469 . . . . 72.01 110.439 -169.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.74 135.76 57.45 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.693 2.262 . . . . 61.14 111.359 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.23 152.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.237 0.541 . . . . 74.02 111.097 -174.159 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.32 144.93 49.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 53.12 110.028 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.28 164.18 15.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.175 -0.676 . . . . 74.41 109.175 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -63.96 131.47 47.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.943 0.401 . . . . 73.4 110.969 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -152.85 157.36 40.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.828 -0.624 . . . . 64.11 110.121 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' HIS . . . . . 0.428 ' CG ' ' H ' ' A' ' 64' ' ' HIS . 2.4 t-80 63.87 -153.56 0.31 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.596 0.56 . . . . 75.02 109.756 -179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.428 ' H ' ' CG ' ' A' ' 63' ' ' HIS . 27.7 t-80 73.93 -29.03 0.19 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.249 0.62 . . . . 64.32 111.979 176.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.406 ' H ' ' C ' ' A' ' 63' ' ' HIS . 2.1 m-70 -59.82 -40.36 88.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.512 . . . . 72.53 110.079 173.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.6 p80 . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.327 -0.851 . . . . 71.11 108.762 175.227 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 109.347 -0.612 . . . . 75.219999999999999 109.347 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -135.27 161.71 61.79 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.605 -0.27 . . . . 75.25 110.295 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.86 117.55 4.32 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.274 1.983 . . . . 74.140000000000001 111.191 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.85 1.36 24.15 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.892 -0.67 . . . . 63.420000000000002 111.897 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.33 141.72 32.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.93 0.395 . . . . 61.0 110.948 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -82.55 129.96 35.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 33.229999999999997 110.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -132.36 153.02 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 71.219999999999999 111.565 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -117.13 137.04 52.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.515 -0.766 . . . . 73.519999999999996 109.969 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.4 t -80.42 115.26 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 71.310000000000002 110.353 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.49 18.52 22.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 112.21 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -89.82 113.9 25.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.177 -0.675 . . . . 62.200000000000003 109.177 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.11 -28.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.767 -0.651 . . . . 54.210000000000001 111.976 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -93.07 23.54 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 65.540000000000006 110.791 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.72 160.96 18.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.791 -0.568 . . . . 55.0 110.527 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -71.06 -32.09 68.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 52.530000000000001 111.173 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.471 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 71.6 m-85 -96.85 25.45 5.29 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.886 0.328 . . . . 70.129999999999995 111.886 -175.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -59.23 131.32 50.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.537 -0.301 . . . . 70.239999999999995 110.198 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 78.23 -16.84 0.62 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.885 0.874 . . . . 75.340000000000003 111.577 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -75.25 157.46 34.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 63.43 110.686 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.61 139.63 50.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.859 -0.609 . . . . 65.109999999999999 110.854 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 179.88 18.46 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.785 -0.643 . . . . 41.039999999999999 111.506 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.2 tp -119.0 123.23 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.311 -0.255 . . . . 63.530000000000001 110.311 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.93 116.81 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.845 -0.428 . . . . 74.299999999999997 109.845 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -90.49 -33.65 15.88 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.938 -0.574 . . . . 54.409999999999997 110.914 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -169.84 154.02 5.11 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.764 -0.653 . . . . 63.439999999999998 110.177 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.16 124.74 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.097 -0.956 . . . . 55.25 109.115 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -120.2 98.84 6.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.992 0.425 . . . . 75.540000000000006 111.179 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 54.29 39.45 30.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.356 -0.838 . . . . 74.209999999999994 112.178 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.47 -11.72 65.0 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.642 -0.789 . . . . 62.539999999999999 112.569 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 99.0 mttt -99.13 177.61 5.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.113 -0.329 . . . . 75.140000000000001 110.113 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.99 126.18 40.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 70.519999999999996 110.604 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.817 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -83.58 107.52 16.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.291 -0.413 . . . . 74.400000000000006 109.957 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.12 124.02 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.137 -0.483 . . . . 72.329999999999998 110.822 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -99.13 126.51 44.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.511 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -103.59 136.46 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.535 -0.913 . . . . 62.200000000000003 108.535 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -141.83 133.22 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.807 -0.442 . . . . 55.039999999999999 109.807 -172.597 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -129.11 21.78 5.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.196 0.522 . . . . 71.109999999999999 111.09 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . 98.13 9.26 54.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.643 -0.789 . . . . 50.340000000000003 112.951 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 28.6 t-20 169.34 -46.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.087 -0.709 . . . . 73.420000000000002 109.087 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -80.25 138.69 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.501 -0.772 . . . . 74.230000000000004 109.894 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -154.8 163.21 40.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.736 -0.665 . . . . 60.32 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -165.39 106.79 0.78 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.242 -0.89 . . . . 72.129999999999995 109.462 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.817 HD21 ' HB1' ' A' ' 33' ' ' ALA . 8.7 tt -77.52 119.25 20.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 51.340000000000003 109.649 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.15 124.26 62.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.861 -0.422 . . . . 75.530000000000001 109.861 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -84.09 129.2 34.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.225 0.536 . . . . 52.310000000000002 110.729 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 95.7 m-85 -124.73 178.45 5.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.454 -0.793 . . . . 65.219999999999999 109.182 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.943 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 49.7 mtt180 -87.08 163.02 17.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.296 -0.631 . . . . 64.540000000000006 109.296 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.37 -31.24 69.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.724 -0.843 . . . . 71.310000000000002 108.724 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 p -67.82 -21.34 65.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 114.933 -1.03 . . . . 50.100000000000001 110.466 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.943 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 41.2 mm-40 -87.95 -7.9 56.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.501 -0.48 . . . . 65.230000000000004 111.254 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 8' ' ' VAL . 49.9 mt -122.88 156.63 34.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.973 0.416 . . . . 74.329999999999998 111.719 -173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -129.22 147.24 51.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.114 -0.698 . . . . 52.140000000000001 109.114 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.94 132.33 36.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 74.299999999999997 111.127 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 177.969 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.7 HD12 HD22 ' A' ' 49' ' ' LEU . 52.3 mt . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.145 -0.317 . . . . 73.439999999999998 110.145 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.47 143.46 30.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.249 -0.432 . . . . 71.439999999999998 110.762 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.85 134.6 44.23 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.675 2.25 . . . . 63.240000000000002 111.544 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.83 -5.01 50.23 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.991 -0.624 . . . . 62.210000000000001 112.331 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.7 161.07 13.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.831 0.348 . . . . 53.32 110.695 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -99.69 131.79 45.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.264 -0.425 . . . . 75.129999999999995 110.234 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 52' ' ' LEU . 25.9 m -125.7 155.52 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 110.206 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -109.47 143.07 39.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.669 -0.493 . . . . 44.439999999999998 109.669 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.16 113.96 16.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.032 -0.359 . . . . 63.0 110.032 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -89.69 -19.02 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 73.439999999999998 111.142 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.03 106.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 74.420000000000002 110.5 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.15 -30.42 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 71.549999999999997 111.132 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.66 -26.55 68.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 71.439999999999998 111.125 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.16 155.37 25.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 63.229999999999997 110.647 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 -27.5 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.002 -0.545 . . . . 73.109999999999999 110.945 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.43 22.66 2.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.276 -0.42 . . . . 71.25 111.489 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 35.6 t80 -63.32 134.61 56.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.239 -0.437 . . . . 74.409999999999997 110.332 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.7 mtp180 76.17 1.82 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.761 0.825 . . . . 74.549999999999997 112.293 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -85.35 150.51 24.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 75.129999999999995 110.212 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 125.25 53.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 74.519999999999996 109.744 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -125.72 155.27 18.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.586 -0.816 . . . . 41.329999999999998 111.85 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.66 116.48 28.98 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 110.252 -0.277 . . . . 75.409999999999997 110.252 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.01 106.34 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.85 -0.426 . . . . 61.310000000000002 109.85 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -79.37 -34.5 41.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.101 0.477 . . . . 72.019999999999996 110.521 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -167.03 143.72 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.695 -0.684 . . . . 70.140000000000001 109.65 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.18 136.14 25.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.431 -0.804 . . . . 72.519999999999996 109.276 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 m -127.03 93.75 3.84 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.264 -0.273 . . . . 63.009999999999998 110.264 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.92 -76.82 0.06 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.298 -0.864 . . . . 65.129999999999995 111.085 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -140.76 11.73 2.9 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.332 -1.304 . . . . 44.310000000000002 111.132 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 47.4 mtmt -114.6 165.95 12.23 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.115 -0.543 . . . . 74.019999999999996 109.55 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.98 133.4 37.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.681 0.277 . . . . 51.229999999999997 110.5 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.74 99.6 10.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.18 -0.674 . . . . 42.340000000000003 109.18 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG1' ' HA3' ' A' ' 22' ' ' GLY . 55.4 t -91.78 118.09 36.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 64.099999999999994 110.793 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.8 tp -94.6 122.59 37.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.781 -0.645 . . . . 72.209999999999994 110.509 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 92.3 m-85 -99.95 146.77 26.3 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.957 -0.757 . . . . 71.340000000000003 108.957 174.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 30.8 tt0 -129.55 -56.06 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.669 -0.412 . . . . 60.310000000000002 111.805 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 64.64 -66.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.825 0.45 . . . . 74.019999999999996 111.523 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . -168.73 93.5 0.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.334 -0.706 . . . . 52.009999999999998 111.334 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 8.6 t30 72.59 -36.79 0.37 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.492 0.717 . . . . 74.120000000000005 111.743 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 48.1 t90 -57.41 155.38 9.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 73.040000000000006 110.789 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.0 p-10 -148.54 153.45 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 71.409999999999997 110.301 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -169.45 110.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.362 -0.836 . . . . 73.129999999999995 109.378 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.544 HD11 ' HB1' ' A' ' 33' ' ' ALA . 37.8 tp -90.91 105.98 18.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.066 -0.516 . . . . 73.129999999999995 110.067 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -118.0 118.09 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 110.004 -0.369 . . . . 73.400000000000006 110.004 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 m -79.27 129.6 34.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.08 0.467 . . . . 54.539999999999999 110.583 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -124.84 178.41 5.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.613 -0.721 . . . . 65.439999999999998 109.119 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.961 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 62.8 mmt-85 -90.17 162.85 15.07 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.959 -0.756 . . . . 74.129999999999995 108.959 175.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.7 HD22 HD12 ' A' ' 2' ' ' ILE . 87.0 mt -79.36 -22.31 44.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.27 0.557 . . . . 71.319999999999993 109.882 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 p -75.21 -15.12 60.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.399 -0.819 . . . . 64.209999999999994 110.003 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.961 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 13.4 mm-40 -91.89 -13.17 31.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.732 -0.667 . . . . 63.539999999999999 110.604 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 8' ' ' VAL . 62.9 mt -115.56 161.54 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.73 . . . . 73.230000000000004 111.01 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.64 128.99 48.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.802 -0.636 . . . . 75.129999999999995 109.549 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.602 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -79.93 108.74 13.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.71 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 108.837 -0.801 . . . . 72.140000000000001 108.837 176.878 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.007 -0.738 . . . . 74.25 109.007 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -149.62 144.27 17.63 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.887 -0.412 . . . . 74.219999999999999 109.887 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.36 131.57 44.08 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.71 2.273 . . . . 53.119999999999997 111.857 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.2 -13.26 48.52 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.985 -0.626 . . . . 32.520000000000003 111.883 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 164.39 13.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.877 0.37 . . . . 22.129999999999999 110.561 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -97.36 134.42 40.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.902 -0.59 . . . . 72.040000000000006 110.085 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.79 148.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.991 0.425 . . . . 72.420000000000002 111.008 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 22.2 ttt180 -104.92 122.23 45.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.66 -0.7 . . . . 73.430000000000007 109.504 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 52' ' ' LEU . 41.2 t -70.82 103.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.1 0.476 . . . . 64.420000000000002 110.16 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -108.88 23.94 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.799 -0.637 . . . . 75.319999999999993 111.572 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -72.87 106.43 4.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.876 -0.787 . . . . 72.329999999999998 108.876 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.41 -25.47 38.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.179 0.514 . . . . 73.129999999999995 111.178 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.08 -23.26 26.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.308 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.79 155.8 18.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 73.310000000000002 110.905 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -78.94 -23.4 44.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 54.119999999999997 111.822 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -76.91 11.77 1.62 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 73.420000000000002 111.28 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 64.9 t80 -71.33 78.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.516 -0.765 . . . . 75.230000000000004 110.055 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 14.8 ptt180 168.9 -20.38 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.182 -0.917 . . . . 71.430000000000007 109.629 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.12 148.07 23.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.305 0.574 . . . . 74.140000000000001 111.408 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 41.5 mt-10 -125.91 118.12 24.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.246 -1.02 . . . . 74.109999999999999 108.246 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.76 176.81 17.86 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.132 -1.032 . . . . 60.43 113.148 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -93.67 140.4 29.68 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.553 0.216 . . . . 71.109999999999999 110.632 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.27 117.33 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.254 -0.43 . . . . 53.219999999999999 110.667 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 35' ' ' LEU . 2.6 mp0 -75.9 -37.71 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 55.130000000000003 110.108 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -170.67 141.06 1.79 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.798 -0.637 . . . . 64.25 110.615 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.75 108.25 21.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.264 -0.88 . . . . 63.219999999999999 108.788 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -88.92 41.71 1.04 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.523 -0.308 . . . . 60.240000000000002 110.955 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 63.5 88.93 0.09 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.317 -0.856 . . . . 61.310000000000002 111.143 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.24 -30.55 9.66 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.656 -0.702 . . . . 60.5 112.448 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -120.65 162.66 19.29 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.214 0.206 . . . . 73.439999999999998 110.491 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.94 140.7 28.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.519 0.2 . . . . 73.230000000000004 111.019 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.64 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -93.02 116.57 29.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.51 -0.552 . . . . 71.010000000000005 109.51 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 127.21 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.398 -0.364 . . . . 74.439999999999998 110.66 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' HB2' ' OE1' ' A' ' 25' ' ' GLN . 37.0 tp -88.72 125.88 35.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.454 . . . . 72.319999999999993 110.889 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.592 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 91.4 m-85 -102.91 142.22 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.766 -0.652 . . . . 71.230000000000004 109.445 173.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -143.3 119.7 10.95 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.65 -0.5 . . . . 62.130000000000003 109.65 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 55.5 t30 -137.92 91.36 2.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 54.109999999999999 110.62 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.19 -91.76 0.83 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.747 -0.66 . . . . 64.0 112.473 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -114.49 -11.61 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 75.409999999999997 110.385 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.481 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 63.8 t90 -89.01 139.15 30.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 72.319999999999993 111.39 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.74 154.4 46.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.303 -0.862 . . . . 72.439999999999998 109.784 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -163.5 121.34 1.89 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.679 -0.691 . . . . 71.239999999999995 110.503 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.64 HD21 ' HB1' ' A' ' 33' ' ' ALA . 9.1 tt -91.03 113.76 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.244 -0.65 . . . . 74.439999999999998 109.244 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.592 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 44.3 t -123.14 129.05 75.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.364 . . . . 63.350000000000001 110.636 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.8 m -84.37 132.62 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.991 0.424 . . . . 72.430000000000007 110.585 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -128.44 -176.61 3.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.911 -0.586 . . . . 74.099999999999994 110.053 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 25.2 mtp180 -100.47 157.01 16.95 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.298 -0.631 . . . . 74.219999999999999 109.298 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.5 -23.04 50.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.059 0.457 . . . . 72.219999999999999 110.424 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -74.47 -18.04 60.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.667 -0.697 . . . . 65.340000000000003 110.315 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.559 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp0 -99.0 -4.63 32.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.58 . . . . 74.200000000000003 111.294 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 10' ' ' VAL . 84.0 mt -120.18 130.18 54.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.458 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.95 135.34 45.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.104 -0.702 . . . . 75.030000000000001 109.104 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 128.9 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.085 -0.507 . . . . 73.409999999999997 110.579 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.32 -0.689 0 N-CA-C 108.6 -0.889 . . . . 70.519999999999996 108.6 177.149 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.927 -0.397 . . . . 74.219999999999999 109.927 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 36.9 m-85 -149.4 167.48 12.94 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.678 -0.692 . . . . 72.140000000000001 110.028 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.815 ' HG3' ' HA ' ' A' ' 26' ' ' ARG . 51.6 Cg_exo -53.83 124.33 15.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.696 2.264 . . . . 64.150000000000006 112.061 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.27 -16.3 35.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.129 -0.558 . . . . 73.200000000000003 112.036 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.26 155.27 30.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 71.019999999999996 110.792 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -98.39 130.37 45.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.341 -0.39 . . . . 62.439999999999998 110.401 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.48 157.45 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.435 . . . . 62.43 110.459 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -133.98 135.7 43.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.061 -0.518 . . . . 70.540000000000006 110.365 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.77 120.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 75.329999999999998 110.678 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.9 p -100.1 5.88 44.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 43.119999999999997 111.817 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.3 t30 -80.86 108.48 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 64.129999999999995 109.616 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.3 t -71.17 -28.14 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 74.010000000000005 111.528 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.45 -6.5 57.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 72.510000000000005 110.933 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.482 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 8.8 t70 -94.24 160.64 14.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.756 0.312 . . . . 74.049999999999997 110.306 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -82.92 -19.71 36.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.23 -0.441 . . . . 72.120000000000005 110.708 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.45 19.61 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 63.109999999999999 110.351 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.56 128.63 36.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.683 -0.69 . . . . 75.420000000000002 111.145 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 70.05 7.44 6.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.245 -0.889 . . . . 61.130000000000003 112.512 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.74 145.29 32.97 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.168 -0.678 . . . . 74.239999999999995 109.168 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -113.19 129.92 56.37 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.5 -0.773 . . . . 71.219999999999999 109.804 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.75 164.67 25.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.444 -0.884 . . . . 71.540000000000006 112.047 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.03 129.95 44.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 110.283 -0.266 . . . . 73.150000000000006 110.283 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.05 112.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 62.009999999999998 109.845 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -71.25 -37.68 71.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 71.239999999999995 109.524 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.815 ' HA ' ' HG3' ' A' ' 4' ' ' PRO . 33.0 ptt180 -174.78 150.22 1.27 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.086 -0.961 . . . . 72.25 109.011 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.18 128.57 45.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.552 -0.749 . . . . 74.109999999999999 109.414 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -124.94 78.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.877 -0.416 . . . . 64.409999999999997 109.877 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.3 t70 49.56 82.86 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.29 -0.868 . . . . 72.439999999999998 112.416 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 -12.39 19.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.98 -0.628 . . . . 63.310000000000002 113.209 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 59.1 mtpt -115.38 158.27 22.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.567 0.223 . . . . 71.150000000000006 110.513 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.62 131.46 27.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.475 -0.329 . . . . 71.299999999999997 110.361 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.63 105.43 14.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.413 -0.588 . . . . 72.150000000000006 109.413 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -92.26 121.01 42.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.265 -0.425 . . . . 62.020000000000003 110.812 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.3 tp -97.88 108.55 21.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.754 -0.461 . . . . 75.129999999999995 109.754 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -82.42 134.42 35.23 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.038 -0.727 . . . . 73.129999999999995 109.038 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.34 -54.92 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.555 . . . . 70.310000000000002 111.165 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 24.4 t-20 68.89 -48.22 0.58 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.971 0.508 . . . . 72.239999999999995 111.971 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.9 -48.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.203 -0.523 . . . . 51.350000000000001 111.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -132.25 4.93 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.585 1.183 . . . . 72.450000000000003 108.985 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 26.4 t90 -103.12 172.7 6.67 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.725 -1.58 . . . . 64.409999999999997 109.828 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 3.3 p30 -154.08 153.79 32.5 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.272 -0.27 . . . . 72.109999999999999 110.272 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HE2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -175.52 109.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.531 -0.759 . . . . 62.399999999999999 110.237 175.192 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.401 HD11 ' HB1' ' A' ' 33' ' ' ALA . 62.9 tp -97.68 109.97 22.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.176 -0.305 . . . . 63.399999999999999 110.176 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.3 t -134.76 129.64 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 70.120000000000005 109.932 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -90.13 135.14 33.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.251 0.548 . . . . 63.420000000000002 110.683 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -130.38 -176.36 3.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.701 -0.851 . . . . 64.120000000000005 108.701 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.058 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 68.4 mtt180 -87.48 168.43 13.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.455 -0.572 . . . . 64.329999999999998 109.455 174.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.36 -24.07 42.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.135 -0.691 . . . . 75.010000000000005 109.135 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -80.46 -20.42 43.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.171 -0.922 . . . . 72.409999999999997 110.58 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 1.058 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 10.4 mm-40 -85.83 -14.39 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.363 0.601 . . . . 71.349999999999994 110.409 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.0 mt -115.42 155.7 26.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.567 -0.742 . . . . 74.319999999999993 110.151 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.87 133.58 52.7 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.409 -0.589 . . . . 63.450000000000003 109.409 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.3 120.59 22.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.233 -0.44 . . . . 40.439999999999998 109.845 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 109.447 -0.575 . . . . 74.430000000000007 109.447 -179.731 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.404 ' CG2' HG21 ' A' ' 24' ' ' VAL . 32.4 mt . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.775 0.322 . . . . 75.519999999999996 110.451 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.69 159.92 69.77 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 115.898 -0.592 . . . . 73.25 109.751 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.84 127.76 23.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.504 2.136 . . . . 73.040000000000006 111.782 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.37 -5.68 52.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 71.049999999999997 112.618 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.7 146.28 26.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.63 0.253 . . . . 51.25 111.253 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 124.78 32.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.115 -0.493 . . . . 71.409999999999997 110.083 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.704 HG21 HD13 ' A' ' 52' ' ' LEU . 16.5 m -128.39 144.52 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 72.540000000000006 111.37 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.749 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 11.5 ttt85 -100.89 130.12 46.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.659 -0.701 . . . . 54.119999999999997 110.174 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 49.0 t -68.31 111.9 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.054 -0.721 . . . . 72.129999999999995 109.054 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -112.58 10.78 19.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.121 0.486 . . . . 44.43 111.806 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -82.35 112.73 19.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.784 -0.821 . . . . 65.329999999999998 108.784 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -66.56 -21.47 28.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.645 . . . . 62.340000000000003 111.431 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.81 -31.0 68.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.969 -0.56 . . . . 73.219999999999999 111.415 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.22 161.57 17.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 75.230000000000004 111.077 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 m -77.87 -23.29 48.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 75.540000000000006 111.53 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 82.6 m-85 -88.63 20.41 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.654 0.264 . . . . 74.519999999999996 111.57 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -71.2 77.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 62.340000000000003 110.876 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 166.67 -30.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.02 -0.991 . . . . 70.439999999999998 109.675 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -78.38 151.21 32.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.678 -0.692 . . . . 74.450000000000003 111.539 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.749 ' HG2' ' HB2' ' A' ' 9' ' ' ARG . 29.3 mt-10 -125.38 122.95 38.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 109.509 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.77 -178.68 15.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.75 . . . . 71.219999999999999 112.472 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.07 135.94 42.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.764 0.316 . . . . 74.030000000000001 111.191 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' A' ' 2' ' ' ILE . 62.0 t -75.66 111.09 11.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.937 0.399 . . . . 71.349999999999994 110.04 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -72.84 -41.39 64.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.659 0.742 . . . . 62.299999999999997 109.669 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -164.95 138.53 4.81 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.575 -1.193 . . . . 73.310000000000002 109.569 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.507 HG13 HD21 ' A' ' 49' ' ' LEU . 60.3 t -95.21 139.77 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.396 -0.82 . . . . 51.329999999999998 109.77 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 6.0 t -130.43 63.29 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.475 -0.565 . . . . 62.530000000000001 109.475 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 16.25 81.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.291 1.436 . . . . 54.009999999999998 113.386 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.99 -41.83 1.87 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.673 -1.149 . . . . 70.230000000000004 110.672 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 51.7 mmtt -109.78 167.35 10.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.76 0.424 . . . . 52.240000000000002 110.195 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.4 139.06 9.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.211 -0.45 . . . . 44.149999999999999 110.147 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -90.9 114.57 27.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.942 -0.392 . . . . 65.030000000000001 109.942 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.481 HG21 HD21 ' A' ' 52' ' ' LEU . 42.2 t -99.21 120.29 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 73.319999999999993 110.819 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.9 tp -97.65 114.52 26.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.566 -0.531 . . . . 62.039999999999999 109.566 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.4 141.97 30.46 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.95 -0.568 . . . . 72.109999999999999 109.925 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.49 113.94 11.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 72.200000000000003 109.648 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -142.39 79.71 1.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.062 0.458 . . . . 74.129999999999995 110.936 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.42 -104.04 2.12 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.848 -0.615 . . . . 64.340000000000003 112.656 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -96.78 -16.58 20.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.665 0.745 . . . . 64.120000000000005 109.625 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -95.04 141.17 29.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.211 -0.904 . . . . 63.299999999999997 111.239 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -153.39 150.91 29.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.88 -1.055 . . . . 75.310000000000002 109.527 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HE2' ' CG2' ' A' ' 45' ' ' VAL . 87.3 tttt -158.09 131.31 7.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.27 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.454 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.9 tp -99.81 110.7 23.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.358 -0.383 . . . . 71.129999999999995 110.3 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.454 ' CG2' ' HE2' ' A' ' 43' ' ' LYS . 40.2 t -124.27 120.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.981 0.419 . . . . 64.530000000000001 110.425 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.2 m -75.88 130.01 37.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.206 0.527 . . . . 73.400000000000006 110.493 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -125.28 -171.06 2.28 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.504 -0.771 . . . . 54.340000000000003 108.979 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.717 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 19.9 mtm180 -99.33 171.04 8.23 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.466 -0.568 . . . . 74.109999999999999 109.466 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD21 HG13 ' A' ' 27' ' ' VAL . 75.3 mt -76.6 -30.99 57.18 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.014 0.435 . . . . 64.219999999999999 110.039 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 p -71.58 -12.78 61.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.718 -0.674 . . . . 45.420000000000002 110.345 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.717 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 4.8 mm-40 -86.67 -14.68 41.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.519999999999996 110.744 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.704 HD13 HG21 ' A' ' 8' ' ' VAL . 79.7 mt -110.74 130.67 55.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.283 0.563 . . . . 72.230000000000004 112.403 -168.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -109.89 116.0 30.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.35 -0.841 . . . . 75.310000000000002 109.081 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 131.35 50.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.343 . . . . 72.109999999999999 110.485 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 109.245 -0.65 . . . . 72.120000000000005 109.245 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.586 HG12 ' HB2' ' A' ' 54' ' ' ALA . 48.1 mt . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 109.796 -0.446 . . . . 71.010000000000005 109.796 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -119.64 153.08 54.14 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.056 -0.52 . . . . 73.239999999999995 110.753 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.17 130.81 28.28 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.619 2.213 . . . . 74.319999999999993 111.463 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 103.39 -13.1 54.8 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 74.030000000000001 112.16 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 150.63 24.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 64.0 111.232 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -87.24 130.27 34.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.716 -0.674 . . . . 72.0 109.882 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 54' ' ' ALA . 22.9 m -128.93 152.29 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.898 0.38 . . . . 73.409999999999997 110.601 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HD2' ' OE2' ' A' ' 53' ' ' GLU . 44.7 ttm180 -110.46 138.05 47.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.246 -0.65 . . . . 73.120000000000005 109.246 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.5 t -76.25 113.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.907 0.384 . . . . 70.540000000000006 110.818 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -96.87 2.32 51.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 65.299999999999997 110.577 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.8 115.26 11.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.528 -0.76 . . . . 65.019999999999996 110.32 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.77 -8.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.422 0.63 . . . . 63.140000000000001 110.471 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.37 -37.81 88.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 64.349999999999994 110.637 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' OD2' ' HD2' ' A' ' 17' ' ' TYR . 13.6 t70 -103.45 173.47 6.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 72.230000000000004 109.877 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -88.94 -12.1 42.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.713 0.264 . . . . 71.299999999999997 111.713 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 58.4 m-85 -79.27 30.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 73.409999999999997 112.068 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 86.2 t80 -70.54 138.31 50.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 75.400000000000006 109.432 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 41.3 mtt180 70.59 18.96 6.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.506 0.504 . . . . 74.319999999999993 112.049 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -93.73 150.74 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 44.210000000000001 110.522 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -103.57 121.52 43.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.221 -0.9 . . . . 73.109999999999999 109.341 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.84 162.84 23.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.508 -0.853 . . . . 63.109999999999999 112.318 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.428 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.6 tt -116.74 123.69 47.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.703 -0.48 . . . . 65.439999999999998 109.703 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 32' ' ' ALA . 75.6 t -65.74 114.85 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 63.409999999999997 110.954 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -79.21 -35.46 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.366 0.603 . . . . 63.450000000000003 110.145 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -165.68 154.47 11.66 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.136 -0.938 . . . . 72.420000000000002 108.923 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.75 126.36 68.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.535 -0.757 . . . . 72.129999999999995 109.305 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.7 t -125.43 84.98 2.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.55 -0.296 . . . . 71.019999999999996 110.8 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 40.59 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.263 0.977 . . . . 52.049999999999997 112.969 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 96.09 -29.9 9.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.586 -0.816 . . . . 71.340000000000003 112.804 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HB3' HG22 ' A' ' 46' ' ' THR . 41.4 mttt -109.71 163.82 13.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.995 0.426 . . . . 71.239999999999995 111.379 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 24' ' ' VAL . . . -143.7 137.14 27.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 71.319999999999993 109.93 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.592 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.82 105.34 14.64 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.961 -0.385 . . . . 71.129999999999995 109.961 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.77 118.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.18 -0.463 . . . . 72.310000000000002 110.925 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.34 118.79 31.71 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.638 -0.504 . . . . 73.420000000000002 109.638 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -86.76 147.35 25.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.941 -0.572 . . . . 74.239999999999995 109.93 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -135.54 119.99 18.03 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 71.230000000000004 108.988 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -138.97 42.26 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.565 0.697 . . . . 72.219999999999999 110.046 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.18 -102.54 2.42 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 44.450000000000003 111.671 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -93.29 -32.87 14.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.211 0.529 . . . . 72.329999999999998 109.793 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -74.96 140.63 43.81 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.491 -0.777 . . . . 70.25 111.007 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.9 165.62 27.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.66 -1.155 . . . . 74.040000000000006 108.77 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -164.7 137.93 4.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.144 -0.317 . . . . 70.109999999999999 110.144 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.592 HD11 ' HB1' ' A' ' 33' ' ' ALA . 47.8 tp -109.16 109.24 20.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.809 0.338 . . . . 73.099999999999994 110.178 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -124.44 124.06 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.064 0.459 . . . . 74.0 110.265 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -87.33 111.13 20.76 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.393 0.616 . . . . 73.219999999999999 110.796 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.78 178.1 4.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.245 -0.889 . . . . 70.430000000000007 109.455 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.738 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 54.0 mtt85 -88.9 159.19 17.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.706 -0.479 . . . . 71.120000000000005 109.706 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 30' ' ' GLY . 94.0 mt -71.45 -26.91 62.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.343 0.592 . . . . 74.109999999999999 109.792 -176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 p -80.0 -12.03 59.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.289 -0.869 . . . . 71.409999999999997 109.994 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.738 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.5 mt-10 -98.93 3.08 47.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.838 -0.619 . . . . 74.5 110.558 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.01 153.55 46.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 71.430000000000007 110.361 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 9' ' ' ARG . 11.7 pt-20 -118.28 123.14 44.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 74.219999999999999 109.28 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.717 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -78.5 123.86 27.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.319 -0.4 . . . . 73.329999999999998 110.03 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 108.899 -0.778 . . . . 63.310000000000002 108.899 177.825 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 54' ' ' ALA . 41.1 mt . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.234 0.54 . . . . 73.439999999999998 111.444 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -130.77 154.64 81.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 73.019999999999996 109.714 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.82 119.15 6.11 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.354 2.036 . . . . 75.430000000000007 111.425 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.24 -3.83 31.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 43.43 111.949 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.15 153.77 19.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 73.019999999999996 110.811 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -91.82 132.44 36.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.564 . . . . 72.420000000000002 110.29 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.64 160.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.0 0.428 . . . . 63.399999999999999 110.828 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -124.81 130.59 52.69 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.884 -0.784 . . . . 72.230000000000004 108.884 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.2 t -68.73 108.81 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.155 0.503 . . . . 65.329999999999998 110.767 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -88.13 -17.98 29.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.484 -0.78 . . . . 72.0 110.416 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 42.7 t30 -66.85 106.99 2.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 71.219999999999999 110.573 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.22 -24.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 74.140000000000001 110.54 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.01 -27.09 67.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.362 -0.835 . . . . 71.140000000000001 111.189 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 11.2 t70 -85.86 164.94 17.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.2 -0.455 . . . . 63.009999999999998 110.766 -176.221 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -82.65 -23.77 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.346 -0.388 . . . . 72.329999999999998 110.705 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.38 21.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.949 0.404 . . . . 72.209999999999994 111.026 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 29.9 t80 -63.19 133.04 53.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.032 -0.531 . . . . 73.329999999999998 110.268 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 62.8 mtt180 76.66 3.23 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.621 0.768 . . . . 72.340000000000003 112.22 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.5 157.21 21.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.885 0.374 . . . . 75.349999999999994 110.251 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -118.05 141.94 47.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 72.319999999999993 110.122 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.55 165.19 33.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.551 -0.833 . . . . 51.229999999999997 111.793 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -104.43 131.52 51.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 110.26 -0.274 . . . . 73.109999999999999 110.26 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.515 HG11 HG22 ' A' ' 27' ' ' VAL . 59.9 t -70.46 117.08 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.023 -0.535 . . . . 74.019999999999996 110.199 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 29.3 mm-40 -83.33 -31.7 26.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.496 0.665 . . . . 75.340000000000003 110.279 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -158.18 128.55 6.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.96 -1.018 . . . . 73.329999999999998 110.373 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG22 HG11 ' A' ' 24' ' ' VAL . 57.8 t -98.38 120.14 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.572 -0.74 . . . . 75.420000000000002 110.036 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.5 m -102.09 -178.86 3.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.053 -0.721 . . . . 74.310000000000002 109.053 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.18 81.93 3.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.342 0.592 . . . . 70.219999999999999 110.069 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.416 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 121.84 -31.24 5.04 Favored Glycine 0 C--N 1.318 -0.444 0 CA-C-N 115.364 -0.834 . . . . 74.109999999999999 112.447 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 46' ' ' THR . 97.1 mttt -120.28 159.79 24.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.868 0.366 . . . . 52.350000000000001 111.262 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.0 135.92 36.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.047 -0.524 . . . . 71.120000000000005 109.812 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -89.19 109.36 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.909 0.385 . . . . 32.549999999999997 110.263 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.0 126.58 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 64.430000000000007 110.423 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 34.4 tp -90.79 123.61 34.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 65.209999999999994 110.666 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 88.6 m-85 -107.85 134.0 51.41 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.55 -0.907 . . . . 61.119999999999997 108.55 171.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -143.05 128.69 19.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.392 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -134.31 74.9 1.56 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.415 -0.587 . . . . 60.439999999999998 109.415 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.34 -97.82 0.35 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.684 -0.689 . . . . 40.009999999999998 112.554 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.55 -22.5 24.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.266 0.555 . . . . 71.209999999999994 110.201 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.446 ' HZ2' ' HD2' ' A' ' 43' ' ' LYS . 87.1 t90 -91.75 146.93 23.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 73.430000000000007 110.983 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -150.27 159.07 44.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.442 -0.799 . . . . 63.149999999999999 110.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 11.9 mttm -163.88 133.49 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.688 -0.687 . . . . 31.449999999999999 110.828 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.7 tp -106.3 104.12 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.523 . . . . 71.239999999999995 109.587 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.44 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 29.0 t -113.53 118.04 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.071 0.463 . . . . 62.43 110.411 -176.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.4 m -82.81 130.28 35.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.875 -0.602 . . . . 64.140000000000001 110.469 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 52' ' ' LEU . 91.2 m-85 -123.13 178.97 4.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.607 -0.724 . . . . 55.399999999999999 109.062 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 57.7 mtp180 -96.63 162.83 13.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.048 0.451 . . . . 72.540000000000006 110.563 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.428 HD22 HD12 ' A' ' 2' ' ' ILE . 94.4 mt -76.3 -22.92 54.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.929 -0.578 . . . . 55.240000000000002 110.41 -173.514 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 p -85.76 -8.26 58.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 70.150000000000006 109.92 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.7 mt-10 -98.89 -8.31 25.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 64.420000000000002 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 10' ' ' VAL . 57.1 mt -124.15 151.61 43.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.85 -0.614 . . . . 71.140000000000001 110.45 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 147.97 37.17 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.203 -0.665 . . . . 74.439999999999998 109.203 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.545 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -89.27 126.9 35.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.043 0.449 . . . . 61.210000000000001 110.937 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.321 -0.638 0 N-CA-C 108.018 -1.105 . . . . 71.530000000000001 108.018 175.541 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--O 1.232 0.165 0 N-CA-C 109.946 -0.39 . . . . 74.329999999999998 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -133.94 152.65 78.96 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.193 -0.458 . . . . 70.349999999999994 110.726 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HG3' ' H ' ' A' ' 27' ' ' VAL . 24.1 Cg_exo -64.4 123.1 11.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.73 2.287 . . . . 70.340000000000003 111.565 176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.58 -0.81 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.017 -0.611 . . . . 60.409999999999997 112.089 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.88 145.41 32.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.848 0.356 . . . . 70.040000000000006 111.043 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -84.93 131.18 34.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.757 -0.656 . . . . 73.209999999999994 110.021 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 54' ' ' ALA . 32.7 m -129.46 150.85 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.778 0.323 . . . . 62.140000000000001 110.832 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 9' ' ' ARG . 17.3 ttt85 -104.33 134.83 46.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.856 -0.424 . . . . 62.119999999999997 109.856 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HA ' HD23 ' A' ' 52' ' ' LEU . 49.0 t -60.9 114.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.131 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -98.05 -9.73 25.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.39 0.614 . . . . 73.400000000000006 110.184 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.714 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 36.0 t30 -74.25 113.89 11.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 74.239999999999995 110.556 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.46 -26.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 54.25 110.889 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.64 -30.25 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 62.420000000000002 111.408 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -75.37 158.49 32.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 65.230000000000004 111.418 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -90.42 -12.31 37.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.817 -0.628 . . . . 71.439999999999998 110.938 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -98.51 21.4 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 72.25 110.169 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -66.63 80.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.7 . . . . 64.129999999999995 111.3 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 165.22 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.728 -1.124 . . . . 75.349999999999994 109.206 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -76.73 152.44 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.491 0.662 . . . . 75.25 111.854 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -119.42 109.78 16.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.856 -1.065 . . . . 73.129999999999995 109.232 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.05 174.89 15.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.726 -0.75 . . . . 44.439999999999998 112.565 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 23' ' ' LEU . 1.2 tm? -102.38 126.54 49.43 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.592 -0.521 . . . . 54.420000000000002 109.592 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' A' ' 32' ' ' ALA . 92.0 t -78.3 112.44 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.263 -0.273 . . . . 75.439999999999998 110.263 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -79.11 -34.39 43.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.956 0.407 . . . . 74.239999999999995 110.551 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -164.01 134.63 4.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.899 -0.591 . . . . 74.120000000000005 110.41 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.466 ' H ' ' HG3' ' A' ' 4' ' ' PRO . 96.9 t -91.58 123.3 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.386 -0.825 . . . . 74.540000000000006 109.096 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.6 t -126.91 91.36 3.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.702 0.286 . . . . 64.099999999999994 110.765 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 49.94 75.88 0.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 53.420000000000002 112.586 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.33 -20.99 6.42 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.06 -0.59 . . . . 43.109999999999999 113.404 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 55.8 mtpt -110.48 165.48 11.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.767 -0.255 . . . . 73.200000000000003 110.607 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -142.79 141.25 31.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 72.030000000000001 110.48 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.14 107.8 19.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.578 -0.527 . . . . 70.109999999999999 109.578 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.8 t -102.85 118.87 50.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.974 -0.557 . . . . 74.109999999999999 110.897 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.68 119.28 31.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.837 -0.619 . . . . 64.400000000000006 110.74 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 47.3 m-85 -89.59 134.12 34.28 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.594 -1.262 . . . . 71.549999999999997 107.594 169.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -149.38 124.39 10.02 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.934 -0.395 . . . . 72.120000000000005 109.934 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.12 86.09 1.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 54.229999999999997 110.667 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.7 -93.73 0.94 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.625 -0.716 . . . . 75.040000000000006 113.516 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -91.63 -21.97 20.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.869 0.366 . . . . 72.0 111.217 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t90 -111.07 143.5 41.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.315 0.578 . . . . 71.519999999999996 111.857 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 4.2 p-10 -147.99 153.06 38.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.664 -1.153 . . . . 74.140000000000001 109.176 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HG3' HG23 ' A' ' 45' ' ' VAL . 57.1 tptt -160.39 111.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 110.594 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -92.09 104.71 17.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 70.140000000000001 110.082 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.419 HG23 ' HG3' ' A' ' 43' ' ' LYS . 21.1 t -117.88 125.74 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 51.140000000000001 109.958 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.492 HG22 ' HE2' ' A' ' 31' ' ' LYS . 4.4 m -85.03 130.83 34.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.076 -0.511 . . . . 55.219999999999999 110.607 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.725 ' HB2' HD11 ' A' ' 52' ' ' LEU . 88.1 m-85 -126.53 -175.27 3.34 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.684 -0.689 . . . . 70.230000000000004 109.772 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.882 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 15.8 mmt180 -88.91 161.33 16.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.445 . . . . 73.549999999999997 109.8 174.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 32' ' ' ALA . 94.0 mt -83.41 -27.03 29.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.56 0.695 . . . . 74.519999999999996 109.343 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -76.45 -10.17 59.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.066 -0.97 . . . . 74.549999999999997 110.8 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.882 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 19.1 pt-20 -117.22 16.57 14.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.367 -0.533 . . . . 73.450000000000003 111.278 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.725 HD11 ' HB2' ' A' ' 47' ' ' PHE . 95.8 mt -131.86 154.35 49.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.857 -0.611 . . . . 71.299999999999997 109.97 175.49 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -149.06 141.37 24.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.624 -0.51 . . . . 73.519999999999996 109.624 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.3 138.34 51.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 53.210000000000001 111.594 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.544 -0.753 . . . . 64.140000000000001 109.057 177.555 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.281 0.563 . . . . 73.109999999999999 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 55.0 m-85 -95.19 139.78 22.16 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 75.129999999999995 110.752 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 16.8 Cg_exo -67.67 137.94 43.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.636 2.224 . . . . 73.519999999999996 111.458 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.22 4.37 64.58 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.844 -0.694 . . . . 72.209999999999994 111.799 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.44 161.68 13.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.617 0.246 . . . . 70.150000000000006 110.446 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -87.43 131.26 34.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.091 -0.504 . . . . 75.140000000000001 110.239 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.69 150.29 34.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 71.120000000000005 111.055 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.9 ttp180 -117.41 142.22 47.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.754 -0.657 . . . . 73.239999999999995 109.366 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.8 t -77.86 105.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.742 -0.466 . . . . 72.430000000000007 109.742 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -89.52 -4.21 58.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 72.329999999999998 111.053 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 15' ' ' ASP . 2.4 t-20 -69.38 102.86 1.85 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.7 -0.482 . . . . 70.239999999999995 109.7 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.524 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 22.4 t -63.03 -35.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.73 . . . . 45.119999999999997 112.14 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.96 -10.94 59.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.027 0.441 . . . . 71.010000000000005 111.597 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB2' ' OD1' ' A' ' 12' ' ' ASN . 5.6 t70 -84.4 160.37 20.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.012 -0.43 . . . . 72.239999999999995 110.7 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 m -71.06 -32.37 69.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 74.310000000000002 110.507 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 91.2 m-85 -87.86 21.13 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 53.5 111.25 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 32.9 t80 -59.27 132.25 53.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.02 0.438 . . . . 75.519999999999996 111.146 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 74.81 -3.8 2.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.924 -1.034 . . . . 65.329999999999998 111.917 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -77.78 149.87 34.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 63.43 109.652 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 37.1 mt-10 -125.34 136.2 53.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.55 . . . . 70.040000000000006 110.726 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.12 -171.24 17.62 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.009 -0.836 . . . . 73.340000000000003 111.009 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.9 mp -112.85 150.8 31.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.431 0.616 . . . . 71.299999999999997 110.923 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.01 115.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 73.239999999999995 110.231 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -79.58 -28.24 41.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 75.209999999999994 110.71 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -170.28 133.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 72.420000000000002 110.665 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 49' ' ' LEU . 58.0 t -93.88 135.4 28.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.318 -0.855 . . . . 62.520000000000003 109.786 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t -107.34 -159.94 0.71 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.929 -0.397 . . . . 73.409999999999997 109.929 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.8 -33.83 72.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.525 0.678 . . . . 71.319999999999993 111.709 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -155.16 -12.46 0.06 OUTLIER Glycine 0 C--N 1.31 -0.865 0 CA-C-N 114.791 -1.095 . . . . 54.43 112.319 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 63.8 mttp -104.27 172.09 6.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.844 0.354 . . . . 71.349999999999994 111.255 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.11 140.87 21.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 73.530000000000001 110.03 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.61 111.73 22.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.692 -0.484 . . . . 73.519999999999996 109.692 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 40.1 t -104.17 122.77 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 63.439999999999998 111.067 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.46 121.59 31.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.269 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.453 ' CE2' ' HE2' ' A' ' 47' ' ' PHE . 96.4 m-85 -101.41 151.96 21.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.993 -0.549 . . . . 71.430000000000007 110.244 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -122.32 -63.46 1.28 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.891 -0.595 . . . . 75.439999999999998 110.168 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.08 -57.32 0.42 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.538 0.735 . . . . 73.450000000000003 111.525 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . 158.35 102.55 0.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.904 -0.878 . . . . 44.32 110.904 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 24.9 t30 75.09 -40.59 0.44 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.422 0.689 . . . . 74.329999999999998 110.623 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -64.26 154.68 34.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.521 -0.763 . . . . 70.219999999999999 110.7 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -152.62 143.7 23.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.099 0.476 . . . . 74.340000000000003 109.882 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -168.22 125.25 1.08 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.568 -0.742 . . . . 74.109999999999999 109.904 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -100.09 102.55 13.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.3 -0.63 . . . . 71.409999999999997 109.3 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.35 120.04 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.061 -0.518 . . . . 53.210000000000001 110.609 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.23 129.25 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.942 -0.572 . . . . 72.400000000000006 110.269 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' HE2' ' CE2' ' A' ' 36' ' ' PHE . 45.2 m-85 -126.99 -174.37 3.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.938 -0.574 . . . . 72.230000000000004 109.542 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.567 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 33.5 mtt180 -103.93 162.13 13.39 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.462 -0.57 . . . . 72.150000000000006 109.462 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 27' ' ' VAL . 90.4 mt -73.06 -33.8 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.261 -0.427 . . . . 71.540000000000006 110.508 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -73.44 -16.08 61.32 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.751 -0.659 . . . . 70.430000000000007 110.579 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.567 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 3.5 mp0 -89.95 -8.85 50.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.827 -0.624 . . . . 74.040000000000006 111.387 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.88 157.39 25.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.341 -0.391 . . . . 74.510000000000005 111.391 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.54 148.42 52.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.045 -0.724 . . . . 74.010000000000005 109.045 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.37 121.73 21.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.995 0.426 . . . . 71.349999999999994 110.067 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.194 -0.669 . . . . 72.409999999999997 109.194 177.776 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.451 ' O ' HG21 ' A' ' 27' ' ' VAL . 48.8 mt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.341 -0.614 . . . . 74.450000000000003 109.341 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 39.4 p90 -115.79 149.24 42.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.595 0.236 . . . . 74.420000000000002 110.98 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 34.5 Cg_exo -62.13 142.79 93.33 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.607 2.205 . . . . 64.25 111.744 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.58 -7.85 65.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.975 -0.631 . . . . 54.219999999999999 112.128 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 143.6 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.929 0.395 . . . . 75.150000000000006 110.864 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -80.59 125.03 29.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 74.120000000000005 109.907 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.1 148.22 33.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.314 0.578 . . . . 42.200000000000003 111.349 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -111.76 133.85 53.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.285 -0.87 . . . . 62.43 109.3 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.3 t -80.08 101.17 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.576 -0.527 . . . . 64.219999999999999 109.576 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -103.31 13.7 33.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.895 -0.593 . . . . 64.450000000000003 110.526 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.9 t30 -61.6 107.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.533 -0.914 . . . . 71.430000000000007 108.533 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.84 -47.04 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 74.120000000000005 112.298 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.58 40.57 1.18 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.363 0.602 . . . . 71.530000000000001 110.537 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 6.1 t70 -110.44 161.13 15.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.129 -0.487 . . . . 74.409999999999997 110.111 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -81.14 -23.17 38.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.591 . . . . 70.310000000000002 110.104 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CD1' ' HZ ' ' A' ' 47' ' ' PHE . 73.7 m-85 -98.66 24.72 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 70.109999999999999 110.848 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 46.0 t80 -62.44 127.88 33.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.954 -0.566 . . . . 74.349999999999994 110.023 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 17.4 mtp180 76.12 10.54 3.09 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.057 0.848 . . . . 71.230000000000004 112.308 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -87.66 148.26 24.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.425 -0.583 . . . . 71.549999999999997 109.425 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -128.73 142.48 50.99 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.702 -0.681 . . . . 63.350000000000001 110.401 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -166.96 -169.03 30.03 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.82 -0.705 . . . . 53.409999999999997 111.709 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.77 136.66 52.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.716 0.293 . . . . 72.219999999999999 110.914 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.36 122.91 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 52.340000000000003 109.654 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG3' HD13 ' A' ' 44' ' ' LEU . 31.2 mm-40 -89.4 -33.09 16.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.285 0.564 . . . . 71.140000000000001 110.177 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -169.03 136.55 1.88 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.289 -0.869 . . . . 74.450000000000003 110.204 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 29' ' ' ASP . 43.7 t -103.35 142.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.485 -0.78 . . . . 73.430000000000007 109.689 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 t -121.91 34.8 5.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.078 0.466 . . . . 73.549999999999997 109.868 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 27' ' ' VAL . 24.4 m-20 50.04 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.953 -1.021 . . . . 71.150000000000006 111.533 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.29 -46.26 1.19 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.842 -0.903 . . . . 53.109999999999999 110.842 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 30.5 mtpp -112.28 161.02 17.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.844 -0.428 . . . . 73.129999999999995 109.844 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.55 142.63 21.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.751 -0.204 . . . . 51.439999999999998 110.556 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.637 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -91.67 115.48 28.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 75.230000000000004 109.593 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 52' ' ' LEU . 18.3 t -100.67 124.79 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.119 -0.491 . . . . 73.519999999999996 110.594 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.6 tp -94.92 107.29 19.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 73.200000000000003 109.579 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 81.4 m-85 -86.63 142.33 28.33 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.16 -0.682 . . . . 63.149999999999999 109.16 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -140.1 131.32 26.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.96 0.41 . . . . 71.510000000000005 110.449 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 44.1 t30 -141.14 91.07 2.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 63.43 108.951 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.66 -114.61 4.04 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.651 -0.704 . . . . 54.439999999999998 111.774 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -89.87 -30.24 18.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.622 0.725 . . . . 71.349999999999994 109.079 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.48 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 65.8 t90 -72.27 138.9 47.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.994 -1.003 . . . . 75.239999999999995 111.556 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.14 155.17 44.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.824 -1.08 . . . . 65.030000000000001 109.181 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.462 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 76.4 tttt -153.97 120.18 5.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.458 -0.337 . . . . 71.439999999999998 110.516 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.51 HD11 ' HB1' ' A' ' 33' ' ' ALA . 62.6 tp -93.88 110.4 22.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 73.129999999999995 110.566 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.497 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 25.3 t -126.2 127.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.014 -0.539 . . . . 71.239999999999995 109.799 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.5 m -83.26 133.0 35.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.247 0.546 . . . . 61.299999999999997 110.826 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.46 ' HZ ' ' CD1' ' A' ' 17' ' ' TYR . 55.7 m-85 -131.83 -160.15 1.02 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.425 -0.807 . . . . 70.099999999999994 109.656 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.8 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 63.7 mtm180 -109.08 173.66 6.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.77 -0.455 . . . . 75.340000000000003 109.77 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 27' ' ' VAL . 95.5 mt -81.45 -28.56 34.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.116 0.484 . . . . 72.409999999999997 109.912 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 p -68.9 -17.86 64.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.675 -0.693 . . . . 55.219999999999999 110.178 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.8 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.3 mm-40 -86.62 -13.07 46.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.865 -0.607 . . . . 73.109999999999999 110.622 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 34' ' ' VAL . 87.5 mt -112.73 140.93 47.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 73.209999999999994 112.144 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -117.0 112.8 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.699 -0.682 . . . . 62.509999999999998 109.714 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.78 134.26 52.76 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.865 -0.421 . . . . 55.109999999999999 109.865 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 109.586 -0.524 . . . . 52.539999999999999 109.586 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 49' ' ' LEU . 72.7 mt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 74.409999999999997 110.18 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -131.16 146.09 60.55 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.309 -0.405 . . . . 73.310000000000002 110.639 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.77 125.6 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.54 2.16 . . . . 63.109999999999999 111.207 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.12 -3.0 47.57 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.051 -0.595 . . . . 62.310000000000002 112.026 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.38 154.94 18.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.74 0.305 . . . . 75.439999999999998 110.825 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -88.43 134.79 33.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.765 -0.652 . . . . 71.409999999999997 110.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.488 HG21 HD13 ' A' ' 52' ' ' LEU . 16.3 m -124.22 153.56 30.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.426 . . . . 72.540000000000006 110.702 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 53' ' ' GLU . 53.8 ttt180 -110.98 119.87 40.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.699 -0.682 . . . . 72.120000000000005 109.73 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 25.8 t -76.15 98.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.005 0.431 . . . . 63.409999999999997 110.249 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -105.8 13.83 29.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.313 -0.403 . . . . 72.409999999999997 111.273 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 54.3 t30 -62.8 112.65 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 41.25 109.671 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 23.5 t -69.54 -27.92 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 63.32 111.411 -172.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -100.39 40.36 1.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.817 0.818 . . . . 51.009999999999998 109.395 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 3.7 t70 -119.47 -174.53 2.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.511 -0.768 . . . . 73.329999999999998 110.671 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -109.59 -28.85 8.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.967 -0.56 . . . . 75.409999999999997 110.241 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 92.6 m-85 -101.07 38.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.098 -0.501 . . . . 72.209999999999994 111.151 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.678 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 10.1 t80 -59.35 126.3 27.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.742 -0.663 . . . . 75.409999999999997 110.263 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.678 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 87.1 mtt180 80.09 4.05 1.93 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.097 0.959 . . . . 72.510000000000005 112.681 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -83.71 149.09 26.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.46 . . . . 71.219999999999999 110.153 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.29 125.46 43.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.606 -0.724 . . . . 71.409999999999997 110.221 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.61 171.67 23.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.844 -0.693 . . . . 61.450000000000003 111.754 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.21 124.88 46.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.867 0.365 . . . . 74.510000000000005 110.976 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.03 119.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.88 -0.6 . . . . 64.340000000000003 110.313 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -77.86 -36.71 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.3 0.571 . . . . 74.209999999999994 109.854 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -170.03 143.0 2.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.063 -0.971 . . . . 72.209999999999994 109.408 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.22 92.85 2.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.605 -0.725 . . . . 75.219999999999999 109.373 174.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -103.54 114.12 28.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.277 -0.42 . . . . 64.239999999999995 111.12 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 61.67 37.68 15.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.427 -0.806 . . . . 64.120000000000005 111.624 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.44 6.14 89.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.609 -0.805 . . . . 34.149999999999999 112.772 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -117.4 144.74 44.65 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.305 -0.628 . . . . 62.219999999999999 109.305 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 124.25 51.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.764 0.316 . . . . 75.120000000000005 111.113 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -81.93 101.09 10.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.241 -0.652 . . . . 63.539999999999999 109.241 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.97 121.36 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.874 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.33 126.74 36.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.8 -0.636 . . . . 63.119999999999997 110.493 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.11 143.7 39.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 74.510000000000005 110.409 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.78 129.19 27.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.395 -0.821 . . . . 74.540000000000006 109.126 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -135.86 87.53 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.717 0.294 . . . . 71.129999999999995 110.291 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.18 -77.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.962 -0.563 . . . . 71.409999999999997 112.576 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.39 -4.79 5.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.78 . . . . 43.539999999999999 109.17 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -89.98 138.25 31.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 73.209999999999994 111.022 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.33 146.23 49.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.067 -0.969 . . . . 64.340000000000003 109.787 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -166.28 136.49 3.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.049 0.452 . . . . 72.219999999999999 111.156 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.507 HD11 ' HB1' ' A' ' 33' ' ' ALA . 54.0 tp -106.48 109.49 21.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 75.349999999999994 110.128 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.25 117.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.913 0.387 . . . . 72.239999999999995 110.293 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.3 m -78.6 127.94 32.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 51.009999999999998 110.643 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.64 179.01 4.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.772 -0.649 . . . . 73.420000000000002 110.173 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 mpt_? -98.77 154.83 17.7 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.66 -0.867 . . . . 74.319999999999993 108.66 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.582 HD22 HD12 ' A' ' 2' ' ' ILE . 84.5 mt -72.82 -32.86 65.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.45 0.643 . . . . 64.209999999999994 109.388 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 p -71.03 -12.21 61.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.994 -1.003 . . . . 61.439999999999998 110.764 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 2.9 mp0 -108.02 7.15 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.791 -0.641 . . . . 72.420000000000002 111.589 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.488 HD13 HG21 ' A' ' 8' ' ' VAL . 93.0 mt -121.97 146.22 47.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.111 0.481 . . . . 73.140000000000001 111.591 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 40.0 tt0 -102.48 108.43 19.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.838 -0.801 . . . . 40.340000000000003 108.838 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.11 22.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.181 -0.463 . . . . 51.210000000000001 110.015 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.234 -0.439 . . . . 65.519999999999996 109.827 -178.99 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 HD22 ' A' ' 49' ' ' LEU . 54.3 mt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.342 -0.614 . . . . 74.319999999999993 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.08 146.62 51.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.438 0.161 . . . . 74.5 110.609 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.97 127.79 27.53 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.762 2.308 . . . . 75.549999999999997 111.902 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.84 0.29 39.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.834 -0.698 . . . . 54.219999999999999 112.187 -176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.41 135.38 34.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.649 0.262 . . . . 64.329999999999998 110.48 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -83.12 125.07 31.1 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.591 -0.522 . . . . 44.109999999999999 109.591 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 54' ' ' ALA . 17.0 m -122.18 143.39 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.221 -0.445 . . . . 71.329999999999998 111.014 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -98.77 129.54 45.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 109.702 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.84 120.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.078 -0.341 . . . . 74.450000000000003 110.078 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 11' ' ' THR . 17.9 m -116.29 8.85 14.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 55.229999999999997 110.303 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -74.21 106.83 6.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.749 -0.834 . . . . 74.409999999999997 108.749 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.76 -21.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 112.846 0.684 . . . . 75.409999999999997 112.846 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.14 -32.12 21.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.442 . . . . 72.310000000000002 110.612 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.19 158.24 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 70.340000000000003 111.824 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -81.43 -24.19 37.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.46 -0.791 . . . . 63.25 111.279 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -92.68 21.2 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 74.239999999999995 110.61 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.522 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 42.9 t80 -70.49 77.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 74.510000000000005 111.293 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 9.7 ptp85 163.58 -22.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.59 1.156 . . . . 74.510000000000005 108.633 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -77.98 154.73 31.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.35 -0.841 . . . . 74.450000000000003 111.224 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -125.02 127.85 47.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.2 -0.909 . . . . 63.509999999999998 109.298 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.96 168.17 21.43 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.529 -0.843 . . . . 73.409999999999997 112.228 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.47 126.37 41.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.639 0.257 . . . . 73.5 110.473 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 27' ' ' VAL . 59.1 t -67.96 119.8 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 74.209999999999994 110.132 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.05 -30.38 22.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.828 -0.623 . . . . 51.240000000000002 110.578 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 26' ' ' ARG . 12.2 ptp180 -164.31 143.15 7.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 75.230000000000004 109.63 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG22 HG11 ' A' ' 24' ' ' VAL . 40.0 t -114.69 142.33 27.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.214 -0.903 . . . . 63.210000000000001 110.369 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 p -132.42 -175.56 3.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.658 -0.497 . . . . 54.119999999999997 109.658 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.74 75.35 4.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 72.400000000000006 110.517 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.43 -27.16 5.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.536 -0.756 . . . . 72.230000000000004 112.586 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 47.7 mtmt -120.11 162.23 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.693 0.282 . . . . 74.109999999999999 111.34 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.04 143.78 21.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.561 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.83 115.37 27.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.83 -0.433 . . . . 64.109999999999999 109.83 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.88 128.99 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 71.340000000000003 110.814 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.2 tp -102.34 120.06 39.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 73.430000000000007 110.934 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -104.9 146.37 29.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.841 -0.618 . . . . 73.519999999999996 109.532 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -149.27 127.41 12.03 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.28 -0.267 . . . . 71.340000000000003 110.28 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.72 85.71 1.9 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 54.219999999999999 109.666 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.0 -105.11 1.54 Allowed Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.602 -0.727 . . . . 62.200000000000003 112.159 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -87.56 -32.17 19.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.204 0.525 . . . . 72.400000000000006 110.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -75.93 138.53 41.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.592 -0.731 . . . . 72.120000000000005 111.272 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.11 155.99 44.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.824 -1.08 . . . . 71.450000000000003 108.813 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HG3' HG23 ' A' ' 45' ' ' VAL . 41.9 tptt -155.94 108.8 2.66 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.664 -0.415 . . . . 73.540000000000006 111.247 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.23 109.57 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.389 -0.597 . . . . 71.140000000000001 109.389 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 43' ' ' LYS . 46.1 t -130.28 131.99 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 71.140000000000001 110.247 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -83.29 126.54 32.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.067 0.46 . . . . 71.230000000000004 110.682 177.155 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -123.25 -170.34 2.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.765 -0.828 . . . . 74.510000000000005 108.765 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 1.06 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mtt180 -95.03 176.96 6.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.325 -0.621 . . . . 73.420000000000002 109.325 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.496 HD21 HG13 ' A' ' 27' ' ' VAL . 97.3 mt -84.1 -32.01 24.98 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.038 -0.727 . . . . 62.509999999999998 109.038 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 p -71.21 -19.63 62.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.087 -0.96 . . . . 62.149999999999999 110.862 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 1.06 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.0 mm-40 -85.54 -7.84 58.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 110.81 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 8' ' ' VAL . 73.4 mt -116.85 138.47 51.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.094 0.473 . . . . 73.109999999999999 111.751 -172.087 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.68 104.46 16.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.094 -1.076 . . . . 64.329999999999998 108.094 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.799 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.08 107.86 3.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.25 -0.432 . . . . 63.109999999999999 110.838 -176.339 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.63 0 N-CA-C 108.877 -0.786 . . . . 72.099999999999994 108.877 177.695 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.936 -0.394 . . . . 74.230000000000004 109.936 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -117.72 141.21 28.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.512 -0.313 . . . . 64.349999999999994 110.864 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.6 137.2 62.8 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.492 2.128 . . . . 51.399999999999999 110.975 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 55.219999999999999 112.018 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.82 165.76 12.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.881 0.372 . . . . 72.340000000000003 110.706 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -93.31 138.95 31.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.092 -0.504 . . . . 74.400000000000006 110.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.568 HG21 HD13 ' A' ' 52' ' ' LEU . 6.7 m -130.65 148.06 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 65.430000000000007 111.083 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.64 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 34.2 ttm180 -109.97 141.81 42.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.838 -0.619 . . . . 54.020000000000003 109.483 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 55.4 t -79.54 110.56 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 64.230000000000004 110.019 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -91.29 -11.78 37.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.718 -0.674 . . . . 74.420000000000002 111.159 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.23 106.33 1.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.182 -0.463 . . . . 52.549999999999997 109.808 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.34 -24.16 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 75.230000000000004 111.375 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.98 -8.13 52.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.867 -0.606 . . . . 72.319999999999993 110.759 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.05 165.22 16.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.919 0.39 . . . . 61.130000000000003 110.445 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 m -72.16 -35.96 69.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 42.0 111.893 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -94.97 27.97 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.689 -172.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 45.5 t80 -61.86 130.97 48.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 64.439999999999998 110.038 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.6 mtm180 77.82 6.04 2.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.827 0.851 . . . . 72.140000000000001 111.833 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -96.33 148.29 22.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.832 -0.433 . . . . 71.400000000000006 109.832 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.64 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 33.5 mt-10 -127.92 128.15 44.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 74.049999999999997 110.245 -175.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.49 -177.11 14.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.939 -0.648 . . . . 62.140000000000001 112.335 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.89 132.48 49.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.491 0.186 . . . . 75.209999999999994 110.555 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.74 111.85 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.153 -0.314 . . . . 74.129999999999995 110.153 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -78.08 -34.98 49.95 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.192 -0.67 . . . . 74.430000000000007 109.192 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.28 136.59 0.37 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.325 -0.852 . . . . 65.230000000000004 110.16 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.9 108.56 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.645 -0.872 . . . . 71.209999999999994 108.645 172.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 t -152.47 142.62 22.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.523 -0.308 . . . . 53.420000000000002 111.056 -172.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.79 18.95 10.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.457 -0.792 . . . . 62.329999999999998 111.386 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 -1.15 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.927 -0.654 . . . . 72.329999999999998 112.81 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 26.2 mtmt -124.09 174.28 7.74 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.629 0.372 . . . . 72.450000000000003 110.118 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.07 129.92 28.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.622 0.249 . . . . 65.209999999999994 110.446 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -86.52 115.01 23.73 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.705 -0.48 . . . . 42.210000000000001 109.705 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 52' ' ' LEU . 55.9 t -98.53 119.09 46.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.285 0.564 . . . . 73.540000000000006 110.648 -177.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.6 tp -89.81 118.78 29.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.546 -0.752 . . . . 73.450000000000003 110.072 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.77 137.43 33.87 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.929 -0.767 . . . . 72.439999999999998 108.929 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -156.41 108.59 2.53 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.71 -0.848 . . . . 74.329999999999998 108.71 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -136.89 100.88 4.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 54.240000000000002 110.84 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.96 -77.81 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.583 -0.735 . . . . 72.209999999999994 112.471 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -127.27 -17.41 4.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.205 0.526 . . . . 40.229999999999997 110.385 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -88.76 138.24 31.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.786 -0.643 . . . . 75.150000000000006 111.683 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.9 143.6 47.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.712 -1.131 . . . . 64.439999999999998 109.741 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -167.61 120.45 0.92 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.919 0.39 . . . . 73.530000000000001 110.631 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.18 109.72 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.304 -0.407 . . . . 71.540000000000006 110.032 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.19 120.74 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 74.25 109.97 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.8 m -78.19 130.73 36.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.206 0.527 . . . . 74.299999999999997 109.673 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -123.17 180.0 4.49 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.477 -0.783 . . . . 75.510000000000005 109.746 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 73.4 mtp180 -94.62 161.65 14.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.738 -0.665 . . . . 75.120000000000005 109.565 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.44 -26.44 63.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.108 -0.496 . . . . 64.530000000000001 110.064 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 m -76.2 -11.32 59.9 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.687 -0.688 . . . . 65.549999999999997 110.726 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -85.02 -23.4 28.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 74.310000000000002 111.116 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 8' ' ' VAL . 62.1 mt -115.79 144.7 43.61 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.331 0.493 . . . . 74.319999999999993 112.331 -168.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -111.85 140.92 46.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.783 -0.821 . . . . 75.540000000000006 108.783 167.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.49 115.43 17.25 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.145 -0.317 . . . . 54.240000000000002 110.145 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 8' ' ' VAL . 10.3 t . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.139 -0.689 . . . . 73.530000000000001 109.139 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--O 1.233 0.2 0 N-CA-C 110.068 -0.345 . . . . 74.200000000000003 110.068 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -126.92 158.68 67.82 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 70.129999999999995 110.507 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.71 128.79 18.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.543 2.162 . . . . 73.209999999999994 111.241 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.497 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 94.11 27.2 12.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.555 -0.831 . . . . 64.030000000000001 111.646 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.83 144.34 48.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 72.109999999999999 110.778 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -82.72 130.2 35.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 63.530000000000001 110.574 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.78 162.37 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 32.43 110.846 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HB3' ' OE2' ' A' ' 53' ' ' GLU . 41.5 ttp180 -119.88 124.0 44.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.397 -0.819 . . . . 73.510000000000005 109.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 t -66.4 113.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.373 . . . . 73.409999999999997 110.65 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' THR . . . . . 0.412 ' OG1' ' HG3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -96.24 -11.41 26.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.961 -0.563 . . . . 61.109999999999999 111.007 -176.378 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 41.7 t30 -65.93 113.12 4.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.472 . . . . 63.100000000000001 110.288 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.98 -39.07 76.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 45.409999999999997 111.532 -174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.59 34.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.903 0.859 . . . . 63.399999999999999 109.66 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.529 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 7.1 t70 -116.42 159.17 22.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.447 -0.797 . . . . 71.439999999999998 110.269 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -75.76 -31.31 59.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.191 0.519 . . . . 74.120000000000005 110.325 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -99.72 25.02 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.859 -0.609 . . . . 74.230000000000004 111.089 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 18.4 t80 -58.39 128.88 39.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.651 . . . . 64.010000000000005 111.126 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 74.2 mtp180 77.14 -8.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.138 0.975 . . . . 71.209999999999994 112.376 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.39 158.03 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.018 0.437 . . . . 62.219999999999999 110.809 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -104.91 138.76 40.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.688 -0.687 . . . . 61.520000000000003 110.445 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.36 171.83 26.31 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.552 -0.619 . . . . 53.020000000000003 111.552 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD21 ' HA2' ' A' ' 5' ' ' GLY . 4.4 tt -120.08 122.54 41.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.062 0.431 . . . . 32.200000000000003 109.889 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.545 HG11 HG22 ' A' ' 27' ' ' VAL . 39.5 t -69.21 122.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 73.420000000000002 110.762 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.61 -30.78 12.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.914 -0.585 . . . . 75.439999999999998 110.752 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 26' ' ' ARG . 19.0 ttt180 -146.61 118.92 8.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 74.329999999999998 109.903 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG22 HG11 ' A' ' 24' ' ' VAL . 59.4 t -103.64 128.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 75.129999999999995 110.888 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.9 t -106.42 -179.35 3.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.903 -0.777 . . . . 62.229999999999997 108.903 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.61 29.91 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 71.299999999999997 111.099 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.0 -29.64 0.17 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.956 -0.566 . . . . 52.32 111.777 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.06 164.92 11.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.58 0.229 . . . . 63.109999999999999 110.44 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.49 137.9 19.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.586 -0.279 . . . . 62.539999999999999 110.405 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -101.06 110.73 22.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.893 -0.41 . . . . 73.239999999999995 109.893 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -100.26 129.39 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 55.439999999999998 110.858 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 tp -95.19 129.15 42.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.681 -0.69 . . . . 64.549999999999997 110.399 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.74 136.91 48.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.469 -0.567 . . . . 74.299999999999997 109.469 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.85 116.82 25.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.085 -0.507 . . . . 70.129999999999995 111.059 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 17.2 t30 -110.2 -10.9 14.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.706 . . . . 70.219999999999999 110.295 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.58 -71.98 0.22 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.899 -0.667 . . . . 53.5 111.545 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.16 -18.89 24.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.602 0.715 . . . . 72.450000000000003 109.935 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 73.7 t90 -112.92 135.14 54.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 65.439999999999998 111.022 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.43 149.06 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.039 -0.982 . . . . 71.25 109.256 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HE2' HG22 ' A' ' 45' ' ' VAL . 88.5 tttt -165.14 119.06 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.934 0.397 . . . . 75.019999999999996 110.865 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.6 tp -92.7 108.36 19.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.675 -0.693 . . . . 51.450000000000003 109.562 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.588 HG22 ' HE2' ' A' ' 43' ' ' LYS . 10.8 t -108.51 125.43 65.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.427 -0.351 . . . . 44.200000000000003 110.766 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -85.17 130.76 34.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.405 0.621 . . . . 72.129999999999995 110.679 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -125.56 -164.55 1.31 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.252 -0.885 . . . . 64.030000000000001 108.838 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.844 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 86.6 mtm180 -106.37 162.6 13.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.285 -0.635 . . . . 70.530000000000001 109.285 171.747 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.41 -25.15 60.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.101 0.477 . . . . 74.329999999999998 109.941 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 p -82.48 -9.19 59.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 61.43 110.432 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.844 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 7.7 mm-40 -88.17 -12.96 42.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.274 0.559 . . . . 71.340000000000003 110.929 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 10' ' ' VAL . 27.2 mt -126.59 167.28 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.611 -0.722 . . . . 54.530000000000001 110.732 -173.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.58 ' OE2' ' HB3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -151.27 148.77 28.6 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.993 -0.743 . . . . 71.299999999999997 108.993 167.894 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.44 141.31 34.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.682 0.277 . . . . 55.439999999999998 110.631 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.784 -0.821 . . . . 74.010000000000005 108.784 177.282 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.746 HD12 HD22 ' A' ' 49' ' ' LEU . 48.9 mt . . . . . 0 C--O 1.233 0.202 0 N-CA-C 109.552 -0.536 . . . . 53.340000000000003 109.552 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.13 147.19 37.3 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.719 0.295 . . . . 44.539999999999999 111.173 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.97 151.66 73.48 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.738 2.292 . . . . 64.200000000000003 111.438 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.48 2.54 90.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.843 -0.694 . . . . 50.310000000000002 112.004 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.91 153.02 20.24 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.773 0.32 . . . . 74.329999999999998 110.496 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -89.56 129.91 35.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.556 . . . . 72.209999999999994 110.649 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG21 HD13 ' A' ' 52' ' ' LEU . 17.3 m -124.34 158.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.908 -0.587 . . . . 72.430000000000007 110.023 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.402 ' HB3' ' CG ' ' A' ' 53' ' ' GLU . 35.7 ttt180 -118.59 126.53 52.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.907 -0.405 . . . . 74.150000000000006 109.907 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.27 115.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 75.150000000000006 110.941 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 m -100.36 -3.68 30.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 64.120000000000005 110.6 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.593 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 27.0 t-20 -64.94 113.67 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 63.229999999999997 110.042 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.08 -13.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 72.409999999999997 111.54 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.59 -48.89 17.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.967 0.358 . . . . 74.25 111.967 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.98 161.43 25.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.063 0.458 . . . . 71.329999999999998 110.97 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.92 -30.49 71.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.502 -0.772 . . . . 64.019999999999996 112.605 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -80.91 24.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.286 0.476 . . . . 73.420000000000002 112.286 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 50.7 t80 -64.99 127.88 33.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 109.795 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 35.7 mtm180 74.72 27.15 1.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.288 0.635 . . . . 70.430000000000007 111.892 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.42 152.87 24.11 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.954 -0.387 . . . . 73.5 109.954 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -102.96 142.18 34.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.581 -0.526 . . . . 73.420000000000002 109.581 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -144.24 170.0 26.15 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.719 -0.753 . . . . 73.25 112.067 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.8 tp -109.91 123.04 48.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.647 0.26 . . . . 73.319999999999993 110.577 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 27' ' ' VAL . 52.2 t -68.32 115.42 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.535 -0.302 . . . . 60.509999999999998 110.52 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -81.48 -33.08 32.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 75.299999999999997 110.463 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.454 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -169.38 143.6 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.643 -0.873 . . . . 73.439999999999998 108.643 177.444 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.44 HG22 HG11 ' A' ' 24' ' ' VAL . 23.6 t -99.14 135.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.69 -0.686 . . . . 63.009999999999998 110.332 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 8.5 t -104.89 -176.19 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.695 -0.854 . . . . 73.349999999999994 108.695 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.39 77.69 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.495 0.664 . . . . 71.209999999999994 110.081 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 3.24 39.64 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.039 -0.982 . . . . 71.25 111.84 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 27.7 ttmt -141.5 172.88 12.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.903 -0.777 . . . . 65.150000000000006 108.903 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.8 143.73 6.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.479 0.18 . . . . 53.530000000000001 110.887 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.19 119.07 32.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 72.140000000000001 110.276 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.478 HG21 HD21 ' A' ' 52' ' ' LEU . 39.9 t -100.82 124.65 54.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 53.509999999999998 111.028 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.5 tp -96.44 121.59 38.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.129 -0.487 . . . . 62.25 110.295 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.75 137.23 36.14 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.655 -0.869 . . . . 74.540000000000006 108.655 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.47 114.51 8.61 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.823 -0.436 . . . . 64.310000000000002 109.823 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 29.4 t-20 -137.04 90.31 2.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.215 0.531 . . . . 60.200000000000003 111.157 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.13 -90.7 0.52 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.46 -0.791 . . . . 62.030000000000001 112.833 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.0 -16.23 11.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 75.209999999999994 109.943 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.411 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 66.9 t90 -94.28 144.07 25.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 72.329999999999998 110.682 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.2 158.29 43.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.368 -0.833 . . . . 72.230000000000004 110.018 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.58 132.11 6.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.957 -0.565 . . . . 74.150000000000006 110.132 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.411 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.0 tp -103.92 109.44 21.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.311 -0.404 . . . . 62.329999999999998 110.301 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.59 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 62.509999999999998 110.307 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.3 m -81.12 132.65 35.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.267 0.556 . . . . 53.43 110.755 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -129.61 177.89 6.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.82 -0.808 . . . . 73.239999999999995 108.82 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.547 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -97.61 178.11 5.28 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.816 -0.354 . . . . 64.340000000000003 110.265 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.746 HD22 HD12 ' A' ' 2' ' ' ILE . 68.8 mt -78.56 -25.96 45.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.195 0.521 . . . . 64.140000000000001 110.02 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 p -76.3 -17.5 59.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 62.399999999999999 109.996 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.593 ' HG3' ' HB2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -86.44 -18.84 30.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.1 -0.955 . . . . 63.399999999999999 110.835 -178.202 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.478 HD21 HG21 ' A' ' 34' ' ' VAL . 55.6 mt -122.65 122.63 39.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.957 -0.565 . . . . 73.409999999999997 111.202 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -88.34 118.26 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.114 -0.698 . . . . 73.209999999999994 109.114 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -75.11 106.29 6.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.977 -0.556 . . . . 71.540000000000006 109.967 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 71.310000000000002 110.107 -177.674 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.464 HD12 HD22 ' A' ' 49' ' ' LEU . 57.9 mt . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.585 -0.895 . . . . 72.340000000000003 108.585 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 97.6 m-85 -127.85 145.55 55.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.75 0.31 . . . . 61.43 111.281 -175.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 35.6 Cg_exo -59.86 142.91 99.49 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.092 2.528 . . . . 64.230000000000004 112.313 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.25 6.08 63.23 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.846 -0.692 . . . . 62.219999999999999 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.669 0.271 . . . . 53.009999999999998 110.305 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -92.03 130.55 37.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.399 . . . . 64.329999999999998 110.45 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.63 142.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 110.154 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -102.18 125.44 48.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.954 -0.566 . . . . 72.140000000000001 110.047 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.64 115.85 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.684 -0.689 . . . . 64.540000000000006 110.406 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -105.69 10.52 32.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 73.140000000000001 110.319 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.0 109.71 0.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.93 -0.577 . . . . 71.409999999999997 109.979 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.37 -35.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.011 -0.54 . . . . 75.120000000000005 112.141 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.89 -2.61 34.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.394 0.616 . . . . 63.450000000000003 111.018 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.98 165.61 16.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.256 -0.429 . . . . 72.540000000000006 110.263 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.82 -27.29 26.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.268 -0.424 . . . . 72.239999999999995 110.84 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -87.95 24.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.085 0.469 . . . . 73.299999999999997 111.16 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 53.6 t80 -63.12 136.81 57.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 72.540000000000006 110.027 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 40.3 mtm180 82.44 -10.91 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.802 0.841 . . . . 63.229999999999997 112.251 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -72.92 150.64 42.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 73.420000000000002 110.398 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -117.62 133.38 56.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.13 -0.486 . . . . 73.439999999999998 110.235 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.68 172.97 21.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.583 -0.818 . . . . 73.230000000000004 112.484 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.47 125.96 48.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.422 -0.214 . . . . 74.019999999999996 110.422 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.87 115.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.133 -0.321 . . . . 75.120000000000005 110.133 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' HG3' HD13 ' A' ' 44' ' ' LEU . 27.6 mm-40 -87.35 -35.81 18.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.959 -0.564 . . . . 74.5 110.418 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -166.81 148.87 6.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.692 -0.686 . . . . 74.530000000000001 109.574 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 2' ' ' ILE . 44.4 t -105.4 140.93 21.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.334 -0.848 . . . . 73.310000000000002 109.755 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -129.3 -162.27 1.19 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.859 -0.423 . . . . 72.420000000000002 109.859 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.42 86.85 1.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.541 . . . . 75.230000000000004 110.139 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.64 5.67 86.32 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 114.739 -1.119 . . . . 73.010000000000005 111.854 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 36.7 mtmm -129.41 166.25 19.93 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 122.625 0.37 . . . . 71.25 110.637 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 141.88 24.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.268 -0.423 . . . . 62.219999999999999 110.242 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -89.71 108.48 19.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.971 -0.381 . . . . 73.25 109.971 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.6 122.42 47.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.609 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.0 tp -96.63 120.09 36.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 110.553 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 95.9 m-85 -93.44 141.62 28.25 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.82 -0.807 . . . . 73.120000000000005 108.82 171.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -140.72 133.21 28.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.263 -0.426 . . . . 33.219999999999999 110.028 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -147.44 70.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.172 0.51 . . . . 71.209999999999994 110.127 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.54 -88.02 1.22 Allowed Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.653 -0.703 . . . . 54.149999999999999 112.441 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -104.53 -20.81 13.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.394 0.616 . . . . 51.109999999999999 109.878 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -81.69 132.01 35.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.261 -0.881 . . . . 75.510000000000005 111.394 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -128.93 152.57 48.42 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.458 -1.246 . . . . 72.540000000000006 109.346 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 54.5 tttp -157.73 100.92 1.79 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.517 -0.311 . . . . 62.420000000000002 110.224 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.5 tp -95.15 106.32 18.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.387 -0.369 . . . . 74.340000000000003 110.324 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG23 ' HG2' ' A' ' 43' ' ' LYS . 54.8 t -126.33 126.46 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.195 -0.457 . . . . 52.240000000000002 110.487 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.1 m -77.65 131.8 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 62.340000000000003 110.347 177.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -124.44 -174.59 3.05 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.134 -0.691 . . . . 65.5 109.134 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.605 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 9.4 mtt180 -102.28 164.1 11.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.723 0.297 . . . . 54.530000000000001 110.31 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 2' ' ' ILE . 91.7 mt -78.64 -20.89 49.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.269 0.556 . . . . 75.150000000000006 110.378 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 p -88.53 -16.49 32.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.65 -0.704 . . . . 34.229999999999997 110.102 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.605 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 12.3 mm-40 -93.55 -4.18 51.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.561 -0.745 . . . . 62.020000000000003 110.347 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -121.58 158.74 27.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 72.019999999999996 110.768 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -139.63 123.84 17.92 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.457 -0.572 . . . . 62.219999999999999 109.457 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 132.04 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 63.530000000000001 110.697 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.154 -0.476 . . . . 64.319999999999993 110.166 -177.619 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.673 HD12 HD22 ' A' ' 49' ' ' LEU . 56.8 mt . . . . . 0 C--O 1.231 0.103 0 N-CA-C 109.703 -0.48 . . . . 70.010000000000005 109.703 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.36 147.82 66.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.308 -0.405 . . . . 51.109999999999999 110.519 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.6 129.77 30.73 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.613 2.209 . . . . 73.120000000000005 111.209 175.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.18 27.67 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.115 -0.564 . . . . 61.530000000000001 111.829 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 147.27 24.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.612 0.244 . . . . 64.439999999999998 110.617 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -89.31 132.71 34.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 75.349999999999994 110.381 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 52' ' ' LEU . 12.0 m -133.61 149.27 30.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.935 0.398 . . . . 73.129999999999995 111.552 -176.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -114.96 135.83 53.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.776 -0.647 . . . . 43.240000000000002 109.695 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -75.2 106.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 64.140000000000001 109.927 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -90.97 -5.97 54.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.756 0.312 . . . . 63.030000000000001 111.48 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -65.68 111.37 3.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.309 -0.626 . . . . 73.340000000000003 109.309 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 3.0 t -80.78 -1.14 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.395 0.617 . . . . 54.32 111.033 -173.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -101.35 -22.99 14.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.99 -0.55 . . . . 73.209999999999994 110.673 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.72 158.03 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.964 -170.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.1 m -65.31 -32.6 74.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.979 -1.009 . . . . 72.120000000000005 111.555 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -101.4 30.62 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 64.209999999999994 111.232 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 25.0 t80 -55.37 138.16 46.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 75.540000000000006 111.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 56.08 18.3 3.11 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.239 1.416 . . . . 70.209999999999994 113.276 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.27 151.27 24.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.786 -0.82 . . . . 74.420000000000002 108.786 167.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.19 130.16 53.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.006 -0.543 . . . . 72.439999999999998 110.067 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.16 -174.67 16.62 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.522 -0.847 . . . . 32.439999999999998 112.384 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.1 tp -113.1 132.81 55.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.336 -0.246 . . . . 74.530000000000001 110.336 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.51 114.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 74.349999999999994 110.043 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HG3' HD13 ' A' ' 44' ' ' LEU . 28.6 mm-40 -79.11 -35.3 42.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.145 0.498 . . . . 73.510000000000005 110.366 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -172.24 146.24 1.84 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.366 -0.834 . . . . 74.230000000000004 109.259 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.327 -0.851 . . . . 73.219999999999999 110.17 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 t -106.63 67.87 0.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.492 -0.558 . . . . 50.119999999999997 109.492 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 68.85 -72.34 0.1 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.9 -1.046 . . . . 54.119999999999997 112.531 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.55 -9.76 20.73 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 115.257 -0.883 . . . . 35.409999999999997 113.022 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -124.28 170.35 10.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 110.2 -0.296 . . . . 53.119999999999997 110.2 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.72 149.1 30.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.532 0.206 . . . . 65.099999999999994 110.973 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -96.16 117.07 30.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.731 -0.47 . . . . 53.420000000000002 109.731 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.2 t -100.36 120.94 50.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 65.439999999999998 110.85 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.69 115.72 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 75.230000000000004 109.912 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -91.75 144.73 25.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 62.020000000000003 109.508 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.87 112.37 7.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.693 -0.484 . . . . 74.040000000000006 109.693 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -130.73 79.68 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.106 -0.497 . . . . 52.140000000000001 110.262 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.49 -90.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.055 -0.52 . . . . 73.329999999999998 112.672 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -100.73 -22.38 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 62.329999999999998 110.1 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.9 t90 -92.16 144.49 25.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.401 -0.818 . . . . 65.349999999999994 110.978 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -149.69 153.59 37.2 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.076 -0.965 . . . . 71.430000000000007 109.266 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HG3' HG23 ' A' ' 45' ' ' VAL . 24.2 tptm -162.53 128.43 3.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.409 -0.359 . . . . 72.140000000000001 110.82 -175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.571 HD11 ' HB1' ' A' ' 33' ' ' ALA . 63.8 tp -98.12 112.03 24.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 109.959 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG23 ' HG3' ' A' ' 43' ' ' LYS . 42.0 t -126.53 125.81 67.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.839 0.352 . . . . 74.109999999999999 110.483 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.5 m -73.68 140.4 46.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.189 0.519 . . . . 71.540000000000006 110.844 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.0 -176.06 4.25 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 72.439999999999998 109.262 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.849 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 98.9 mtt180 -91.39 -179.28 5.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.099 -0.704 . . . . 72.310000000000002 109.099 170.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.673 HD22 HD12 ' A' ' 2' ' ' ILE . 87.0 mt -87.25 -33.03 19.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.951 -0.759 . . . . 74.409999999999997 108.951 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.8 m -70.63 -14.41 62.47 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.57 -0.741 . . . . 75.420000000000002 111.106 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.849 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 11.1 mm-40 -80.53 -18.71 47.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.204 0.526 . . . . 74.340000000000003 110.591 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 8' ' ' VAL . 38.8 mt -115.68 157.38 24.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 74.5 111.325 -172.776 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.84 146.6 49.19 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.7 -0.852 . . . . 74.150000000000006 108.7 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.87 123.57 26.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.761 0.315 . . . . 52.119999999999997 110.238 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 108.947 -0.76 . . . . 64.319999999999993 108.947 177.166 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 121.44 0.638 . . . . 74.209999999999994 110.421 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -146.17 162.56 34.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.177 -0.92 . . . . 71.299999999999997 109.533 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.47 113.11 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.181 1.921 . . . . 72.230000000000004 111.098 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.11 -9.58 15.51 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.798 -0.715 . . . . 44.420000000000002 111.983 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.95 147.12 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 63.340000000000003 110.433 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -89.89 132.58 35.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.116 -0.493 . . . . 64.219999999999999 110.158 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -127.7 152.59 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.954 0.407 . . . . 62.450000000000003 110.736 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 43.5 ttm180 -110.06 129.28 55.71 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.032 -0.729 . . . . 65.109999999999999 109.032 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.36 101.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.085 0.469 . . . . 63.130000000000003 110.915 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -79.76 -12.45 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 64.439999999999998 109.573 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -68.6 107.42 2.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.28 -0.873 . . . . 71.010000000000005 110.125 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -89.94 -13.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 64.430000000000007 110.601 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.69 -36.17 82.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.418 -0.81 . . . . 72.5 110.47 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.99 -174.91 5.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 73.010000000000005 109.874 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 m -93.92 -21.13 19.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.085 0.469 . . . . 65.150000000000006 110.807 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.534 ' OH ' ' HG3' ' A' ' 43' ' ' LYS . 54.2 m-85 -90.25 40.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 74.340000000000003 111.329 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 29.7 t80 -57.65 132.46 53.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.813 -0.631 . . . . 73.340000000000003 111.096 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 18' ' ' TYR . 36.2 ptt180 59.84 14.93 4.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.147 1.379 . . . . 71.329999999999998 112.77 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.22 156.57 26.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.106 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.73 117.66 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 109.901 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.6 176.47 17.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.615 -0.803 . . . . 71.099999999999994 112.478 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.95 123.18 48.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.232 . . . . 73.040000000000006 110.383 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG11 HG22 ' A' ' 27' ' ' VAL . 58.0 t -67.56 122.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 71.340000000000003 110.007 177.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 24.9 mm-40 -91.49 -27.56 18.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.976 -0.557 . . . . 61.32 111.005 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -168.2 135.5 2.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.389 -0.823 . . . . 73.040000000000006 109.938 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG22 HG11 ' A' ' 24' ' ' VAL . 42.5 t -104.06 150.36 7.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.256 -0.884 . . . . 62.5 110.086 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.85 -177.63 4.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.3 -0.63 . . . . 54.109999999999999 109.3 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.44 80.43 3.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.595 0.712 . . . . 71.140000000000001 110.759 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.41 -24.58 9.1 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 114.809 -1.087 . . . . 61.020000000000003 112.025 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -118.82 157.83 26.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.556 0.217 . . . . 64.120000000000005 111.161 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.06 138.43 22.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.347 -0.388 . . . . 63.25 110.163 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -95.0 112.15 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.125 -0.324 . . . . 61.420000000000002 110.125 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.9 124.52 50.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 73.219999999999999 110.586 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 33.8 tp -93.53 119.79 33.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.007 -0.542 . . . . 64.319999999999993 110.467 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -100.46 141.06 33.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.95 -0.759 . . . . 61.329999999999998 108.95 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -139.03 141.08 38.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.549 -0.296 . . . . 65.420000000000002 110.37 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -153.8 76.49 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.239 -0.652 . . . . 74.319999999999993 109.239 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.94 -110.08 3.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 44.310000000000002 111.877 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.37 -15.83 44.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.885 0.374 . . . . 75.239999999999995 110.736 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -87.16 142.78 27.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.363 0.602 . . . . 73.439999999999998 110.582 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.31 163.35 36.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.919 -1.037 . . . . 72.510000000000005 109.45 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HD2' ' CG2' ' A' ' 45' ' ' VAL . 4.3 tmtp? -166.5 109.23 0.73 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 73.409999999999997 110.221 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.34 104.05 15.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.764 -0.458 . . . . 75.329999999999998 109.764 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.557 ' CG2' ' HD2' ' A' ' 43' ' ' LYS . 17.9 t -111.95 126.37 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 60.5 110.251 -176.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.6 m -85.68 120.28 26.94 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.328 0.585 . . . . 42.109999999999999 109.815 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.42 -168.32 1.3 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.402 -0.817 . . . . 74.510000000000005 109.106 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.95 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 55.3 mmt-85 -105.63 160.45 15.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.187 -0.672 . . . . 64.409999999999997 109.187 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -71.07 -27.86 63.93 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.254 0.549 . . . . 74.040000000000006 110.035 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 p -75.43 -22.47 57.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.477 -0.783 . . . . 50.240000000000002 110.305 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.95 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 20.6 mm-40 -88.28 -5.38 58.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.0 -0.545 . . . . 70.010000000000005 111.378 -173.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.417 HD13 HG21 ' A' ' 8' ' ' VAL . 72.5 mt -120.02 143.04 48.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.059 -0.519 . . . . 71.030000000000001 110.263 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 9' ' ' ARG . 9.7 pt-20 -107.59 130.66 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.183 -0.673 . . . . 52.149999999999999 109.183 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.64 24.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.34 -0.391 . . . . 75.209999999999994 110.093 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.323 -0.572 0 N-CA-C 108.849 -0.797 . . . . 64.219999999999999 108.849 177.547 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.71 ' HB ' HD22 ' A' ' 49' ' ' LEU . 59.7 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.14 0.495 . . . . 72.409999999999997 111.856 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -135.83 155.88 77.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.306 -0.861 . . . . 73.120000000000005 109.448 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.72 132.38 34.92 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.063 1.842 . . . . 74.25 111.59 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.52 -7.54 58.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.98 -0.628 . . . . 63.329999999999998 112.216 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.81 147.31 23.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.312 . . . . 72.109999999999999 111.15 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -87.02 126.15 34.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 74.519999999999996 110.068 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 52' ' ' LEU . 21.0 m -124.97 148.16 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.211 0.529 . . . . 72.420000000000002 110.973 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 23.5 ttp180 -111.05 132.41 54.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.46 -0.791 . . . . 73.030000000000001 109.682 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.08 100.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.362 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 p -102.06 7.26 41.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.216 0.532 . . . . 75.420000000000002 111.176 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.93 100.12 2.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.55 -0.75 . . . . 74.129999999999995 109.549 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.95 -30.18 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 72.540000000000006 111.984 -171.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.66 -7.43 59.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.438 . . . . 75.400000000000006 111.637 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -87.92 162.09 17.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.048 -0.408 . . . . 73.200000000000003 111.277 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 m -77.05 -26.63 53.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.083 -0.508 . . . . 72.340000000000003 111.696 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' OH ' ' HE2' ' A' ' 43' ' ' LYS . 89.9 m-85 -106.91 28.89 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 73.239999999999995 111.265 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.425 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 t80 -68.88 82.2 0.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 64.5 110.408 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 25.9 ptt180 169.91 -27.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.376 -0.829 . . . . 73.430000000000007 110.421 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.61 158.4 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.291 0.567 . . . . 74.239999999999995 112.013 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 81.4 mt-10 -125.8 134.16 51.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.183 -0.917 . . . . 72.299999999999997 108.962 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.61 178.45 21.05 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.373 -0.918 . . . . 73.239999999999995 112.335 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.94 129.69 56.09 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.943 0.372 . . . . 61.32 110.388 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 ' CG2' ' A' ' 2' ' ' ILE . 74.4 t -68.31 124.83 24.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.295 -0.412 . . . . 73.140000000000001 110.764 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -93.63 -29.17 15.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 73.0 110.82 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 26' ' ' ARG . 11.3 ptm180 -165.3 133.06 3.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.509 -0.769 . . . . 73.329999999999998 110.689 -174.1 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 29' ' ' ASP . 96.5 t -97.4 131.54 44.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.554 -0.748 . . . . 75.329999999999998 109.057 173.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -116.06 36.37 4.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.17 0.51 . . . . 72.129999999999995 109.996 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.511 ' H ' HG12 ' A' ' 27' ' ' VAL . 10.5 m-20 63.0 99.85 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.032 -0.985 . . . . 70.329999999999998 111.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.02 3.87 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.873 -0.603 . . . . 73.439999999999998 111.64 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 23.3 ttmt -118.62 165.24 14.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 64.109999999999999 109.062 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.97 146.02 18.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.513 -0.312 . . . . 53.229999999999997 110.676 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.54 114.34 26.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.823 -0.436 . . . . 74.540000000000006 109.823 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.58 125.66 47.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 63.25 110.408 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.0 tp -98.14 110.77 23.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 43.340000000000003 110.39 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 78.6 m-85 -91.66 142.87 27.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.66 -0.866 . . . . 73.310000000000002 108.66 173.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 3.8 tm-20 -155.77 126.59 6.93 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.168 -0.678 . . . . 73.299999999999997 109.168 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -153.56 102.91 2.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.2 -0.454 . . . . 72.530000000000001 110.627 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.6 -84.93 1.18 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.823 -0.626 . . . . 63.119999999999997 112.398 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -129.39 -4.9 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.509 0.671 . . . . 51.130000000000003 109.95 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ2' ' HB2' ' A' ' 43' ' ' LYS . 35.3 t90 -100.38 135.97 41.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.764 -0.653 . . . . 72.319999999999993 112.251 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.2 144.12 48.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.764 -1.107 . . . . 74.439999999999998 109.154 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 44.9 tptt -146.76 110.39 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.585 0.231 . . . . 63.439999999999998 110.431 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -106.74 105.46 15.51 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 73.540000000000006 110.087 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG23 ' HG3' ' A' ' 43' ' ' LYS . 24.7 t -127.98 133.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 71.439999999999998 110.018 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -85.07 122.88 29.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 120.972 0.415 . . . . 71.230000000000004 111.206 -179.271 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.91 175.67 6.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.765 -0.828 . . . . 73.340000000000003 108.765 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.851 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 63.6 mtt180 -89.11 165.11 14.71 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.256 0.55 . . . . 72.319999999999993 110.589 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.71 HD22 ' HB ' ' A' ' 2' ' ' ILE . 96.5 mt -79.53 -24.78 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.497 -0.774 . . . . 74.109999999999999 110.139 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 t -91.63 -5.98 52.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.603 -0.726 . . . . 64.040000000000006 110.101 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.851 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 52.8 mt-10 -92.73 -9.38 40.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.64 -0.424 . . . . 70.340000000000003 111.91 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 2' ' ' ILE . 44.5 mt -120.66 163.78 17.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.559 -0.291 . . . . 73.120000000000005 110.694 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -123.57 155.09 38.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.891 -0.411 . . . . 73.030000000000001 109.891 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.6 125.06 39.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.863 0.363 . . . . 73.030000000000001 110.955 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.8 -0.815 . . . . 74.099999999999994 108.8 177.479 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 C--O 1.232 0.156 0 N-CA-C 108.8 -0.815 . . . . 75.319999999999993 108.8 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.93 154.83 53.21 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.68 0.276 . . . . 65.439999999999998 110.899 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' PRO . . . . . 0.64 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 15.8 Cg_endo -59.82 126.03 19.34 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.366 2.044 . . . . 71.040000000000006 111.214 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 108.78 -7.48 33.61 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.623 -0.799 . . . . 45.340000000000003 111.811 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.57 152.73 19.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 71.0 110.715 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -95.32 130.46 42.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 61.329999999999998 110.117 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 52' ' ' LEU . 21.6 m -124.52 155.8 32.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.908 0.385 . . . . 73.140000000000001 111.395 -177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 9' ' ' ARG . 19.2 ttt180 -122.8 121.32 35.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 73.310000000000002 109.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.99 116.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 54.399999999999999 111.238 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -90.74 -28.32 18.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 62.439999999999998 111.514 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.031 -0.359 . . . . 75.019999999999996 110.031 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.482 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 30.5 t -72.81 -26.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.175 0.512 . . . . 73.239999999999995 111.515 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.47 -15.39 55.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 65.340000000000003 111.281 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 160.16 29.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.093 0.473 . . . . 54.399999999999999 111.3 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -66.88 -38.69 86.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.739 -0.664 . . . . 75.540000000000006 111.637 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.61 26.8 5.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.897 0.379 . . . . 71.109999999999999 111.345 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 13' ' ' VAL . 37.4 t80 -57.98 140.51 52.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.048 -0.524 . . . . 74.549999999999997 110.86 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 73.87 9.5 4.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.405 -0.816 . . . . 75.409999999999997 111.485 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -102.58 153.04 20.48 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.896 -0.409 . . . . 74.510000000000005 109.896 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.88 139.38 49.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 62.420000000000002 110.181 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.53 175.92 23.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.815 -0.707 . . . . 53.350000000000001 112.228 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.8 tt -112.6 124.95 53.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.112 -0.329 . . . . 74.420000000000002 110.112 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.54 117.31 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 62.299999999999997 110.804 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -78.09 -36.13 48.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.987 -0.552 . . . . 64.299999999999997 110.161 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 4' ' ' PRO . 30.5 ptt180 -170.8 145.98 2.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.695 -0.684 . . . . 62.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.608 HG13 HD21 ' A' ' 49' ' ' LEU . 89.7 t -106.76 121.52 59.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.279 -0.873 . . . . 62.329999999999998 109.302 172.75 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.4 m -155.29 139.31 16.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.726 -0.215 . . . . 61.350000000000001 110.873 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 67.67 15.29 9.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.799 -0.637 . . . . 64.209999999999994 111.474 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.98 2.7 71.2 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.709 -0.758 . . . . 54.43 111.907 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 61.2 mtpt -115.31 163.05 16.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 110.182 -0.303 . . . . 62.219999999999999 110.182 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.25 125.87 25.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.256 -0.429 . . . . 42.450000000000003 110.048 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.728 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.38 113.12 20.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 71.299999999999997 109.891 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.18 119.65 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 71.420000000000002 111.238 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.7 tp -94.1 108.79 20.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.945 -0.571 . . . . 74.340000000000003 109.685 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 96.6 m-85 -80.36 141.36 35.46 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.284 -0.636 . . . . 63.509999999999998 109.284 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -139.24 124.37 18.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.488 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -128.85 86.3 2.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 60.210000000000001 109.916 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.81 -95.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.205 -0.758 . . . . 71.519999999999996 111.205 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -122.37 87.77 2.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.529 1.156 . . . . 74.420000000000002 108.554 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 t90 178.8 138.46 0.09 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.283 -2.235 . . . . 74.540000000000006 109.463 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.6 p30 -137.03 152.71 50.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.489 -0.778 . . . . 74.099999999999994 110.558 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HG3' HG23 ' A' ' 45' ' ' VAL . 17.1 tppt? -156.56 107.14 2.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 73.420000000000002 110.044 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 ' HB1' ' A' ' 33' ' ' ALA . 57.4 tp -89.21 110.86 21.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.169 -0.469 . . . . 71.200000000000003 110.716 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 43' ' ' LYS . 34.8 t -125.65 120.73 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 65.540000000000006 109.213 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.0 m -81.41 130.93 35.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.282 0.563 . . . . 71.439999999999998 111.067 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 52' ' ' LEU . 81.9 m-85 -124.53 -167.27 1.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.19 -0.914 . . . . 72.140000000000001 109.038 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.722 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 65.2 mtt-85 -110.24 162.81 14.25 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.885 -0.413 . . . . 65.349999999999994 109.885 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.608 HD21 HG13 ' A' ' 27' ' ' VAL . 3.6 mm? -66.4 -33.29 75.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.429 0.633 . . . . 63.25 109.999 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 p -78.16 -6.38 54.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.514 -0.766 . . . . 64.329999999999998 110.573 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.722 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 15.4 mm-40 -94.13 -15.57 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 62.420000000000002 111.001 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 47' ' ' PHE . 29.4 mt -127.79 150.07 49.98 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.066 -0.515 . . . . 74.109999999999999 111.645 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -121.25 143.45 49.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.655 -0.868 . . . . 75.209999999999994 108.655 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.18 136.37 37.08 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.958 -0.297 . . . . 53.240000000000002 110.246 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.534 -0.543 . . . . 34.350000000000001 109.534 179.037 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.858 0.361 . . . . 71.519999999999996 110.5 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.0 mt -131.88 142.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.347 -0.612 . . . . 75.219999999999999 109.347 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -135.27 161.71 61.79 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.605 -0.27 . . . . 75.25 110.295 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.86 117.55 4.32 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.274 1.983 . . . . 74.140000000000001 111.191 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.85 1.36 24.15 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.892 -0.67 . . . . 63.420000000000002 111.897 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.33 141.72 32.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.93 0.395 . . . . 61.0 110.948 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -82.55 129.96 35.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 33.229999999999997 110.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -132.36 153.02 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 71.219999999999999 111.565 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -117.13 137.04 52.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.515 -0.766 . . . . 73.519999999999996 109.969 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.4 t -80.42 115.26 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 71.310000000000002 110.353 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.49 18.52 22.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 112.21 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -89.82 113.9 25.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.177 -0.675 . . . . 62.200000000000003 109.177 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.11 -28.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.767 -0.651 . . . . 54.210000000000001 111.976 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -93.07 23.54 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 65.540000000000006 110.791 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.72 160.96 18.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.791 -0.568 . . . . 55.0 110.527 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -71.06 -32.09 68.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 52.530000000000001 111.173 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.471 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 71.6 m-85 -96.85 25.45 5.29 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.886 0.328 . . . . 70.129999999999995 111.886 -175.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -59.23 131.32 50.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.537 -0.301 . . . . 70.239999999999995 110.198 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 78.23 -16.84 0.62 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.885 0.874 . . . . 75.340000000000003 111.577 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -75.25 157.46 34.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 63.43 110.686 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.61 139.63 50.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.859 -0.609 . . . . 65.109999999999999 110.854 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 179.88 18.46 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.785 -0.643 . . . . 41.039999999999999 111.506 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.2 tp -119.0 123.23 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.311 -0.255 . . . . 63.530000000000001 110.311 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.93 116.81 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.845 -0.428 . . . . 74.299999999999997 109.845 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -90.49 -33.65 15.88 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.938 -0.574 . . . . 54.409999999999997 110.914 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -169.84 154.02 5.11 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.764 -0.653 . . . . 63.439999999999998 110.177 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.16 124.74 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.097 -0.956 . . . . 55.25 109.115 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -120.2 98.84 6.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.992 0.425 . . . . 75.540000000000006 111.179 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 54.29 39.45 30.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.356 -0.838 . . . . 74.209999999999994 112.178 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.47 -11.72 65.0 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.642 -0.789 . . . . 62.539999999999999 112.569 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 99.0 mttt -99.13 177.61 5.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.113 -0.329 . . . . 75.140000000000001 110.113 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.99 126.18 40.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 70.519999999999996 110.604 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.817 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -83.58 107.52 16.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.291 -0.413 . . . . 74.400000000000006 109.957 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.12 124.02 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.137 -0.483 . . . . 72.329999999999998 110.822 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -99.13 126.51 44.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.511 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -103.59 136.46 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.535 -0.913 . . . . 62.200000000000003 108.535 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -141.83 133.22 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.807 -0.442 . . . . 55.039999999999999 109.807 -172.597 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -129.11 21.78 5.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.196 0.522 . . . . 71.109999999999999 111.09 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . 98.13 9.26 54.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.643 -0.789 . . . . 50.340000000000003 112.951 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 28.6 t-20 169.34 -46.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.087 -0.709 . . . . 73.420000000000002 109.087 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -80.25 138.69 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.501 -0.772 . . . . 74.230000000000004 109.894 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -154.8 163.21 40.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.736 -0.665 . . . . 60.32 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -165.39 106.79 0.78 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.242 -0.89 . . . . 72.129999999999995 109.462 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.817 HD21 ' HB1' ' A' ' 33' ' ' ALA . 8.7 tt -77.52 119.25 20.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 51.340000000000003 109.649 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.15 124.26 62.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.861 -0.422 . . . . 75.530000000000001 109.861 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -84.09 129.2 34.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.225 0.536 . . . . 52.310000000000002 110.729 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 95.7 m-85 -124.73 178.45 5.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.454 -0.793 . . . . 65.219999999999999 109.182 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.943 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 49.7 mtt180 -87.08 163.02 17.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.296 -0.631 . . . . 64.540000000000006 109.296 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.37 -31.24 69.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.724 -0.843 . . . . 71.310000000000002 108.724 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 p -67.82 -21.34 65.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 114.933 -1.03 . . . . 50.100000000000001 110.466 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.943 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 41.2 mm-40 -87.95 -7.9 56.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.501 -0.48 . . . . 65.230000000000004 111.254 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 8' ' ' VAL . 49.9 mt -122.88 156.63 34.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.973 0.416 . . . . 74.329999999999998 111.719 -173.125 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -129.22 147.24 51.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.114 -0.698 . . . . 52.140000000000001 109.114 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.94 132.33 36.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 74.299999999999997 111.127 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.7 t -93.88 174.39 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' H ' HG12 ' A' ' 55' ' ' VAL . 14.5 mptt -90.02 134.52 31.58 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-O 120.63 0.252 . . . . 73.219999999999999 110.584 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.44 -168.28 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.939 2.426 . . . . 74.430000000000007 111.846 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.824 HD12 ' H ' ' A' ' 58' ' ' ILE . 2.6 mp -67.0 152.36 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.151 -0.685 . . . . 61.25 109.151 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 59' ' ' LEU . 3.4 mm? -88.35 82.07 7.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.137 0.494 . . . . 73.239999999999995 110.923 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.32 156.13 33.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.628 -0.715 . . . . 53.539999999999999 109.938 174.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -97.65 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.689 -0.486 . . . . 73.329999999999998 109.689 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -84.43 146.55 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.531 . . . . 73.230000000000004 109.568 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -160.7 142.63 12.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.925 0.393 . . . . 74.420000000000002 110.839 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -138.02 163.72 30.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.887 -0.783 . . . . 73.400000000000006 108.887 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.75 153.92 36.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.895 0.378 . . . . 74.230000000000004 110.928 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.192 -0.909 . . . . 72.209999999999994 109.239 176.91 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.875 0.369 . . . . 60.310000000000002 110.194 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.7 HD12 HD22 ' A' ' 49' ' ' LEU . 52.3 mt -98.37 144.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.385 -0.37 . . . . 73.439999999999998 110.145 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.47 143.46 30.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.249 -0.432 . . . . 71.439999999999998 110.762 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.85 134.6 44.23 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.675 2.25 . . . . 63.240000000000002 111.544 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.83 -5.01 50.23 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.991 -0.624 . . . . 62.210000000000001 112.331 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.7 161.07 13.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.831 0.348 . . . . 53.32 110.695 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -99.69 131.79 45.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.264 -0.425 . . . . 75.129999999999995 110.234 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 52' ' ' LEU . 25.9 m -125.7 155.52 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 110.206 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -109.47 143.07 39.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.669 -0.493 . . . . 44.439999999999998 109.669 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.16 113.96 16.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.032 -0.359 . . . . 63.0 110.032 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -89.69 -19.02 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 73.439999999999998 111.142 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.03 106.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 74.420000000000002 110.5 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.15 -30.42 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 71.549999999999997 111.132 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.66 -26.55 68.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 71.439999999999998 111.125 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.16 155.37 25.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 63.229999999999997 110.647 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 -27.5 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.002 -0.545 . . . . 73.109999999999999 110.945 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.43 22.66 2.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.276 -0.42 . . . . 71.25 111.489 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 35.6 t80 -63.32 134.61 56.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.239 -0.437 . . . . 74.409999999999997 110.332 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.7 mtp180 76.17 1.82 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.761 0.825 . . . . 74.549999999999997 112.293 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -85.35 150.51 24.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 75.129999999999995 110.212 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 125.25 53.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 74.519999999999996 109.744 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -125.72 155.27 18.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.586 -0.816 . . . . 41.329999999999998 111.85 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.66 116.48 28.98 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 110.252 -0.277 . . . . 75.409999999999997 110.252 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.01 106.34 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.85 -0.426 . . . . 61.310000000000002 109.85 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -79.37 -34.5 41.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.101 0.477 . . . . 72.019999999999996 110.521 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -167.03 143.72 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.695 -0.684 . . . . 70.140000000000001 109.65 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.18 136.14 25.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.431 -0.804 . . . . 72.519999999999996 109.276 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 m -127.03 93.75 3.84 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.264 -0.273 . . . . 63.009999999999998 110.264 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.92 -76.82 0.06 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.298 -0.864 . . . . 65.129999999999995 111.085 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -140.76 11.73 2.9 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.332 -1.304 . . . . 44.310000000000002 111.132 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 47.4 mtmt -114.6 165.95 12.23 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.115 -0.543 . . . . 74.019999999999996 109.55 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.98 133.4 37.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.681 0.277 . . . . 51.229999999999997 110.5 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.74 99.6 10.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.18 -0.674 . . . . 42.340000000000003 109.18 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG1' ' HA3' ' A' ' 22' ' ' GLY . 55.4 t -91.78 118.09 36.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 64.099999999999994 110.793 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.8 tp -94.6 122.59 37.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.781 -0.645 . . . . 72.209999999999994 110.509 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 92.3 m-85 -99.95 146.77 26.3 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.957 -0.757 . . . . 71.340000000000003 108.957 174.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 30.8 tt0 -129.55 -56.06 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.669 -0.412 . . . . 60.310000000000002 111.805 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 64.64 -66.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.825 0.45 . . . . 74.019999999999996 111.523 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . -168.73 93.5 0.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.334 -0.706 . . . . 52.009999999999998 111.334 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 8.6 t30 72.59 -36.79 0.37 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.492 0.717 . . . . 74.120000000000005 111.743 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 48.1 t90 -57.41 155.38 9.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 73.040000000000006 110.789 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.0 p-10 -148.54 153.45 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 71.409999999999997 110.301 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -169.45 110.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.362 -0.836 . . . . 73.129999999999995 109.378 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.544 HD11 ' HB1' ' A' ' 33' ' ' ALA . 37.8 tp -90.91 105.98 18.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.066 -0.516 . . . . 73.129999999999995 110.067 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -118.0 118.09 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 110.004 -0.369 . . . . 73.400000000000006 110.004 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 m -79.27 129.6 34.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.08 0.467 . . . . 54.539999999999999 110.583 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -124.84 178.41 5.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.613 -0.721 . . . . 65.439999999999998 109.119 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.961 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 62.8 mmt-85 -90.17 162.85 15.07 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.959 -0.756 . . . . 74.129999999999995 108.959 175.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.7 HD22 HD12 ' A' ' 2' ' ' ILE . 87.0 mt -79.36 -22.31 44.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.27 0.557 . . . . 71.319999999999993 109.882 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 p -75.21 -15.12 60.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.399 -0.819 . . . . 64.209999999999994 110.003 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.961 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 13.4 mm-40 -91.89 -13.17 31.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.732 -0.667 . . . . 63.539999999999999 110.604 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 8' ' ' VAL . 62.9 mt -115.56 161.54 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.73 . . . . 73.230000000000004 111.01 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.64 128.99 48.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.802 -0.636 . . . . 75.129999999999995 109.549 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.602 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -79.93 108.74 13.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.71 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -73.63 173.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.837 -0.801 . . . . 72.140000000000001 108.837 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' H ' HG12 ' A' ' 55' ' ' VAL . 19.9 pttp -63.16 134.75 95.93 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.878 0.37 . . . . 62.450000000000003 110.626 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 8.5 Cg_exo -72.64 -173.68 1.25 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.964 2.442 . . . . 63.25 111.945 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -79.34 152.0 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.027 -0.731 . . . . 74.340000000000003 109.027 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 pp -92.98 150.3 20.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.27 -0.423 . . . . 74.430000000000007 111.321 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.81 -78.2 0.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 52.149999999999999 108.845 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -156.01 174.95 14.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.189 -0.914 . . . . 72.310000000000002 109.375 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -83.71 102.99 12.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 74.420000000000002 110.717 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.19 147.62 26.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.762 . . . . 74.25 109.39 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -70.89 115.34 9.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.011 -0.737 . . . . 75.409999999999997 109.011 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -73.51 162.17 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.575 -0.739 . . . . 70.349999999999994 111.895 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.8 m80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.168 -0.92 . . . . 62.109999999999999 109.464 175.931 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptm . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.898 0.38 . . . . 74.140000000000001 111.007 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.15 136.5 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.007 -0.738 . . . . 74.25 109.007 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -149.62 144.27 17.63 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.887 -0.412 . . . . 74.219999999999999 109.887 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.36 131.57 44.08 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.71 2.273 . . . . 53.119999999999997 111.857 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.2 -13.26 48.52 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.985 -0.626 . . . . 32.520000000000003 111.883 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 164.39 13.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.877 0.37 . . . . 22.129999999999999 110.561 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -97.36 134.42 40.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.902 -0.59 . . . . 72.040000000000006 110.085 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.79 148.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.991 0.425 . . . . 72.420000000000002 111.008 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 22.2 ttt180 -104.92 122.23 45.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.66 -0.7 . . . . 73.430000000000007 109.504 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 52' ' ' LEU . 41.2 t -70.82 103.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.1 0.476 . . . . 64.420000000000002 110.16 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -108.88 23.94 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.799 -0.637 . . . . 75.319999999999993 111.572 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -72.87 106.43 4.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.876 -0.787 . . . . 72.329999999999998 108.876 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.41 -25.47 38.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.179 0.514 . . . . 73.129999999999995 111.178 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.08 -23.26 26.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.308 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.79 155.8 18.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 73.310000000000002 110.905 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -78.94 -23.4 44.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 54.119999999999997 111.822 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -76.91 11.77 1.62 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 73.420000000000002 111.28 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 64.9 t80 -71.33 78.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.516 -0.765 . . . . 75.230000000000004 110.055 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 14.8 ptt180 168.9 -20.38 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.182 -0.917 . . . . 71.430000000000007 109.629 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.12 148.07 23.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.305 0.574 . . . . 74.140000000000001 111.408 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 41.5 mt-10 -125.91 118.12 24.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.246 -1.02 . . . . 74.109999999999999 108.246 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.76 176.81 17.86 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.132 -1.032 . . . . 60.43 113.148 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -93.67 140.4 29.68 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.553 0.216 . . . . 71.109999999999999 110.632 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.27 117.33 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.254 -0.43 . . . . 53.219999999999999 110.667 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 35' ' ' LEU . 2.6 mp0 -75.9 -37.71 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 55.130000000000003 110.108 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -170.67 141.06 1.79 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.798 -0.637 . . . . 64.25 110.615 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.75 108.25 21.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.264 -0.88 . . . . 63.219999999999999 108.788 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -88.92 41.71 1.04 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.523 -0.308 . . . . 60.240000000000002 110.955 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 63.5 88.93 0.09 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.317 -0.856 . . . . 61.310000000000002 111.143 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.24 -30.55 9.66 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.656 -0.702 . . . . 60.5 112.448 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -120.65 162.66 19.29 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.214 0.206 . . . . 73.439999999999998 110.491 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.94 140.7 28.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.519 0.2 . . . . 73.230000000000004 111.019 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.64 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -93.02 116.57 29.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.51 -0.552 . . . . 71.010000000000005 109.51 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 127.21 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.398 -0.364 . . . . 74.439999999999998 110.66 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' HB2' ' OE1' ' A' ' 25' ' ' GLN . 37.0 tp -88.72 125.88 35.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.454 . . . . 72.319999999999993 110.889 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.592 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 91.4 m-85 -102.91 142.22 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.766 -0.652 . . . . 71.230000000000004 109.445 173.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -143.3 119.7 10.95 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.65 -0.5 . . . . 62.130000000000003 109.65 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 55.5 t30 -137.92 91.36 2.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 54.109999999999999 110.62 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.19 -91.76 0.83 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.747 -0.66 . . . . 64.0 112.473 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -114.49 -11.61 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 75.409999999999997 110.385 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.481 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 63.8 t90 -89.01 139.15 30.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 72.319999999999993 111.39 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.74 154.4 46.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.303 -0.862 . . . . 72.439999999999998 109.784 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -163.5 121.34 1.89 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.679 -0.691 . . . . 71.239999999999995 110.503 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.64 HD21 ' HB1' ' A' ' 33' ' ' ALA . 9.1 tt -91.03 113.76 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.244 -0.65 . . . . 74.439999999999998 109.244 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.592 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 44.3 t -123.14 129.05 75.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.364 . . . . 63.350000000000001 110.636 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.8 m -84.37 132.62 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.991 0.424 . . . . 72.430000000000007 110.585 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -128.44 -176.61 3.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.911 -0.586 . . . . 74.099999999999994 110.053 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 25.2 mtp180 -100.47 157.01 16.95 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.298 -0.631 . . . . 74.219999999999999 109.298 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.5 -23.04 50.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.059 0.457 . . . . 72.219999999999999 110.424 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -74.47 -18.04 60.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.667 -0.697 . . . . 65.340000000000003 110.315 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.559 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp0 -99.0 -4.63 32.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.58 . . . . 74.200000000000003 111.294 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 10' ' ' VAL . 84.0 mt -120.18 130.18 54.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.458 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.95 135.34 45.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.104 -0.702 . . . . 75.030000000000001 109.104 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 128.9 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.085 -0.507 . . . . 73.409999999999997 110.579 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -102.05 168.34 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.6 -0.889 . . . . 70.519999999999996 108.6 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' H ' HG12 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -104.73 138.28 19.46 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.579 -0.526 . . . . 74.140000000000001 109.579 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.87 144.21 67.91 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.716 2.278 . . . . 73.530000000000001 111.718 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.836 HD12 ' H ' ' A' ' 58' ' ' ILE . 1.9 mp -60.43 148.22 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.523 -0.547 . . . . 73.209999999999994 109.523 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.52 117.91 22.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.819 -0.628 . . . . 64.349999999999994 110.021 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.62 144.57 50.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.949 -0.76 . . . . 73.219999999999999 108.949 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -128.84 113.67 15.56 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.724 -0.39 . . . . 74.329999999999998 110.716 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -65.49 118.06 8.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.374 -0.602 . . . . 75.010000000000005 109.374 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -137.13 124.6 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.07 0.462 . . . . 75.409999999999997 111.377 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -77.42 143.99 38.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.939 -0.763 . . . . 75.140000000000001 108.939 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -59.45 104.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 70.510000000000005 111.578 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.398 -0.819 . . . . 61.210000000000001 109.143 175.996 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.847 -0.427 . . . . 75.099999999999994 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.2 mt -71.66 131.75 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.927 -0.397 . . . . 74.219999999999999 109.927 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 36.9 m-85 -149.4 167.48 12.94 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.678 -0.692 . . . . 72.140000000000001 110.028 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.815 ' HG3' ' HA ' ' A' ' 26' ' ' ARG . 51.6 Cg_exo -53.83 124.33 15.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.696 2.264 . . . . 64.150000000000006 112.061 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.27 -16.3 35.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.129 -0.558 . . . . 73.200000000000003 112.036 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.26 155.27 30.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 71.019999999999996 110.792 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -98.39 130.37 45.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.341 -0.39 . . . . 62.439999999999998 110.401 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.48 157.45 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.435 . . . . 62.43 110.459 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -133.98 135.7 43.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.061 -0.518 . . . . 70.540000000000006 110.365 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.77 120.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 75.329999999999998 110.678 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.9 p -100.1 5.88 44.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 43.119999999999997 111.817 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.3 t30 -80.86 108.48 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 64.129999999999995 109.616 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.3 t -71.17 -28.14 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 74.010000000000005 111.528 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.45 -6.5 57.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 72.510000000000005 110.933 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.482 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 8.8 t70 -94.24 160.64 14.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.756 0.312 . . . . 74.049999999999997 110.306 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -82.92 -19.71 36.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.23 -0.441 . . . . 72.120000000000005 110.708 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.45 19.61 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 63.109999999999999 110.351 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.56 128.63 36.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.683 -0.69 . . . . 75.420000000000002 111.145 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 70.05 7.44 6.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.245 -0.889 . . . . 61.130000000000003 112.512 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.74 145.29 32.97 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.168 -0.678 . . . . 74.239999999999995 109.168 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -113.19 129.92 56.37 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.5 -0.773 . . . . 71.219999999999999 109.804 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.75 164.67 25.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.444 -0.884 . . . . 71.540000000000006 112.047 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.03 129.95 44.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 110.283 -0.266 . . . . 73.150000000000006 110.283 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.05 112.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 62.009999999999998 109.845 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -71.25 -37.68 71.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 71.239999999999995 109.524 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.815 ' HA ' ' HG3' ' A' ' 4' ' ' PRO . 33.0 ptt180 -174.78 150.22 1.27 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.086 -0.961 . . . . 72.25 109.011 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.18 128.57 45.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.552 -0.749 . . . . 74.109999999999999 109.414 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -124.94 78.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.877 -0.416 . . . . 64.409999999999997 109.877 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.3 t70 49.56 82.86 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.29 -0.868 . . . . 72.439999999999998 112.416 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 -12.39 19.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.98 -0.628 . . . . 63.310000000000002 113.209 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 59.1 mtpt -115.38 158.27 22.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.567 0.223 . . . . 71.150000000000006 110.513 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.62 131.46 27.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.475 -0.329 . . . . 71.299999999999997 110.361 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.63 105.43 14.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.413 -0.588 . . . . 72.150000000000006 109.413 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -92.26 121.01 42.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.265 -0.425 . . . . 62.020000000000003 110.812 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.3 tp -97.88 108.55 21.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.754 -0.461 . . . . 75.129999999999995 109.754 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -82.42 134.42 35.23 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.038 -0.727 . . . . 73.129999999999995 109.038 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.34 -54.92 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.555 . . . . 70.310000000000002 111.165 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 24.4 t-20 68.89 -48.22 0.58 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.971 0.508 . . . . 72.239999999999995 111.971 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.9 -48.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.203 -0.523 . . . . 51.350000000000001 111.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -132.25 4.93 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.585 1.183 . . . . 72.450000000000003 108.985 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 26.4 t90 -103.12 172.7 6.67 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.725 -1.58 . . . . 64.409999999999997 109.828 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 3.3 p30 -154.08 153.79 32.5 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.272 -0.27 . . . . 72.109999999999999 110.272 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HE2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -175.52 109.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.531 -0.759 . . . . 62.399999999999999 110.237 175.192 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.401 HD11 ' HB1' ' A' ' 33' ' ' ALA . 62.9 tp -97.68 109.97 22.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.176 -0.305 . . . . 63.399999999999999 110.176 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.3 t -134.76 129.64 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 70.120000000000005 109.932 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -90.13 135.14 33.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.251 0.548 . . . . 63.420000000000002 110.683 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -130.38 -176.36 3.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.701 -0.851 . . . . 64.120000000000005 108.701 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.058 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 68.4 mtt180 -87.48 168.43 13.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.455 -0.572 . . . . 64.329999999999998 109.455 174.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.36 -24.07 42.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.135 -0.691 . . . . 75.010000000000005 109.135 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -80.46 -20.42 43.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.171 -0.922 . . . . 72.409999999999997 110.58 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 1.058 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 10.4 mm-40 -85.83 -14.39 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.363 0.601 . . . . 71.349999999999994 110.409 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.0 mt -115.42 155.7 26.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.567 -0.742 . . . . 74.319999999999993 110.151 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.87 133.58 52.7 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.409 -0.589 . . . . 63.450000000000003 109.409 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.3 120.59 22.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.233 -0.44 . . . . 40.439999999999998 109.845 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -80.85 166.6 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.447 -0.575 . . . . 74.430000000000007 109.447 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' H ' HG12 ' A' ' 55' ' ' VAL . 98.0 mttt -99.04 154.97 37.06 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.475 -0.329 . . . . 74.030000000000001 110.739 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.09 145.79 97.62 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.505 2.137 . . . . 64.310000000000002 111.425 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.833 HD12 ' H ' ' A' ' 58' ' ' ILE . 2.2 mp -67.34 153.03 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.123 0.487 . . . . 74.329999999999998 110.563 -175.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.4 118.72 31.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.487 -0.779 . . . . 72.540000000000006 109.847 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 72.04 130.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.043 0.839 . . . . 54.530000000000001 111.105 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -82.46 115.84 21.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.981 -0.554 . . . . 74.209999999999994 110.56 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.53 94.34 0.97 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.134 -1.062 . . . . 73.129999999999995 108.134 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -71.13 -19.38 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.332 0.864 . . . . 71.150000000000006 113.332 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 60.11 -152.8 0.39 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.791 -0.448 . . . . 74.430000000000007 109.791 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -123.41 116.03 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.312 -0.625 . . . . 52.100000000000001 109.312 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.577 -0.725 . . . . 65.040000000000006 110.358 -177.539 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.467 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 1.7 tpt . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.793 0.33 . . . . 63.219999999999999 110.151 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' CG2' HG21 ' A' ' 24' ' ' VAL . 32.4 mt -77.92 136.51 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 75.519999999999996 110.451 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.69 159.92 69.77 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 115.898 -0.592 . . . . 73.25 109.751 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.84 127.76 23.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.504 2.136 . . . . 73.040000000000006 111.782 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.37 -5.68 52.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 71.049999999999997 112.618 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.7 146.28 26.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.63 0.253 . . . . 51.25 111.253 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 124.78 32.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.115 -0.493 . . . . 71.409999999999997 110.083 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.704 HG21 HD13 ' A' ' 52' ' ' LEU . 16.5 m -128.39 144.52 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 72.540000000000006 111.37 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.749 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 11.5 ttt85 -100.89 130.12 46.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.659 -0.701 . . . . 54.119999999999997 110.174 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 49.0 t -68.31 111.9 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.054 -0.721 . . . . 72.129999999999995 109.054 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -112.58 10.78 19.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.121 0.486 . . . . 44.43 111.806 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -82.35 112.73 19.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.784 -0.821 . . . . 65.329999999999998 108.784 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -66.56 -21.47 28.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.645 . . . . 62.340000000000003 111.431 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.81 -31.0 68.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.969 -0.56 . . . . 73.219999999999999 111.415 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.22 161.57 17.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 75.230000000000004 111.077 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 m -77.87 -23.29 48.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 75.540000000000006 111.53 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 82.6 m-85 -88.63 20.41 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.654 0.264 . . . . 74.519999999999996 111.57 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -71.2 77.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 62.340000000000003 110.876 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 166.67 -30.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.02 -0.991 . . . . 70.439999999999998 109.675 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -78.38 151.21 32.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.678 -0.692 . . . . 74.450000000000003 111.539 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.749 ' HG2' ' HB2' ' A' ' 9' ' ' ARG . 29.3 mt-10 -125.38 122.95 38.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 109.509 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.77 -178.68 15.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.75 . . . . 71.219999999999999 112.472 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.07 135.94 42.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.764 0.316 . . . . 74.030000000000001 111.191 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' A' ' 2' ' ' ILE . 62.0 t -75.66 111.09 11.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.937 0.399 . . . . 71.349999999999994 110.04 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -72.84 -41.39 64.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.659 0.742 . . . . 62.299999999999997 109.669 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -164.95 138.53 4.81 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.575 -1.193 . . . . 73.310000000000002 109.569 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.507 HG13 HD21 ' A' ' 49' ' ' LEU . 60.3 t -95.21 139.77 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.396 -0.82 . . . . 51.329999999999998 109.77 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 6.0 t -130.43 63.29 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.475 -0.565 . . . . 62.530000000000001 109.475 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 16.25 81.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.291 1.436 . . . . 54.009999999999998 113.386 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.99 -41.83 1.87 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.673 -1.149 . . . . 70.230000000000004 110.672 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 51.7 mmtt -109.78 167.35 10.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.76 0.424 . . . . 52.240000000000002 110.195 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.4 139.06 9.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.211 -0.45 . . . . 44.149999999999999 110.147 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -90.9 114.57 27.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.942 -0.392 . . . . 65.030000000000001 109.942 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.481 HG21 HD21 ' A' ' 52' ' ' LEU . 42.2 t -99.21 120.29 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 73.319999999999993 110.819 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.9 tp -97.65 114.52 26.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.566 -0.531 . . . . 62.039999999999999 109.566 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.4 141.97 30.46 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.95 -0.568 . . . . 72.109999999999999 109.925 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.49 113.94 11.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 72.200000000000003 109.648 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -142.39 79.71 1.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.062 0.458 . . . . 74.129999999999995 110.936 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.42 -104.04 2.12 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.848 -0.615 . . . . 64.340000000000003 112.656 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -96.78 -16.58 20.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.665 0.745 . . . . 64.120000000000005 109.625 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -95.04 141.17 29.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.211 -0.904 . . . . 63.299999999999997 111.239 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -153.39 150.91 29.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.88 -1.055 . . . . 75.310000000000002 109.527 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HE2' ' CG2' ' A' ' 45' ' ' VAL . 87.3 tttt -158.09 131.31 7.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.27 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.454 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.9 tp -99.81 110.7 23.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.358 -0.383 . . . . 71.129999999999995 110.3 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' CG2' ' HE2' ' A' ' 43' ' ' LYS . 40.2 t -124.27 120.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.981 0.419 . . . . 64.530000000000001 110.425 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.2 m -75.88 130.01 37.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.206 0.527 . . . . 73.400000000000006 110.493 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -125.28 -171.06 2.28 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.504 -0.771 . . . . 54.340000000000003 108.979 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.717 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 19.9 mtm180 -99.33 171.04 8.23 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.466 -0.568 . . . . 74.109999999999999 109.466 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD21 HG13 ' A' ' 27' ' ' VAL . 75.3 mt -76.6 -30.99 57.18 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.014 0.435 . . . . 64.219999999999999 110.039 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 p -71.58 -12.78 61.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.718 -0.674 . . . . 45.420000000000002 110.345 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.717 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 4.8 mm-40 -86.67 -14.68 41.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.519999999999996 110.744 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.704 HD13 HG21 ' A' ' 8' ' ' VAL . 79.7 mt -110.74 130.67 55.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.283 0.563 . . . . 72.230000000000004 112.403 -168.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -109.89 116.0 30.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.35 -0.841 . . . . 75.310000000000002 109.081 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 131.35 50.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.343 . . . . 72.109999999999999 110.485 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.7 t -80.54 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.245 -0.65 . . . . 72.120000000000005 109.245 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.592 ' H ' HG12 ' A' ' 55' ' ' VAL . 62.9 pttt -67.17 142.53 97.05 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 110.076 -0.342 . . . . 55.439999999999998 110.076 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.17 154.11 54.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.407 2.071 . . . . 72.340000000000003 111.103 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.797 ' H ' HD12 ' A' ' 58' ' ' ILE . 1.8 mp -58.26 147.47 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 75.140000000000001 109.926 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.852 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.6 pt? -85.06 102.44 13.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.556 -0.747 . . . . 72.200000000000003 110.665 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 61' ' ' HIS . 30.7 mt-10 -111.27 -82.95 0.58 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.818 -0.628 . . . . 70.310000000000002 109.683 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.415 ' H ' ' HB2' ' A' ' 60' ' ' GLU . 81.2 m-70 -145.43 138.56 26.28 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 74.439999999999998 109.535 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.74 91.2 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.933 -0.395 . . . . 74.239999999999995 109.933 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -68.58 142.62 55.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.057 -0.719 . . . . 73.420000000000002 109.057 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -72.41 159.83 33.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.986 0.422 . . . . 53.43 111.459 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -68.97 169.74 11.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.507 -0.769 . . . . 54.420000000000002 111.924 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.0 t60 . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.044 -0.98 . . . . 74.319999999999993 110.208 176.479 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.963 0.411 . . . . 75.239999999999995 110.342 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.586 HG12 ' HB2' ' A' ' 54' ' ' ALA . 48.1 mt -122.33 138.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.976 -0.557 . . . . 71.010000000000005 109.796 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -119.64 153.08 54.14 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.056 -0.52 . . . . 73.239999999999995 110.753 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.17 130.81 28.28 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.619 2.213 . . . . 74.319999999999993 111.463 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 103.39 -13.1 54.8 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 74.030000000000001 112.16 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 150.63 24.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 64.0 111.232 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -87.24 130.27 34.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.716 -0.674 . . . . 72.0 109.882 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 54' ' ' ALA . 22.9 m -128.93 152.29 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.898 0.38 . . . . 73.409999999999997 110.601 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HD2' ' OE2' ' A' ' 53' ' ' GLU . 44.7 ttm180 -110.46 138.05 47.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.246 -0.65 . . . . 73.120000000000005 109.246 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.5 t -76.25 113.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.907 0.384 . . . . 70.540000000000006 110.818 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -96.87 2.32 51.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 65.299999999999997 110.577 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.8 115.26 11.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.528 -0.76 . . . . 65.019999999999996 110.32 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.77 -8.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.422 0.63 . . . . 63.140000000000001 110.471 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.37 -37.81 88.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 64.349999999999994 110.637 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' OD2' ' HD2' ' A' ' 17' ' ' TYR . 13.6 t70 -103.45 173.47 6.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 72.230000000000004 109.877 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -88.94 -12.1 42.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.713 0.264 . . . . 71.299999999999997 111.713 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 58.4 m-85 -79.27 30.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 73.409999999999997 112.068 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 86.2 t80 -70.54 138.31 50.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 75.400000000000006 109.432 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 41.3 mtt180 70.59 18.96 6.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.506 0.504 . . . . 74.319999999999993 112.049 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -93.73 150.74 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 44.210000000000001 110.522 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -103.57 121.52 43.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.221 -0.9 . . . . 73.109999999999999 109.341 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.84 162.84 23.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.508 -0.853 . . . . 63.109999999999999 112.318 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.428 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.6 tt -116.74 123.69 47.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.703 -0.48 . . . . 65.439999999999998 109.703 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 32' ' ' ALA . 75.6 t -65.74 114.85 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 63.409999999999997 110.954 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -79.21 -35.46 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.366 0.603 . . . . 63.450000000000003 110.145 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -165.68 154.47 11.66 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.136 -0.938 . . . . 72.420000000000002 108.923 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.75 126.36 68.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.535 -0.757 . . . . 72.129999999999995 109.305 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.7 t -125.43 84.98 2.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.55 -0.296 . . . . 71.019999999999996 110.8 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 40.59 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.263 0.977 . . . . 52.049999999999997 112.969 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 96.09 -29.9 9.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.586 -0.816 . . . . 71.340000000000003 112.804 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HB3' HG22 ' A' ' 46' ' ' THR . 41.4 mttt -109.71 163.82 13.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.995 0.426 . . . . 71.239999999999995 111.379 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 24' ' ' VAL . . . -143.7 137.14 27.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 71.319999999999993 109.93 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.592 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.82 105.34 14.64 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.961 -0.385 . . . . 71.129999999999995 109.961 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.77 118.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.18 -0.463 . . . . 72.310000000000002 110.925 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.34 118.79 31.71 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.638 -0.504 . . . . 73.420000000000002 109.638 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -86.76 147.35 25.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.941 -0.572 . . . . 74.239999999999995 109.93 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -135.54 119.99 18.03 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 71.230000000000004 108.988 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -138.97 42.26 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.565 0.697 . . . . 72.219999999999999 110.046 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.18 -102.54 2.42 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 44.450000000000003 111.671 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -93.29 -32.87 14.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.211 0.529 . . . . 72.329999999999998 109.793 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -74.96 140.63 43.81 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.491 -0.777 . . . . 70.25 111.007 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.9 165.62 27.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.66 -1.155 . . . . 74.040000000000006 108.77 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -164.7 137.93 4.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.144 -0.317 . . . . 70.109999999999999 110.144 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.592 HD11 ' HB1' ' A' ' 33' ' ' ALA . 47.8 tp -109.16 109.24 20.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.809 0.338 . . . . 73.099999999999994 110.178 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -124.44 124.06 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.064 0.459 . . . . 74.0 110.265 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -87.33 111.13 20.76 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.393 0.616 . . . . 73.219999999999999 110.796 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.78 178.1 4.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.245 -0.889 . . . . 70.430000000000007 109.455 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.738 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 54.0 mtt85 -88.9 159.19 17.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.706 -0.479 . . . . 71.120000000000005 109.706 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 30' ' ' GLY . 94.0 mt -71.45 -26.91 62.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.343 0.592 . . . . 74.109999999999999 109.792 -176.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 p -80.0 -12.03 59.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.289 -0.869 . . . . 71.409999999999997 109.994 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.738 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.5 mt-10 -98.93 3.08 47.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.838 -0.619 . . . . 74.5 110.558 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.01 153.55 46.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 71.430000000000007 110.361 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 9' ' ' ARG . 11.7 pt-20 -118.28 123.14 44.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 74.219999999999999 109.28 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.717 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -78.5 123.86 27.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.319 -0.4 . . . . 73.329999999999998 110.03 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -86.37 164.7 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.899 -0.778 . . . . 63.310000000000002 108.899 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 55' ' ' VAL . 34.0 ttpt 63.27 111.4 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 123.906 0.753 . . . . 75.439999999999998 110.495 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.07 151.66 64.76 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.436 2.091 . . . . 73.340000000000003 111.92 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.81 HD12 ' H ' ' A' ' 58' ' ' ILE . 3.0 mp -63.33 158.96 3.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.602 -0.518 . . . . 74.209999999999994 109.602 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.815 ' HG ' ' H ' ' A' ' 60' ' ' GLU . 30.6 tp 73.0 -172.08 0.14 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.763 0.664 . . . . 71.519999999999996 109.384 -174.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.815 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 32.2 mt-10 -93.48 150.73 20.22 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.688 -0.486 . . . . 65.420000000000002 109.688 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -48.62 126.75 12.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.191 0.519 . . . . 64.010000000000005 111.11 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.5 p-80 -129.19 165.51 21.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.484 -0.78 . . . . 71.310000000000002 110.602 -173.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.21 114.08 13.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.286 -0.415 . . . . 64.450000000000003 110.975 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -71.53 173.53 7.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.453 -0.34 . . . . 75.409999999999997 110.943 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -64.25 -64.68 0.82 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.299 0.571 . . . . 72.129999999999995 109.751 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 C--O 1.249 1.039 0 N-CA-C 108.906 -0.776 . . . . 72.150000000000006 108.906 175.41 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptm . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.058 0.456 . . . . 73.450000000000003 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 54' ' ' ALA . 41.1 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.234 0.54 . . . . 73.439999999999998 111.444 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -130.77 154.64 81.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 73.019999999999996 109.714 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.82 119.15 6.11 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.354 2.036 . . . . 75.430000000000007 111.425 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.24 -3.83 31.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 43.43 111.949 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.15 153.77 19.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 73.019999999999996 110.811 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -91.82 132.44 36.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.564 . . . . 72.420000000000002 110.29 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.64 160.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.0 0.428 . . . . 63.399999999999999 110.828 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -124.81 130.59 52.69 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.884 -0.784 . . . . 72.230000000000004 108.884 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.2 t -68.73 108.81 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.155 0.503 . . . . 65.329999999999998 110.767 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -88.13 -17.98 29.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.484 -0.78 . . . . 72.0 110.416 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 42.7 t30 -66.85 106.99 2.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 71.219999999999999 110.573 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.22 -24.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 74.140000000000001 110.54 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.01 -27.09 67.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.362 -0.835 . . . . 71.140000000000001 111.189 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 11.2 t70 -85.86 164.94 17.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.2 -0.455 . . . . 63.009999999999998 110.766 -176.221 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -82.65 -23.77 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.346 -0.388 . . . . 72.329999999999998 110.705 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.38 21.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.949 0.404 . . . . 72.209999999999994 111.026 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 29.9 t80 -63.19 133.04 53.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.032 -0.531 . . . . 73.329999999999998 110.268 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 62.8 mtt180 76.66 3.23 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.621 0.768 . . . . 72.340000000000003 112.22 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.5 157.21 21.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.885 0.374 . . . . 75.349999999999994 110.251 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -118.05 141.94 47.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 72.319999999999993 110.122 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.55 165.19 33.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.551 -0.833 . . . . 51.229999999999997 111.793 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -104.43 131.52 51.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 110.26 -0.274 . . . . 73.109999999999999 110.26 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.515 HG11 HG22 ' A' ' 27' ' ' VAL . 59.9 t -70.46 117.08 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.023 -0.535 . . . . 74.019999999999996 110.199 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 29.3 mm-40 -83.33 -31.7 26.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.496 0.665 . . . . 75.340000000000003 110.279 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -158.18 128.55 6.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.96 -1.018 . . . . 73.329999999999998 110.373 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG22 HG11 ' A' ' 24' ' ' VAL . 57.8 t -98.38 120.14 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.572 -0.74 . . . . 75.420000000000002 110.036 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.5 m -102.09 -178.86 3.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.053 -0.721 . . . . 74.310000000000002 109.053 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.18 81.93 3.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.342 0.592 . . . . 70.219999999999999 110.069 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 121.84 -31.24 5.04 Favored Glycine 0 C--N 1.318 -0.444 0 CA-C-N 115.364 -0.834 . . . . 74.109999999999999 112.447 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 46' ' ' THR . 97.1 mttt -120.28 159.79 24.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.868 0.366 . . . . 52.350000000000001 111.262 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.0 135.92 36.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.047 -0.524 . . . . 71.120000000000005 109.812 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -89.19 109.36 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.909 0.385 . . . . 32.549999999999997 110.263 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.0 126.58 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 64.430000000000007 110.423 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 34.4 tp -90.79 123.61 34.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 65.209999999999994 110.666 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 88.6 m-85 -107.85 134.0 51.41 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.55 -0.907 . . . . 61.119999999999997 108.55 171.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -143.05 128.69 19.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.392 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -134.31 74.9 1.56 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.415 -0.587 . . . . 60.439999999999998 109.415 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.34 -97.82 0.35 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.684 -0.689 . . . . 40.009999999999998 112.554 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.55 -22.5 24.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.266 0.555 . . . . 71.209999999999994 110.201 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.446 ' HZ2' ' HD2' ' A' ' 43' ' ' LYS . 87.1 t90 -91.75 146.93 23.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 73.430000000000007 110.983 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -150.27 159.07 44.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.442 -0.799 . . . . 63.149999999999999 110.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 11.9 mttm -163.88 133.49 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.688 -0.687 . . . . 31.449999999999999 110.828 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.7 tp -106.3 104.12 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.523 . . . . 71.239999999999995 109.587 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.44 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 29.0 t -113.53 118.04 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.071 0.463 . . . . 62.43 110.411 -176.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.4 m -82.81 130.28 35.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.875 -0.602 . . . . 64.140000000000001 110.469 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 52' ' ' LEU . 91.2 m-85 -123.13 178.97 4.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.607 -0.724 . . . . 55.399999999999999 109.062 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 57.7 mtp180 -96.63 162.83 13.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.048 0.451 . . . . 72.540000000000006 110.563 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.428 HD22 HD12 ' A' ' 2' ' ' ILE . 94.4 mt -76.3 -22.92 54.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.929 -0.578 . . . . 55.240000000000002 110.41 -173.514 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 p -85.76 -8.26 58.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 70.150000000000006 109.92 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.7 mt-10 -98.89 -8.31 25.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 64.420000000000002 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 10' ' ' VAL . 57.1 mt -124.15 151.61 43.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.85 -0.614 . . . . 71.140000000000001 110.45 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 147.97 37.17 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.203 -0.665 . . . . 74.439999999999998 109.203 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.545 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -89.27 126.9 35.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.043 0.449 . . . . 61.210000000000001 110.937 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.9 t -100.38 -175.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.018 -1.105 . . . . 71.530000000000001 108.018 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.762 ' H ' HG12 ' A' ' 55' ' ' VAL . 86.5 tttt 70.31 109.29 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 121.322 0.582 . . . . 74.140000000000001 110.774 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 27.7 Cg_endo -61.86 142.37 93.15 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.835 2.357 . . . . 64.030000000000001 112.867 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mt -71.7 159.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.823 -0.626 . . . . 72.329999999999998 109.52 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -85.71 113.03 21.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.999 0.428 . . . . 62.520000000000003 110.281 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -151.21 -171.01 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.269 -1.011 . . . . 62.329999999999998 108.269 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.447 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 64.9 m80 -87.49 -72.9 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 74.120000000000005 109.451 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -150.65 168.19 25.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.632 -0.713 . . . . 62.340000000000003 109.2 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -103.65 157.61 16.94 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.618 -0.512 . . . . 53.420000000000002 109.618 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -86.06 156.67 20.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.226 -0.443 . . . . 71.329999999999998 110.378 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -65.37 155.28 35.86 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.793 -0.447 . . . . 55.109999999999999 109.793 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.7 m170 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.356 -0.831 . . . . 74.420000000000002 109.714 -179.101 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.993 0.425 . . . . 61.530000000000001 110.353 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.4 mt -126.28 140.79 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.501 . . . . 74.329999999999998 109.946 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -133.94 152.65 78.96 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.193 -0.458 . . . . 70.349999999999994 110.726 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HG3' ' H ' ' A' ' 27' ' ' VAL . 24.1 Cg_exo -64.4 123.1 11.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.73 2.287 . . . . 70.340000000000003 111.565 176.015 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.58 -0.81 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.017 -0.611 . . . . 60.409999999999997 112.089 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.88 145.41 32.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.848 0.356 . . . . 70.040000000000006 111.043 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -84.93 131.18 34.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.757 -0.656 . . . . 73.209999999999994 110.021 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 54' ' ' ALA . 32.7 m -129.46 150.85 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.778 0.323 . . . . 62.140000000000001 110.832 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 9' ' ' ARG . 17.3 ttt85 -104.33 134.83 46.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.856 -0.424 . . . . 62.119999999999997 109.856 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HA ' HD23 ' A' ' 52' ' ' LEU . 49.0 t -60.9 114.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.131 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -98.05 -9.73 25.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.39 0.614 . . . . 73.400000000000006 110.184 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.714 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 36.0 t30 -74.25 113.89 11.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 74.239999999999995 110.556 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.46 -26.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 54.25 110.889 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.64 -30.25 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 62.420000000000002 111.408 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -75.37 158.49 32.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 65.230000000000004 111.418 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -90.42 -12.31 37.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.817 -0.628 . . . . 71.439999999999998 110.938 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -98.51 21.4 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 72.25 110.169 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -66.63 80.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.7 . . . . 64.129999999999995 111.3 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 165.22 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.728 -1.124 . . . . 75.349999999999994 109.206 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -76.73 152.44 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.491 0.662 . . . . 75.25 111.854 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -119.42 109.78 16.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.856 -1.065 . . . . 73.129999999999995 109.232 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.05 174.89 15.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.726 -0.75 . . . . 44.439999999999998 112.565 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 23' ' ' LEU . 1.2 tm? -102.38 126.54 49.43 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.592 -0.521 . . . . 54.420000000000002 109.592 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' A' ' 32' ' ' ALA . 92.0 t -78.3 112.44 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.263 -0.273 . . . . 75.439999999999998 110.263 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -79.11 -34.39 43.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.956 0.407 . . . . 74.239999999999995 110.551 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -164.01 134.63 4.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.899 -0.591 . . . . 74.120000000000005 110.41 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.466 ' H ' ' HG3' ' A' ' 4' ' ' PRO . 96.9 t -91.58 123.3 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.386 -0.825 . . . . 74.540000000000006 109.096 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.6 t -126.91 91.36 3.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.702 0.286 . . . . 64.099999999999994 110.765 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 49.94 75.88 0.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 53.420000000000002 112.586 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.33 -20.99 6.42 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.06 -0.59 . . . . 43.109999999999999 113.404 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 55.8 mtpt -110.48 165.48 11.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.767 -0.255 . . . . 73.200000000000003 110.607 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -142.79 141.25 31.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 72.030000000000001 110.48 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.14 107.8 19.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.578 -0.527 . . . . 70.109999999999999 109.578 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.8 t -102.85 118.87 50.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.974 -0.557 . . . . 74.109999999999999 110.897 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.68 119.28 31.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.837 -0.619 . . . . 64.400000000000006 110.74 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 47.3 m-85 -89.59 134.12 34.28 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.594 -1.262 . . . . 71.549999999999997 107.594 169.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -149.38 124.39 10.02 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.934 -0.395 . . . . 72.120000000000005 109.934 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.12 86.09 1.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 54.229999999999997 110.667 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.7 -93.73 0.94 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.625 -0.716 . . . . 75.040000000000006 113.516 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -91.63 -21.97 20.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.869 0.366 . . . . 72.0 111.217 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t90 -111.07 143.5 41.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.315 0.578 . . . . 71.519999999999996 111.857 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 4.2 p-10 -147.99 153.06 38.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.664 -1.153 . . . . 74.140000000000001 109.176 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HG3' HG23 ' A' ' 45' ' ' VAL . 57.1 tptt -160.39 111.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 110.594 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -92.09 104.71 17.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 70.140000000000001 110.082 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.419 HG23 ' HG3' ' A' ' 43' ' ' LYS . 21.1 t -117.88 125.74 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 51.140000000000001 109.958 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.492 HG22 ' HE2' ' A' ' 31' ' ' LYS . 4.4 m -85.03 130.83 34.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.076 -0.511 . . . . 55.219999999999999 110.607 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.725 ' HB2' HD11 ' A' ' 52' ' ' LEU . 88.1 m-85 -126.53 -175.27 3.34 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.684 -0.689 . . . . 70.230000000000004 109.772 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.882 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 15.8 mmt180 -88.91 161.33 16.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.445 . . . . 73.549999999999997 109.8 174.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 32' ' ' ALA . 94.0 mt -83.41 -27.03 29.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.56 0.695 . . . . 74.519999999999996 109.343 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -76.45 -10.17 59.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.066 -0.97 . . . . 74.549999999999997 110.8 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.882 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 19.1 pt-20 -117.22 16.57 14.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.367 -0.533 . . . . 73.450000000000003 111.278 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.725 HD11 ' HB2' ' A' ' 47' ' ' PHE . 95.8 mt -131.86 154.35 49.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.857 -0.611 . . . . 71.299999999999997 109.97 175.49 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -149.06 141.37 24.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.624 -0.51 . . . . 73.519999999999996 109.624 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.3 138.34 51.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 53.210000000000001 111.594 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -86.15 171.08 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.544 -0.753 . . . . 64.140000000000001 109.057 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.567 ' H ' HG12 ' A' ' 55' ' ' VAL . 93.3 mttt -121.22 158.43 53.08 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 116.685 -0.234 . . . . 65.120000000000005 110.457 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.33 131.21 41.63 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.087 1.858 . . . . 70.219999999999999 110.016 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.801 HD12 ' H ' ' A' ' 58' ' ' ILE . 3.0 mp -62.84 149.69 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.318 0.58 . . . . 74.329999999999998 109.833 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.0 pt? -111.47 146.3 37.48 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.411 -0.813 . . . . 75.400000000000006 109.728 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.15 92.93 1.77 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.311 0.577 . . . . 71.5 109.54 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.12 116.28 22.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.392 -0.822 . . . . 75.530000000000001 109.965 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 11.9 m-70 -95.11 158.53 15.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.768 -0.651 . . . . 74.109999999999999 111.164 -176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.5 p-80 -66.23 102.3 0.82 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.302 -0.863 . . . . 53.020000000000003 109.623 169.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.6 p-80 -142.33 80.46 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.7 0.762 . . . . 75.109999999999999 111.595 -177.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -136.84 71.61 1.41 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.934 -0.575 . . . . 74.400000000000006 110.607 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.599 -0.715 . . . . 73.510000000000005 109.367 177.36 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 111.179 0.066 . . . . 63.450000000000003 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.9 mt 69.94 147.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.281 0.563 . . . . 73.109999999999999 110.928 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 55.0 m-85 -95.19 139.78 22.16 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 75.129999999999995 110.752 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 16.8 Cg_exo -67.67 137.94 43.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.636 2.224 . . . . 73.519999999999996 111.458 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.22 4.37 64.58 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.844 -0.694 . . . . 72.209999999999994 111.799 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.44 161.68 13.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.617 0.246 . . . . 70.150000000000006 110.446 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -87.43 131.26 34.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.091 -0.504 . . . . 75.140000000000001 110.239 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.69 150.29 34.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 71.120000000000005 111.055 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.9 ttp180 -117.41 142.22 47.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.754 -0.657 . . . . 73.239999999999995 109.366 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.8 t -77.86 105.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.742 -0.466 . . . . 72.430000000000007 109.742 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -89.52 -4.21 58.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 72.329999999999998 111.053 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.457 ' OD1' ' HB2' ' A' ' 15' ' ' ASP . 2.4 t-20 -69.38 102.86 1.85 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.7 -0.482 . . . . 70.239999999999995 109.7 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.524 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 22.4 t -63.03 -35.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.73 . . . . 45.119999999999997 112.14 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.96 -10.94 59.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.027 0.441 . . . . 71.010000000000005 111.597 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' HB2' ' OD1' ' A' ' 12' ' ' ASN . 5.6 t70 -84.4 160.37 20.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.012 -0.43 . . . . 72.239999999999995 110.7 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 m -71.06 -32.37 69.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 74.310000000000002 110.507 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 91.2 m-85 -87.86 21.13 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 53.5 111.25 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 32.9 t80 -59.27 132.25 53.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.02 0.438 . . . . 75.519999999999996 111.146 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 74.81 -3.8 2.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.924 -1.034 . . . . 65.329999999999998 111.917 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -77.78 149.87 34.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 63.43 109.652 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 37.1 mt-10 -125.34 136.2 53.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.55 . . . . 70.040000000000006 110.726 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.12 -171.24 17.62 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.009 -0.836 . . . . 73.340000000000003 111.009 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.9 mp -112.85 150.8 31.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.431 0.616 . . . . 71.299999999999997 110.923 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.01 115.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 73.239999999999995 110.231 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -79.58 -28.24 41.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 75.209999999999994 110.71 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -170.28 133.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 72.420000000000002 110.665 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 49' ' ' LEU . 58.0 t -93.88 135.4 28.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.318 -0.855 . . . . 62.520000000000003 109.786 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t -107.34 -159.94 0.71 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.929 -0.397 . . . . 73.409999999999997 109.929 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.8 -33.83 72.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.525 0.678 . . . . 71.319999999999993 111.709 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -155.16 -12.46 0.06 OUTLIER Glycine 0 C--N 1.31 -0.865 0 CA-C-N 114.791 -1.095 . . . . 54.43 112.319 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 63.8 mttp -104.27 172.09 6.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.844 0.354 . . . . 71.349999999999994 111.255 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.11 140.87 21.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 73.530000000000001 110.03 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.61 111.73 22.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.692 -0.484 . . . . 73.519999999999996 109.692 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 40.1 t -104.17 122.77 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 63.439999999999998 111.067 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.46 121.59 31.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.269 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.453 ' CE2' ' HE2' ' A' ' 47' ' ' PHE . 96.4 m-85 -101.41 151.96 21.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.993 -0.549 . . . . 71.430000000000007 110.244 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -122.32 -63.46 1.28 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.891 -0.595 . . . . 75.439999999999998 110.168 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.08 -57.32 0.42 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.538 0.735 . . . . 73.450000000000003 111.525 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . 158.35 102.55 0.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.904 -0.878 . . . . 44.32 110.904 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 24.9 t30 75.09 -40.59 0.44 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.422 0.689 . . . . 74.329999999999998 110.623 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -64.26 154.68 34.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.521 -0.763 . . . . 70.219999999999999 110.7 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -152.62 143.7 23.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.099 0.476 . . . . 74.340000000000003 109.882 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -168.22 125.25 1.08 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.568 -0.742 . . . . 74.109999999999999 109.904 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -100.09 102.55 13.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.3 -0.63 . . . . 71.409999999999997 109.3 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.35 120.04 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.061 -0.518 . . . . 53.210000000000001 110.609 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.23 129.25 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.942 -0.572 . . . . 72.400000000000006 110.269 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' HE2' ' CE2' ' A' ' 36' ' ' PHE . 45.2 m-85 -126.99 -174.37 3.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.938 -0.574 . . . . 72.230000000000004 109.542 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.567 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 33.5 mtt180 -103.93 162.13 13.39 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.462 -0.57 . . . . 72.150000000000006 109.462 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 27' ' ' VAL . 90.4 mt -73.06 -33.8 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.261 -0.427 . . . . 71.540000000000006 110.508 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -73.44 -16.08 61.32 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.751 -0.659 . . . . 70.430000000000007 110.579 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.567 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 3.5 mp0 -89.95 -8.85 50.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.827 -0.624 . . . . 74.040000000000006 111.387 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.88 157.39 25.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.341 -0.391 . . . . 74.510000000000005 111.391 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.54 148.42 52.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.045 -0.724 . . . . 74.010000000000005 109.045 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.37 121.73 21.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.995 0.426 . . . . 71.349999999999994 110.067 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 56' ' ' LYS . 12.4 t -76.05 170.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.194 -0.669 . . . . 72.409999999999997 109.194 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.608 ' H ' HG12 ' A' ' 55' ' ' VAL . 1.8 mppt? -107.37 128.98 24.93 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 115.732 -0.667 . . . . 61.32 109.378 -175.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -52.06 138.51 53.12 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.525 2.15 . . . . 65.349999999999994 111.362 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.83 HD12 ' H ' ' A' ' 58' ' ' ILE . 1.4 mp -61.85 146.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.508 . . . . 74.030000000000001 109.693 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -148.02 -178.56 6.35 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.419 -0.81 . . . . 71.329999999999998 110.944 -170.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.24 115.2 29.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.065 0.459 . . . . 64.409999999999997 110.554 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 21.2 m80 -135.59 120.24 18.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.728 -0.669 . . . . 64.340000000000003 109.436 170.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -66.85 130.91 44.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.983 0.42 . . . . 61.130000000000003 110.138 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -69.71 160.0 32.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.493 -0.776 . . . . 74.430000000000007 111.431 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -46.52 143.13 2.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.075 -0.966 . . . . 71.530000000000001 112.01 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -93.9 137.21 33.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.043 -0.526 . . . . 74.129999999999995 110.438 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.51 -0.757 . . . . 73.209999999999994 110.295 178.604 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.871 0.367 . . . . 70.230000000000004 110.599 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.451 ' O ' HG21 ' A' ' 27' ' ' VAL . 48.8 mt -125.34 140.96 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 74.450000000000003 109.341 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 39.4 p90 -115.79 149.24 42.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.595 0.236 . . . . 74.420000000000002 110.98 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 34.5 Cg_exo -62.13 142.79 93.33 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.607 2.205 . . . . 64.25 111.744 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.58 -7.85 65.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.975 -0.631 . . . . 54.219999999999999 112.128 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 143.6 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.929 0.395 . . . . 75.150000000000006 110.864 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -80.59 125.03 29.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 74.120000000000005 109.907 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.1 148.22 33.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.314 0.578 . . . . 42.200000000000003 111.349 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -111.76 133.85 53.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.285 -0.87 . . . . 62.43 109.3 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.3 t -80.08 101.17 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.576 -0.527 . . . . 64.219999999999999 109.576 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -103.31 13.7 33.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.895 -0.593 . . . . 64.450000000000003 110.526 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.9 t30 -61.6 107.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.533 -0.914 . . . . 71.430000000000007 108.533 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.84 -47.04 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 74.120000000000005 112.298 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.58 40.57 1.18 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.363 0.602 . . . . 71.530000000000001 110.537 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 6.1 t70 -110.44 161.13 15.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.129 -0.487 . . . . 74.409999999999997 110.111 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -81.14 -23.17 38.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.591 . . . . 70.310000000000002 110.104 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CD1' ' HZ ' ' A' ' 47' ' ' PHE . 73.7 m-85 -98.66 24.72 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 70.109999999999999 110.848 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 46.0 t80 -62.44 127.88 33.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.954 -0.566 . . . . 74.349999999999994 110.023 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 17.4 mtp180 76.12 10.54 3.09 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.057 0.848 . . . . 71.230000000000004 112.308 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -87.66 148.26 24.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.425 -0.583 . . . . 71.549999999999997 109.425 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -128.73 142.48 50.99 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.702 -0.681 . . . . 63.350000000000001 110.401 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -166.96 -169.03 30.03 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.82 -0.705 . . . . 53.409999999999997 111.709 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.77 136.66 52.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.716 0.293 . . . . 72.219999999999999 110.914 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.36 122.91 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 52.340000000000003 109.654 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG3' HD13 ' A' ' 44' ' ' LEU . 31.2 mm-40 -89.4 -33.09 16.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.285 0.564 . . . . 71.140000000000001 110.177 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -169.03 136.55 1.88 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.289 -0.869 . . . . 74.450000000000003 110.204 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 29' ' ' ASP . 43.7 t -103.35 142.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.485 -0.78 . . . . 73.430000000000007 109.689 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 t -121.91 34.8 5.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.078 0.466 . . . . 73.549999999999997 109.868 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 27' ' ' VAL . 24.4 m-20 50.04 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.953 -1.021 . . . . 71.150000000000006 111.533 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.29 -46.26 1.19 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.842 -0.903 . . . . 53.109999999999999 110.842 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 30.5 mtpp -112.28 161.02 17.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.844 -0.428 . . . . 73.129999999999995 109.844 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.55 142.63 21.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.751 -0.204 . . . . 51.439999999999998 110.556 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.637 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -91.67 115.48 28.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 75.230000000000004 109.593 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 52' ' ' LEU . 18.3 t -100.67 124.79 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.119 -0.491 . . . . 73.519999999999996 110.594 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.6 tp -94.92 107.29 19.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 73.200000000000003 109.579 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 81.4 m-85 -86.63 142.33 28.33 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.16 -0.682 . . . . 63.149999999999999 109.16 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -140.1 131.32 26.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.96 0.41 . . . . 71.510000000000005 110.449 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 44.1 t30 -141.14 91.07 2.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 63.43 108.951 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.66 -114.61 4.04 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.651 -0.704 . . . . 54.439999999999998 111.774 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -89.87 -30.24 18.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.622 0.725 . . . . 71.349999999999994 109.079 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.48 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 65.8 t90 -72.27 138.9 47.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.994 -1.003 . . . . 75.239999999999995 111.556 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.14 155.17 44.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.824 -1.08 . . . . 65.030000000000001 109.181 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.462 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 76.4 tttt -153.97 120.18 5.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.458 -0.337 . . . . 71.439999999999998 110.516 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.51 HD11 ' HB1' ' A' ' 33' ' ' ALA . 62.6 tp -93.88 110.4 22.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 73.129999999999995 110.566 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.497 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 25.3 t -126.2 127.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.014 -0.539 . . . . 71.239999999999995 109.799 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.5 m -83.26 133.0 35.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.247 0.546 . . . . 61.299999999999997 110.826 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.46 ' HZ ' ' CD1' ' A' ' 17' ' ' TYR . 55.7 m-85 -131.83 -160.15 1.02 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.425 -0.807 . . . . 70.099999999999994 109.656 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.8 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 63.7 mtm180 -109.08 173.66 6.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.77 -0.455 . . . . 75.340000000000003 109.77 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 27' ' ' VAL . 95.5 mt -81.45 -28.56 34.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.116 0.484 . . . . 72.409999999999997 109.912 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 p -68.9 -17.86 64.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.675 -0.693 . . . . 55.219999999999999 110.178 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.8 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.3 mm-40 -86.62 -13.07 46.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.865 -0.607 . . . . 73.109999999999999 110.622 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 34' ' ' VAL . 87.5 mt -112.73 140.93 47.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 73.209999999999994 112.144 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -117.0 112.8 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.699 -0.682 . . . . 62.509999999999998 109.714 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.78 134.26 52.76 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.865 -0.421 . . . . 55.109999999999999 109.865 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 2.1 t -80.3 157.76 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.586 -0.524 . . . . 52.539999999999999 109.586 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 12.9 pttm 55.65 146.88 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.945 1.298 . . . . 73.329999999999998 112.739 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.48 157.5 58.81 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.439 2.092 . . . . 73.519999999999996 112.021 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 58' ' ' ILE . 3.1 mt -64.81 150.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.33 -0.619 . . . . 75.230000000000004 109.33 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.535 HD11 ' HE2' ' A' ' 56' ' ' LYS . 5.3 mp -103.46 115.16 30.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.57 0.581 . . . . 71.129999999999995 112.57 -167.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 59.02 92.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.085 -0.961 . . . . 73.019999999999996 113.238 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -139.2 164.3 30.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.061 -0.518 . . . . 74.420000000000002 110.147 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -84.3 111.57 19.52 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.154 -0.684 . . . . 75.129999999999995 109.154 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -127.26 134.29 50.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.005 -0.543 . . . . 75.299999999999997 110.089 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.99 120.02 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 73.540000000000006 109.964 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.38 133.76 43.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 63.420000000000002 110.957 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.932 -0.766 . . . . 74.340000000000003 108.932 174.708 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 17.3 tpt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.366 0.126 . . . . 72.25 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 49' ' ' LEU . 72.7 mt 74.83 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 123.667 0.604 . . . . 74.409999999999997 110.18 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -131.16 146.09 60.55 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.309 -0.405 . . . . 73.310000000000002 110.639 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.77 125.6 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.54 2.16 . . . . 63.109999999999999 111.207 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.12 -3.0 47.57 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.051 -0.595 . . . . 62.310000000000002 112.026 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.38 154.94 18.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.74 0.305 . . . . 75.439999999999998 110.825 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -88.43 134.79 33.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.765 -0.652 . . . . 71.409999999999997 110.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG21 HD13 ' A' ' 52' ' ' LEU . 16.3 m -124.22 153.56 30.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.426 . . . . 72.540000000000006 110.702 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 53' ' ' GLU . 53.8 ttt180 -110.98 119.87 40.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.699 -0.682 . . . . 72.120000000000005 109.73 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 25.8 t -76.15 98.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.005 0.431 . . . . 63.409999999999997 110.249 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -105.8 13.83 29.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.313 -0.403 . . . . 72.409999999999997 111.273 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 54.3 t30 -62.8 112.65 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 41.25 109.671 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 23.5 t -69.54 -27.92 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 63.32 111.411 -172.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -100.39 40.36 1.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.817 0.818 . . . . 51.009999999999998 109.395 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 3.7 t70 -119.47 -174.53 2.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.511 -0.768 . . . . 73.329999999999998 110.671 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -109.59 -28.85 8.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.967 -0.56 . . . . 75.409999999999997 110.241 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 92.6 m-85 -101.07 38.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.098 -0.501 . . . . 72.209999999999994 111.151 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.678 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 10.1 t80 -59.35 126.3 27.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.742 -0.663 . . . . 75.409999999999997 110.263 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.678 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 87.1 mtt180 80.09 4.05 1.93 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.097 0.959 . . . . 72.510000000000005 112.681 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -83.71 149.09 26.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.46 . . . . 71.219999999999999 110.153 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.29 125.46 43.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.606 -0.724 . . . . 71.409999999999997 110.221 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.61 171.67 23.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.844 -0.693 . . . . 61.450000000000003 111.754 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.21 124.88 46.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.867 0.365 . . . . 74.510000000000005 110.976 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.03 119.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.88 -0.6 . . . . 64.340000000000003 110.313 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -77.86 -36.71 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.3 0.571 . . . . 74.209999999999994 109.854 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -170.03 143.0 2.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.063 -0.971 . . . . 72.209999999999994 109.408 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.22 92.85 2.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.605 -0.725 . . . . 75.219999999999999 109.373 174.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -103.54 114.12 28.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.277 -0.42 . . . . 64.239999999999995 111.12 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 61.67 37.68 15.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.427 -0.806 . . . . 64.120000000000005 111.624 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.44 6.14 89.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.609 -0.805 . . . . 34.149999999999999 112.772 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -117.4 144.74 44.65 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.305 -0.628 . . . . 62.219999999999999 109.305 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 124.25 51.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.764 0.316 . . . . 75.120000000000005 111.113 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -81.93 101.09 10.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.241 -0.652 . . . . 63.539999999999999 109.241 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.97 121.36 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.874 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.33 126.74 36.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.8 -0.636 . . . . 63.119999999999997 110.493 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.11 143.7 39.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 74.510000000000005 110.409 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.78 129.19 27.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.395 -0.821 . . . . 74.540000000000006 109.126 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -135.86 87.53 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.717 0.294 . . . . 71.129999999999995 110.291 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.18 -77.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.962 -0.563 . . . . 71.409999999999997 112.576 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.39 -4.79 5.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.78 . . . . 43.539999999999999 109.17 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -89.98 138.25 31.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 73.209999999999994 111.022 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.33 146.23 49.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.067 -0.969 . . . . 64.340000000000003 109.787 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -166.28 136.49 3.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.049 0.452 . . . . 72.219999999999999 111.156 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.507 HD11 ' HB1' ' A' ' 33' ' ' ALA . 54.0 tp -106.48 109.49 21.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 75.349999999999994 110.128 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.25 117.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.913 0.387 . . . . 72.239999999999995 110.293 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.3 m -78.6 127.94 32.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 51.009999999999998 110.643 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.64 179.01 4.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.772 -0.649 . . . . 73.420000000000002 110.173 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 mpt_? -98.77 154.83 17.7 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.66 -0.867 . . . . 74.319999999999993 108.66 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.582 HD22 HD12 ' A' ' 2' ' ' ILE . 84.5 mt -72.82 -32.86 65.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.45 0.643 . . . . 64.209999999999994 109.388 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 p -71.03 -12.21 61.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.994 -1.003 . . . . 61.439999999999998 110.764 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 2.9 mp0 -108.02 7.15 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.791 -0.641 . . . . 72.420000000000002 111.589 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.488 HD13 HG21 ' A' ' 8' ' ' VAL . 93.0 mt -121.97 146.22 47.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.111 0.481 . . . . 73.140000000000001 111.591 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 40.0 tt0 -102.48 108.43 19.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.838 -0.801 . . . . 40.340000000000003 108.838 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.11 22.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.181 -0.463 . . . . 51.210000000000001 110.015 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.8 t -78.65 170.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.234 -0.439 . . . . 65.519999999999996 109.827 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.591 ' H ' HG12 ' A' ' 55' ' ' VAL . 21.6 pttp -73.67 144.88 83.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.998 -0.547 . . . . 72.230000000000004 110.339 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.68 130.21 27.29 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.075 1.85 . . . . 73.219999999999999 111.415 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 59' ' ' LEU . 9.3 mt -73.54 163.94 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.025 -0.534 . . . . 65.420000000000002 109.85 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' N ' HG22 ' A' ' 58' ' ' ILE . 92.5 mt 71.31 39.89 0.9 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.554 0.534 . . . . 72.239999999999995 110.75 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.53 119.3 9.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 60.509999999999998 109.666 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -73.49 110.18 7.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.597 . . . . 75.230000000000004 111.282 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -84.23 103.37 13.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 65.450000000000003 110.457 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 55.5 73.07 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.693 0.621 . . . . 74.230000000000004 110.621 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.56 103.37 3.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.705 -0.85 . . . . 65.109999999999999 108.705 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -74.77 96.94 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.218 -0.446 . . . . 63.32 111.197 -170.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.591 -0.732 . . . . 51.119999999999997 109.655 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.885 0.374 . . . . 72.420000000000002 110.748 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 HD22 ' A' ' 49' ' ' LEU . 54.3 mt -92.16 148.29 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 109.342 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.08 146.62 51.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.438 0.161 . . . . 74.5 110.609 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.97 127.79 27.53 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.762 2.308 . . . . 75.549999999999997 111.902 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.84 0.29 39.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.834 -0.698 . . . . 54.219999999999999 112.187 -176.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.41 135.38 34.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.649 0.262 . . . . 64.329999999999998 110.48 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -83.12 125.07 31.1 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.591 -0.522 . . . . 44.109999999999999 109.591 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 54' ' ' ALA . 17.0 m -122.18 143.39 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.221 -0.445 . . . . 71.329999999999998 111.014 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -98.77 129.54 45.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 109.702 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.84 120.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.078 -0.341 . . . . 74.450000000000003 110.078 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 11' ' ' THR . 17.9 m -116.29 8.85 14.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 55.229999999999997 110.303 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -74.21 106.83 6.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.749 -0.834 . . . . 74.409999999999997 108.749 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.76 -21.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 112.846 0.684 . . . . 75.409999999999997 112.846 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.14 -32.12 21.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.442 . . . . 72.310000000000002 110.612 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.19 158.24 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 70.340000000000003 111.824 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -81.43 -24.19 37.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.46 -0.791 . . . . 63.25 111.279 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -92.68 21.2 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 74.239999999999995 110.61 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.522 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 42.9 t80 -70.49 77.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 74.510000000000005 111.293 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 9.7 ptp85 163.58 -22.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.59 1.156 . . . . 74.510000000000005 108.633 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -77.98 154.73 31.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.35 -0.841 . . . . 74.450000000000003 111.224 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -125.02 127.85 47.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.2 -0.909 . . . . 63.509999999999998 109.298 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.96 168.17 21.43 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.529 -0.843 . . . . 73.409999999999997 112.228 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.47 126.37 41.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.639 0.257 . . . . 73.5 110.473 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 27' ' ' VAL . 59.1 t -67.96 119.8 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 74.209999999999994 110.132 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.05 -30.38 22.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.828 -0.623 . . . . 51.240000000000002 110.578 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 26' ' ' ARG . 12.2 ptp180 -164.31 143.15 7.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 75.230000000000004 109.63 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG22 HG11 ' A' ' 24' ' ' VAL . 40.0 t -114.69 142.33 27.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.214 -0.903 . . . . 63.210000000000001 110.369 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 p -132.42 -175.56 3.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.658 -0.497 . . . . 54.119999999999997 109.658 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.74 75.35 4.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 72.400000000000006 110.517 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.43 -27.16 5.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.536 -0.756 . . . . 72.230000000000004 112.586 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 47.7 mtmt -120.11 162.23 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.693 0.282 . . . . 74.109999999999999 111.34 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.04 143.78 21.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.561 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.83 115.37 27.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.83 -0.433 . . . . 64.109999999999999 109.83 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.88 128.99 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 71.340000000000003 110.814 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.2 tp -102.34 120.06 39.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 73.430000000000007 110.934 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -104.9 146.37 29.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.841 -0.618 . . . . 73.519999999999996 109.532 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -149.27 127.41 12.03 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.28 -0.267 . . . . 71.340000000000003 110.28 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.72 85.71 1.9 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 54.219999999999999 109.666 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.0 -105.11 1.54 Allowed Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.602 -0.727 . . . . 62.200000000000003 112.159 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -87.56 -32.17 19.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.204 0.525 . . . . 72.400000000000006 110.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -75.93 138.53 41.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.592 -0.731 . . . . 72.120000000000005 111.272 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.11 155.99 44.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.824 -1.08 . . . . 71.450000000000003 108.813 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HG3' HG23 ' A' ' 45' ' ' VAL . 41.9 tptt -155.94 108.8 2.66 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.664 -0.415 . . . . 73.540000000000006 111.247 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.23 109.57 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.389 -0.597 . . . . 71.140000000000001 109.389 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 43' ' ' LYS . 46.1 t -130.28 131.99 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 71.140000000000001 110.247 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -83.29 126.54 32.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.067 0.46 . . . . 71.230000000000004 110.682 177.155 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -123.25 -170.34 2.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.765 -0.828 . . . . 74.510000000000005 108.765 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 1.06 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mtt180 -95.03 176.96 6.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.325 -0.621 . . . . 73.420000000000002 109.325 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.496 HD21 HG13 ' A' ' 27' ' ' VAL . 97.3 mt -84.1 -32.01 24.98 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.038 -0.727 . . . . 62.509999999999998 109.038 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 p -71.21 -19.63 62.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.087 -0.96 . . . . 62.149999999999999 110.862 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 1.06 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.0 mm-40 -85.54 -7.84 58.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 110.81 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 8' ' ' VAL . 73.4 mt -116.85 138.47 51.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.094 0.473 . . . . 73.109999999999999 111.751 -172.087 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.68 104.46 16.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.094 -1.076 . . . . 64.329999999999998 108.094 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.799 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.08 107.86 3.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.25 -0.432 . . . . 63.109999999999999 110.838 -176.339 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -88.48 169.25 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.877 -0.786 . . . . 72.099999999999994 108.877 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' H ' HG12 ' A' ' 55' ' ' VAL . 98.6 mttt -110.13 132.61 21.37 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 116.501 -0.318 . . . . 72.219999999999999 110.363 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 31.6 Cg_exo -59.23 143.26 99.82 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.542 2.161 . . . . 43.210000000000001 111.179 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.799 HD12 ' H ' ' A' ' 58' ' ' ILE . 1.1 mp -64.33 144.8 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.705 -0.479 . . . . 62.310000000000002 109.705 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.7 pp -125.91 148.89 49.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.605 -0.725 . . . . 73.530000000000001 110.572 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.17 165.16 12.54 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.643 -0.708 . . . . 73.319999999999993 111.493 -174.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -131.68 134.26 45.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 54.439999999999998 110.397 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -120.9 167.28 12.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 109.872 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -135.8 145.63 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.148 -0.316 . . . . 74.120000000000005 110.148 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -92.48 132.52 36.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.357 -0.609 . . . . 75.310000000000002 109.357 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -59.64 -83.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.859 0.318 . . . . 75.519999999999996 111.859 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.653 -0.689 . . . . 71.439999999999998 109.857 -178.018 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.928 0.394 . . . . 73.340000000000003 110.448 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt -115.72 143.79 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.56 -0.745 . . . . 74.230000000000004 109.936 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -117.72 141.21 28.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.512 -0.313 . . . . 64.349999999999994 110.864 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.6 137.2 62.8 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.492 2.128 . . . . 51.399999999999999 110.975 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 55.219999999999999 112.018 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.82 165.76 12.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.881 0.372 . . . . 72.340000000000003 110.706 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -93.31 138.95 31.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.092 -0.504 . . . . 74.400000000000006 110.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.568 HG21 HD13 ' A' ' 52' ' ' LEU . 6.7 m -130.65 148.06 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 65.430000000000007 111.083 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.64 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 34.2 ttm180 -109.97 141.81 42.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.838 -0.619 . . . . 54.020000000000003 109.483 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 55.4 t -79.54 110.56 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 64.230000000000004 110.019 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -91.29 -11.78 37.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.718 -0.674 . . . . 74.420000000000002 111.159 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.23 106.33 1.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.182 -0.463 . . . . 52.549999999999997 109.808 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.34 -24.16 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 75.230000000000004 111.375 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.98 -8.13 52.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.867 -0.606 . . . . 72.319999999999993 110.759 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.05 165.22 16.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.919 0.39 . . . . 61.130000000000003 110.445 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 m -72.16 -35.96 69.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 42.0 111.893 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -94.97 27.97 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.689 -172.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 45.5 t80 -61.86 130.97 48.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 64.439999999999998 110.038 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.6 mtm180 77.82 6.04 2.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.827 0.851 . . . . 72.140000000000001 111.833 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -96.33 148.29 22.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.832 -0.433 . . . . 71.400000000000006 109.832 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.64 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 33.5 mt-10 -127.92 128.15 44.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 74.049999999999997 110.245 -175.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.49 -177.11 14.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.939 -0.648 . . . . 62.140000000000001 112.335 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.89 132.48 49.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.491 0.186 . . . . 75.209999999999994 110.555 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.74 111.85 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.153 -0.314 . . . . 74.129999999999995 110.153 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -78.08 -34.98 49.95 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.192 -0.67 . . . . 74.430000000000007 109.192 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.28 136.59 0.37 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.325 -0.852 . . . . 65.230000000000004 110.16 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.9 108.56 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.645 -0.872 . . . . 71.209999999999994 108.645 172.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 t -152.47 142.62 22.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.523 -0.308 . . . . 53.420000000000002 111.056 -172.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.79 18.95 10.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.457 -0.792 . . . . 62.329999999999998 111.386 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 -1.15 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.927 -0.654 . . . . 72.329999999999998 112.81 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 26.2 mtmt -124.09 174.28 7.74 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.629 0.372 . . . . 72.450000000000003 110.118 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.07 129.92 28.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.622 0.249 . . . . 65.209999999999994 110.446 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -86.52 115.01 23.73 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.705 -0.48 . . . . 42.210000000000001 109.705 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 52' ' ' LEU . 55.9 t -98.53 119.09 46.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.285 0.564 . . . . 73.540000000000006 110.648 -177.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.6 tp -89.81 118.78 29.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.546 -0.752 . . . . 73.450000000000003 110.072 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.77 137.43 33.87 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.929 -0.767 . . . . 72.439999999999998 108.929 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -156.41 108.59 2.53 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.71 -0.848 . . . . 74.329999999999998 108.71 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -136.89 100.88 4.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 54.240000000000002 110.84 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.96 -77.81 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.583 -0.735 . . . . 72.209999999999994 112.471 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -127.27 -17.41 4.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.205 0.526 . . . . 40.229999999999997 110.385 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -88.76 138.24 31.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.786 -0.643 . . . . 75.150000000000006 111.683 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.9 143.6 47.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.712 -1.131 . . . . 64.439999999999998 109.741 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -167.61 120.45 0.92 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.919 0.39 . . . . 73.530000000000001 110.631 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.18 109.72 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.304 -0.407 . . . . 71.540000000000006 110.032 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.19 120.74 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 74.25 109.97 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.8 m -78.19 130.73 36.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.206 0.527 . . . . 74.299999999999997 109.673 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -123.17 180.0 4.49 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.477 -0.783 . . . . 75.510000000000005 109.746 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 73.4 mtp180 -94.62 161.65 14.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.738 -0.665 . . . . 75.120000000000005 109.565 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.44 -26.44 63.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.108 -0.496 . . . . 64.530000000000001 110.064 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 m -76.2 -11.32 59.9 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.687 -0.688 . . . . 65.549999999999997 110.726 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -85.02 -23.4 28.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 74.310000000000002 111.116 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 8' ' ' VAL . 62.1 mt -115.79 144.7 43.61 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.331 0.493 . . . . 74.319999999999993 112.331 -168.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -111.85 140.92 46.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.783 -0.821 . . . . 75.540000000000006 108.783 167.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.49 115.43 17.25 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.145 -0.317 . . . . 54.240000000000002 110.145 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 56' ' ' LYS . 10.3 t -70.58 170.98 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.139 -0.689 . . . . 73.530000000000001 109.139 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.623 ' H ' HG12 ' A' ' 55' ' ' VAL . 50.2 mttp -82.98 150.44 61.61 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.996 -0.547 . . . . 72.219999999999999 110.129 -173.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.78 160.12 22.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.646 2.231 . . . . 73.049999999999997 112.42 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.64 HD12 ' H ' ' A' ' 58' ' ' ILE . 3.8 mp -77.38 155.05 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.677 -0.86 . . . . 70.25 108.677 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.79 105.48 16.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.134 0.492 . . . . 74.329999999999998 111.179 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -112.14 12.84 20.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.688 0.756 . . . . 72.25 109.685 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -136.59 169.37 17.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.892 -0.595 . . . . 74.0 111.085 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -61.75 138.64 58.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.374 -0.83 . . . . 64.239999999999995 110.401 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.26 154.32 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.071 0.462 . . . . 65.150000000000006 111.159 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -106.64 170.47 7.92 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.64 . . . . 70.019999999999996 109.273 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -98.94 160.52 14.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 72.25 110.761 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.5 m80 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.649 -0.691 . . . . 75.209999999999994 109.436 177.701 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.065 0.46 . . . . 72.530000000000001 110.767 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt -105.24 140.97 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 110.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -126.92 158.68 67.82 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 70.129999999999995 110.507 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.71 128.79 18.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.543 2.162 . . . . 73.209999999999994 111.241 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.497 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 94.11 27.2 12.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.555 -0.831 . . . . 64.030000000000001 111.646 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.83 144.34 48.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 72.109999999999999 110.778 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -82.72 130.2 35.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 63.530000000000001 110.574 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.78 162.37 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 32.43 110.846 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HB3' ' OE2' ' A' ' 53' ' ' GLU . 41.5 ttp180 -119.88 124.0 44.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.397 -0.819 . . . . 73.510000000000005 109.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 t -66.4 113.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.373 . . . . 73.409999999999997 110.65 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' THR . . . . . 0.412 ' OG1' ' HG3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -96.24 -11.41 26.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.961 -0.563 . . . . 61.109999999999999 111.007 -176.378 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 41.7 t30 -65.93 113.12 4.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.472 . . . . 63.100000000000001 110.288 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.98 -39.07 76.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 45.409999999999997 111.532 -174.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.59 34.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.903 0.859 . . . . 63.399999999999999 109.66 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.529 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 7.1 t70 -116.42 159.17 22.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.447 -0.797 . . . . 71.439999999999998 110.269 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -75.76 -31.31 59.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.191 0.519 . . . . 74.120000000000005 110.325 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -99.72 25.02 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.859 -0.609 . . . . 74.230000000000004 111.089 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 18.4 t80 -58.39 128.88 39.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.651 . . . . 64.010000000000005 111.126 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 74.2 mtp180 77.14 -8.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.138 0.975 . . . . 71.209999999999994 112.376 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.39 158.03 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.018 0.437 . . . . 62.219999999999999 110.809 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -104.91 138.76 40.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.688 -0.687 . . . . 61.520000000000003 110.445 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.36 171.83 26.31 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.552 -0.619 . . . . 53.020000000000003 111.552 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD21 ' HA2' ' A' ' 5' ' ' GLY . 4.4 tt -120.08 122.54 41.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.062 0.431 . . . . 32.200000000000003 109.889 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.545 HG11 HG22 ' A' ' 27' ' ' VAL . 39.5 t -69.21 122.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 73.420000000000002 110.762 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -98.61 -30.78 12.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.914 -0.585 . . . . 75.439999999999998 110.752 -177.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 26' ' ' ARG . 19.0 ttt180 -146.61 118.92 8.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 74.329999999999998 109.903 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG22 HG11 ' A' ' 24' ' ' VAL . 59.4 t -103.64 128.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 75.129999999999995 110.888 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.9 t -106.42 -179.35 3.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.903 -0.777 . . . . 62.229999999999997 108.903 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.61 29.91 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 71.299999999999997 111.099 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.0 -29.64 0.17 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.956 -0.566 . . . . 52.32 111.777 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.06 164.92 11.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.58 0.229 . . . . 63.109999999999999 110.44 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.49 137.9 19.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.586 -0.279 . . . . 62.539999999999999 110.405 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -101.06 110.73 22.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.893 -0.41 . . . . 73.239999999999995 109.893 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -100.26 129.39 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 55.439999999999998 110.858 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 tp -95.19 129.15 42.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.681 -0.69 . . . . 64.549999999999997 110.399 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.74 136.91 48.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.469 -0.567 . . . . 74.299999999999997 109.469 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.85 116.82 25.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.085 -0.507 . . . . 70.129999999999995 111.059 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 17.2 t30 -110.2 -10.9 14.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.706 . . . . 70.219999999999999 110.295 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.58 -71.98 0.22 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.899 -0.667 . . . . 53.5 111.545 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.16 -18.89 24.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.602 0.715 . . . . 72.450000000000003 109.935 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 73.7 t90 -112.92 135.14 54.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 65.439999999999998 111.022 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.43 149.06 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.039 -0.982 . . . . 71.25 109.256 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HE2' HG22 ' A' ' 45' ' ' VAL . 88.5 tttt -165.14 119.06 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.934 0.397 . . . . 75.019999999999996 110.865 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.6 tp -92.7 108.36 19.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.675 -0.693 . . . . 51.450000000000003 109.562 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.588 HG22 ' HE2' ' A' ' 43' ' ' LYS . 10.8 t -108.51 125.43 65.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.427 -0.351 . . . . 44.200000000000003 110.766 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -85.17 130.76 34.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.405 0.621 . . . . 72.129999999999995 110.679 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -125.56 -164.55 1.31 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.252 -0.885 . . . . 64.030000000000001 108.838 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.844 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 86.6 mtm180 -106.37 162.6 13.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.285 -0.635 . . . . 70.530000000000001 109.285 171.747 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.41 -25.15 60.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.101 0.477 . . . . 74.329999999999998 109.941 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 p -82.48 -9.19 59.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 61.43 110.432 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.844 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 7.7 mm-40 -88.17 -12.96 42.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.274 0.559 . . . . 71.340000000000003 110.929 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 10' ' ' VAL . 27.2 mt -126.59 167.28 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.611 -0.722 . . . . 54.530000000000001 110.732 -173.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.58 ' OE2' ' HB3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -151.27 148.77 28.6 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.993 -0.743 . . . . 71.299999999999997 108.993 167.894 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.44 141.31 34.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.682 0.277 . . . . 55.439999999999998 110.631 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -73.37 169.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.784 -0.821 . . . . 74.010000000000005 108.784 177.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.51 ' H ' HG12 ' A' ' 55' ' ' VAL . 29.2 mtpp -75.62 135.07 72.0 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 116.66 -0.246 . . . . 54.130000000000003 110.652 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.52 119.58 5.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.165 1.91 . . . . 72.150000000000006 109.209 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.71 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -48.39 135.83 4.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.998 0.904 . . . . 63.399999999999999 112.726 -164.01 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.56 103.19 11.25 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.827 -1.533 . . . . 73.439999999999998 107.194 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -53.13 148.11 8.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.948 0.78 . . . . 73.510000000000005 111.367 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -42.73 112.69 0.38 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 124.124 0.89 . . . . 74.409999999999997 112.366 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -69.6 148.39 49.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.909 -1.041 . . . . 73.140000000000001 110.506 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -77.28 178.07 7.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.573 -0.739 . . . . 64.239999999999995 110.757 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -72.14 114.9 10.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.014 -0.736 . . . . 73.319999999999993 109.014 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -120.65 169.22 10.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.834 0.349 . . . . 72.439999999999998 110.779 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 42.2 m80 . . . . . 0 C--O 1.244 0.766 0 N-CA-C 109.199 -0.667 . . . . 72.409999999999997 109.199 176.899 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptp . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.808 0.337 . . . . 75.329999999999998 110.661 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.746 HD12 HD22 ' A' ' 49' ' ' LEU . 48.9 mt -112.59 146.61 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.552 -0.536 . . . . 53.340000000000003 109.552 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.13 147.19 37.3 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.719 0.295 . . . . 44.539999999999999 111.173 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.97 151.66 73.48 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.738 2.292 . . . . 64.200000000000003 111.438 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.48 2.54 90.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.843 -0.694 . . . . 50.310000000000002 112.004 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.91 153.02 20.24 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.773 0.32 . . . . 74.329999999999998 110.496 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -89.56 129.91 35.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.556 . . . . 72.209999999999994 110.649 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG21 HD13 ' A' ' 52' ' ' LEU . 17.3 m -124.34 158.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.908 -0.587 . . . . 72.430000000000007 110.023 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.402 ' HB3' ' CG ' ' A' ' 53' ' ' GLU . 35.7 ttt180 -118.59 126.53 52.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.907 -0.405 . . . . 74.150000000000006 109.907 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.27 115.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 75.150000000000006 110.941 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 m -100.36 -3.68 30.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 64.120000000000005 110.6 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.593 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 27.0 t-20 -64.94 113.67 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 63.229999999999997 110.042 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.08 -13.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 72.409999999999997 111.54 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.59 -48.89 17.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.967 0.358 . . . . 74.25 111.967 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.98 161.43 25.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.063 0.458 . . . . 71.329999999999998 110.97 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.92 -30.49 71.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.502 -0.772 . . . . 64.019999999999996 112.605 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -80.91 24.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.286 0.476 . . . . 73.420000000000002 112.286 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 50.7 t80 -64.99 127.88 33.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 109.795 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 35.7 mtm180 74.72 27.15 1.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.288 0.635 . . . . 70.430000000000007 111.892 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.42 152.87 24.11 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.954 -0.387 . . . . 73.5 109.954 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -102.96 142.18 34.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.581 -0.526 . . . . 73.420000000000002 109.581 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -144.24 170.0 26.15 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.719 -0.753 . . . . 73.25 112.067 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.8 tp -109.91 123.04 48.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.647 0.26 . . . . 73.319999999999993 110.577 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 27' ' ' VAL . 52.2 t -68.32 115.42 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.535 -0.302 . . . . 60.509999999999998 110.52 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -81.48 -33.08 32.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 75.299999999999997 110.463 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.454 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -169.38 143.6 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.643 -0.873 . . . . 73.439999999999998 108.643 177.444 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.44 HG22 HG11 ' A' ' 24' ' ' VAL . 23.6 t -99.14 135.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.69 -0.686 . . . . 63.009999999999998 110.332 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 8.5 t -104.89 -176.19 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.695 -0.854 . . . . 73.349999999999994 108.695 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.39 77.69 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.495 0.664 . . . . 71.209999999999994 110.081 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 3.24 39.64 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.039 -0.982 . . . . 71.25 111.84 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.541 ' HG2' HG22 ' A' ' 46' ' ' THR . 27.7 ttmt -141.5 172.88 12.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.903 -0.777 . . . . 65.150000000000006 108.903 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.8 143.73 6.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.479 0.18 . . . . 53.530000000000001 110.887 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.19 119.07 32.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 72.140000000000001 110.276 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.478 HG21 HD21 ' A' ' 52' ' ' LEU . 39.9 t -100.82 124.65 54.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 53.509999999999998 111.028 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.5 tp -96.44 121.59 38.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.129 -0.487 . . . . 62.25 110.295 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.75 137.23 36.14 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.655 -0.869 . . . . 74.540000000000006 108.655 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.47 114.51 8.61 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.823 -0.436 . . . . 64.310000000000002 109.823 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 29.4 t-20 -137.04 90.31 2.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.215 0.531 . . . . 60.200000000000003 111.157 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.13 -90.7 0.52 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.46 -0.791 . . . . 62.030000000000001 112.833 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.0 -16.23 11.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 75.209999999999994 109.943 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.411 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 66.9 t90 -94.28 144.07 25.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 72.329999999999998 110.682 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.2 158.29 43.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.368 -0.833 . . . . 72.230000000000004 110.018 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.58 132.11 6.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.957 -0.565 . . . . 74.150000000000006 110.132 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.411 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.0 tp -103.92 109.44 21.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.311 -0.404 . . . . 62.329999999999998 110.301 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.59 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 62.509999999999998 110.307 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.3 m -81.12 132.65 35.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.267 0.556 . . . . 53.43 110.755 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -129.61 177.89 6.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.82 -0.808 . . . . 73.239999999999995 108.82 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.547 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -97.61 178.11 5.28 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.816 -0.354 . . . . 64.340000000000003 110.265 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.746 HD22 HD12 ' A' ' 2' ' ' ILE . 68.8 mt -78.56 -25.96 45.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.195 0.521 . . . . 64.140000000000001 110.02 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 p -76.3 -17.5 59.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 62.399999999999999 109.996 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' HG3' ' HB2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -86.44 -18.84 30.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.1 -0.955 . . . . 63.399999999999999 110.835 -178.202 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.478 HD21 HG21 ' A' ' 34' ' ' VAL . 55.6 mt -122.65 122.63 39.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.957 -0.565 . . . . 73.409999999999997 111.202 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -88.34 118.26 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.114 -0.698 . . . . 73.209999999999994 109.114 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -75.11 106.29 6.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.977 -0.556 . . . . 71.540000000000006 109.967 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.1 t -74.84 168.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 71.310000000000002 110.107 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' H ' HG12 ' A' ' 55' ' ' VAL . 49.2 pttt -78.13 148.99 75.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.918 -0.583 . . . . 73.329999999999998 109.808 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.94 163.97 26.43 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.332 2.021 . . . . 70.109999999999999 112.059 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 59' ' ' LEU . 12.4 mm -65.65 165.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.852 . . . . 74.25 108.698 176.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' H ' HG22 ' A' ' 58' ' ' ILE . 76.2 mt -70.66 75.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 74.420000000000002 112.365 -173.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -92.81 130.85 38.29 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.187 -1.042 . . . . 55.229999999999997 108.187 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -80.55 65.81 5.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.657 0.741 . . . . 72.219999999999999 111.453 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 18.0 t60 -95.7 162.22 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.589 -1.263 . . . . 73.450000000000003 107.589 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 41.6 m-70 72.36 108.2 0.07 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.074 0.464 . . . . 55.210000000000001 109.984 -173.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -83.16 -39.66 20.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.268 -0.424 . . . . 74.25 110.826 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 69.59 138.46 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.998 0.811 . . . . 71.209999999999994 110.617 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.278 -0.868 . . . . 55.32 109.958 177.747 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.051 0.453 . . . . 74.0 111.413 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.464 HD12 HD22 ' A' ' 49' ' ' LEU . 57.9 mt -127.16 142.89 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.585 -0.895 . . . . 72.340000000000003 108.585 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 97.6 m-85 -127.85 145.55 55.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.75 0.31 . . . . 61.43 111.281 -175.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 35.6 Cg_exo -59.86 142.91 99.49 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.092 2.528 . . . . 64.230000000000004 112.313 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.25 6.08 63.23 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.846 -0.692 . . . . 62.219999999999999 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.669 0.271 . . . . 53.009999999999998 110.305 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -92.03 130.55 37.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.399 . . . . 64.329999999999998 110.45 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.63 142.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 110.154 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -102.18 125.44 48.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.954 -0.566 . . . . 72.140000000000001 110.047 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.64 115.85 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.684 -0.689 . . . . 64.540000000000006 110.406 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -105.69 10.52 32.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 73.140000000000001 110.319 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.0 109.71 0.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.93 -0.577 . . . . 71.409999999999997 109.979 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.37 -35.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.011 -0.54 . . . . 75.120000000000005 112.141 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.89 -2.61 34.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.394 0.616 . . . . 63.450000000000003 111.018 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.98 165.61 16.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.256 -0.429 . . . . 72.540000000000006 110.263 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.82 -27.29 26.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.268 -0.424 . . . . 72.239999999999995 110.84 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -87.95 24.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.085 0.469 . . . . 73.299999999999997 111.16 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 53.6 t80 -63.12 136.81 57.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 72.540000000000006 110.027 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 40.3 mtm180 82.44 -10.91 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.802 0.841 . . . . 63.229999999999997 112.251 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -72.92 150.64 42.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 73.420000000000002 110.398 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -117.62 133.38 56.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.13 -0.486 . . . . 73.439999999999998 110.235 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.68 172.97 21.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.583 -0.818 . . . . 73.230000000000004 112.484 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.47 125.96 48.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.422 -0.214 . . . . 74.019999999999996 110.422 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.87 115.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.133 -0.321 . . . . 75.120000000000005 110.133 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' HG3' HD13 ' A' ' 44' ' ' LEU . 27.6 mm-40 -87.35 -35.81 18.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.959 -0.564 . . . . 74.5 110.418 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -166.81 148.87 6.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.692 -0.686 . . . . 74.530000000000001 109.574 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 2' ' ' ILE . 44.4 t -105.4 140.93 21.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.334 -0.848 . . . . 73.310000000000002 109.755 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -129.3 -162.27 1.19 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.859 -0.423 . . . . 72.420000000000002 109.859 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.42 86.85 1.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.541 . . . . 75.230000000000004 110.139 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.64 5.67 86.32 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 114.739 -1.119 . . . . 73.010000000000005 111.854 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 36.7 mtmm -129.41 166.25 19.93 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 122.625 0.37 . . . . 71.25 110.637 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 141.88 24.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.268 -0.423 . . . . 62.219999999999999 110.242 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -89.71 108.48 19.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.971 -0.381 . . . . 73.25 109.971 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.6 122.42 47.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.609 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.0 tp -96.63 120.09 36.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 110.553 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 95.9 m-85 -93.44 141.62 28.25 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.82 -0.807 . . . . 73.120000000000005 108.82 171.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -140.72 133.21 28.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.263 -0.426 . . . . 33.219999999999999 110.028 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -147.44 70.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.172 0.51 . . . . 71.209999999999994 110.127 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.54 -88.02 1.22 Allowed Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.653 -0.703 . . . . 54.149999999999999 112.441 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -104.53 -20.81 13.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.394 0.616 . . . . 51.109999999999999 109.878 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -81.69 132.01 35.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.261 -0.881 . . . . 75.510000000000005 111.394 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -128.93 152.57 48.42 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.458 -1.246 . . . . 72.540000000000006 109.346 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 54.5 tttp -157.73 100.92 1.79 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.517 -0.311 . . . . 62.420000000000002 110.224 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.5 tp -95.15 106.32 18.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.387 -0.369 . . . . 74.340000000000003 110.324 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG23 ' HG2' ' A' ' 43' ' ' LYS . 54.8 t -126.33 126.46 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.195 -0.457 . . . . 52.240000000000002 110.487 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.1 m -77.65 131.8 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 62.340000000000003 110.347 177.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -124.44 -174.59 3.05 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.134 -0.691 . . . . 65.5 109.134 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.605 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 9.4 mtt180 -102.28 164.1 11.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.723 0.297 . . . . 54.530000000000001 110.31 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 2' ' ' ILE . 91.7 mt -78.64 -20.89 49.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.269 0.556 . . . . 75.150000000000006 110.378 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 p -88.53 -16.49 32.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.65 -0.704 . . . . 34.229999999999997 110.102 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.605 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 12.3 mm-40 -93.55 -4.18 51.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.561 -0.745 . . . . 62.020000000000003 110.347 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -121.58 158.74 27.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 72.019999999999996 110.768 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -139.63 123.84 17.92 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.457 -0.572 . . . . 62.219999999999999 109.457 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 132.04 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 63.530000000000001 110.697 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.831 HG12 ' H ' ' A' ' 56' ' ' LYS . 1.8 t -103.15 -169.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.154 -0.476 . . . . 64.319999999999993 110.166 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.831 ' H ' HG12 ' A' ' 55' ' ' VAL . 18.5 ptpt -63.48 153.67 81.95 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.712 -0.677 . . . . 53.210000000000001 111.929 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 2.8 Cg_exo -77.57 164.04 28.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.684 2.256 . . . . 65.109999999999999 109.613 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.6 mp -75.65 161.7 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.23 -0.656 . . . . 72.099999999999994 109.23 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.887 ' HG ' ' H ' ' A' ' 60' ' ' GLU . 19.4 tp 68.58 -169.83 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.602 0.761 . . . . 72.319999999999993 110.157 -174.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.887 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 41.8 tt0 -60.75 113.55 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.508 0.323 . . . . 74.0 110.75 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -80.5 121.29 25.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.482 -0.562 . . . . 64.540000000000006 109.482 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -91.44 136.81 32.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.981 -0.554 . . . . 73.540000000000006 111.178 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -67.28 151.03 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.372 -0.831 . . . . 64.010000000000005 109.84 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.04 146.69 31.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.161 0.505 . . . . 62.340000000000003 111.447 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -96.29 -165.94 1.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.517 -0.765 . . . . 73.109999999999999 110.999 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.564 -0.731 . . . . 75.420000000000002 110.136 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.843 0.354 . . . . 73.0 110.514 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.673 HD12 HD22 ' A' ' 49' ' ' LEU . 56.8 mt -130.24 142.84 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.703 -0.48 . . . . 70.010000000000005 109.703 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.36 147.82 66.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.308 -0.405 . . . . 51.109999999999999 110.519 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.6 129.77 30.73 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.613 2.209 . . . . 73.120000000000005 111.209 175.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.18 27.67 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.115 -0.564 . . . . 61.530000000000001 111.829 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 147.27 24.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.612 0.244 . . . . 64.439999999999998 110.617 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -89.31 132.71 34.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 75.349999999999994 110.381 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 52' ' ' LEU . 12.0 m -133.61 149.27 30.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.935 0.398 . . . . 73.129999999999995 111.552 -176.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -114.96 135.83 53.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.776 -0.647 . . . . 43.240000000000002 109.695 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -75.2 106.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 64.140000000000001 109.927 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -90.97 -5.97 54.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.756 0.312 . . . . 63.030000000000001 111.48 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -65.68 111.37 3.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.309 -0.626 . . . . 73.340000000000003 109.309 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 3.0 t -80.78 -1.14 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.395 0.617 . . . . 54.32 111.033 -173.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -101.35 -22.99 14.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.99 -0.55 . . . . 73.209999999999994 110.673 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.72 158.03 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.964 -170.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.1 m -65.31 -32.6 74.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.979 -1.009 . . . . 72.120000000000005 111.555 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -101.4 30.62 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 64.209999999999994 111.232 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 25.0 t80 -55.37 138.16 46.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 75.540000000000006 111.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 56.08 18.3 3.11 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.239 1.416 . . . . 70.209999999999994 113.276 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.27 151.27 24.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.786 -0.82 . . . . 74.420000000000002 108.786 167.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.19 130.16 53.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.006 -0.543 . . . . 72.439999999999998 110.067 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.16 -174.67 16.62 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.522 -0.847 . . . . 32.439999999999998 112.384 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.1 tp -113.1 132.81 55.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.336 -0.246 . . . . 74.530000000000001 110.336 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.51 114.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 74.349999999999994 110.043 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HG3' HD13 ' A' ' 44' ' ' LEU . 28.6 mm-40 -79.11 -35.3 42.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.145 0.498 . . . . 73.510000000000005 110.366 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -172.24 146.24 1.84 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.366 -0.834 . . . . 74.230000000000004 109.259 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.327 -0.851 . . . . 73.219999999999999 110.17 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 t -106.63 67.87 0.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.492 -0.558 . . . . 50.119999999999997 109.492 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 68.85 -72.34 0.1 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.9 -1.046 . . . . 54.119999999999997 112.531 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.55 -9.76 20.73 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 115.257 -0.883 . . . . 35.409999999999997 113.022 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -124.28 170.35 10.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 110.2 -0.296 . . . . 53.119999999999997 110.2 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.72 149.1 30.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.532 0.206 . . . . 65.099999999999994 110.973 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -96.16 117.07 30.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.731 -0.47 . . . . 53.420000000000002 109.731 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.2 t -100.36 120.94 50.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 65.439999999999998 110.85 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.69 115.72 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 75.230000000000004 109.912 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -91.75 144.73 25.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 62.020000000000003 109.508 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.87 112.37 7.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.693 -0.484 . . . . 74.040000000000006 109.693 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -130.73 79.68 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.106 -0.497 . . . . 52.140000000000001 110.262 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.49 -90.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.055 -0.52 . . . . 73.329999999999998 112.672 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -100.73 -22.38 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 62.329999999999998 110.1 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.9 t90 -92.16 144.49 25.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.401 -0.818 . . . . 65.349999999999994 110.978 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -149.69 153.59 37.2 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.076 -0.965 . . . . 71.430000000000007 109.266 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HG3' HG23 ' A' ' 45' ' ' VAL . 24.2 tptm -162.53 128.43 3.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.409 -0.359 . . . . 72.140000000000001 110.82 -175.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.571 HD11 ' HB1' ' A' ' 33' ' ' ALA . 63.8 tp -98.12 112.03 24.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 109.959 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG23 ' HG3' ' A' ' 43' ' ' LYS . 42.0 t -126.53 125.81 67.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.839 0.352 . . . . 74.109999999999999 110.483 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.5 m -73.68 140.4 46.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.189 0.519 . . . . 71.540000000000006 110.844 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.0 -176.06 4.25 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 72.439999999999998 109.262 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.849 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 98.9 mtt180 -91.39 -179.28 5.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.099 -0.704 . . . . 72.310000000000002 109.099 170.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.673 HD22 HD12 ' A' ' 2' ' ' ILE . 87.0 mt -87.25 -33.03 19.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.951 -0.759 . . . . 74.409999999999997 108.951 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.8 m -70.63 -14.41 62.47 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.57 -0.741 . . . . 75.420000000000002 111.106 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.849 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 11.1 mm-40 -80.53 -18.71 47.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.204 0.526 . . . . 74.340000000000003 110.591 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 8' ' ' VAL . 38.8 mt -115.68 157.38 24.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 74.5 111.325 -172.776 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.84 146.6 49.19 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.7 -0.852 . . . . 74.150000000000006 108.7 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.87 123.57 26.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.761 0.315 . . . . 52.119999999999997 110.238 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.8 t -79.44 162.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.947 -0.76 . . . . 64.319999999999993 108.947 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.453 ' H ' HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -102.4 126.17 33.99 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.847 -0.615 . . . . 75.439999999999998 109.754 -173.572 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 9.7 Cg_endo -52.96 130.6 38.62 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.666 2.244 . . . . 73.209999999999994 111.277 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.09 150.25 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.153 0.501 . . . . 75.420000000000002 109.959 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.2 tp -132.45 162.51 30.99 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.425 -0.954 . . . . 73.099999999999994 108.425 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.35 66.43 3.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.623 0.725 . . . . 75.120000000000005 111.28 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.62 147.77 51.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.943 -1.026 . . . . 72.120000000000005 108.787 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -96.96 11.65 35.24 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.812 -0.355 . . . . 71.209999999999994 111.158 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.3 m80 55.75 -158.35 0.23 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.559 0.537 . . . . 61.009999999999998 110.957 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -155.55 90.42 1.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 54.329999999999998 109.591 174.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -99.29 158.05 15.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 71.329999999999998 111.36 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.8 t60 . . . . . 0 C--N 1.321 -0.674 0 CA-C-O 118.232 -0.889 . . . . 72.239999999999995 108.772 172.972 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 tpt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.357 0.122 . . . . 74.319999999999993 111.116 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.3 mt 77.11 133.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.44 0.638 . . . . 74.209999999999994 110.421 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -146.17 162.56 34.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.177 -0.92 . . . . 71.299999999999997 109.533 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.47 113.11 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.181 1.921 . . . . 72.230000000000004 111.098 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.11 -9.58 15.51 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.798 -0.715 . . . . 44.420000000000002 111.983 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.95 147.12 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 63.340000000000003 110.433 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -89.89 132.58 35.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.116 -0.493 . . . . 64.219999999999999 110.158 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -127.7 152.59 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.954 0.407 . . . . 62.450000000000003 110.736 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 43.5 ttm180 -110.06 129.28 55.71 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.032 -0.729 . . . . 65.109999999999999 109.032 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.36 101.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.085 0.469 . . . . 63.130000000000003 110.915 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -79.76 -12.45 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 64.439999999999998 109.573 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -68.6 107.42 2.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.28 -0.873 . . . . 71.010000000000005 110.125 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -89.94 -13.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 64.430000000000007 110.601 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.69 -36.17 82.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.418 -0.81 . . . . 72.5 110.47 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.99 -174.91 5.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 73.010000000000005 109.874 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 m -93.92 -21.13 19.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.085 0.469 . . . . 65.150000000000006 110.807 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.534 ' OH ' ' HG3' ' A' ' 43' ' ' LYS . 54.2 m-85 -90.25 40.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 74.340000000000003 111.329 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 29.7 t80 -57.65 132.46 53.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.813 -0.631 . . . . 73.340000000000003 111.096 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 18' ' ' TYR . 36.2 ptt180 59.84 14.93 4.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.147 1.379 . . . . 71.329999999999998 112.77 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.22 156.57 26.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.106 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.73 117.66 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 109.901 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.6 176.47 17.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.615 -0.803 . . . . 71.099999999999994 112.478 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.95 123.18 48.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.232 . . . . 73.040000000000006 110.383 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.419 HG11 HG22 ' A' ' 27' ' ' VAL . 58.0 t -67.56 122.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 71.340000000000003 110.007 177.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 24.9 mm-40 -91.49 -27.56 18.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.976 -0.557 . . . . 61.32 111.005 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -168.2 135.5 2.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.389 -0.823 . . . . 73.040000000000006 109.938 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG22 HG11 ' A' ' 24' ' ' VAL . 42.5 t -104.06 150.36 7.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.256 -0.884 . . . . 62.5 110.086 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.85 -177.63 4.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.3 -0.63 . . . . 54.109999999999999 109.3 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.44 80.43 3.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.595 0.712 . . . . 71.140000000000001 110.759 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.41 -24.58 9.1 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 114.809 -1.087 . . . . 61.020000000000003 112.025 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -118.82 157.83 26.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.556 0.217 . . . . 64.120000000000005 111.161 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.06 138.43 22.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.347 -0.388 . . . . 63.25 110.163 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -95.0 112.15 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.125 -0.324 . . . . 61.420000000000002 110.125 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.9 124.52 50.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 73.219999999999999 110.586 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 33.8 tp -93.53 119.79 33.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.007 -0.542 . . . . 64.319999999999993 110.467 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -100.46 141.06 33.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.95 -0.759 . . . . 61.329999999999998 108.95 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -139.03 141.08 38.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.549 -0.296 . . . . 65.420000000000002 110.37 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -153.8 76.49 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.239 -0.652 . . . . 74.319999999999993 109.239 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.94 -110.08 3.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 44.310000000000002 111.877 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.37 -15.83 44.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.885 0.374 . . . . 75.239999999999995 110.736 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -87.16 142.78 27.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.363 0.602 . . . . 73.439999999999998 110.582 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.31 163.35 36.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.919 -1.037 . . . . 72.510000000000005 109.45 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HD2' ' CG2' ' A' ' 45' ' ' VAL . 4.3 tmtp? -166.5 109.23 0.73 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 73.409999999999997 110.221 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.34 104.05 15.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.764 -0.458 . . . . 75.329999999999998 109.764 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.557 ' CG2' ' HD2' ' A' ' 43' ' ' LYS . 17.9 t -111.95 126.37 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 60.5 110.251 -176.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.6 m -85.68 120.28 26.94 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.328 0.585 . . . . 42.109999999999999 109.815 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.42 -168.32 1.3 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.402 -0.817 . . . . 74.510000000000005 109.106 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.95 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 55.3 mmt-85 -105.63 160.45 15.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.187 -0.672 . . . . 64.409999999999997 109.187 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -71.07 -27.86 63.93 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.254 0.549 . . . . 74.040000000000006 110.035 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 p -75.43 -22.47 57.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.477 -0.783 . . . . 50.240000000000002 110.305 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.95 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 20.6 mm-40 -88.28 -5.38 58.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.0 -0.545 . . . . 70.010000000000005 111.378 -173.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.417 HD13 HG21 ' A' ' 8' ' ' VAL . 72.5 mt -120.02 143.04 48.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.059 -0.519 . . . . 71.030000000000001 110.263 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 9' ' ' ARG . 9.7 pt-20 -107.59 130.66 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.183 -0.673 . . . . 52.149999999999999 109.183 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.64 24.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.34 -0.391 . . . . 75.209999999999994 110.093 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.9 t -83.01 168.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.849 -0.797 . . . . 64.219999999999999 108.849 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.53 ' H ' HG12 ' A' ' 55' ' ' VAL . 11.0 mptt -88.13 132.99 38.0 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.715 -0.476 . . . . 72.0 109.715 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.04 177.97 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.349 2.032 . . . . 72.329999999999998 112.015 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.31 152.86 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.257 -0.646 . . . . 74.230000000000004 109.257 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.86 104.35 13.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.047 0.451 . . . . 52.530000000000001 111.116 -175.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 63' ' ' HIS . 1.2 tm-20 -60.11 121.2 11.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.878 -1.156 . . . . 73.319999999999993 107.878 171.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.912 0.708 . . . . 75.439999999999998 112.912 -167.124 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -100.27 8.34 43.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.819 0.342 . . . . 75.219999999999999 110.778 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' HIS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 27.2 t60 -82.58 115.41 21.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.209 -0.45 . . . . 72.0 110.138 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -90.17 176.38 6.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.205 0.526 . . . . 54.310000000000002 110.784 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -125.21 162.18 25.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 64.200000000000003 109.553 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 C--O 1.246 0.888 0 N-CA-C 109.101 -0.703 . . . . 72.25 109.101 175.195 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.866 -0.42 . . . . 64.230000000000004 109.866 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.71 ' HB ' HD22 ' A' ' 49' ' ' LEU . 59.7 mt -87.14 144.28 9.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.14 0.495 . . . . 72.409999999999997 111.856 -174.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -135.83 155.88 77.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.306 -0.861 . . . . 73.120000000000005 109.448 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.72 132.38 34.92 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.063 1.842 . . . . 74.25 111.59 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.52 -7.54 58.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.98 -0.628 . . . . 63.329999999999998 112.216 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.81 147.31 23.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.312 . . . . 72.109999999999999 111.15 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -87.02 126.15 34.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 74.519999999999996 110.068 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 52' ' ' LEU . 21.0 m -124.97 148.16 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.211 0.529 . . . . 72.420000000000002 110.973 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 23.5 ttp180 -111.05 132.41 54.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.46 -0.791 . . . . 73.030000000000001 109.682 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.08 100.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.362 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 p -102.06 7.26 41.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.216 0.532 . . . . 75.420000000000002 111.176 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -71.93 100.12 2.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.55 -0.75 . . . . 74.129999999999995 109.549 175.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.95 -30.18 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 72.540000000000006 111.984 -171.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.66 -7.43 59.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.438 . . . . 75.400000000000006 111.637 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -87.92 162.09 17.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.048 -0.408 . . . . 73.200000000000003 111.277 -175.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 m -77.05 -26.63 53.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.083 -0.508 . . . . 72.340000000000003 111.696 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' OH ' ' HE2' ' A' ' 43' ' ' LYS . 89.9 m-85 -106.91 28.89 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 73.239999999999995 111.265 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.425 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 t80 -68.88 82.2 0.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 64.5 110.408 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 25.9 ptt180 169.91 -27.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.376 -0.829 . . . . 73.430000000000007 110.421 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.61 158.4 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.291 0.567 . . . . 74.239999999999995 112.013 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 81.4 mt-10 -125.8 134.16 51.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.183 -0.917 . . . . 72.299999999999997 108.962 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.61 178.45 21.05 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.373 -0.918 . . . . 73.239999999999995 112.335 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.94 129.69 56.09 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.943 0.372 . . . . 61.32 110.388 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 ' CG2' ' A' ' 2' ' ' ILE . 74.4 t -68.31 124.83 24.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.295 -0.412 . . . . 73.140000000000001 110.764 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -93.63 -29.17 15.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 73.0 110.82 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 26' ' ' ARG . 11.3 ptm180 -165.3 133.06 3.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.509 -0.769 . . . . 73.329999999999998 110.689 -174.1 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 29' ' ' ASP . 96.5 t -97.4 131.54 44.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.554 -0.748 . . . . 75.329999999999998 109.057 173.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -116.06 36.37 4.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.17 0.51 . . . . 72.129999999999995 109.996 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.511 ' H ' HG12 ' A' ' 27' ' ' VAL . 10.5 m-20 63.0 99.85 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.032 -0.985 . . . . 70.329999999999998 111.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.02 3.87 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.873 -0.603 . . . . 73.439999999999998 111.64 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 23.3 ttmt -118.62 165.24 14.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 64.109999999999999 109.062 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.97 146.02 18.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.513 -0.312 . . . . 53.229999999999997 110.676 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.54 114.34 26.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.823 -0.436 . . . . 74.540000000000006 109.823 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.58 125.66 47.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 63.25 110.408 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.0 tp -98.14 110.77 23.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 43.340000000000003 110.39 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 78.6 m-85 -91.66 142.87 27.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.66 -0.866 . . . . 73.310000000000002 108.66 173.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 3.8 tm-20 -155.77 126.59 6.93 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.168 -0.678 . . . . 73.299999999999997 109.168 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -153.56 102.91 2.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.2 -0.454 . . . . 72.530000000000001 110.627 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.6 -84.93 1.18 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.823 -0.626 . . . . 63.119999999999997 112.398 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -129.39 -4.9 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.509 0.671 . . . . 51.130000000000003 109.95 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ2' ' HB2' ' A' ' 43' ' ' LYS . 35.3 t90 -100.38 135.97 41.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.764 -0.653 . . . . 72.319999999999993 112.251 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.2 144.12 48.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.764 -1.107 . . . . 74.439999999999998 109.154 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 44.9 tptt -146.76 110.39 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.585 0.231 . . . . 63.439999999999998 110.431 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -106.74 105.46 15.51 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 73.540000000000006 110.087 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG23 ' HG3' ' A' ' 43' ' ' LYS . 24.7 t -127.98 133.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 71.439999999999998 110.018 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -85.07 122.88 29.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 120.972 0.415 . . . . 71.230000000000004 111.206 -179.271 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.91 175.67 6.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.765 -0.828 . . . . 73.340000000000003 108.765 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.851 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 63.6 mtt180 -89.11 165.11 14.71 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.256 0.55 . . . . 72.319999999999993 110.589 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.71 HD22 ' HB ' ' A' ' 2' ' ' ILE . 96.5 mt -79.53 -24.78 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.497 -0.774 . . . . 74.109999999999999 110.139 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 t -91.63 -5.98 52.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.603 -0.726 . . . . 64.040000000000006 110.101 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.851 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 52.8 mt-10 -92.73 -9.38 40.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.64 -0.424 . . . . 70.340000000000003 111.91 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 2' ' ' ILE . 44.5 mt -120.66 163.78 17.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.559 -0.291 . . . . 73.120000000000005 110.694 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -123.57 155.09 38.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.891 -0.411 . . . . 73.030000000000001 109.891 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.6 125.06 39.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.863 0.363 . . . . 73.030000000000001 110.955 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -82.95 170.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.8 -0.815 . . . . 74.099999999999994 108.8 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' H ' HG12 ' A' ' 55' ' ' VAL . 19.1 tptm -103.23 121.68 47.94 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.176 -0.305 . . . . 63.140000000000001 110.176 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.3 152.5 45.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.074 2.516 . . . . 52.200000000000003 112.394 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 58' ' ' ILE . 6.7 mt -63.69 156.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 70.530000000000001 110.15 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.71 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.9 pt? -110.29 -172.39 2.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.153 -0.476 . . . . 71.319999999999993 110.276 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -98.27 45.59 1.01 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.013 0.375 . . . . 63.43 112.013 -174.306 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 70.42 -1.43 2.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.216 0.607 . . . . 64.400000000000006 111.883 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -59.76 -32.22 70.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.856 0.317 . . . . 72.329999999999998 111.856 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.91 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.675 0.61 . . . . 74.439999999999998 110.589 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -102.48 -66.63 0.92 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.75 -0.38 . . . . 75.25 110.287 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 63.91 113.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.78 0.675 . . . . 73.219999999999999 110.541 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.3 p80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.168 -0.92 . . . . 74.239999999999995 110.188 -179.506 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.515 0.191 . . . . 73.420000000000002 111.515 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt -87.41 139.66 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.8 -0.815 . . . . 75.319999999999993 108.8 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.93 154.83 53.21 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.68 0.276 . . . . 65.439999999999998 110.899 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.64 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 15.8 Cg_endo -59.82 126.03 19.34 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.366 2.044 . . . . 71.040000000000006 111.214 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 108.78 -7.48 33.61 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.623 -0.799 . . . . 45.340000000000003 111.811 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.57 152.73 19.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 71.0 110.715 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -95.32 130.46 42.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 61.329999999999998 110.117 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 52' ' ' LEU . 21.6 m -124.52 155.8 32.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.908 0.385 . . . . 73.140000000000001 111.395 -177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 9' ' ' ARG . 19.2 ttt180 -122.8 121.32 35.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 73.310000000000002 109.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.99 116.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 54.399999999999999 111.238 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -90.74 -28.32 18.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 62.439999999999998 111.514 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.031 -0.359 . . . . 75.019999999999996 110.031 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.482 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 30.5 t -72.81 -26.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.175 0.512 . . . . 73.239999999999995 111.515 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.47 -15.39 55.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 65.340000000000003 111.281 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 160.16 29.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.093 0.473 . . . . 54.399999999999999 111.3 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -66.88 -38.69 86.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.739 -0.664 . . . . 75.540000000000006 111.637 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.61 26.8 5.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.897 0.379 . . . . 71.109999999999999 111.345 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 13' ' ' VAL . 37.4 t80 -57.98 140.51 52.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.048 -0.524 . . . . 74.549999999999997 110.86 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 73.87 9.5 4.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.405 -0.816 . . . . 75.409999999999997 111.485 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -102.58 153.04 20.48 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.896 -0.409 . . . . 74.510000000000005 109.896 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.88 139.38 49.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 62.420000000000002 110.181 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.53 175.92 23.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.815 -0.707 . . . . 53.350000000000001 112.228 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.8 tt -112.6 124.95 53.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.112 -0.329 . . . . 74.420000000000002 110.112 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.54 117.31 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 62.299999999999997 110.804 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -78.09 -36.13 48.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.987 -0.552 . . . . 64.299999999999997 110.161 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 4' ' ' PRO . 30.5 ptt180 -170.8 145.98 2.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.695 -0.684 . . . . 62.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.608 HG13 HD21 ' A' ' 49' ' ' LEU . 89.7 t -106.76 121.52 59.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.279 -0.873 . . . . 62.329999999999998 109.302 172.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.4 m -155.29 139.31 16.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.726 -0.215 . . . . 61.350000000000001 110.873 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 67.67 15.29 9.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.799 -0.637 . . . . 64.209999999999994 111.474 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.98 2.7 71.2 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.709 -0.758 . . . . 54.43 111.907 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 61.2 mtpt -115.31 163.05 16.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 110.182 -0.303 . . . . 62.219999999999999 110.182 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.25 125.87 25.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.256 -0.429 . . . . 42.450000000000003 110.048 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.728 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.38 113.12 20.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 71.299999999999997 109.891 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.18 119.65 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 71.420000000000002 111.238 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.7 tp -94.1 108.79 20.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.945 -0.571 . . . . 74.340000000000003 109.685 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 96.6 m-85 -80.36 141.36 35.46 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.284 -0.636 . . . . 63.509999999999998 109.284 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -139.24 124.37 18.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.488 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -128.85 86.3 2.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 60.210000000000001 109.916 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.81 -95.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.205 -0.758 . . . . 71.519999999999996 111.205 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -122.37 87.77 2.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.529 1.156 . . . . 74.420000000000002 108.554 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 t90 178.8 138.46 0.09 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.283 -2.235 . . . . 74.540000000000006 109.463 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.6 p30 -137.03 152.71 50.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.489 -0.778 . . . . 74.099999999999994 110.558 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HG3' HG23 ' A' ' 45' ' ' VAL . 17.1 tppt? -156.56 107.14 2.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 73.420000000000002 110.044 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 ' HB1' ' A' ' 33' ' ' ALA . 57.4 tp -89.21 110.86 21.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.169 -0.469 . . . . 71.200000000000003 110.716 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 43' ' ' LYS . 34.8 t -125.65 120.73 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 65.540000000000006 109.213 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.0 m -81.41 130.93 35.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.282 0.563 . . . . 71.439999999999998 111.067 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 52' ' ' LEU . 81.9 m-85 -124.53 -167.27 1.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.19 -0.914 . . . . 72.140000000000001 109.038 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.722 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 65.2 mtt-85 -110.24 162.81 14.25 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.885 -0.413 . . . . 65.349999999999994 109.885 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.608 HD21 HG13 ' A' ' 27' ' ' VAL . 3.6 mm? -66.4 -33.29 75.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.429 0.633 . . . . 63.25 109.999 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 p -78.16 -6.38 54.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.514 -0.766 . . . . 64.329999999999998 110.573 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.722 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 15.4 mm-40 -94.13 -15.57 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 62.420000000000002 111.001 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 47' ' ' PHE . 29.4 mt -127.79 150.07 49.98 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.066 -0.515 . . . . 74.109999999999999 111.645 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -121.25 143.45 49.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.655 -0.868 . . . . 75.209999999999994 108.655 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.18 136.37 37.08 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.958 -0.297 . . . . 53.240000000000002 110.246 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 56' ' ' LYS . 3.0 t -67.27 164.17 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.534 -0.543 . . . . 34.350000000000001 109.534 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.532 ' H ' HG12 ' A' ' 55' ' ' VAL . 87.6 tttt -130.53 137.02 29.89 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.168 -0.469 . . . . 72.010000000000005 110.439 -169.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.74 135.76 57.45 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.693 2.262 . . . . 61.140000000000001 111.359 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.23 152.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.237 0.541 . . . . 64.219999999999999 111.097 -174.159 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.32 144.93 49.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 53.119999999999997 110.028 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.28 164.18 15.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.175 -0.676 . . . . 74.409999999999997 109.175 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -63.96 131.47 47.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.943 0.401 . . . . 73.400000000000006 110.969 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -152.85 157.36 40.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.828 -0.624 . . . . 64.109999999999999 110.121 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 63.87 -153.56 0.31 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.596 0.56 . . . . 75.019999999999996 109.756 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 73.93 -29.03 0.19 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.249 0.62 . . . . 64.230000000000004 111.979 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -59.82 -40.36 88.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.512 . . . . 72.530000000000001 110.079 173.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.6 p80 . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.327 -0.851 . . . . 71.109999999999999 108.762 175.227 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.0 mt . . . . . 0 N--CA 1.455 -0.191 0 N-CA-C 109.347 -0.612 . . . . 75.219999999999999 109.347 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -135.27 161.71 61.79 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.605 -0.27 . . . . 75.25 110.295 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.86 117.55 4.32 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.274 1.983 . . . . 74.140000000000001 111.191 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.85 1.36 24.15 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.892 -0.67 . . . . 63.420000000000002 111.897 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.33 141.72 32.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.93 0.395 . . . . 61.0 110.948 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -82.55 129.96 35.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 33.229999999999997 110.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -132.36 153.02 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 71.219999999999999 111.565 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -117.13 137.04 52.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.515 -0.766 . . . . 73.519999999999996 109.969 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.4 t -80.42 115.26 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 71.310000000000002 110.353 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.49 18.52 22.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 112.21 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -89.82 113.9 25.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.177 -0.675 . . . . 62.200000000000003 109.177 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.11 -28.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.767 -0.651 . . . . 54.210000000000001 111.976 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -93.07 23.54 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 65.540000000000006 110.791 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.72 160.96 18.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.791 -0.568 . . . . 55.0 110.527 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -71.06 -32.09 68.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 52.530000000000001 111.173 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.471 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 71.6 m-85 -96.85 25.45 5.29 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.886 0.328 . . . . 70.129999999999995 111.886 -175.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -59.23 131.32 50.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.537 -0.301 . . . . 70.239999999999995 110.198 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 78.23 -16.84 0.62 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.885 0.874 . . . . 75.340000000000003 111.577 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -75.25 157.46 34.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 63.43 110.686 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.61 139.63 50.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.859 -0.609 . . . . 65.109999999999999 110.854 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 179.88 18.46 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.785 -0.643 . . . . 41.039999999999999 111.506 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.2 tp -119.0 123.23 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.311 -0.255 . . . . 63.530000000000001 110.311 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.93 116.81 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.845 -0.428 . . . . 74.299999999999997 109.845 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -90.49 -33.65 15.88 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.938 -0.574 . . . . 54.409999999999997 110.914 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -169.84 154.02 5.11 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.764 -0.653 . . . . 63.439999999999998 110.177 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.16 124.74 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.097 -0.956 . . . . 55.25 109.115 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -120.2 98.84 6.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.992 0.425 . . . . 75.540000000000006 111.179 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 54.29 39.45 30.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.356 -0.838 . . . . 74.209999999999994 112.178 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.47 -11.72 65.0 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.642 -0.789 . . . . 62.539999999999999 112.569 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 99.0 mttt -99.13 177.61 5.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.113 -0.329 . . . . 75.140000000000001 110.113 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.99 126.18 40.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 70.519999999999996 110.604 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.817 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -83.58 107.52 16.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.291 -0.413 . . . . 74.400000000000006 109.957 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.12 124.02 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.137 -0.483 . . . . 72.329999999999998 110.822 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -99.13 126.51 44.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.511 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -103.59 136.46 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.535 -0.913 . . . . 62.200000000000003 108.535 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -141.83 133.22 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.807 -0.442 . . . . 55.039999999999999 109.807 -172.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -129.11 21.78 5.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.196 0.522 . . . . 71.109999999999999 111.09 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . 98.13 9.26 54.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.643 -0.789 . . . . 50.340000000000003 112.951 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 28.6 t-20 169.34 -46.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.087 -0.709 . . . . 73.420000000000002 109.087 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -80.25 138.69 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.501 -0.772 . . . . 74.230000000000004 109.894 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -154.8 163.21 40.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.736 -0.665 . . . . 60.32 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -165.39 106.79 0.78 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.242 -0.89 . . . . 72.129999999999995 109.462 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.817 HD21 ' HB1' ' A' ' 33' ' ' ALA . 8.7 tt -77.52 119.25 20.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 51.340000000000003 109.649 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.15 124.26 62.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.861 -0.422 . . . . 75.530000000000001 109.861 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -84.09 129.2 34.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.225 0.536 . . . . 52.310000000000002 110.729 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 95.7 m-85 -124.73 178.45 5.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.454 -0.793 . . . . 65.219999999999999 109.182 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.943 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 49.7 mtt180 -87.08 163.02 17.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.296 -0.631 . . . . 64.540000000000006 109.296 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.37 -31.24 69.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.724 -0.843 . . . . 71.310000000000002 108.724 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 p -67.82 -21.34 65.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 114.933 -1.03 . . . . 50.100000000000001 110.466 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.943 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 41.2 mm-40 -87.95 -7.9 56.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.501 -0.48 . . . . 65.230000000000004 111.254 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 8' ' ' VAL . 49.9 mt -122.88 156.63 34.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.973 0.416 . . . . 74.329999999999998 111.719 -173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -129.22 147.24 51.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.114 -0.698 . . . . 52.140000000000001 109.114 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.94 132.33 36.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 74.299999999999997 111.127 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.323 -0.546 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 177.969 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.7 HD12 HD22 ' A' ' 49' ' ' LEU . 52.3 mt . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 110.145 -0.317 . . . . 73.439999999999998 110.145 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.47 143.46 30.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.249 -0.432 . . . . 71.439999999999998 110.762 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.85 134.6 44.23 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.675 2.25 . . . . 63.240000000000002 111.544 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.83 -5.01 50.23 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.991 -0.624 . . . . 62.210000000000001 112.331 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.7 161.07 13.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.831 0.348 . . . . 53.32 110.695 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -99.69 131.79 45.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.264 -0.425 . . . . 75.129999999999995 110.234 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 52' ' ' LEU . 25.9 m -125.7 155.52 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 110.206 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -109.47 143.07 39.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.669 -0.493 . . . . 44.439999999999998 109.669 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.16 113.96 16.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.032 -0.359 . . . . 63.0 110.032 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -89.69 -19.02 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 73.439999999999998 111.142 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.03 106.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 74.420000000000002 110.5 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.15 -30.42 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 71.549999999999997 111.132 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.66 -26.55 68.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 71.439999999999998 111.125 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.16 155.37 25.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 63.229999999999997 110.647 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 -27.5 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.002 -0.545 . . . . 73.109999999999999 110.945 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.43 22.66 2.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.276 -0.42 . . . . 71.25 111.489 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 35.6 t80 -63.32 134.61 56.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.239 -0.437 . . . . 74.409999999999997 110.332 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.7 mtp180 76.17 1.82 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.761 0.825 . . . . 74.549999999999997 112.293 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -85.35 150.51 24.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 75.129999999999995 110.212 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 125.25 53.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 74.519999999999996 109.744 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -125.72 155.27 18.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.586 -0.816 . . . . 41.329999999999998 111.85 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.66 116.48 28.98 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 110.252 -0.277 . . . . 75.409999999999997 110.252 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.01 106.34 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.85 -0.426 . . . . 61.310000000000002 109.85 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -79.37 -34.5 41.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.101 0.477 . . . . 72.019999999999996 110.521 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -167.03 143.72 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.695 -0.684 . . . . 70.140000000000001 109.65 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.18 136.14 25.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.431 -0.804 . . . . 72.519999999999996 109.276 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 m -127.03 93.75 3.84 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.264 -0.273 . . . . 63.009999999999998 110.264 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.92 -76.82 0.06 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.298 -0.864 . . . . 65.129999999999995 111.085 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -140.76 11.73 2.9 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.332 -1.304 . . . . 44.310000000000002 111.132 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.521 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 47.4 mtmt -114.6 165.95 12.23 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.115 -0.543 . . . . 74.019999999999996 109.55 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.98 133.4 37.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.681 0.277 . . . . 51.229999999999997 110.5 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.74 99.6 10.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.18 -0.674 . . . . 42.340000000000003 109.18 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG1' ' HA3' ' A' ' 22' ' ' GLY . 55.4 t -91.78 118.09 36.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 64.099999999999994 110.793 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.8 tp -94.6 122.59 37.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.781 -0.645 . . . . 72.209999999999994 110.509 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 92.3 m-85 -99.95 146.77 26.3 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.957 -0.757 . . . . 71.340000000000003 108.957 174.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 30.8 tt0 -129.55 -56.06 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.669 -0.412 . . . . 60.310000000000002 111.805 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 64.64 -66.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.825 0.45 . . . . 74.019999999999996 111.523 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . -168.73 93.5 0.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.334 -0.706 . . . . 52.009999999999998 111.334 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 8.6 t30 72.59 -36.79 0.37 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.492 0.717 . . . . 74.120000000000005 111.743 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 48.1 t90 -57.41 155.38 9.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 73.040000000000006 110.789 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.0 p-10 -148.54 153.45 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 71.409999999999997 110.301 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -169.45 110.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.362 -0.836 . . . . 73.129999999999995 109.378 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.544 HD11 ' HB1' ' A' ' 33' ' ' ALA . 37.8 tp -90.91 105.98 18.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.066 -0.516 . . . . 73.129999999999995 110.067 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -118.0 118.09 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 110.004 -0.369 . . . . 73.400000000000006 110.004 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 m -79.27 129.6 34.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.08 0.467 . . . . 54.539999999999999 110.583 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -124.84 178.41 5.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.613 -0.721 . . . . 65.439999999999998 109.119 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.961 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 62.8 mmt-85 -90.17 162.85 15.07 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.959 -0.756 . . . . 74.129999999999995 108.959 175.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.7 HD22 HD12 ' A' ' 2' ' ' ILE . 87.0 mt -79.36 -22.31 44.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.27 0.557 . . . . 71.319999999999993 109.882 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 p -75.21 -15.12 60.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.399 -0.819 . . . . 64.209999999999994 110.003 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.961 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 13.4 mm-40 -91.89 -13.17 31.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.732 -0.667 . . . . 63.539999999999999 110.604 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 8' ' ' VAL . 62.9 mt -115.56 161.54 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.73 . . . . 73.230000000000004 111.01 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.64 128.99 48.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.802 -0.636 . . . . 75.129999999999995 109.549 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.602 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -79.93 108.74 13.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.71 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.326 -0.444 0 N-CA-C 108.837 -0.801 . . . . 72.140000000000001 108.837 176.878 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 109.007 -0.738 . . . . 74.25 109.007 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -149.62 144.27 17.63 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.887 -0.412 . . . . 74.219999999999999 109.887 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.36 131.57 44.08 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.71 2.273 . . . . 53.119999999999997 111.857 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.2 -13.26 48.52 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.985 -0.626 . . . . 32.520000000000003 111.883 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 164.39 13.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.877 0.37 . . . . 22.129999999999999 110.561 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -97.36 134.42 40.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.902 -0.59 . . . . 72.040000000000006 110.085 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.79 148.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.991 0.425 . . . . 72.420000000000002 111.008 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 22.2 ttt180 -104.92 122.23 45.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.66 -0.7 . . . . 73.430000000000007 109.504 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 52' ' ' LEU . 41.2 t -70.82 103.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.1 0.476 . . . . 64.420000000000002 110.16 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -108.88 23.94 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.799 -0.637 . . . . 75.319999999999993 111.572 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -72.87 106.43 4.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.876 -0.787 . . . . 72.329999999999998 108.876 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.41 -25.47 38.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.179 0.514 . . . . 73.129999999999995 111.178 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.08 -23.26 26.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.308 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.79 155.8 18.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 73.310000000000002 110.905 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -78.94 -23.4 44.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 54.119999999999997 111.822 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -76.91 11.77 1.62 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 73.420000000000002 111.28 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 64.9 t80 -71.33 78.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.516 -0.765 . . . . 75.230000000000004 110.055 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 14.8 ptt180 168.9 -20.38 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.182 -0.917 . . . . 71.430000000000007 109.629 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.12 148.07 23.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.305 0.574 . . . . 74.140000000000001 111.408 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 41.5 mt-10 -125.91 118.12 24.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.246 -1.02 . . . . 74.109999999999999 108.246 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.76 176.81 17.86 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.132 -1.032 . . . . 60.43 113.148 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -93.67 140.4 29.68 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.553 0.216 . . . . 71.109999999999999 110.632 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.27 117.33 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.254 -0.43 . . . . 53.219999999999999 110.667 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 35' ' ' LEU . 2.6 mp0 -75.9 -37.71 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 55.130000000000003 110.108 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -170.67 141.06 1.79 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.798 -0.637 . . . . 64.25 110.615 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.75 108.25 21.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.264 -0.88 . . . . 63.219999999999999 108.788 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -88.92 41.71 1.04 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.523 -0.308 . . . . 60.240000000000002 110.955 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 63.5 88.93 0.09 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.317 -0.856 . . . . 61.310000000000002 111.143 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.24 -30.55 9.66 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.656 -0.702 . . . . 60.5 112.448 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -120.65 162.66 19.29 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.214 0.206 . . . . 73.439999999999998 110.491 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.94 140.7 28.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.519 0.2 . . . . 73.230000000000004 111.019 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.64 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -93.02 116.57 29.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.51 -0.552 . . . . 71.010000000000005 109.51 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 127.21 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.398 -0.364 . . . . 74.439999999999998 110.66 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.408 ' HB2' ' OE1' ' A' ' 25' ' ' GLN . 37.0 tp -88.72 125.88 35.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.454 . . . . 72.319999999999993 110.889 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.592 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 91.4 m-85 -102.91 142.22 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.766 -0.652 . . . . 71.230000000000004 109.445 173.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -143.3 119.7 10.95 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.65 -0.5 . . . . 62.130000000000003 109.65 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 55.5 t30 -137.92 91.36 2.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 54.109999999999999 110.62 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.19 -91.76 0.83 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.747 -0.66 . . . . 64.0 112.473 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -114.49 -11.61 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 75.409999999999997 110.385 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.481 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 63.8 t90 -89.01 139.15 30.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 72.319999999999993 111.39 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.74 154.4 46.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.303 -0.862 . . . . 72.439999999999998 109.784 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -163.5 121.34 1.89 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.679 -0.691 . . . . 71.239999999999995 110.503 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.64 HD21 ' HB1' ' A' ' 33' ' ' ALA . 9.1 tt -91.03 113.76 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.244 -0.65 . . . . 74.439999999999998 109.244 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.592 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 44.3 t -123.14 129.05 75.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.364 . . . . 63.350000000000001 110.636 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.8 m -84.37 132.62 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.991 0.424 . . . . 72.430000000000007 110.585 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -128.44 -176.61 3.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.911 -0.586 . . . . 74.099999999999994 110.053 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 25.2 mtp180 -100.47 157.01 16.95 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.298 -0.631 . . . . 74.219999999999999 109.298 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.5 -23.04 50.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.059 0.457 . . . . 72.219999999999999 110.424 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -74.47 -18.04 60.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.667 -0.697 . . . . 65.340000000000003 110.315 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.559 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp0 -99.0 -4.63 32.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.58 . . . . 74.200000000000003 111.294 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 10' ' ' VAL . 84.0 mt -120.18 130.18 54.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.458 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.95 135.34 45.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.104 -0.702 . . . . 75.030000000000001 109.104 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 128.9 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.085 -0.507 . . . . 73.409999999999997 110.579 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.32 -0.689 0 N-CA-C 108.6 -0.889 . . . . 70.519999999999996 108.6 177.149 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.2 mt . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 109.927 -0.397 . . . . 74.219999999999999 109.927 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 36.9 m-85 -149.4 167.48 12.94 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.678 -0.692 . . . . 72.140000000000001 110.028 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.815 ' HG3' ' HA ' ' A' ' 26' ' ' ARG . 51.6 Cg_exo -53.83 124.33 15.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.696 2.264 . . . . 64.150000000000006 112.061 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.27 -16.3 35.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.129 -0.558 . . . . 73.200000000000003 112.036 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.26 155.27 30.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 71.019999999999996 110.792 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -98.39 130.37 45.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.341 -0.39 . . . . 62.439999999999998 110.401 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.48 157.45 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.435 . . . . 62.43 110.459 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -133.98 135.7 43.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.061 -0.518 . . . . 70.540000000000006 110.365 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.77 120.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 75.329999999999998 110.678 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.9 p -100.1 5.88 44.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 43.119999999999997 111.817 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.3 t30 -80.86 108.48 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 64.129999999999995 109.616 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.3 t -71.17 -28.14 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 74.010000000000005 111.528 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.45 -6.5 57.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 72.510000000000005 110.933 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.482 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 8.8 t70 -94.24 160.64 14.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.756 0.312 . . . . 74.049999999999997 110.306 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -82.92 -19.71 36.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.23 -0.441 . . . . 72.120000000000005 110.708 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.45 19.61 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 63.109999999999999 110.351 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.56 128.63 36.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.683 -0.69 . . . . 75.420000000000002 111.145 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 70.05 7.44 6.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.245 -0.889 . . . . 61.130000000000003 112.512 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.74 145.29 32.97 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.168 -0.678 . . . . 74.239999999999995 109.168 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -113.19 129.92 56.37 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.5 -0.773 . . . . 71.219999999999999 109.804 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.75 164.67 25.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.444 -0.884 . . . . 71.540000000000006 112.047 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.03 129.95 44.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 110.283 -0.266 . . . . 73.150000000000006 110.283 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.05 112.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 62.009999999999998 109.845 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -71.25 -37.68 71.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 71.239999999999995 109.524 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.815 ' HA ' ' HG3' ' A' ' 4' ' ' PRO . 33.0 ptt180 -174.78 150.22 1.27 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.086 -0.961 . . . . 72.25 109.011 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.18 128.57 45.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.552 -0.749 . . . . 74.109999999999999 109.414 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -124.94 78.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.877 -0.416 . . . . 64.409999999999997 109.877 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.3 t70 49.56 82.86 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.29 -0.868 . . . . 72.439999999999998 112.416 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 -12.39 19.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.98 -0.628 . . . . 63.310000000000002 113.209 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 59.1 mtpt -115.38 158.27 22.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.567 0.223 . . . . 71.150000000000006 110.513 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.62 131.46 27.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.475 -0.329 . . . . 71.299999999999997 110.361 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.63 105.43 14.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.413 -0.588 . . . . 72.150000000000006 109.413 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -92.26 121.01 42.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.265 -0.425 . . . . 62.020000000000003 110.812 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.3 tp -97.88 108.55 21.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.754 -0.461 . . . . 75.129999999999995 109.754 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -82.42 134.42 35.23 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.038 -0.727 . . . . 73.129999999999995 109.038 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.34 -54.92 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.555 . . . . 70.310000000000002 111.165 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 24.4 t-20 68.89 -48.22 0.58 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.971 0.508 . . . . 72.239999999999995 111.971 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.9 -48.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.203 -0.523 . . . . 51.350000000000001 111.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -132.25 4.93 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.585 1.183 . . . . 72.450000000000003 108.985 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 26.4 t90 -103.12 172.7 6.67 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.725 -1.58 . . . . 64.409999999999997 109.828 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 3.3 p30 -154.08 153.79 32.5 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.272 -0.27 . . . . 72.109999999999999 110.272 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HE2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -175.52 109.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.531 -0.759 . . . . 62.399999999999999 110.237 175.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.401 HD11 ' HB1' ' A' ' 33' ' ' ALA . 62.9 tp -97.68 109.97 22.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.176 -0.305 . . . . 63.399999999999999 110.176 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.3 t -134.76 129.64 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 70.120000000000005 109.932 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -90.13 135.14 33.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.251 0.548 . . . . 63.420000000000002 110.683 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -130.38 -176.36 3.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.701 -0.851 . . . . 64.120000000000005 108.701 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.058 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 68.4 mtt180 -87.48 168.43 13.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.455 -0.572 . . . . 64.329999999999998 109.455 174.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.36 -24.07 42.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.135 -0.691 . . . . 75.010000000000005 109.135 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -80.46 -20.42 43.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.171 -0.922 . . . . 72.409999999999997 110.58 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 1.058 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 10.4 mm-40 -85.83 -14.39 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.363 0.601 . . . . 71.349999999999994 110.409 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.0 mt -115.42 155.7 26.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.567 -0.742 . . . . 74.319999999999993 110.151 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.87 133.58 52.7 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.409 -0.589 . . . . 63.450000000000003 109.409 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.3 120.59 22.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.233 -0.44 . . . . 40.439999999999998 109.845 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.325 -0.475 0 N-CA-C 109.447 -0.575 . . . . 74.430000000000007 109.447 -179.731 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.404 ' CG2' HG21 ' A' ' 24' ' ' VAL . 32.4 mt . . . . . 0 N--CA 1.454 -0.238 0 CA-C-O 120.775 0.322 . . . . 75.519999999999996 110.451 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.69 159.92 69.77 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 115.898 -0.592 . . . . 73.25 109.751 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.84 127.76 23.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.504 2.136 . . . . 73.040000000000006 111.782 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.37 -5.68 52.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 71.049999999999997 112.618 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.7 146.28 26.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.63 0.253 . . . . 51.25 111.253 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 124.78 32.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.115 -0.493 . . . . 71.409999999999997 110.083 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.704 HG21 HD13 ' A' ' 52' ' ' LEU . 16.5 m -128.39 144.52 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 72.540000000000006 111.37 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.749 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 11.5 ttt85 -100.89 130.12 46.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.659 -0.701 . . . . 54.119999999999997 110.174 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 49.0 t -68.31 111.9 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.054 -0.721 . . . . 72.129999999999995 109.054 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -112.58 10.78 19.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.121 0.486 . . . . 44.43 111.806 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -82.35 112.73 19.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.784 -0.821 . . . . 65.329999999999998 108.784 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -66.56 -21.47 28.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.645 . . . . 62.340000000000003 111.431 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.81 -31.0 68.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.969 -0.56 . . . . 73.219999999999999 111.415 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.22 161.57 17.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 75.230000000000004 111.077 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 m -77.87 -23.29 48.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 75.540000000000006 111.53 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 82.6 m-85 -88.63 20.41 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.654 0.264 . . . . 74.519999999999996 111.57 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -71.2 77.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 62.340000000000003 110.876 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 166.67 -30.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.02 -0.991 . . . . 70.439999999999998 109.675 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -78.38 151.21 32.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.678 -0.692 . . . . 74.450000000000003 111.539 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.749 ' HG2' ' HB2' ' A' ' 9' ' ' ARG . 29.3 mt-10 -125.38 122.95 38.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 109.509 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.77 -178.68 15.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.75 . . . . 71.219999999999999 112.472 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.07 135.94 42.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.764 0.316 . . . . 74.030000000000001 111.191 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' A' ' 2' ' ' ILE . 62.0 t -75.66 111.09 11.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.937 0.399 . . . . 71.349999999999994 110.04 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.84 -41.39 64.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.659 0.742 . . . . 62.299999999999997 109.669 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -164.95 138.53 4.81 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.575 -1.193 . . . . 73.310000000000002 109.569 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.507 HG13 HD21 ' A' ' 49' ' ' LEU . 60.3 t -95.21 139.77 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.396 -0.82 . . . . 51.329999999999998 109.77 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 6.0 t -130.43 63.29 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.475 -0.565 . . . . 62.530000000000001 109.475 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 16.25 81.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.291 1.436 . . . . 54.009999999999998 113.386 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.99 -41.83 1.87 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.673 -1.149 . . . . 70.230000000000004 110.672 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 51.7 mmtt -109.78 167.35 10.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.76 0.424 . . . . 52.240000000000002 110.195 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.4 139.06 9.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.211 -0.45 . . . . 44.149999999999999 110.147 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -90.9 114.57 27.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.942 -0.392 . . . . 65.030000000000001 109.942 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.481 HG21 HD21 ' A' ' 52' ' ' LEU . 42.2 t -99.21 120.29 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 73.319999999999993 110.819 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.9 tp -97.65 114.52 26.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.566 -0.531 . . . . 62.039999999999999 109.566 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.4 141.97 30.46 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.95 -0.568 . . . . 72.109999999999999 109.925 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.49 113.94 11.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 72.200000000000003 109.648 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -142.39 79.71 1.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.062 0.458 . . . . 74.129999999999995 110.936 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.42 -104.04 2.12 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.848 -0.615 . . . . 64.340000000000003 112.656 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -96.78 -16.58 20.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.665 0.745 . . . . 64.120000000000005 109.625 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -95.04 141.17 29.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.211 -0.904 . . . . 63.299999999999997 111.239 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -153.39 150.91 29.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.88 -1.055 . . . . 75.310000000000002 109.527 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HE2' ' CG2' ' A' ' 45' ' ' VAL . 87.3 tttt -158.09 131.31 7.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.27 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.454 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.9 tp -99.81 110.7 23.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.358 -0.383 . . . . 71.129999999999995 110.3 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.454 ' CG2' ' HE2' ' A' ' 43' ' ' LYS . 40.2 t -124.27 120.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.981 0.419 . . . . 64.530000000000001 110.425 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.2 m -75.88 130.01 37.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.206 0.527 . . . . 73.400000000000006 110.493 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -125.28 -171.06 2.28 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.504 -0.771 . . . . 54.340000000000003 108.979 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.717 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 19.9 mtm180 -99.33 171.04 8.23 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.466 -0.568 . . . . 74.109999999999999 109.466 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.507 HD21 HG13 ' A' ' 27' ' ' VAL . 75.3 mt -76.6 -30.99 57.18 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.014 0.435 . . . . 64.219999999999999 110.039 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 p -71.58 -12.78 61.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.718 -0.674 . . . . 45.420000000000002 110.345 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.717 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 4.8 mm-40 -86.67 -14.68 41.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.519999999999996 110.744 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.704 HD13 HG21 ' A' ' 8' ' ' VAL . 79.7 mt -110.74 130.67 55.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.283 0.563 . . . . 72.230000000000004 112.403 -168.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -109.89 116.0 30.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.35 -0.841 . . . . 75.310000000000002 109.081 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 131.35 50.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.343 . . . . 72.109999999999999 110.485 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 C--N 1.322 -0.629 0 N-CA-C 109.245 -0.65 . . . . 72.120000000000005 109.245 178.734 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.586 HG12 ' HB2' ' A' ' 54' ' ' ALA . 48.1 mt . . . . . 0 N--CA 1.455 -0.214 0 N-CA-C 109.796 -0.446 . . . . 71.010000000000005 109.796 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -119.64 153.08 54.14 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.056 -0.52 . . . . 73.239999999999995 110.753 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.17 130.81 28.28 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.619 2.213 . . . . 74.319999999999993 111.463 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 103.39 -13.1 54.8 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 74.030000000000001 112.16 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 150.63 24.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 64.0 111.232 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -87.24 130.27 34.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.716 -0.674 . . . . 72.0 109.882 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 54' ' ' ALA . 22.9 m -128.93 152.29 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.898 0.38 . . . . 73.409999999999997 110.601 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HD2' ' OE2' ' A' ' 53' ' ' GLU . 44.7 ttm180 -110.46 138.05 47.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.246 -0.65 . . . . 73.120000000000005 109.246 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.5 t -76.25 113.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.907 0.384 . . . . 70.540000000000006 110.818 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -96.87 2.32 51.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 65.299999999999997 110.577 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.8 115.26 11.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.528 -0.76 . . . . 65.019999999999996 110.32 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.77 -8.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.422 0.63 . . . . 63.140000000000001 110.471 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.37 -37.81 88.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 64.349999999999994 110.637 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.469 ' OD2' ' HD2' ' A' ' 17' ' ' TYR . 13.6 t70 -103.45 173.47 6.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 72.230000000000004 109.877 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -88.94 -12.1 42.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.713 0.264 . . . . 71.299999999999997 111.713 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 58.4 m-85 -79.27 30.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 73.409999999999997 112.068 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 86.2 t80 -70.54 138.31 50.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 75.400000000000006 109.432 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 41.3 mtt180 70.59 18.96 6.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.506 0.504 . . . . 74.319999999999993 112.049 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -93.73 150.74 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 44.210000000000001 110.522 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -103.57 121.52 43.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.221 -0.9 . . . . 73.109999999999999 109.341 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.84 162.84 23.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.508 -0.853 . . . . 63.109999999999999 112.318 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.428 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.6 tt -116.74 123.69 47.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.703 -0.48 . . . . 65.439999999999998 109.703 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 32' ' ' ALA . 75.6 t -65.74 114.85 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 63.409999999999997 110.954 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -79.21 -35.46 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.366 0.603 . . . . 63.450000000000003 110.145 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -165.68 154.47 11.66 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.136 -0.938 . . . . 72.420000000000002 108.923 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.75 126.36 68.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.535 -0.757 . . . . 72.129999999999995 109.305 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.7 t -125.43 84.98 2.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.55 -0.296 . . . . 71.019999999999996 110.8 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 40.59 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.263 0.977 . . . . 52.049999999999997 112.969 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 96.09 -29.9 9.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.586 -0.816 . . . . 71.340000000000003 112.804 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HB3' HG22 ' A' ' 46' ' ' THR . 41.4 mttt -109.71 163.82 13.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.995 0.426 . . . . 71.239999999999995 111.379 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 24' ' ' VAL . . . -143.7 137.14 27.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 71.319999999999993 109.93 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.592 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.82 105.34 14.64 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.961 -0.385 . . . . 71.129999999999995 109.961 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.77 118.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.18 -0.463 . . . . 72.310000000000002 110.925 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.34 118.79 31.71 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.638 -0.504 . . . . 73.420000000000002 109.638 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -86.76 147.35 25.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.941 -0.572 . . . . 74.239999999999995 109.93 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -135.54 119.99 18.03 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 71.230000000000004 108.988 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -138.97 42.26 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.565 0.697 . . . . 72.219999999999999 110.046 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.18 -102.54 2.42 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 44.450000000000003 111.671 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -93.29 -32.87 14.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.211 0.529 . . . . 72.329999999999998 109.793 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -74.96 140.63 43.81 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.491 -0.777 . . . . 70.25 111.007 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.9 165.62 27.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.66 -1.155 . . . . 74.040000000000006 108.77 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -164.7 137.93 4.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.144 -0.317 . . . . 70.109999999999999 110.144 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.592 HD11 ' HB1' ' A' ' 33' ' ' ALA . 47.8 tp -109.16 109.24 20.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.809 0.338 . . . . 73.099999999999994 110.178 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -124.44 124.06 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.064 0.459 . . . . 74.0 110.265 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -87.33 111.13 20.76 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.393 0.616 . . . . 73.219999999999999 110.796 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.78 178.1 4.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.245 -0.889 . . . . 70.430000000000007 109.455 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.738 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 54.0 mtt85 -88.9 159.19 17.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.706 -0.479 . . . . 71.120000000000005 109.706 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 30' ' ' GLY . 94.0 mt -71.45 -26.91 62.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.343 0.592 . . . . 74.109999999999999 109.792 -176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 p -80.0 -12.03 59.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.289 -0.869 . . . . 71.409999999999997 109.994 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.738 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.5 mt-10 -98.93 3.08 47.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.838 -0.619 . . . . 74.5 110.558 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.01 153.55 46.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 71.430000000000007 110.361 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 9' ' ' ARG . 11.7 pt-20 -118.28 123.14 44.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 74.219999999999999 109.28 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.717 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -78.5 123.86 27.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.319 -0.4 . . . . 73.329999999999998 110.03 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.32 -0.69 0 N-CA-C 108.899 -0.778 . . . . 63.310000000000002 108.899 177.825 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 54' ' ' ALA . 41.1 mt . . . . . 0 C--O 1.236 0.346 0 CA-C-O 121.234 0.54 . . . . 73.439999999999998 111.444 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -130.77 154.64 81.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 73.019999999999996 109.714 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.82 119.15 6.11 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.354 2.036 . . . . 75.430000000000007 111.425 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.24 -3.83 31.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 43.43 111.949 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.15 153.77 19.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 73.019999999999996 110.811 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -91.82 132.44 36.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.564 . . . . 72.420000000000002 110.29 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.64 160.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.0 0.428 . . . . 63.399999999999999 110.828 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -124.81 130.59 52.69 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.884 -0.784 . . . . 72.230000000000004 108.884 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.2 t -68.73 108.81 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.155 0.503 . . . . 65.329999999999998 110.767 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -88.13 -17.98 29.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.484 -0.78 . . . . 72.0 110.416 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 42.7 t30 -66.85 106.99 2.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 71.219999999999999 110.573 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.22 -24.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 74.140000000000001 110.54 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.01 -27.09 67.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.362 -0.835 . . . . 71.140000000000001 111.189 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 11.2 t70 -85.86 164.94 17.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.2 -0.455 . . . . 63.009999999999998 110.766 -176.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -82.65 -23.77 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.346 -0.388 . . . . 72.329999999999998 110.705 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.38 21.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.949 0.404 . . . . 72.209999999999994 111.026 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 29.9 t80 -63.19 133.04 53.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.032 -0.531 . . . . 73.329999999999998 110.268 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 62.8 mtt180 76.66 3.23 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.621 0.768 . . . . 72.340000000000003 112.22 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.5 157.21 21.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.885 0.374 . . . . 75.349999999999994 110.251 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -118.05 141.94 47.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 72.319999999999993 110.122 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.55 165.19 33.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.551 -0.833 . . . . 51.229999999999997 111.793 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -104.43 131.52 51.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 110.26 -0.274 . . . . 73.109999999999999 110.26 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.515 HG11 HG22 ' A' ' 27' ' ' VAL . 59.9 t -70.46 117.08 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.023 -0.535 . . . . 74.019999999999996 110.199 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 29.3 mm-40 -83.33 -31.7 26.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.496 0.665 . . . . 75.340000000000003 110.279 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -158.18 128.55 6.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.96 -1.018 . . . . 73.329999999999998 110.373 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.515 HG22 HG11 ' A' ' 24' ' ' VAL . 57.8 t -98.38 120.14 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.572 -0.74 . . . . 75.420000000000002 110.036 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.5 m -102.09 -178.86 3.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.053 -0.721 . . . . 74.310000000000002 109.053 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.18 81.93 3.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.342 0.592 . . . . 70.219999999999999 110.069 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.416 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 121.84 -31.24 5.04 Favored Glycine 0 C--N 1.318 -0.444 0 CA-C-N 115.364 -0.834 . . . . 74.109999999999999 112.447 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 46' ' ' THR . 97.1 mttt -120.28 159.79 24.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.868 0.366 . . . . 52.350000000000001 111.262 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.0 135.92 36.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.047 -0.524 . . . . 71.120000000000005 109.812 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -89.19 109.36 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.909 0.385 . . . . 32.549999999999997 110.263 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.0 126.58 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 64.430000000000007 110.423 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 34.4 tp -90.79 123.61 34.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 65.209999999999994 110.666 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 88.6 m-85 -107.85 134.0 51.41 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.55 -0.907 . . . . 61.119999999999997 108.55 171.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -143.05 128.69 19.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.392 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -134.31 74.9 1.56 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.415 -0.587 . . . . 60.439999999999998 109.415 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.34 -97.82 0.35 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.684 -0.689 . . . . 40.009999999999998 112.554 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.55 -22.5 24.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.266 0.555 . . . . 71.209999999999994 110.201 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.446 ' HZ2' ' HD2' ' A' ' 43' ' ' LYS . 87.1 t90 -91.75 146.93 23.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 73.430000000000007 110.983 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -150.27 159.07 44.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.442 -0.799 . . . . 63.149999999999999 110.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 11.9 mttm -163.88 133.49 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.688 -0.687 . . . . 31.449999999999999 110.828 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.7 tp -106.3 104.12 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.523 . . . . 71.239999999999995 109.587 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.44 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 29.0 t -113.53 118.04 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.071 0.463 . . . . 62.43 110.411 -176.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.4 m -82.81 130.28 35.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.875 -0.602 . . . . 64.140000000000001 110.469 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 52' ' ' LEU . 91.2 m-85 -123.13 178.97 4.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.607 -0.724 . . . . 55.399999999999999 109.062 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 57.7 mtp180 -96.63 162.83 13.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.048 0.451 . . . . 72.540000000000006 110.563 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.428 HD22 HD12 ' A' ' 2' ' ' ILE . 94.4 mt -76.3 -22.92 54.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.929 -0.578 . . . . 55.240000000000002 110.41 -173.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 p -85.76 -8.26 58.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 70.150000000000006 109.92 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.7 mt-10 -98.89 -8.31 25.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 64.420000000000002 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 10' ' ' VAL . 57.1 mt -124.15 151.61 43.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.85 -0.614 . . . . 71.140000000000001 110.45 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 147.97 37.17 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.203 -0.665 . . . . 74.439999999999998 109.203 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.545 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -89.27 126.9 35.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.043 0.449 . . . . 61.210000000000001 110.937 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.321 -0.638 0 N-CA-C 108.018 -1.105 . . . . 71.530000000000001 108.018 175.541 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.4 mt . . . . . 0 C--O 1.232 0.165 0 N-CA-C 109.946 -0.39 . . . . 74.329999999999998 109.946 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -133.94 152.65 78.96 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.193 -0.458 . . . . 70.349999999999994 110.726 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HG3' ' H ' ' A' ' 27' ' ' VAL . 24.1 Cg_exo -64.4 123.1 11.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.73 2.287 . . . . 70.340000000000003 111.565 176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.58 -0.81 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.017 -0.611 . . . . 60.409999999999997 112.089 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.88 145.41 32.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.848 0.356 . . . . 70.040000000000006 111.043 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -84.93 131.18 34.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.757 -0.656 . . . . 73.209999999999994 110.021 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 54' ' ' ALA . 32.7 m -129.46 150.85 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.778 0.323 . . . . 62.140000000000001 110.832 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 9' ' ' ARG . 17.3 ttt85 -104.33 134.83 46.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.856 -0.424 . . . . 62.119999999999997 109.856 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HA ' HD23 ' A' ' 52' ' ' LEU . 49.0 t -60.9 114.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.131 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -98.05 -9.73 25.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.39 0.614 . . . . 73.400000000000006 110.184 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.714 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 36.0 t30 -74.25 113.89 11.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 74.239999999999995 110.556 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.46 -26.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 54.25 110.889 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.64 -30.25 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 62.420000000000002 111.408 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -75.37 158.49 32.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 65.230000000000004 111.418 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -90.42 -12.31 37.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.817 -0.628 . . . . 71.439999999999998 110.938 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -98.51 21.4 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 72.25 110.169 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -66.63 80.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.7 . . . . 64.129999999999995 111.3 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 165.22 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.728 -1.124 . . . . 75.349999999999994 109.206 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -76.73 152.44 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.491 0.662 . . . . 75.25 111.854 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -119.42 109.78 16.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.856 -1.065 . . . . 73.129999999999995 109.232 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.05 174.89 15.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.726 -0.75 . . . . 44.439999999999998 112.565 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 23' ' ' LEU . 1.2 tm? -102.38 126.54 49.43 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.592 -0.521 . . . . 54.420000000000002 109.592 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' A' ' 32' ' ' ALA . 92.0 t -78.3 112.44 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.263 -0.273 . . . . 75.439999999999998 110.263 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -79.11 -34.39 43.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.956 0.407 . . . . 74.239999999999995 110.551 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -164.01 134.63 4.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.899 -0.591 . . . . 74.120000000000005 110.41 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.466 ' H ' ' HG3' ' A' ' 4' ' ' PRO . 96.9 t -91.58 123.3 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.386 -0.825 . . . . 74.540000000000006 109.096 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.6 t -126.91 91.36 3.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.702 0.286 . . . . 64.099999999999994 110.765 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 49.94 75.88 0.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 53.420000000000002 112.586 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.33 -20.99 6.42 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.06 -0.59 . . . . 43.109999999999999 113.404 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 55.8 mtpt -110.48 165.48 11.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.767 -0.255 . . . . 73.200000000000003 110.607 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -142.79 141.25 31.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 72.030000000000001 110.48 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.14 107.8 19.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.578 -0.527 . . . . 70.109999999999999 109.578 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.8 t -102.85 118.87 50.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.974 -0.557 . . . . 74.109999999999999 110.897 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.68 119.28 31.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.837 -0.619 . . . . 64.400000000000006 110.74 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 47.3 m-85 -89.59 134.12 34.28 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.594 -1.262 . . . . 71.549999999999997 107.594 169.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -149.38 124.39 10.02 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.934 -0.395 . . . . 72.120000000000005 109.934 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.12 86.09 1.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 54.229999999999997 110.667 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.7 -93.73 0.94 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.625 -0.716 . . . . 75.040000000000006 113.516 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -91.63 -21.97 20.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.869 0.366 . . . . 72.0 111.217 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t90 -111.07 143.5 41.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.315 0.578 . . . . 71.519999999999996 111.857 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 4.2 p-10 -147.99 153.06 38.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.664 -1.153 . . . . 74.140000000000001 109.176 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HG3' HG23 ' A' ' 45' ' ' VAL . 57.1 tptt -160.39 111.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 110.594 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -92.09 104.71 17.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 70.140000000000001 110.082 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.419 HG23 ' HG3' ' A' ' 43' ' ' LYS . 21.1 t -117.88 125.74 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 51.140000000000001 109.958 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.492 HG22 ' HE2' ' A' ' 31' ' ' LYS . 4.4 m -85.03 130.83 34.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.076 -0.511 . . . . 55.219999999999999 110.607 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.725 ' HB2' HD11 ' A' ' 52' ' ' LEU . 88.1 m-85 -126.53 -175.27 3.34 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.684 -0.689 . . . . 70.230000000000004 109.772 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.882 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 15.8 mmt180 -88.91 161.33 16.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.445 . . . . 73.549999999999997 109.8 174.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 32' ' ' ALA . 94.0 mt -83.41 -27.03 29.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.56 0.695 . . . . 74.519999999999996 109.343 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -76.45 -10.17 59.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.066 -0.97 . . . . 74.549999999999997 110.8 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.882 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 19.1 pt-20 -117.22 16.57 14.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.367 -0.533 . . . . 73.450000000000003 111.278 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.725 HD11 ' HB2' ' A' ' 47' ' ' PHE . 95.8 mt -131.86 154.35 49.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.857 -0.611 . . . . 71.299999999999997 109.97 175.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -149.06 141.37 24.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.624 -0.51 . . . . 73.519999999999996 109.624 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.3 138.34 51.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 53.210000000000001 111.594 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.324 -0.536 0 CA-C-N 115.544 -0.753 . . . . 64.140000000000001 109.057 177.555 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 CA--C 1.535 0.383 0 CA-C-O 121.281 0.563 . . . . 73.109999999999999 110.928 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 55.0 m-85 -95.19 139.78 22.16 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 75.129999999999995 110.752 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 16.8 Cg_exo -67.67 137.94 43.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.636 2.224 . . . . 73.519999999999996 111.458 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.22 4.37 64.58 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.844 -0.694 . . . . 72.209999999999994 111.799 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.44 161.68 13.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.617 0.246 . . . . 70.150000000000006 110.446 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -87.43 131.26 34.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.091 -0.504 . . . . 75.140000000000001 110.239 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.69 150.29 34.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 71.120000000000005 111.055 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.9 ttp180 -117.41 142.22 47.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.754 -0.657 . . . . 73.239999999999995 109.366 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.8 t -77.86 105.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.742 -0.466 . . . . 72.430000000000007 109.742 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -89.52 -4.21 58.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 72.329999999999998 111.053 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.613 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 58.0 t30 -69.38 102.86 1.85 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.7 -0.482 . . . . 70.239999999999995 109.7 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.524 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 22.4 t -63.03 -35.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.73 . . . . 45.119999999999997 112.14 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.96 -10.94 59.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.027 0.441 . . . . 71.010000000000005 111.597 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.613 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 5.6 t70 -84.4 160.37 20.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.012 -0.43 . . . . 72.239999999999995 110.7 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 m -71.06 -32.37 69.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 74.310000000000002 110.507 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 91.2 m-85 -87.86 21.13 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 53.5 111.25 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 32.9 t80 -59.27 132.25 53.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.02 0.438 . . . . 75.519999999999996 111.146 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 74.81 -3.8 2.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.924 -1.034 . . . . 65.329999999999998 111.917 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -77.78 149.87 34.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 63.43 109.652 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 37.1 mt-10 -125.34 136.2 53.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.55 . . . . 70.040000000000006 110.726 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.12 -171.24 17.62 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.009 -0.836 . . . . 73.340000000000003 111.009 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.9 mp -112.85 150.8 31.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.431 0.616 . . . . 71.299999999999997 110.923 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.01 115.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 73.239999999999995 110.231 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -79.58 -28.24 41.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 75.209999999999994 110.71 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -170.28 133.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 72.420000000000002 110.665 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 49' ' ' LEU . 58.0 t -93.88 135.4 28.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.318 -0.855 . . . . 62.520000000000003 109.786 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t -107.34 -159.94 0.71 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.929 -0.397 . . . . 73.409999999999997 109.929 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.8 -33.83 72.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.525 0.678 . . . . 71.319999999999993 111.709 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -155.16 -12.46 0.06 OUTLIER Glycine 0 C--N 1.31 -0.865 0 CA-C-N 114.791 -1.095 . . . . 54.43 112.319 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 63.8 mttp -104.27 172.09 6.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.844 0.354 . . . . 71.349999999999994 111.255 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.11 140.87 21.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 73.530000000000001 110.03 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.61 111.73 22.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.692 -0.484 . . . . 73.519999999999996 109.692 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 40.1 t -104.17 122.77 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 63.439999999999998 111.067 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.46 121.59 31.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.269 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.453 ' CE2' ' HE2' ' A' ' 47' ' ' PHE . 96.4 m-85 -101.41 151.96 21.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.993 -0.549 . . . . 71.430000000000007 110.244 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -122.32 -63.46 1.28 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.891 -0.595 . . . . 75.439999999999998 110.168 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.08 -57.32 0.42 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.538 0.735 . . . . 73.450000000000003 111.525 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . 158.35 102.55 0.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.904 -0.878 . . . . 44.32 110.904 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 24.9 t30 75.09 -40.59 0.44 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.422 0.689 . . . . 74.329999999999998 110.623 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -64.26 154.68 34.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.521 -0.763 . . . . 70.219999999999999 110.7 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -152.62 143.7 23.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.099 0.476 . . . . 74.340000000000003 109.882 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -168.22 125.25 1.08 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.568 -0.742 . . . . 74.109999999999999 109.904 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -100.09 102.55 13.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.3 -0.63 . . . . 71.409999999999997 109.3 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.35 120.04 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.061 -0.518 . . . . 53.210000000000001 110.609 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.23 129.25 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.942 -0.572 . . . . 72.400000000000006 110.269 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.453 ' HE2' ' CE2' ' A' ' 36' ' ' PHE . 45.2 m-85 -126.99 -174.37 3.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.938 -0.574 . . . . 72.230000000000004 109.542 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.567 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 33.5 mtt180 -103.93 162.13 13.39 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.462 -0.57 . . . . 72.150000000000006 109.462 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 27' ' ' VAL . 90.4 mt -73.06 -33.8 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.261 -0.427 . . . . 71.540000000000006 110.508 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -73.44 -16.08 61.32 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.751 -0.659 . . . . 70.430000000000007 110.579 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.567 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 3.5 mp0 -89.95 -8.85 50.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.827 -0.624 . . . . 74.040000000000006 111.387 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.88 157.39 25.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.341 -0.391 . . . . 74.510000000000005 111.391 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.54 148.42 52.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.045 -0.724 . . . . 74.010000000000005 109.045 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.37 121.73 21.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.995 0.426 . . . . 71.349999999999994 110.067 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 C--N 1.323 -0.567 0 N-CA-C 109.194 -0.669 . . . . 72.409999999999997 109.194 177.776 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.451 ' O ' HG21 ' A' ' 27' ' ' VAL . 48.8 mt . . . . . 0 N--CA 1.456 -0.157 0 N-CA-C 109.341 -0.614 . . . . 74.450000000000003 109.341 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 39.4 p90 -115.79 149.24 42.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.595 0.236 . . . . 74.420000000000002 110.98 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 34.5 Cg_exo -62.13 142.79 93.33 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.607 2.205 . . . . 64.25 111.744 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.58 -7.85 65.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.975 -0.631 . . . . 54.219999999999999 112.128 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 143.6 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.929 0.395 . . . . 75.150000000000006 110.864 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -80.59 125.03 29.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 74.120000000000005 109.907 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.1 148.22 33.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.314 0.578 . . . . 42.200000000000003 111.349 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -111.76 133.85 53.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.285 -0.87 . . . . 62.43 109.3 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.3 t -80.08 101.17 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.576 -0.527 . . . . 64.219999999999999 109.576 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -103.31 13.7 33.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.895 -0.593 . . . . 64.450000000000003 110.526 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.9 t30 -61.6 107.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.533 -0.914 . . . . 71.430000000000007 108.533 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.84 -47.04 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 74.120000000000005 112.298 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.58 40.57 1.18 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.363 0.602 . . . . 71.530000000000001 110.537 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 6.1 t70 -110.44 161.13 15.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.129 -0.487 . . . . 74.409999999999997 110.111 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -81.14 -23.17 38.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.591 . . . . 70.310000000000002 110.104 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CD1' ' HZ ' ' A' ' 47' ' ' PHE . 73.7 m-85 -98.66 24.72 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 70.109999999999999 110.848 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 46.0 t80 -62.44 127.88 33.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.954 -0.566 . . . . 74.349999999999994 110.023 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 17.4 mtp180 76.12 10.54 3.09 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.057 0.848 . . . . 71.230000000000004 112.308 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -87.66 148.26 24.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.425 -0.583 . . . . 71.549999999999997 109.425 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -128.73 142.48 50.99 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.702 -0.681 . . . . 63.350000000000001 110.401 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -166.96 -169.03 30.03 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.82 -0.705 . . . . 53.409999999999997 111.709 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.77 136.66 52.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.716 0.293 . . . . 72.219999999999999 110.914 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.36 122.91 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 52.340000000000003 109.654 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG3' HD13 ' A' ' 44' ' ' LEU . 31.2 mm-40 -89.4 -33.09 16.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.285 0.564 . . . . 71.140000000000001 110.177 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -169.03 136.55 1.88 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.289 -0.869 . . . . 74.450000000000003 110.204 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 29' ' ' ASP . 43.7 t -103.35 142.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.485 -0.78 . . . . 73.430000000000007 109.689 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 t -121.91 34.8 5.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.078 0.466 . . . . 73.549999999999997 109.868 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 27' ' ' VAL . 24.4 m-20 50.04 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.953 -1.021 . . . . 71.150000000000006 111.533 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.29 -46.26 1.19 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.842 -0.903 . . . . 53.109999999999999 110.842 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 30.5 mtpp -112.28 161.02 17.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.844 -0.428 . . . . 73.129999999999995 109.844 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.55 142.63 21.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.751 -0.204 . . . . 51.439999999999998 110.556 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.637 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -91.67 115.48 28.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 75.230000000000004 109.593 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 52' ' ' LEU . 18.3 t -100.67 124.79 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.119 -0.491 . . . . 73.519999999999996 110.594 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.6 tp -94.92 107.29 19.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 73.200000000000003 109.579 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.497 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 81.4 m-85 -86.63 142.33 28.33 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.16 -0.682 . . . . 63.149999999999999 109.16 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -140.1 131.32 26.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.96 0.41 . . . . 71.510000000000005 110.449 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 3.2 t-20 -141.14 91.07 2.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 63.43 108.951 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.66 -114.61 4.04 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.651 -0.704 . . . . 54.439999999999998 111.774 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -89.87 -30.24 18.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.622 0.725 . . . . 71.349999999999994 109.079 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.48 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 65.8 t90 -72.27 138.9 47.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.994 -1.003 . . . . 75.239999999999995 111.556 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.14 155.17 44.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.824 -1.08 . . . . 65.030000000000001 109.181 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.462 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 76.4 tttt -153.97 120.18 5.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.458 -0.337 . . . . 71.439999999999998 110.516 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.51 HD11 ' HB1' ' A' ' 33' ' ' ALA . 62.6 tp -93.88 110.4 22.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 73.129999999999995 110.566 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.497 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 25.3 t -126.2 127.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.014 -0.539 . . . . 71.239999999999995 109.799 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.5 m -83.26 133.0 35.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.247 0.546 . . . . 61.299999999999997 110.826 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.46 ' HZ ' ' CD1' ' A' ' 17' ' ' TYR . 55.7 m-85 -131.83 -160.15 1.02 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.425 -0.807 . . . . 70.099999999999994 109.656 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.8 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 63.7 mtm180 -109.08 173.66 6.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.77 -0.455 . . . . 75.340000000000003 109.77 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 27' ' ' VAL . 95.5 mt -81.45 -28.56 34.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.116 0.484 . . . . 72.409999999999997 109.912 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 p -68.9 -17.86 64.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.675 -0.693 . . . . 55.219999999999999 110.178 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.8 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.3 mm-40 -86.62 -13.07 46.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.865 -0.607 . . . . 73.109999999999999 110.622 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 34' ' ' VAL . 87.5 mt -112.73 140.93 47.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 73.209999999999994 112.144 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -117.0 112.8 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.699 -0.682 . . . . 62.509999999999998 109.714 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.78 134.26 52.76 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.865 -0.421 . . . . 55.109999999999999 109.865 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 109.586 -0.524 . . . . 52.539999999999999 109.586 -179.969 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 49' ' ' LEU . 72.7 mt . . . . . 0 N--CA 1.464 0.26 0 CA-C-O 121.102 0.477 . . . . 74.409999999999997 110.18 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -131.16 146.09 60.55 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.309 -0.405 . . . . 73.310000000000002 110.639 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.77 125.6 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.54 2.16 . . . . 63.109999999999999 111.207 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.12 -3.0 47.57 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.051 -0.595 . . . . 62.310000000000002 112.026 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.38 154.94 18.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.74 0.305 . . . . 75.439999999999998 110.825 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -88.43 134.79 33.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.765 -0.652 . . . . 71.409999999999997 110.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.488 HG21 HD13 ' A' ' 52' ' ' LEU . 16.3 m -124.22 153.56 30.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.426 . . . . 72.540000000000006 110.702 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 53' ' ' GLU . 53.8 ttt180 -110.98 119.87 40.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.699 -0.682 . . . . 72.120000000000005 109.73 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 25.8 t -76.15 98.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.005 0.431 . . . . 63.409999999999997 110.249 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -105.8 13.83 29.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.313 -0.403 . . . . 72.409999999999997 111.273 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 54.3 t30 -62.8 112.65 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 41.25 109.671 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 23.5 t -69.54 -27.92 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 63.32 111.411 -172.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -100.39 40.36 1.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.817 0.818 . . . . 51.009999999999998 109.395 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 3.7 t70 -119.47 -174.53 2.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.511 -0.768 . . . . 73.329999999999998 110.671 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -109.59 -28.85 8.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.967 -0.56 . . . . 75.409999999999997 110.241 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 92.6 m-85 -101.07 38.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.098 -0.501 . . . . 72.209999999999994 111.151 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.678 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 10.1 t80 -59.35 126.3 27.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.742 -0.663 . . . . 75.409999999999997 110.263 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.678 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 87.1 mtt180 80.09 4.05 1.93 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.097 0.959 . . . . 72.510000000000005 112.681 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -83.71 149.09 26.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.46 . . . . 71.219999999999999 110.153 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.29 125.46 43.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.606 -0.724 . . . . 71.409999999999997 110.221 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.61 171.67 23.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.844 -0.693 . . . . 61.450000000000003 111.754 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.21 124.88 46.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.867 0.365 . . . . 74.510000000000005 110.976 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.03 119.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.88 -0.6 . . . . 64.340000000000003 110.313 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -77.86 -36.71 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.3 0.571 . . . . 74.209999999999994 109.854 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -170.03 143.0 2.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.063 -0.971 . . . . 72.209999999999994 109.408 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.22 92.85 2.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.605 -0.725 . . . . 75.219999999999999 109.373 174.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -103.54 114.12 28.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.277 -0.42 . . . . 64.239999999999995 111.12 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 61.67 37.68 15.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.427 -0.806 . . . . 64.120000000000005 111.624 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.44 6.14 89.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.609 -0.805 . . . . 34.149999999999999 112.772 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -117.4 144.74 44.65 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.305 -0.628 . . . . 62.219999999999999 109.305 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 124.25 51.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.764 0.316 . . . . 75.120000000000005 111.113 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.507 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -81.93 101.09 10.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.241 -0.652 . . . . 63.539999999999999 109.241 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.97 121.36 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.874 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.33 126.74 36.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.8 -0.636 . . . . 63.119999999999997 110.493 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.11 143.7 39.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 74.510000000000005 110.409 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.78 129.19 27.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.395 -0.821 . . . . 74.540000000000006 109.126 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -135.86 87.53 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.717 0.294 . . . . 71.129999999999995 110.291 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.18 -77.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.962 -0.563 . . . . 71.409999999999997 112.576 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -128.39 -4.79 5.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.78 . . . . 43.539999999999999 109.17 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -89.98 138.25 31.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 73.209999999999994 111.022 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.33 146.23 49.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.067 -0.969 . . . . 64.340000000000003 109.787 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -166.28 136.49 3.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.049 0.452 . . . . 72.219999999999999 111.156 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.507 HD11 ' HB1' ' A' ' 33' ' ' ALA . 54.0 tp -106.48 109.49 21.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 75.349999999999994 110.128 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.25 117.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.913 0.387 . . . . 72.239999999999995 110.293 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.3 m -78.6 127.94 32.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 51.009999999999998 110.643 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.64 179.01 4.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.772 -0.649 . . . . 73.420000000000002 110.173 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.423 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 mpt_? -98.77 154.83 17.7 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.66 -0.867 . . . . 74.319999999999993 108.66 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.582 HD22 HD12 ' A' ' 2' ' ' ILE . 84.5 mt -72.82 -32.86 65.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.45 0.643 . . . . 64.209999999999994 109.388 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 p -71.03 -12.21 61.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.994 -1.003 . . . . 61.439999999999998 110.764 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 2.9 mp0 -108.02 7.15 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.791 -0.641 . . . . 72.420000000000002 111.589 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.488 HD13 HG21 ' A' ' 8' ' ' VAL . 93.0 mt -121.97 146.22 47.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.111 0.481 . . . . 73.140000000000001 111.591 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 40.0 tt0 -102.48 108.43 19.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.838 -0.801 . . . . 40.340000000000003 108.838 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.11 22.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.181 -0.463 . . . . 51.210000000000001 110.015 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.322 -0.615 0 CA-C-N 116.234 -0.439 . . . . 65.519999999999996 109.827 -178.99 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 HD22 ' A' ' 49' ' ' LEU . 54.3 mt . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.342 -0.614 . . . . 74.319999999999993 109.342 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.08 146.62 51.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.438 0.161 . . . . 74.5 110.609 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.97 127.79 27.53 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.762 2.308 . . . . 75.549999999999997 111.902 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.84 0.29 39.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.834 -0.698 . . . . 54.219999999999999 112.187 -176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.41 135.38 34.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.649 0.262 . . . . 64.329999999999998 110.48 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -83.12 125.07 31.1 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.591 -0.522 . . . . 44.109999999999999 109.591 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 54' ' ' ALA . 17.0 m -122.18 143.39 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.221 -0.445 . . . . 71.329999999999998 111.014 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -98.77 129.54 45.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 109.702 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.84 120.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.078 -0.341 . . . . 74.450000000000003 110.078 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 11' ' ' THR . 17.9 m -116.29 8.85 14.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 55.229999999999997 110.303 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -74.21 106.83 6.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.749 -0.834 . . . . 74.409999999999997 108.749 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.76 -21.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 112.846 0.684 . . . . 75.409999999999997 112.846 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.14 -32.12 21.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.442 . . . . 72.310000000000002 110.612 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.19 158.24 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 70.340000000000003 111.824 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -81.43 -24.19 37.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.46 -0.791 . . . . 63.25 111.279 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -92.68 21.2 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 74.239999999999995 110.61 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.522 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 42.9 t80 -70.49 77.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 74.510000000000005 111.293 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 9.7 ptp85 163.58 -22.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.59 1.156 . . . . 74.510000000000005 108.633 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -77.98 154.73 31.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.35 -0.841 . . . . 74.450000000000003 111.224 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -125.02 127.85 47.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.2 -0.909 . . . . 63.509999999999998 109.298 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.96 168.17 21.43 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.529 -0.843 . . . . 73.409999999999997 112.228 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.47 126.37 41.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.639 0.257 . . . . 73.5 110.473 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 27' ' ' VAL . 59.1 t -67.96 119.8 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 74.209999999999994 110.132 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.05 -30.38 22.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.828 -0.623 . . . . 51.240000000000002 110.578 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 26' ' ' ARG . 12.2 ptp180 -164.31 143.15 7.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 75.230000000000004 109.63 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.512 HG22 HG11 ' A' ' 24' ' ' VAL . 40.0 t -114.69 142.33 27.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.214 -0.903 . . . . 63.210000000000001 110.369 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 p -132.42 -175.56 3.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.658 -0.497 . . . . 54.119999999999997 109.658 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.74 75.35 4.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 72.400000000000006 110.517 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.43 -27.16 5.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.536 -0.756 . . . . 72.230000000000004 112.586 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 47.7 mtmt -120.11 162.23 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.693 0.282 . . . . 74.109999999999999 111.34 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.04 143.78 21.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.561 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.83 115.37 27.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.83 -0.433 . . . . 64.109999999999999 109.83 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.88 128.99 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 71.340000000000003 110.814 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.2 tp -102.34 120.06 39.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 73.430000000000007 110.934 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -104.9 146.37 29.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.841 -0.618 . . . . 73.519999999999996 109.532 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -149.27 127.41 12.03 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.28 -0.267 . . . . 71.340000000000003 110.28 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.72 85.71 1.9 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 54.219999999999999 109.666 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.0 -105.11 1.54 Allowed Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.602 -0.727 . . . . 62.200000000000003 112.159 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -87.56 -32.17 19.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.204 0.525 . . . . 72.400000000000006 110.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -75.93 138.53 41.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.592 -0.731 . . . . 72.120000000000005 111.272 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.11 155.99 44.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.824 -1.08 . . . . 71.450000000000003 108.813 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HG3' HG23 ' A' ' 45' ' ' VAL . 41.9 tptt -155.94 108.8 2.66 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.664 -0.415 . . . . 73.540000000000006 111.247 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.23 109.57 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.389 -0.597 . . . . 71.140000000000001 109.389 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 43' ' ' LYS . 46.1 t -130.28 131.99 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 71.140000000000001 110.247 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -83.29 126.54 32.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.067 0.46 . . . . 71.230000000000004 110.682 177.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -123.25 -170.34 2.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.765 -0.828 . . . . 74.510000000000005 108.765 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 1.06 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mtt180 -95.03 176.96 6.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.325 -0.621 . . . . 73.420000000000002 109.325 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.496 HD21 HG13 ' A' ' 27' ' ' VAL . 97.3 mt -84.1 -32.01 24.98 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.038 -0.727 . . . . 62.509999999999998 109.038 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 p -71.21 -19.63 62.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.087 -0.96 . . . . 62.149999999999999 110.862 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 1.06 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.0 mm-40 -85.54 -7.84 58.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 110.81 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 8' ' ' VAL . 73.4 mt -116.85 138.47 51.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.094 0.473 . . . . 73.109999999999999 111.751 -172.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.68 104.46 16.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.094 -1.076 . . . . 64.329999999999998 108.094 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.799 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.08 107.86 3.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.25 -0.432 . . . . 63.109999999999999 110.838 -176.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.63 0 N-CA-C 108.877 -0.786 . . . . 72.099999999999994 108.877 177.695 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt . . . . . 0 N--CA 1.454 -0.253 0 N-CA-C 109.936 -0.394 . . . . 74.230000000000004 109.936 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -117.72 141.21 28.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.512 -0.313 . . . . 64.349999999999994 110.864 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.6 137.2 62.8 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.492 2.128 . . . . 51.399999999999999 110.975 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 55.219999999999999 112.018 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.82 165.76 12.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.881 0.372 . . . . 72.340000000000003 110.706 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -93.31 138.95 31.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.092 -0.504 . . . . 74.400000000000006 110.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.568 HG21 HD13 ' A' ' 52' ' ' LEU . 6.7 m -130.65 148.06 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 65.430000000000007 111.083 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.64 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 34.2 ttm180 -109.97 141.81 42.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.838 -0.619 . . . . 54.020000000000003 109.483 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 55.4 t -79.54 110.56 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 64.230000000000004 110.019 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -91.29 -11.78 37.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.718 -0.674 . . . . 74.420000000000002 111.159 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.23 106.33 1.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.182 -0.463 . . . . 52.549999999999997 109.808 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.34 -24.16 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 75.230000000000004 111.375 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.98 -8.13 52.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.867 -0.606 . . . . 72.319999999999993 110.759 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.05 165.22 16.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.919 0.39 . . . . 61.130000000000003 110.445 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 m -72.16 -35.96 69.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 42.0 111.893 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.503 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -94.97 27.97 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.689 -172.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 45.5 t80 -61.86 130.97 48.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 64.439999999999998 110.038 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.6 mtm180 77.82 6.04 2.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.827 0.851 . . . . 72.140000000000001 111.833 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -96.33 148.29 22.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.832 -0.433 . . . . 71.400000000000006 109.832 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.64 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 33.5 mt-10 -127.92 128.15 44.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 74.049999999999997 110.245 -175.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.49 -177.11 14.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.939 -0.648 . . . . 62.140000000000001 112.335 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.89 132.48 49.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.491 0.186 . . . . 75.209999999999994 110.555 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.74 111.85 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.153 -0.314 . . . . 74.129999999999995 110.153 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -78.08 -34.98 49.95 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.192 -0.67 . . . . 74.430000000000007 109.192 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.28 136.59 0.37 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.325 -0.852 . . . . 65.230000000000004 110.16 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.9 108.56 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.645 -0.872 . . . . 71.209999999999994 108.645 172.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 t -152.47 142.62 22.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.523 -0.308 . . . . 53.420000000000002 111.056 -172.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.79 18.95 10.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.457 -0.792 . . . . 62.329999999999998 111.386 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 -1.15 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.927 -0.654 . . . . 72.329999999999998 112.81 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 26.2 mtmt -124.09 174.28 7.74 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.629 0.372 . . . . 72.450000000000003 110.118 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.07 129.92 28.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.622 0.249 . . . . 65.209999999999994 110.446 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -86.52 115.01 23.73 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.705 -0.48 . . . . 42.210000000000001 109.705 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 52' ' ' LEU . 55.9 t -98.53 119.09 46.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.285 0.564 . . . . 73.540000000000006 110.648 -177.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.6 tp -89.81 118.78 29.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.546 -0.752 . . . . 73.450000000000003 110.072 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.77 137.43 33.87 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.929 -0.767 . . . . 72.439999999999998 108.929 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -156.41 108.59 2.53 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.71 -0.848 . . . . 74.329999999999998 108.71 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -136.89 100.88 4.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 54.240000000000002 110.84 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.96 -77.81 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.583 -0.735 . . . . 72.209999999999994 112.471 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -127.27 -17.41 4.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.205 0.526 . . . . 40.229999999999997 110.385 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -88.76 138.24 31.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.786 -0.643 . . . . 75.150000000000006 111.683 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.9 143.6 47.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.712 -1.131 . . . . 64.439999999999998 109.741 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -167.61 120.45 0.92 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.919 0.39 . . . . 73.530000000000001 110.631 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.18 109.72 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.304 -0.407 . . . . 71.540000000000006 110.032 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.19 120.74 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 74.25 109.97 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.8 m -78.19 130.73 36.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.206 0.527 . . . . 74.299999999999997 109.673 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -123.17 180.0 4.49 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.477 -0.783 . . . . 75.510000000000005 109.746 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 73.4 mtp180 -94.62 161.65 14.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.738 -0.665 . . . . 75.120000000000005 109.565 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.44 -26.44 63.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.108 -0.496 . . . . 64.530000000000001 110.064 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 m -76.2 -11.32 59.9 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.687 -0.688 . . . . 65.549999999999997 110.726 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -85.02 -23.4 28.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 74.310000000000002 111.116 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 8' ' ' VAL . 62.1 mt -115.79 144.7 43.61 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.331 0.493 . . . . 74.319999999999993 112.331 -168.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -111.85 140.92 46.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.783 -0.821 . . . . 75.540000000000006 108.783 167.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.49 115.43 17.25 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.145 -0.317 . . . . 54.240000000000002 110.145 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.401 HG23 ' HA ' ' A' ' 8' ' ' VAL . 10.3 t . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.139 -0.689 . . . . 73.530000000000001 109.139 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt . . . . . 0 C--O 1.233 0.2 0 N-CA-C 110.068 -0.345 . . . . 74.200000000000003 110.068 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -126.92 158.68 67.82 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 70.129999999999995 110.507 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.71 128.79 18.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.543 2.162 . . . . 73.209999999999994 111.241 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.497 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 94.11 27.2 12.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.555 -0.831 . . . . 64.030000000000001 111.646 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.83 144.34 48.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 72.109999999999999 110.778 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -82.72 130.2 35.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 63.530000000000001 110.574 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.78 162.37 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 32.43 110.846 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HB3' ' OE2' ' A' ' 53' ' ' GLU . 41.5 ttp180 -119.88 124.0 44.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.397 -0.819 . . . . 73.510000000000005 109.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 t -66.4 113.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.373 . . . . 73.409999999999997 110.65 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . 0.412 ' OG1' ' HG3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -96.24 -11.41 26.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.961 -0.563 . . . . 61.109999999999999 111.007 -176.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 41.7 t30 -65.93 113.12 4.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.472 . . . . 63.100000000000001 110.288 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.98 -39.07 76.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 45.409999999999997 111.532 -174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.59 34.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.903 0.859 . . . . 63.399999999999999 109.66 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.529 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 7.1 t70 -116.42 159.17 22.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.447 -0.797 . . . . 71.439999999999998 110.269 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -75.76 -31.31 59.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.191 0.519 . . . . 74.120000000000005 110.325 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -99.72 25.02 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.859 -0.609 . . . . 74.230000000000004 111.089 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 18.4 t80 -58.39 128.88 39.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.651 . . . . 64.010000000000005 111.126 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 74.2 mtp180 77.14 -8.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.138 0.975 . . . . 71.209999999999994 112.376 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.39 158.03 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.018 0.437 . . . . 62.219999999999999 110.809 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -104.91 138.76 40.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.688 -0.687 . . . . 61.520000000000003 110.445 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.36 171.83 26.31 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.552 -0.619 . . . . 53.020000000000003 111.552 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.497 HD21 ' HA2' ' A' ' 5' ' ' GLY . 4.4 tt -120.08 122.54 41.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.062 0.431 . . . . 32.200000000000003 109.889 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.545 HG11 HG22 ' A' ' 27' ' ' VAL . 39.5 t -69.21 122.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 73.420000000000002 110.762 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.413 ' NE2' HD22 ' A' ' 23' ' ' LEU . 27.4 mm-40 -98.61 -30.78 12.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.914 -0.585 . . . . 75.439999999999998 110.752 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 26' ' ' ARG . 19.0 ttt180 -146.61 118.92 8.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 74.329999999999998 109.903 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.545 HG22 HG11 ' A' ' 24' ' ' VAL . 59.4 t -103.64 128.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 75.129999999999995 110.888 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.9 t -106.42 -179.35 3.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.903 -0.777 . . . . 62.229999999999997 108.903 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.61 29.91 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 71.299999999999997 111.099 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.0 -29.64 0.17 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.956 -0.566 . . . . 52.32 111.777 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.06 164.92 11.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.58 0.229 . . . . 63.109999999999999 110.44 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.49 137.9 19.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.586 -0.279 . . . . 62.539999999999999 110.405 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -101.06 110.73 22.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.893 -0.41 . . . . 73.239999999999995 109.893 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -100.26 129.39 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 55.439999999999998 110.858 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 tp -95.19 129.15 42.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.681 -0.69 . . . . 64.549999999999997 110.399 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.74 136.91 48.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.469 -0.567 . . . . 74.299999999999997 109.469 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.85 116.82 25.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.085 -0.507 . . . . 70.129999999999995 111.059 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 17.2 t30 -110.2 -10.9 14.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.706 . . . . 70.219999999999999 110.295 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.58 -71.98 0.22 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.899 -0.667 . . . . 53.5 111.545 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.16 -18.89 24.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.602 0.715 . . . . 72.450000000000003 109.935 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 73.7 t90 -112.92 135.14 54.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 65.439999999999998 111.022 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.43 149.06 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.039 -0.982 . . . . 71.25 109.256 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HE2' HG22 ' A' ' 45' ' ' VAL . 88.5 tttt -165.14 119.06 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.934 0.397 . . . . 75.019999999999996 110.865 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.6 tp -92.7 108.36 19.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.675 -0.693 . . . . 51.450000000000003 109.562 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.588 HG22 ' HE2' ' A' ' 43' ' ' LYS . 10.8 t -108.51 125.43 65.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.427 -0.351 . . . . 44.200000000000003 110.766 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -85.17 130.76 34.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.405 0.621 . . . . 72.129999999999995 110.679 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -125.56 -164.55 1.31 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.252 -0.885 . . . . 64.030000000000001 108.838 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.844 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 86.6 mtm180 -106.37 162.6 13.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.285 -0.635 . . . . 70.530000000000001 109.285 171.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.41 -25.15 60.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.101 0.477 . . . . 74.329999999999998 109.941 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 p -82.48 -9.19 59.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 61.43 110.432 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.844 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 7.7 mm-40 -88.17 -12.96 42.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.274 0.559 . . . . 71.340000000000003 110.929 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 10' ' ' VAL . 27.2 mt -126.59 167.28 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.611 -0.722 . . . . 54.530000000000001 110.732 -173.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.58 ' OE2' ' HB3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -151.27 148.77 28.6 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.993 -0.743 . . . . 71.299999999999997 108.993 167.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.44 141.31 34.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.682 0.277 . . . . 55.439999999999998 110.631 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.784 -0.821 . . . . 74.010000000000005 108.784 177.282 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.746 HD12 HD22 ' A' ' 49' ' ' LEU . 48.9 mt . . . . . 0 C--O 1.233 0.202 0 N-CA-C 109.552 -0.536 . . . . 53.340000000000003 109.552 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.13 147.19 37.3 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.719 0.295 . . . . 44.539999999999999 111.173 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.97 151.66 73.48 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.738 2.292 . . . . 64.200000000000003 111.438 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.48 2.54 90.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.843 -0.694 . . . . 50.310000000000002 112.004 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.91 153.02 20.24 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.773 0.32 . . . . 74.329999999999998 110.496 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -89.56 129.91 35.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.556 . . . . 72.209999999999994 110.649 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG21 HD13 ' A' ' 52' ' ' LEU . 17.3 m -124.34 158.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.908 -0.587 . . . . 72.430000000000007 110.023 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.402 ' HB3' ' CG ' ' A' ' 53' ' ' GLU . 35.7 ttt180 -118.59 126.53 52.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.907 -0.405 . . . . 74.150000000000006 109.907 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.27 115.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 75.150000000000006 110.941 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 m -100.36 -3.68 30.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 64.120000000000005 110.6 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.593 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 27.0 t-20 -64.94 113.67 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 63.229999999999997 110.042 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.08 -13.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 72.409999999999997 111.54 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.59 -48.89 17.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.967 0.358 . . . . 74.25 111.967 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.98 161.43 25.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.063 0.458 . . . . 71.329999999999998 110.97 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.92 -30.49 71.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.502 -0.772 . . . . 64.019999999999996 112.605 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -80.91 24.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.286 0.476 . . . . 73.420000000000002 112.286 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 50.7 t80 -64.99 127.88 33.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 109.795 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 35.7 mtm180 74.72 27.15 1.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.288 0.635 . . . . 70.430000000000007 111.892 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.42 152.87 24.11 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.954 -0.387 . . . . 73.5 109.954 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -102.96 142.18 34.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.581 -0.526 . . . . 73.420000000000002 109.581 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.45 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -144.24 170.0 26.15 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.719 -0.753 . . . . 73.25 112.067 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.8 tp -109.91 123.04 48.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.647 0.26 . . . . 73.319999999999993 110.577 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 27' ' ' VAL . 52.2 t -68.32 115.42 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.535 -0.302 . . . . 60.509999999999998 110.52 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -81.48 -33.08 32.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 75.299999999999997 110.463 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.454 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -169.38 143.6 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.643 -0.873 . . . . 73.439999999999998 108.643 177.444 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.44 HG22 HG11 ' A' ' 24' ' ' VAL . 23.6 t -99.14 135.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.69 -0.686 . . . . 63.009999999999998 110.332 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 8.5 t -104.89 -176.19 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.695 -0.854 . . . . 73.349999999999994 108.695 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.39 77.69 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.495 0.664 . . . . 71.209999999999994 110.081 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 3.24 39.64 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.039 -0.982 . . . . 71.25 111.84 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.541 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 27.7 ttmt -141.5 172.88 12.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.903 -0.777 . . . . 65.150000000000006 108.903 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.8 143.73 6.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.479 0.18 . . . . 53.530000000000001 110.887 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.19 119.07 32.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 72.140000000000001 110.276 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.478 HG21 HD21 ' A' ' 52' ' ' LEU . 39.9 t -100.82 124.65 54.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 53.509999999999998 111.028 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.5 tp -96.44 121.59 38.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.129 -0.487 . . . . 62.25 110.295 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.75 137.23 36.14 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.655 -0.869 . . . . 74.540000000000006 108.655 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.47 114.51 8.61 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.823 -0.436 . . . . 64.310000000000002 109.823 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 29.4 t-20 -137.04 90.31 2.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.215 0.531 . . . . 60.200000000000003 111.157 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.13 -90.7 0.52 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.46 -0.791 . . . . 62.030000000000001 112.833 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.0 -16.23 11.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 75.209999999999994 109.943 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.411 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 66.9 t90 -94.28 144.07 25.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 72.329999999999998 110.682 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.2 158.29 43.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.368 -0.833 . . . . 72.230000000000004 110.018 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.58 132.11 6.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.957 -0.565 . . . . 74.150000000000006 110.132 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.411 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.0 tp -103.92 109.44 21.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.311 -0.404 . . . . 62.329999999999998 110.301 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.59 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 62.509999999999998 110.307 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.3 m -81.12 132.65 35.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.267 0.556 . . . . 53.43 110.755 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -129.61 177.89 6.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.82 -0.808 . . . . 73.239999999999995 108.82 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.547 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -97.61 178.11 5.28 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.816 -0.354 . . . . 64.340000000000003 110.265 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.746 HD22 HD12 ' A' ' 2' ' ' ILE . 68.8 mt -78.56 -25.96 45.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.195 0.521 . . . . 64.140000000000001 110.02 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 p -76.3 -17.5 59.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 62.399999999999999 109.996 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.593 ' HG3' ' HB2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -86.44 -18.84 30.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.1 -0.955 . . . . 63.399999999999999 110.835 -178.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.478 HD21 HG21 ' A' ' 34' ' ' VAL . 55.6 mt -122.65 122.63 39.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.957 -0.565 . . . . 73.409999999999997 111.202 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -88.34 118.26 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.114 -0.698 . . . . 73.209999999999994 109.114 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -75.11 106.29 6.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.977 -0.556 . . . . 71.540000000000006 109.967 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 71.310000000000002 110.107 -177.674 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.464 HD12 HD22 ' A' ' 49' ' ' LEU . 57.9 mt . . . . . 0 N--CA 1.455 -0.182 0 N-CA-C 108.585 -0.895 . . . . 72.340000000000003 108.585 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 97.6 m-85 -127.85 145.55 55.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.75 0.31 . . . . 61.43 111.281 -175.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 35.6 Cg_exo -59.86 142.91 99.49 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.092 2.528 . . . . 64.230000000000004 112.313 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.25 6.08 63.23 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.846 -0.692 . . . . 62.219999999999999 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.669 0.271 . . . . 53.009999999999998 110.305 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -92.03 130.55 37.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.399 . . . . 64.329999999999998 110.45 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.63 142.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 110.154 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -102.18 125.44 48.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.954 -0.566 . . . . 72.140000000000001 110.047 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.64 115.85 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.684 -0.689 . . . . 64.540000000000006 110.406 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -105.69 10.52 32.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 73.140000000000001 110.319 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.0 109.71 0.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.93 -0.577 . . . . 71.409999999999997 109.979 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.37 -35.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.011 -0.54 . . . . 75.120000000000005 112.141 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.89 -2.61 34.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.394 0.616 . . . . 63.450000000000003 111.018 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.98 165.61 16.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.256 -0.429 . . . . 72.540000000000006 110.263 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.82 -27.29 26.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.268 -0.424 . . . . 72.239999999999995 110.84 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -87.95 24.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.085 0.469 . . . . 73.299999999999997 111.16 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 53.6 t80 -63.12 136.81 57.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 72.540000000000006 110.027 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 40.3 mtm180 82.44 -10.91 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.802 0.841 . . . . 63.229999999999997 112.251 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -72.92 150.64 42.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 73.420000000000002 110.398 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -117.62 133.38 56.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.13 -0.486 . . . . 73.439999999999998 110.235 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.68 172.97 21.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.583 -0.818 . . . . 73.230000000000004 112.484 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.47 125.96 48.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.422 -0.214 . . . . 74.019999999999996 110.422 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.87 115.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.133 -0.321 . . . . 75.120000000000005 110.133 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.436 ' HG3' HD13 ' A' ' 44' ' ' LEU . 27.6 mm-40 -87.35 -35.81 18.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.959 -0.564 . . . . 74.5 110.418 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -166.81 148.87 6.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.692 -0.686 . . . . 74.530000000000001 109.574 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 2' ' ' ILE . 44.4 t -105.4 140.93 21.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.334 -0.848 . . . . 73.310000000000002 109.755 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -129.3 -162.27 1.19 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.859 -0.423 . . . . 72.420000000000002 109.859 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.42 86.85 1.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.541 . . . . 75.230000000000004 110.139 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.64 5.67 86.32 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 114.739 -1.119 . . . . 73.010000000000005 111.854 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 36.7 mtmm -129.41 166.25 19.93 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 122.625 0.37 . . . . 71.25 110.637 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 141.88 24.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.268 -0.423 . . . . 62.219999999999999 110.242 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -89.71 108.48 19.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.971 -0.381 . . . . 73.25 109.971 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.6 122.42 47.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.609 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.0 tp -96.63 120.09 36.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 110.553 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 95.9 m-85 -93.44 141.62 28.25 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.82 -0.807 . . . . 73.120000000000005 108.82 171.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -140.72 133.21 28.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.263 -0.426 . . . . 33.219999999999999 110.028 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -147.44 70.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.172 0.51 . . . . 71.209999999999994 110.127 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.54 -88.02 1.22 Allowed Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.653 -0.703 . . . . 54.149999999999999 112.441 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -104.53 -20.81 13.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.394 0.616 . . . . 51.109999999999999 109.878 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -81.69 132.01 35.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.261 -0.881 . . . . 75.510000000000005 111.394 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -128.93 152.57 48.42 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.458 -1.246 . . . . 72.540000000000006 109.346 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 54.5 tttp -157.73 100.92 1.79 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.517 -0.311 . . . . 62.420000000000002 110.224 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.5 tp -95.15 106.32 18.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.387 -0.369 . . . . 74.340000000000003 110.324 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.526 HG23 ' HG2' ' A' ' 43' ' ' LYS . 54.8 t -126.33 126.46 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.195 -0.457 . . . . 52.240000000000002 110.487 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.1 m -77.65 131.8 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 62.340000000000003 110.347 177.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -124.44 -174.59 3.05 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.134 -0.691 . . . . 65.5 109.134 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.605 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 9.4 mtt180 -102.28 164.1 11.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.723 0.297 . . . . 54.530000000000001 110.31 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 2' ' ' ILE . 91.7 mt -78.64 -20.89 49.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.269 0.556 . . . . 75.150000000000006 110.378 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 p -88.53 -16.49 32.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.65 -0.704 . . . . 34.229999999999997 110.102 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.605 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 12.3 mm-40 -93.55 -4.18 51.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.561 -0.745 . . . . 62.020000000000003 110.347 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -121.58 158.74 27.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 72.019999999999996 110.768 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -139.63 123.84 17.92 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.457 -0.572 . . . . 62.219999999999999 109.457 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 132.04 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 63.530000000000001 110.697 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 1.8 t . . . . . 0 C--N 1.321 -0.641 0 CA-C-N 116.154 -0.476 . . . . 64.319999999999993 110.166 -177.619 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.673 HD12 HD22 ' A' ' 49' ' ' LEU . 56.8 mt . . . . . 0 C--O 1.231 0.103 0 N-CA-C 109.703 -0.48 . . . . 70.010000000000005 109.703 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.36 147.82 66.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.308 -0.405 . . . . 51.109999999999999 110.519 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.6 129.77 30.73 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.613 2.209 . . . . 73.120000000000005 111.209 175.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.18 27.67 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.115 -0.564 . . . . 61.530000000000001 111.829 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 147.27 24.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.612 0.244 . . . . 64.439999999999998 110.617 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -89.31 132.71 34.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 75.349999999999994 110.381 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 52' ' ' LEU . 12.0 m -133.61 149.27 30.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.935 0.398 . . . . 73.129999999999995 111.552 -176.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -114.96 135.83 53.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.776 -0.647 . . . . 43.240000000000002 109.695 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -75.2 106.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 64.140000000000001 109.927 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -90.97 -5.97 54.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.756 0.312 . . . . 63.030000000000001 111.48 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -65.68 111.37 3.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.309 -0.626 . . . . 73.340000000000003 109.309 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 3.0 t -80.78 -1.14 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.395 0.617 . . . . 54.32 111.033 -173.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -101.35 -22.99 14.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.99 -0.55 . . . . 73.209999999999994 110.673 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.72 158.03 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.964 -170.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.1 m -65.31 -32.6 74.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.979 -1.009 . . . . 72.120000000000005 111.555 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -101.4 30.62 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 64.209999999999994 111.232 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 25.0 t80 -55.37 138.16 46.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 75.540000000000006 111.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 56.08 18.3 3.11 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.239 1.416 . . . . 70.209999999999994 113.276 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.27 151.27 24.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.786 -0.82 . . . . 74.420000000000002 108.786 167.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.19 130.16 53.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.006 -0.543 . . . . 72.439999999999998 110.067 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.16 -174.67 16.62 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.522 -0.847 . . . . 32.439999999999998 112.384 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.1 tp -113.1 132.81 55.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.336 -0.246 . . . . 74.530000000000001 110.336 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.51 114.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 74.349999999999994 110.043 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HG3' HD13 ' A' ' 44' ' ' LEU . 28.6 mm-40 -79.11 -35.3 42.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.145 0.498 . . . . 73.510000000000005 110.366 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -172.24 146.24 1.84 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.366 -0.834 . . . . 74.230000000000004 109.259 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.327 -0.851 . . . . 73.219999999999999 110.17 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 t -106.63 67.87 0.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.492 -0.558 . . . . 50.119999999999997 109.492 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 68.85 -72.34 0.1 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.9 -1.046 . . . . 54.119999999999997 112.531 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.55 -9.76 20.73 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 115.257 -0.883 . . . . 35.409999999999997 113.022 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -124.28 170.35 10.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 110.2 -0.296 . . . . 53.119999999999997 110.2 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.72 149.1 30.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.532 0.206 . . . . 65.099999999999994 110.973 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -96.16 117.07 30.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.731 -0.47 . . . . 53.420000000000002 109.731 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.2 t -100.36 120.94 50.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 65.439999999999998 110.85 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.69 115.72 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 75.230000000000004 109.912 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -91.75 144.73 25.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 62.020000000000003 109.508 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.87 112.37 7.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.693 -0.484 . . . . 74.040000000000006 109.693 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -130.73 79.68 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.106 -0.497 . . . . 52.140000000000001 110.262 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.49 -90.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.055 -0.52 . . . . 73.329999999999998 112.672 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -100.73 -22.38 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 62.329999999999998 110.1 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.9 t90 -92.16 144.49 25.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.401 -0.818 . . . . 65.349999999999994 110.978 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -149.69 153.59 37.2 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.076 -0.965 . . . . 71.430000000000007 109.266 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HG3' HG23 ' A' ' 45' ' ' VAL . 24.2 tptm -162.53 128.43 3.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.409 -0.359 . . . . 72.140000000000001 110.82 -175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.571 HD11 ' HB1' ' A' ' 33' ' ' ALA . 63.8 tp -98.12 112.03 24.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 109.959 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.437 HG23 ' HG3' ' A' ' 43' ' ' LYS . 42.0 t -126.53 125.81 67.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.839 0.352 . . . . 74.109999999999999 110.483 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.5 m -73.68 140.4 46.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.189 0.519 . . . . 71.540000000000006 110.844 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.0 -176.06 4.25 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 72.439999999999998 109.262 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.849 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 98.9 mtt180 -91.39 -179.28 5.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.099 -0.704 . . . . 72.310000000000002 109.099 170.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.673 HD22 HD12 ' A' ' 2' ' ' ILE . 87.0 mt -87.25 -33.03 19.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.951 -0.759 . . . . 74.409999999999997 108.951 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.8 m -70.63 -14.41 62.47 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.57 -0.741 . . . . 75.420000000000002 111.106 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.849 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 11.1 mm-40 -80.53 -18.71 47.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.204 0.526 . . . . 74.340000000000003 110.591 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 8' ' ' VAL . 38.8 mt -115.68 157.38 24.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 74.5 111.325 -172.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.84 146.6 49.19 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.7 -0.852 . . . . 74.150000000000006 108.7 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.87 123.57 26.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.761 0.315 . . . . 52.119999999999997 110.238 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.8 t . . . . . 0 C--N 1.324 -0.508 0 N-CA-C 108.947 -0.76 . . . . 64.319999999999993 108.947 177.166 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.3 mt . . . . . 0 N--CA 1.464 0.266 0 CA-C-O 121.44 0.638 . . . . 74.209999999999994 110.421 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -146.17 162.56 34.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.177 -0.92 . . . . 71.299999999999997 109.533 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.47 113.11 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.181 1.921 . . . . 72.230000000000004 111.098 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.11 -9.58 15.51 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.798 -0.715 . . . . 44.420000000000002 111.983 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.95 147.12 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 63.340000000000003 110.433 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -89.89 132.58 35.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.116 -0.493 . . . . 64.219999999999999 110.158 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -127.7 152.59 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.954 0.407 . . . . 62.450000000000003 110.736 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 43.5 ttm180 -110.06 129.28 55.71 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.032 -0.729 . . . . 65.109999999999999 109.032 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.36 101.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.085 0.469 . . . . 63.130000000000003 110.915 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -79.76 -12.45 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 64.439999999999998 109.573 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -68.6 107.42 2.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.28 -0.873 . . . . 71.010000000000005 110.125 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -89.94 -13.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 64.430000000000007 110.601 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.69 -36.17 82.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.418 -0.81 . . . . 72.5 110.47 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.99 -174.91 5.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 73.010000000000005 109.874 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 m -93.92 -21.13 19.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.085 0.469 . . . . 65.150000000000006 110.807 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.534 ' OH ' ' HG3' ' A' ' 43' ' ' LYS . 54.2 m-85 -90.25 40.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 74.340000000000003 111.329 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 29.7 t80 -57.65 132.46 53.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.813 -0.631 . . . . 73.340000000000003 111.096 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 18' ' ' TYR . 36.2 ptt180 59.84 14.93 4.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.147 1.379 . . . . 71.329999999999998 112.77 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.22 156.57 26.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.106 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.73 117.66 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 109.901 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.6 176.47 17.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.615 -0.803 . . . . 71.099999999999994 112.478 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.95 123.18 48.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.232 . . . . 73.040000000000006 110.383 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.419 HG11 HG22 ' A' ' 27' ' ' VAL . 58.0 t -67.56 122.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 71.340000000000003 110.007 177.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 24.9 mm-40 -91.49 -27.56 18.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.976 -0.557 . . . . 61.32 111.005 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -168.2 135.5 2.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.389 -0.823 . . . . 73.040000000000006 109.938 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.419 HG22 HG11 ' A' ' 24' ' ' VAL . 42.5 t -104.06 150.36 7.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.256 -0.884 . . . . 62.5 110.086 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.85 -177.63 4.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.3 -0.63 . . . . 54.109999999999999 109.3 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.44 80.43 3.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.595 0.712 . . . . 71.140000000000001 110.759 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.41 -24.58 9.1 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 114.809 -1.087 . . . . 61.020000000000003 112.025 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -118.82 157.83 26.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.556 0.217 . . . . 64.120000000000005 111.161 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.06 138.43 22.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.347 -0.388 . . . . 63.25 110.163 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -95.0 112.15 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.125 -0.324 . . . . 61.420000000000002 110.125 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.9 124.52 50.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 73.219999999999999 110.586 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 33.8 tp -93.53 119.79 33.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.007 -0.542 . . . . 64.319999999999993 110.467 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -100.46 141.06 33.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.95 -0.759 . . . . 61.329999999999998 108.95 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -139.03 141.08 38.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.549 -0.296 . . . . 65.420000000000002 110.37 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -153.8 76.49 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.239 -0.652 . . . . 74.319999999999993 109.239 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.94 -110.08 3.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 44.310000000000002 111.877 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.37 -15.83 44.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.885 0.374 . . . . 75.239999999999995 110.736 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -87.16 142.78 27.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.363 0.602 . . . . 73.439999999999998 110.582 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.31 163.35 36.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.919 -1.037 . . . . 72.510000000000005 109.45 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HD2' ' CG2' ' A' ' 45' ' ' VAL . 4.3 tmtp? -166.5 109.23 0.73 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 73.409999999999997 110.221 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.34 104.05 15.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.764 -0.458 . . . . 75.329999999999998 109.764 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.557 ' CG2' ' HD2' ' A' ' 43' ' ' LYS . 17.9 t -111.95 126.37 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 60.5 110.251 -176.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.6 m -85.68 120.28 26.94 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.328 0.585 . . . . 42.109999999999999 109.815 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.42 -168.32 1.3 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.402 -0.817 . . . . 74.510000000000005 109.106 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.95 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 55.3 mmt-85 -105.63 160.45 15.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.187 -0.672 . . . . 64.409999999999997 109.187 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -71.07 -27.86 63.93 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.254 0.549 . . . . 74.040000000000006 110.035 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 p -75.43 -22.47 57.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.477 -0.783 . . . . 50.240000000000002 110.305 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.95 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 20.6 mm-40 -88.28 -5.38 58.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.0 -0.545 . . . . 70.010000000000005 111.378 -173.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.417 HD13 HG21 ' A' ' 8' ' ' VAL . 72.5 mt -120.02 143.04 48.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.059 -0.519 . . . . 71.030000000000001 110.263 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 9' ' ' ARG . 9.7 pt-20 -107.59 130.66 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.183 -0.673 . . . . 52.149999999999999 109.183 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.64 24.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.34 -0.391 . . . . 75.209999999999994 110.093 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 C--N 1.323 -0.572 0 N-CA-C 108.849 -0.797 . . . . 64.219999999999999 108.849 177.547 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.71 ' HB ' HD22 ' A' ' 49' ' ' LEU . 59.7 mt . . . . . 0 N--CA 1.455 -0.189 0 CA-C-O 121.14 0.495 . . . . 72.409999999999997 111.856 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -135.83 155.88 77.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.306 -0.861 . . . . 73.120000000000005 109.448 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.72 132.38 34.92 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.063 1.842 . . . . 74.25 111.59 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.52 -7.54 58.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.98 -0.628 . . . . 63.329999999999998 112.216 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.81 147.31 23.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.312 . . . . 72.109999999999999 111.15 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -87.02 126.15 34.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 74.519999999999996 110.068 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 52' ' ' LEU . 21.0 m -124.97 148.16 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.211 0.529 . . . . 72.420000000000002 110.973 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 23.5 ttp180 -111.05 132.41 54.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.46 -0.791 . . . . 73.030000000000001 109.682 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.08 100.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.362 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 p -102.06 7.26 41.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.216 0.532 . . . . 75.420000000000002 111.176 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 48.1 t30 -71.93 100.12 2.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.55 -0.75 . . . . 74.129999999999995 109.549 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.95 -30.18 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 72.540000000000006 111.984 -171.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.66 -7.43 59.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.438 . . . . 75.400000000000006 111.637 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 18.3 t70 -87.92 162.09 17.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.048 -0.408 . . . . 73.200000000000003 111.277 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 m -77.05 -26.63 53.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.083 -0.508 . . . . 72.340000000000003 111.696 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' OH ' ' HE2' ' A' ' 43' ' ' LYS . 89.9 m-85 -106.91 28.89 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 73.239999999999995 111.265 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.425 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 t80 -68.88 82.2 0.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 64.5 110.408 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 25.9 ptt180 169.91 -27.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.376 -0.829 . . . . 73.430000000000007 110.421 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.61 158.4 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.291 0.567 . . . . 74.239999999999995 112.013 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 81.4 mt-10 -125.8 134.16 51.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.183 -0.917 . . . . 72.299999999999997 108.962 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.61 178.45 21.05 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.373 -0.918 . . . . 73.239999999999995 112.335 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.94 129.69 56.09 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.943 0.372 . . . . 61.32 110.388 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 ' CG2' ' A' ' 2' ' ' ILE . 74.4 t -68.31 124.83 24.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.295 -0.412 . . . . 73.140000000000001 110.764 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -93.63 -29.17 15.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 73.0 110.82 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 26' ' ' ARG . 11.3 ptm180 -165.3 133.06 3.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.509 -0.769 . . . . 73.329999999999998 110.689 -174.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 29' ' ' ASP . 96.5 t -97.4 131.54 44.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.554 -0.748 . . . . 75.329999999999998 109.057 173.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -116.06 36.37 4.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.17 0.51 . . . . 72.129999999999995 109.996 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.511 ' H ' HG12 ' A' ' 27' ' ' VAL . 10.5 m-20 63.0 99.85 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.032 -0.985 . . . . 70.329999999999998 111.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.02 3.87 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.873 -0.603 . . . . 73.439999999999998 111.64 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 23.3 ttmt -118.62 165.24 14.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 64.109999999999999 109.062 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.97 146.02 18.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.513 -0.312 . . . . 53.229999999999997 110.676 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.54 114.34 26.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.823 -0.436 . . . . 74.540000000000006 109.823 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.58 125.66 47.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 63.25 110.408 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.0 tp -98.14 110.77 23.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 43.340000000000003 110.39 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 78.6 m-85 -91.66 142.87 27.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.66 -0.866 . . . . 73.310000000000002 108.66 173.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 3.8 tm-20 -155.77 126.59 6.93 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.168 -0.678 . . . . 73.299999999999997 109.168 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -153.56 102.91 2.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.2 -0.454 . . . . 72.530000000000001 110.627 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.6 -84.93 1.18 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.823 -0.626 . . . . 63.119999999999997 112.398 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -129.39 -4.9 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.509 0.671 . . . . 51.130000000000003 109.95 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ2' ' HB2' ' A' ' 43' ' ' LYS . 35.3 t90 -100.38 135.97 41.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.764 -0.653 . . . . 72.319999999999993 112.251 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.2 144.12 48.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.764 -1.107 . . . . 74.439999999999998 109.154 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 44.9 tptt -146.76 110.39 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.585 0.231 . . . . 63.439999999999998 110.431 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -106.74 105.46 15.51 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 73.540000000000006 110.087 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.415 HG23 ' HG3' ' A' ' 43' ' ' LYS . 24.7 t -127.98 133.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 71.439999999999998 110.018 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -85.07 122.88 29.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 120.972 0.415 . . . . 71.230000000000004 111.206 -179.271 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.91 175.67 6.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.765 -0.828 . . . . 73.340000000000003 108.765 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.851 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 63.6 mtt180 -89.11 165.11 14.71 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.256 0.55 . . . . 72.319999999999993 110.589 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.71 HD22 ' HB ' ' A' ' 2' ' ' ILE . 96.5 mt -79.53 -24.78 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.497 -0.774 . . . . 74.109999999999999 110.139 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 t -91.63 -5.98 52.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.603 -0.726 . . . . 64.040000000000006 110.101 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.851 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 52.8 mt-10 -92.73 -9.38 40.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.64 -0.424 . . . . 70.340000000000003 111.91 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 2' ' ' ILE . 44.5 mt -120.66 163.78 17.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.559 -0.291 . . . . 73.120000000000005 110.694 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -123.57 155.09 38.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.891 -0.411 . . . . 73.030000000000001 109.891 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.6 125.06 39.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.863 0.363 . . . . 73.030000000000001 110.955 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--N 1.324 -0.52 0 N-CA-C 108.8 -0.815 . . . . 74.099999999999994 108.8 177.479 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt . . . . . 0 C--O 1.232 0.156 0 N-CA-C 108.8 -0.815 . . . . 75.319999999999993 108.8 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.93 154.83 53.21 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.68 0.276 . . . . 65.439999999999998 110.899 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' PRO . . . . . 0.64 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 15.8 Cg_endo -59.82 126.03 19.34 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.366 2.044 . . . . 71.040000000000006 111.214 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 108.78 -7.48 33.61 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.623 -0.799 . . . . 45.340000000000003 111.811 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.57 152.73 19.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 71.0 110.715 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -95.32 130.46 42.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 61.329999999999998 110.117 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 52' ' ' LEU . 21.6 m -124.52 155.8 32.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.908 0.385 . . . . 73.140000000000001 111.395 -177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 9' ' ' ARG . 19.2 ttt180 -122.8 121.32 35.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 73.310000000000002 109.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.99 116.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 54.399999999999999 111.238 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -90.74 -28.32 18.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 62.439999999999998 111.514 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.031 -0.359 . . . . 75.019999999999996 110.031 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.482 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 30.5 t -72.81 -26.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.175 0.512 . . . . 73.239999999999995 111.515 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.47 -15.39 55.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 65.340000000000003 111.281 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 160.16 29.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.093 0.473 . . . . 54.399999999999999 111.3 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -66.88 -38.69 86.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.739 -0.664 . . . . 75.540000000000006 111.637 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.61 26.8 5.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.897 0.379 . . . . 71.109999999999999 111.345 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 13' ' ' VAL . 37.4 t80 -57.98 140.51 52.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.048 -0.524 . . . . 74.549999999999997 110.86 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 73.87 9.5 4.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.405 -0.816 . . . . 75.409999999999997 111.485 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -102.58 153.04 20.48 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.896 -0.409 . . . . 74.510000000000005 109.896 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.88 139.38 49.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 62.420000000000002 110.181 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.53 175.92 23.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.815 -0.707 . . . . 53.350000000000001 112.228 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.8 tt -112.6 124.95 53.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.112 -0.329 . . . . 74.420000000000002 110.112 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.54 117.31 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 62.299999999999997 110.804 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -78.09 -36.13 48.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.987 -0.552 . . . . 64.299999999999997 110.161 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 4' ' ' PRO . 30.5 ptt180 -170.8 145.98 2.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.695 -0.684 . . . . 62.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.608 HG13 HD21 ' A' ' 49' ' ' LEU . 89.7 t -106.76 121.52 59.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.279 -0.873 . . . . 62.329999999999998 109.302 172.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.4 m -155.29 139.31 16.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.726 -0.215 . . . . 61.350000000000001 110.873 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 67.67 15.29 9.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.799 -0.637 . . . . 64.209999999999994 111.474 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.98 2.7 71.2 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.709 -0.758 . . . . 54.43 111.907 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 61.2 mtpt -115.31 163.05 16.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 110.182 -0.303 . . . . 62.219999999999999 110.182 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.25 125.87 25.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.256 -0.429 . . . . 42.450000000000003 110.048 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.728 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.38 113.12 20.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 71.299999999999997 109.891 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.18 119.65 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 71.420000000000002 111.238 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.7 tp -94.1 108.79 20.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.945 -0.571 . . . . 74.340000000000003 109.685 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 96.6 m-85 -80.36 141.36 35.46 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.284 -0.636 . . . . 63.509999999999998 109.284 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -139.24 124.37 18.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.488 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -128.85 86.3 2.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 60.210000000000001 109.916 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.81 -95.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.205 -0.758 . . . . 71.519999999999996 111.205 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -122.37 87.77 2.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.529 1.156 . . . . 74.420000000000002 108.554 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 t90 178.8 138.46 0.09 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.283 -2.235 . . . . 74.540000000000006 109.463 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.6 p30 -137.03 152.71 50.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.489 -0.778 . . . . 74.099999999999994 110.558 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HG3' HG23 ' A' ' 45' ' ' VAL . 17.1 tppt? -156.56 107.14 2.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 73.420000000000002 110.044 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 ' HB1' ' A' ' 33' ' ' ALA . 57.4 tp -89.21 110.86 21.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.169 -0.469 . . . . 71.200000000000003 110.716 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 43' ' ' LYS . 34.8 t -125.65 120.73 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 65.540000000000006 109.213 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.0 m -81.41 130.93 35.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.282 0.563 . . . . 71.439999999999998 111.067 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 52' ' ' LEU . 81.9 m-85 -124.53 -167.27 1.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.19 -0.914 . . . . 72.140000000000001 109.038 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.722 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 65.2 mtt-85 -110.24 162.81 14.25 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.885 -0.413 . . . . 65.349999999999994 109.885 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.608 HD21 HG13 ' A' ' 27' ' ' VAL . 3.6 mm? -66.4 -33.29 75.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.429 0.633 . . . . 63.25 109.999 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 p -78.16 -6.38 54.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.514 -0.766 . . . . 64.329999999999998 110.573 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.722 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 15.4 mm-40 -94.13 -15.57 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 62.420000000000002 111.001 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 47' ' ' PHE . 29.4 mt -127.79 150.07 49.98 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.066 -0.515 . . . . 74.109999999999999 111.645 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -121.25 143.45 49.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.655 -0.868 . . . . 75.209999999999994 108.655 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.18 136.37 37.08 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.958 -0.297 . . . . 53.240000000000002 110.246 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 C--O 1.235 0.326 0 N-CA-C 109.534 -0.543 . . . . 34.350000000000001 109.534 179.037 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.4 ptp . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 120.858 0.361 . . . . 71.519999999999996 110.5 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 58.0 mt -131.88 142.32 43.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 N-CA-C 109.347 -0.612 . . . . 75.219999999999999 109.347 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -135.27 161.71 61.79 Favored Pre-proline 0 C--N 1.326 -0.43 0 CA-C-N 116.605 -0.27 . . . . 75.25 110.295 -176.235 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.86 117.55 4.32 Favored 'Trans proline' 0 C--O 1.234 0.296 0 C-N-CA 122.274 1.983 . . . . 74.140000000000001 111.191 173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.85 1.36 24.15 Favored Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.892 -0.67 . . . . 63.420000000000002 111.897 -174.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -100.33 141.72 32.79 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 120.93 0.395 . . . . 61.0 110.948 177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.6 m -82.55 129.96 35.02 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.804 -0.634 . . . . 33.229999999999997 110.51 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.479 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -132.36 153.02 37.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.114 0.483 . . . . 71.219999999999999 111.565 -176.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 24.7 ttm180 -117.13 137.04 52.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.515 -0.766 . . . . 73.519999999999996 109.969 177.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.4 t -80.42 115.26 22.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.3 -0.409 . . . . 71.310000000000002 110.353 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -105.49 18.52 22.09 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.212 -0.449 . . . . 75.430000000000007 112.21 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 -89.82 113.9 25.55 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.177 -0.675 . . . . 62.200000000000003 109.177 174.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 31.2 t -67.11 -28.35 42.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.767 -0.651 . . . . 54.210000000000001 111.976 -171.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -93.07 23.54 4.25 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.464 0.649 . . . . 65.540000000000006 110.791 -175.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -114.72 160.96 18.77 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.791 -0.568 . . . . 55.0 110.527 177.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 18.7 m -71.06 -32.09 68.67 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.232 -0.44 . . . . 52.530000000000001 111.173 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.471 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 71.6 m-85 -96.85 25.45 5.29 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 111.886 0.328 . . . . 70.129999999999995 111.886 -175.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 67.1 t80 -59.23 131.32 50.65 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.537 -0.301 . . . . 70.239999999999995 110.198 175.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 31.3 ttt180 78.23 -16.84 0.62 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.885 0.874 . . . . 75.340000000000003 111.577 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -75.25 157.46 34.41 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.923 0.392 . . . . 63.43 110.686 179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -116.61 139.63 50.3 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.859 -0.609 . . . . 65.109999999999999 110.854 -174.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 179.88 18.46 Favored Glycine 0 N--CA 1.443 -0.861 0 CA-C-N 115.785 -0.643 . . . . 41.039999999999999 111.506 179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 32.2 tp -119.0 123.23 44.03 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 110.311 -0.255 . . . . 63.530000000000001 110.311 -178.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 67.7 t -62.93 116.81 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.35 0 N-CA-C 109.845 -0.428 . . . . 74.299999999999997 109.845 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 27.9 mm-40 -90.49 -33.65 15.88 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.938 -0.574 . . . . 54.409999999999997 110.914 -177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.7 ptp180 -169.84 154.02 5.11 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.764 -0.653 . . . . 63.439999999999998 110.177 -174.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.6 t -88.16 124.74 41.42 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 CA-C-N 115.097 -0.956 . . . . 55.25 109.115 172.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.2 m -120.2 98.84 6.26 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 120.992 0.425 . . . . 75.540000000000006 111.179 -177.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 54.29 39.45 30.87 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.356 -0.838 . . . . 74.209999999999994 112.178 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.47 -11.72 65.0 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.642 -0.789 . . . . 62.539999999999999 112.569 177.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.426 ' HB3' ' O ' ' A' ' 47' ' ' PHE . 99.0 mttt -99.13 177.61 5.17 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 110.113 -0.329 . . . . 75.140000000000001 110.113 176.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.99 126.18 40.86 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.742 0.306 . . . . 70.519999999999996 110.604 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.817 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -83.58 107.52 16.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.291 -0.413 . . . . 74.400000000000006 109.957 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -94.12 124.02 46.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.137 -0.483 . . . . 72.329999999999998 110.822 -176.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 43.2 tp -99.13 126.51 44.9 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.821 -0.627 . . . . 74.310000000000002 110.511 177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -103.59 136.46 43.26 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 108.535 -0.913 . . . . 62.200000000000003 108.535 172.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 39' ' ' GLY . 0.6 OUTLIER -141.83 133.22 26.6 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.807 -0.442 . . . . 55.039999999999999 109.807 -172.597 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -129.11 21.78 5.74 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.196 0.522 . . . . 71.109999999999999 111.09 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 40' ' ' ASN . . . 98.13 9.26 54.17 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.643 -0.789 . . . . 50.340000000000003 112.951 175.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.402 ' HB2' ' O ' ' A' ' 39' ' ' GLY . 28.6 t-20 169.34 -46.41 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.333 0 N-CA-C 109.087 -0.709 . . . . 73.420000000000002 109.087 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.2 t90 -80.25 138.69 36.84 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.501 -0.772 . . . . 74.230000000000004 109.894 175.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.1 p-10 -154.8 163.21 40.59 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.736 -0.665 . . . . 60.32 110.602 -179.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -165.39 106.79 0.78 Allowed 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.242 -0.89 . . . . 72.129999999999995 109.462 173.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.817 HD21 ' HB1' ' A' ' 33' ' ' ALA . 8.7 tt -77.52 119.25 20.84 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.649 -0.5 . . . . 51.340000000000003 109.649 178.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.4 t -128.15 124.26 62.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.861 -0.422 . . . . 75.530000000000001 109.861 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.539 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -84.09 129.2 34.92 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.225 0.536 . . . . 52.310000000000002 110.729 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.426 ' O ' ' HB3' ' A' ' 31' ' ' LYS . 95.7 m-85 -124.73 178.45 5.45 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.454 -0.793 . . . . 65.219999999999999 109.182 177.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.943 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 49.7 mtt180 -87.08 163.02 17.25 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.296 -0.631 . . . . 64.540000000000006 109.296 175.241 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -69.37 -31.24 69.51 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 108.724 -0.843 . . . . 71.310000000000002 108.724 174.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.5 p -67.82 -21.34 65.22 Favored 'General case' 0 N--CA 1.449 -0.475 0 CA-C-N 114.933 -1.03 . . . . 50.100000000000001 110.466 175.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.943 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 41.2 mm-40 -87.95 -7.9 56.45 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.501 -0.48 . . . . 65.230000000000004 111.254 -175.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.479 HD13 HG21 ' A' ' 8' ' ' VAL . 49.9 mt -122.88 156.63 34.24 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.973 0.416 . . . . 74.329999999999998 111.719 -173.125 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -129.22 147.24 51.05 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.114 -0.698 . . . . 52.140000000000001 109.114 167.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -78.94 132.33 36.68 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.819 0.342 . . . . 74.299999999999997 111.127 -175.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.7 t -93.88 174.39 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 109.041 -0.725 . . . . 72.5 109.041 177.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.644 ' H ' HG12 ' A' ' 55' ' ' VAL . 14.5 mptt -90.02 134.52 31.58 Favored Pre-proline 0 C--N 1.32 -0.691 0 CA-C-O 120.63 0.252 . . . . 73.219999999999999 110.584 -179.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -75.44 -168.28 0.51 Allowed 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.939 2.426 . . . . 74.430000000000007 111.846 176.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.824 HD12 ' H ' ' A' ' 58' ' ' ILE . 2.6 mp -67.0 152.36 9.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 109.151 -0.685 . . . . 61.25 109.151 177.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD13 ' HA ' ' A' ' 59' ' ' LEU . 3.4 mm? -88.35 82.07 7.11 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.137 0.494 . . . . 73.239999999999995 110.923 -174.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -76.32 156.13 33.62 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.628 -0.715 . . . . 53.539999999999999 109.938 174.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 33.2 t60 -97.65 98.11 9.6 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.689 -0.486 . . . . 73.329999999999998 109.689 175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 23.4 p-80 -84.43 146.55 27.58 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 109.568 -0.531 . . . . 73.230000000000004 109.568 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 14.7 p80 -160.7 142.63 12.45 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.925 0.393 . . . . 74.420000000000002 110.839 -179.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.5 m80 -138.02 163.72 30.85 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 108.887 -0.783 . . . . 73.400000000000006 108.887 174.227 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -150.75 153.92 36.39 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 120.895 0.378 . . . . 74.230000000000004 110.928 -179.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 118.192 -0.909 . . . . 72.209999999999994 109.239 176.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.5 ttt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 120.875 0.369 . . . . 60.310000000000002 110.194 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.7 HD12 HD22 ' A' ' 49' ' ' LEU . 52.3 mt -98.37 144.98 10.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 116.385 -0.37 . . . . 73.439999999999998 110.145 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -115.47 143.46 30.54 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 116.249 -0.432 . . . . 71.439999999999998 110.762 -177.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -63.85 134.6 44.23 Favored 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.675 2.25 . . . . 63.240000000000002 111.544 177.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.83 -5.01 50.23 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.991 -0.624 . . . . 62.210000000000001 112.331 -177.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -98.7 161.07 13.85 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.831 0.348 . . . . 53.32 110.695 178.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -99.69 131.79 45.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.264 -0.425 . . . . 75.129999999999995 110.234 178.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.629 HG21 HD13 ' A' ' 52' ' ' LEU . 25.9 m -125.7 155.52 35.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.163 -0.471 . . . . 72.439999999999998 110.206 178.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 12.3 ttp180 -109.47 143.07 39.59 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.669 -0.493 . . . . 44.439999999999998 109.669 177.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 60.8 t -77.16 113.96 16.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.032 -0.359 . . . . 63.0 110.032 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 6.6 m -89.69 -19.02 25.32 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.084 -0.507 . . . . 73.439999999999998 111.142 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 58.0 t30 -66.03 106.83 1.7 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.984 0.421 . . . . 74.420000000000002 110.5 -178.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 52.8 t -68.15 -30.42 47.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.665 -0.698 . . . . 71.549999999999997 111.132 -175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -64.66 -26.55 68.43 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.72 -0.673 . . . . 71.439999999999998 111.125 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -82.16 155.37 25.02 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.931 0.396 . . . . 63.229999999999997 110.647 -176.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -72.85 -27.5 61.97 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.002 -0.545 . . . . 73.109999999999999 110.945 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -88.43 22.66 2.45 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.276 -0.42 . . . . 71.25 111.489 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.439 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 35.6 t80 -63.32 134.61 56.08 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.239 -0.437 . . . . 74.409999999999997 110.332 177.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.7 mtp180 76.17 1.82 3.48 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 123.761 0.825 . . . . 74.549999999999997 112.293 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -85.35 150.51 24.69 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.076 0.465 . . . . 75.129999999999995 110.212 174.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -111.2 125.25 53.6 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.444 -0.798 . . . . 74.519999999999996 109.744 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.527 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -125.72 155.27 18.96 Favored Glycine 0 N--CA 1.442 -0.942 0 C-N-CA 120.586 -0.816 . . . . 41.329999999999998 111.85 -177.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 7.1 mp -93.66 116.48 28.98 Favored 'General case' 0 N--CA 1.441 -0.887 0 N-CA-C 110.252 -0.277 . . . . 75.409999999999997 110.252 -178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -65.01 106.34 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 109.85 -0.426 . . . . 61.310000000000002 109.85 177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -79.37 -34.5 41.96 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.101 0.477 . . . . 72.019999999999996 110.521 -177.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 -167.03 143.72 4.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.695 -0.684 . . . . 70.140000000000001 109.65 -179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -92.18 136.14 25.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.016 0 CA-C-N 115.431 -0.804 . . . . 72.519999999999996 109.276 173.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.9 m -127.03 93.75 3.84 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 110.264 -0.273 . . . . 63.009999999999998 110.264 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 68.92 -76.82 0.06 Allowed 'General case' 0 CA--C 1.515 -0.374 0 CA-C-N 115.298 -0.864 . . . . 65.129999999999995 111.085 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -140.76 11.73 2.9 Favored Glycine 0 C--N 1.3 -1.444 0 CA-C-N 114.332 -1.304 . . . . 44.310000000000002 111.132 179.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.521 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 47.4 mtmt -114.6 165.95 12.23 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.115 -0.543 . . . . 74.019999999999996 109.55 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -135.98 133.4 37.5 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.681 0.277 . . . . 51.229999999999997 110.5 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.544 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.74 99.6 10.37 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.18 -0.674 . . . . 42.340000000000003 109.18 177.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.527 ' CG1' ' HA3' ' A' ' 22' ' ' GLY . 55.4 t -91.78 118.09 36.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 116.036 -0.529 . . . . 64.099999999999994 110.793 -174.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.8 tp -94.6 122.59 37.35 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.781 -0.645 . . . . 72.209999999999994 110.509 178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 92.3 m-85 -99.95 146.77 26.3 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.957 -0.757 . . . . 71.340000000000003 108.957 174.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.491 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 30.8 tt0 -129.55 -56.06 1.15 Allowed 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 120.669 -0.412 . . . . 60.310000000000002 111.805 -176.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 64.64 -66.2 0.13 Allowed 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 122.825 0.45 . . . . 74.019999999999996 111.523 -175.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . -168.73 93.5 0.1 Allowed Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.334 -0.706 . . . . 52.009999999999998 111.334 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.406 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 8.6 t30 72.59 -36.79 0.37 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.492 0.717 . . . . 74.120000000000005 111.743 -177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.491 ' O ' ' HA ' ' A' ' 37' ' ' GLU . 48.1 t90 -57.41 155.38 9.34 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.879 -0.6 . . . . 73.040000000000006 110.789 175.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.449 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.0 p-10 -148.54 153.45 38.41 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.267 -0.424 . . . . 71.409999999999997 110.301 177.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.8 tttp -169.45 110.58 0.46 Allowed 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.362 -0.836 . . . . 73.129999999999995 109.378 178.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.544 HD11 ' HB1' ' A' ' 33' ' ' ALA . 37.8 tp -90.91 105.98 18.2 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.066 -0.516 . . . . 73.129999999999995 110.067 -178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 23.9 t -118.0 118.09 57.06 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 110.004 -0.369 . . . . 73.400000000000006 110.004 -179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.7 m -79.27 129.6 34.62 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.08 0.467 . . . . 54.539999999999999 110.583 179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.6 m-85 -124.84 178.41 5.5 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.613 -0.721 . . . . 65.439999999999998 109.119 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.961 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 62.8 mmt-85 -90.17 162.85 15.07 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.959 -0.756 . . . . 74.129999999999995 108.959 175.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.7 HD22 HD12 ' A' ' 2' ' ' ILE . 87.0 mt -79.36 -22.31 44.6 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.27 0.557 . . . . 71.319999999999993 109.882 -176.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.2 p -75.21 -15.12 60.57 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.399 -0.819 . . . . 64.209999999999994 110.003 175.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.961 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 13.4 mm-40 -91.89 -13.17 31.71 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.732 -0.667 . . . . 63.539999999999999 110.604 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.629 HD13 HG21 ' A' ' 8' ' ' VAL . 62.9 mt -115.56 161.54 18.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.593 -0.73 . . . . 73.230000000000004 111.01 -174.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -125.64 128.99 48.72 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.802 -0.636 . . . . 75.129999999999995 109.549 172.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.602 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -79.93 108.74 13.74 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.254 -0.43 . . . . 72.340000000000003 110.71 -178.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.562 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -73.63 173.32 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 108.837 -0.801 . . . . 72.140000000000001 108.837 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.562 ' H ' HG12 ' A' ' 55' ' ' VAL . 19.9 pttp -63.16 134.75 95.93 Favored Pre-proline 0 C--N 1.321 -0.641 0 CA-C-O 120.878 0.37 . . . . 62.450000000000003 110.626 -179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.516 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 8.5 Cg_exo -72.64 -173.68 1.25 Allowed 'Trans proline' 0 C--O 1.234 0.314 0 C-N-CA 122.964 2.442 . . . . 63.25 111.945 -179.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.6 mt -79.34 152.0 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.027 -0.731 . . . . 74.340000000000003 109.027 176.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.5 pp -92.98 150.3 20.65 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 116.27 -0.423 . . . . 74.430000000000007 111.321 -174.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -90.81 -78.2 0.39 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.845 -0.798 . . . . 52.149999999999999 108.845 178.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 10.4 m80 -156.01 174.95 14.61 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.189 -0.914 . . . . 72.310000000000002 109.375 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -83.71 102.99 12.65 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.196 0.522 . . . . 74.420000000000002 110.717 178.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -101.19 147.62 26.05 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.525 -0.762 . . . . 74.25 109.39 179.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 56.8 p-80 -70.89 115.34 9.92 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.011 -0.737 . . . . 75.409999999999997 109.011 174.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -73.51 162.17 29.56 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.575 -0.739 . . . . 70.349999999999994 111.895 -169.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.8 m80 . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.168 -0.92 . . . . 62.109999999999999 109.464 175.931 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ptm . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.898 0.38 . . . . 74.140000000000001 111.007 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 45.2 mt -97.15 136.5 27.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 109.007 -0.738 . . . . 74.25 109.007 173.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -149.62 144.27 17.63 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 109.887 -0.412 . . . . 74.219999999999999 109.887 -173.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -53.36 131.57 44.08 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.71 2.273 . . . . 53.119999999999997 111.857 175.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.2 -13.26 48.52 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.985 -0.626 . . . . 32.520000000000003 111.883 -177.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.1 164.39 13.09 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.877 0.37 . . . . 22.129999999999999 110.561 -179.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.1 m -97.36 134.42 40.66 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.902 -0.59 . . . . 72.040000000000006 110.085 179.104 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 15.3 m -125.79 148.68 30.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-O 120.991 0.425 . . . . 72.420000000000002 111.008 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.422 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 22.2 ttt180 -104.92 122.23 45.38 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.66 -0.7 . . . . 73.430000000000007 109.504 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 52' ' ' LEU . 41.2 t -70.82 103.41 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-O 121.1 0.476 . . . . 64.420000000000002 110.16 -178.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 9.8 p -108.88 23.94 13.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.799 -0.637 . . . . 75.319999999999993 111.572 -175.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 54.7 t-20 -72.87 106.43 4.8 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.876 -0.787 . . . . 72.329999999999998 108.876 174.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.2 t -64.41 -25.47 38.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.179 0.514 . . . . 73.129999999999995 111.178 -174.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -86.08 -23.26 26.75 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.168 -0.469 . . . . 73.109999999999999 111.308 -177.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -89.79 155.8 18.93 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.887 0.375 . . . . 73.310000000000002 110.905 -175.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 88.9 m -78.94 -23.4 44.66 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.302 -0.408 . . . . 54.119999999999997 111.822 -176.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.8 m-85 -76.91 11.77 1.62 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.022 0.439 . . . . 73.420000000000002 111.28 -178.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.468 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 64.9 t80 -71.33 78.13 0.74 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.516 -0.765 . . . . 75.230000000000004 110.055 177.556 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.468 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 14.8 ptt180 168.9 -20.38 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.154 0 CA-C-N 115.182 -0.917 . . . . 71.430000000000007 109.629 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 -90.12 148.07 23.22 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.305 0.574 . . . . 74.140000000000001 111.408 -178.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.422 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 41.5 mt-10 -125.91 118.12 24.76 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.246 -1.02 . . . . 74.109999999999999 108.246 175.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.76 176.81 17.86 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.132 -1.032 . . . . 60.43 113.148 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 93.8 mt -93.67 140.4 29.68 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.553 0.216 . . . . 71.109999999999999 110.632 -178.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.3 t -84.27 117.33 29.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 CA-C-N 116.254 -0.43 . . . . 53.219999999999999 110.667 177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.408 ' OE1' ' HB2' ' A' ' 35' ' ' LEU . 2.6 mp0 -75.9 -37.71 58.52 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.111 0.481 . . . . 55.130000000000003 110.108 176.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 -170.67 141.06 1.79 Allowed 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.798 -0.637 . . . . 64.25 110.615 -175.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 58.0 t -98.75 108.25 21.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.939 0 CA-C-N 115.264 -0.88 . . . . 63.219999999999999 108.788 170.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -88.92 41.71 1.04 Allowed 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.523 -0.308 . . . . 60.240000000000002 110.955 -175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 35.2 t70 63.5 88.93 0.09 Allowed 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 115.317 -0.856 . . . . 61.310000000000002 111.143 178.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.24 -30.55 9.66 Favored Glycine 0 C--O 1.236 0.228 0 CA-C-N 115.656 -0.702 . . . . 60.5 112.448 -178.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.6 mtpt -120.65 162.66 19.29 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 122.214 0.206 . . . . 73.439999999999998 110.491 -179.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.94 140.7 28.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 120.519 0.2 . . . . 73.230000000000004 111.019 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.64 ' HB1' HD21 ' A' ' 44' ' ' LEU . . . -93.02 116.57 29.17 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.51 -0.552 . . . . 71.010000000000005 109.51 177.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 43.4 t -107.28 127.21 63.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 116.398 -0.364 . . . . 74.439999999999998 110.66 -176.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.408 ' HB2' ' OE1' ' A' ' 25' ' ' GLN . 37.0 tp -88.72 125.88 35.06 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.2 -0.454 . . . . 72.319999999999993 110.889 176.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.592 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 91.4 m-85 -102.91 142.22 34.39 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.766 -0.652 . . . . 71.230000000000004 109.445 173.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -143.3 119.7 10.95 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.65 -0.5 . . . . 62.130000000000003 109.65 -174.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.481 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 55.5 t30 -137.92 91.36 2.57 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.996 0.427 . . . . 54.109999999999999 110.62 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.19 -91.76 0.83 Allowed Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 115.747 -0.66 . . . . 64.0 112.473 178.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -114.49 -11.61 12.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.307 0.575 . . . . 75.409999999999997 110.385 176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.481 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 63.8 t90 -89.01 139.15 30.75 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.704 -0.68 . . . . 72.319999999999993 111.39 -177.002 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -140.74 154.4 46.3 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.303 -0.862 . . . . 72.439999999999998 109.784 177.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -163.5 121.34 1.89 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.679 -0.691 . . . . 71.239999999999995 110.503 -179.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.64 HD21 ' HB1' ' A' ' 33' ' ' ALA . 9.1 tt -91.03 113.76 26.11 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.244 -0.65 . . . . 74.439999999999998 109.244 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.592 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 44.3 t -123.14 129.05 75.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 120.863 0.364 . . . . 63.350000000000001 110.636 -179.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.8 m -84.37 132.62 34.57 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.991 0.424 . . . . 72.430000000000007 110.585 177.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 59.6 m-85 -128.44 -176.61 3.87 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.911 -0.586 . . . . 74.099999999999994 110.053 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.559 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 25.2 mtp180 -100.47 157.01 16.95 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 109.298 -0.631 . . . . 74.219999999999999 109.298 178.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 85.4 mt -77.5 -23.04 50.37 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.059 0.457 . . . . 72.219999999999999 110.424 -174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.5 p -74.47 -18.04 60.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.667 -0.697 . . . . 65.340000000000003 110.315 175.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.559 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 4.1 mp0 -99.0 -4.63 32.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.923 -0.58 . . . . 74.200000000000003 111.294 -177.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 10' ' ' VAL . 84.0 mt -120.18 130.18 54.45 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.199 -0.455 . . . . 74.430000000000007 110.458 -177.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -103.95 135.34 45.66 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.104 -0.702 . . . . 75.030000000000001 109.104 172.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.44 128.9 36.78 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.085 -0.507 . . . . 73.409999999999997 110.579 -176.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.481 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -102.05 168.34 2.08 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 N-CA-C 108.6 -0.889 . . . . 70.519999999999996 108.6 177.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.481 ' H ' HG12 ' A' ' 55' ' ' VAL . 0.8 OUTLIER -104.73 138.28 19.46 Favored Pre-proline 0 C--N 1.312 -1.048 0 N-CA-C 109.579 -0.526 . . . . 74.140000000000001 109.579 -179.228 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -54.87 144.21 67.91 Favored 'Trans proline' 0 C--O 1.236 0.401 0 C-N-CA 122.716 2.278 . . . . 73.530000000000001 111.718 177.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.836 HD12 ' H ' ' A' ' 58' ' ' ILE . 1.9 mp -60.43 148.22 8.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 109.523 -0.547 . . . . 73.209999999999994 109.523 -178.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.7 tt -128.52 117.91 22.13 Favored 'General case' 0 C--N 1.312 -1.058 0 CA-C-N 115.819 -0.628 . . . . 64.349999999999994 110.021 -172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -124.62 144.57 50.1 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.949 -0.76 . . . . 73.219999999999999 108.949 174.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 11.8 t-80 -128.84 113.67 15.56 Favored 'General case' 0 C--N 1.32 -0.693 0 C-N-CA 120.724 -0.39 . . . . 74.329999999999998 110.716 -178.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.6 m170 -65.49 118.06 8.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.374 -0.602 . . . . 75.010000000000005 109.374 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 47.2 t-80 -137.13 124.6 22.07 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.07 0.462 . . . . 75.409999999999997 111.377 -171.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -77.42 143.99 38.2 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.939 -0.763 . . . . 75.140000000000001 108.939 172.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 19.7 t-80 -59.45 104.35 0.26 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.998 0.428 . . . . 70.510000000000005 111.578 -176.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 39.9 t-80 . . . . . 0 C--O 1.244 0.805 0 CA-C-N 115.398 -0.819 . . . . 61.210000000000001 109.143 175.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 12.1 tpt . . . . . 0 N--CA 1.479 0.976 0 N-CA-C 109.847 -0.427 . . . . 75.099999999999994 109.847 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 30.2 mt -71.66 131.75 34.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 109.927 -0.397 . . . . 74.219999999999999 109.927 179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HB3' ' HD2' ' A' ' 4' ' ' PRO . 36.9 m-85 -149.4 167.48 12.94 Favored Pre-proline 0 C--N 1.32 -0.695 0 CA-C-N 115.678 -0.692 . . . . 72.140000000000001 110.028 -177.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.815 ' HG3' ' HA ' ' A' ' 26' ' ' ARG . 51.6 Cg_exo -53.83 124.33 15.6 Favored 'Trans proline' 0 C--N 1.349 0.563 0 C-N-CA 122.696 2.264 . . . . 64.150000000000006 112.061 176.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 108.27 -16.3 35.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.129 -0.558 . . . . 73.200000000000003 112.036 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.26 155.27 30.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.756 0.312 . . . . 71.019999999999996 110.792 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -98.39 130.37 45.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.341 -0.39 . . . . 62.439999999999998 110.401 179.547 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 14.7 m -129.48 157.45 42.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.242 -0.435 . . . . 62.43 110.459 178.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 39.2 ttp180 -133.98 135.7 43.64 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 116.061 -0.518 . . . . 70.540000000000006 110.365 -177.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 51.3 t -73.77 120.89 23.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.099 -0.5 . . . . 75.329999999999998 110.678 -178.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 49.9 p -100.1 5.88 44.93 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.175 -0.466 . . . . 43.119999999999997 111.817 -177.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.482 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.3 t30 -80.86 108.48 14.56 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.616 -0.513 . . . . 64.129999999999995 109.616 177.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 37.3 t -71.17 -28.14 31.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.902 -0.59 . . . . 74.010000000000005 111.528 -172.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -79.45 -6.5 57.02 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.014 0.435 . . . . 72.510000000000005 110.933 -177.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.482 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 8.8 t70 -94.24 160.64 14.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.756 0.312 . . . . 74.049999999999997 110.306 -178.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 23.6 m -82.92 -19.71 36.76 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.23 -0.441 . . . . 72.120000000000005 110.708 -178.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -90.45 19.61 5.12 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.244 0.545 . . . . 63.109999999999999 110.351 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -64.56 128.63 36.59 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.683 -0.69 . . . . 75.420000000000002 111.145 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 87.2 mtt180 70.05 7.44 6.22 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 115.245 -0.889 . . . . 61.130000000000003 112.512 177.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -79.74 145.29 32.97 Favored 'General case' 0 N--CA 1.445 -0.689 0 N-CA-C 109.168 -0.678 . . . . 74.239999999999995 109.168 170.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -113.19 129.92 56.37 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-N 115.5 -0.773 . . . . 71.219999999999999 109.804 -176.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.75 164.67 25.45 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.444 -0.884 . . . . 71.540000000000006 112.047 -176.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -98.03 129.95 44.87 Favored 'General case' 0 N--CA 1.443 -0.804 0 N-CA-C 110.283 -0.266 . . . . 73.150000000000006 110.283 -178.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.5 t -65.05 112.18 1.51 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 116.187 -0.46 . . . . 62.009999999999998 109.845 176.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.7 mm-40 -71.25 -37.68 71.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.297 0.57 . . . . 71.239999999999995 109.524 179.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.815 ' HA ' ' HG3' ' A' ' 4' ' ' PRO . 33.0 ptt180 -174.78 150.22 1.27 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 115.086 -0.961 . . . . 72.25 109.011 178.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -94.18 128.57 45.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.064 0 CA-C-N 115.552 -0.749 . . . . 74.109999999999999 109.414 175.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.1 t -124.94 78.59 1.71 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.877 -0.416 . . . . 64.409999999999997 109.877 -177.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 22.3 t70 49.56 82.86 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 115.29 -0.868 . . . . 72.439999999999998 112.416 176.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.27 -12.39 19.75 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.98 -0.628 . . . . 63.310000000000002 113.209 177.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 59.1 mtpt -115.38 158.27 22.7 Favored 'General case' 0 N--CA 1.442 -0.868 0 CA-C-O 120.567 0.223 . . . . 71.150000000000006 110.513 179.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.62 131.46 27.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.475 -0.329 . . . . 71.299999999999997 110.361 178.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.63 105.43 14.54 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.413 -0.588 . . . . 72.150000000000006 109.413 178.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -92.26 121.01 42.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 116.265 -0.425 . . . . 62.020000000000003 110.812 -175.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 27.3 tp -97.88 108.55 21.29 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 109.754 -0.461 . . . . 75.129999999999995 109.754 175.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 75.3 m-85 -82.42 134.42 35.23 Favored 'General case' 0 C--N 1.312 -1.063 0 N-CA-C 109.038 -0.727 . . . . 73.129999999999995 109.038 176.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -113.34 -54.92 2.57 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.978 -0.555 . . . . 70.310000000000002 111.165 -173.287 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.668 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 24.4 t-20 68.89 -48.22 0.58 Allowed 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 122.971 0.508 . . . . 72.239999999999995 111.971 -176.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 156.9 -48.29 0.46 Allowed Glycine 0 N--CA 1.453 -0.227 0 C-N-CA 121.203 -0.523 . . . . 51.350000000000001 111.985 179.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.7 t-20 -132.25 4.93 4.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 122.585 1.183 . . . . 72.450000000000003 108.985 178.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.668 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 26.4 t90 -103.12 172.7 6.67 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 113.725 -1.58 . . . . 64.409999999999997 109.828 -175.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.525 ' O ' ' HE2' ' A' ' 43' ' ' LYS . 3.3 p30 -154.08 153.79 32.5 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 110.272 -0.27 . . . . 72.109999999999999 110.272 176.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HE2' ' O ' ' A' ' 42' ' ' ASP . 0.0 OUTLIER -175.52 109.43 0.1 Allowed 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.531 -0.759 . . . . 62.399999999999999 110.237 175.192 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.401 HD11 ' HB1' ' A' ' 33' ' ' ALA . 62.9 tp -97.68 109.97 22.62 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.176 -0.305 . . . . 63.399999999999999 110.176 175.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 31.3 t -134.76 129.64 51.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.103 -0.499 . . . . 70.120000000000005 109.932 178.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 m -90.13 135.14 33.84 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.251 0.548 . . . . 63.420000000000002 110.683 178.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -130.38 -176.36 3.94 Favored 'General case' 0 C--N 1.317 -0.816 0 N-CA-C 108.701 -0.851 . . . . 64.120000000000005 108.701 176.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.058 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 68.4 mtt180 -87.48 168.43 13.1 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.455 -0.572 . . . . 64.329999999999998 109.455 174.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 95.6 mt -79.36 -24.07 42.94 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 109.135 -0.691 . . . . 75.010000000000005 109.135 178.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.8 p -80.46 -20.42 43.79 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.171 -0.922 . . . . 72.409999999999997 110.58 177.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 1.058 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 10.4 mm-40 -85.83 -14.39 45.17 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-O 121.363 0.601 . . . . 71.349999999999994 110.409 -177.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 41.0 mt -115.42 155.7 26.94 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.567 -0.742 . . . . 74.319999999999993 110.151 -176.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -108.87 133.58 52.7 Favored 'General case' 0 C--N 1.318 -0.767 0 N-CA-C 109.409 -0.589 . . . . 63.450000000000003 109.409 171.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.3 120.59 22.54 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.233 -0.44 . . . . 40.439999999999998 109.845 176.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -80.85 166.6 2.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 109.447 -0.575 . . . . 74.430000000000007 109.447 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.511 ' H ' HG12 ' A' ' 55' ' ' VAL . 98.0 mttt -99.04 154.97 37.06 Favored Pre-proline 0 C--N 1.317 -0.84 0 CA-C-N 116.475 -0.329 . . . . 74.030000000000001 110.739 -174.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -60.09 145.79 97.62 Favored 'Trans proline' 0 C--O 1.235 0.338 0 C-N-CA 122.505 2.137 . . . . 64.310000000000002 111.425 173.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.833 HD12 ' H ' ' A' ' 58' ' ' ILE . 2.2 mp -67.34 153.03 9.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.123 0.487 . . . . 74.329999999999998 110.563 -175.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -120.4 118.72 31.05 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.487 -0.779 . . . . 72.540000000000006 109.847 179.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 72.04 130.92 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.215 0 O-C-N 124.043 0.839 . . . . 54.530000000000001 111.105 -179.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -82.46 115.84 21.65 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.981 -0.554 . . . . 74.209999999999994 110.56 177.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 15.1 t60 -70.53 94.34 0.97 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.134 -1.062 . . . . 73.129999999999995 108.134 173.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 4.9 p80 -71.13 -19.38 62.44 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 113.332 0.864 . . . . 71.150000000000006 113.332 -164.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 96.5 m-70 60.11 -152.8 0.39 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 109.791 -0.448 . . . . 74.430000000000007 109.791 -178.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 81.4 m-70 -123.41 116.03 22.58 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.312 -0.625 . . . . 52.100000000000001 109.312 170.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 56.1 m80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.577 -0.725 . . . . 65.040000000000006 110.358 -177.539 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.467 ' HA ' ' HE3' ' A' ' 1' ' ' MET . 1.7 tpt . . . . . 0 N--CA 1.48 1.068 0 CA-C-O 120.793 0.33 . . . . 63.219999999999999 110.151 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.404 ' CG2' HG21 ' A' ' 24' ' ' VAL . 32.4 mt -77.92 136.51 24.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 116.103 -0.499 . . . . 75.519999999999996 110.451 -179.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 46.9 p90 -131.69 159.92 69.77 Favored Pre-proline 0 N--CA 1.443 -0.795 0 CA-C-N 115.898 -0.592 . . . . 73.25 109.751 179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_exo -60.84 127.76 23.44 Favored 'Trans proline' 0 C--N 1.343 0.289 0 C-N-CA 122.504 2.136 . . . . 73.040000000000006 111.782 178.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 102.37 -5.68 52.35 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.065 -0.588 . . . . 71.049999999999997 112.618 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.7 146.28 26.9 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.63 0.253 . . . . 51.25 111.253 -178.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -85.65 124.78 32.57 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 116.115 -0.493 . . . . 71.409999999999997 110.083 176.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.704 HG21 HD13 ' A' ' 52' ' ' LEU . 16.5 m -128.39 144.52 37.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.194 0.521 . . . . 72.540000000000006 111.37 -177.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.749 ' HB2' ' HG2' ' A' ' 21' ' ' GLU . 11.5 ttt85 -100.89 130.12 46.85 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.659 -0.701 . . . . 54.119999999999997 110.174 177.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 49.0 t -68.31 111.9 2.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 109.054 -0.721 . . . . 72.129999999999995 109.054 176.477 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -112.58 10.78 19.57 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.121 0.486 . . . . 44.43 111.806 -171.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 -82.35 112.73 19.59 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 108.784 -0.821 . . . . 65.329999999999998 108.784 173.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 t -66.56 -21.47 28.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.78 -0.645 . . . . 62.340000000000003 111.431 -174.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -69.81 -31.0 68.66 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.969 -0.56 . . . . 73.219999999999999 111.415 -178.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -87.22 161.57 17.95 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.141 0.496 . . . . 75.230000000000004 111.077 -174.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.7 m -77.87 -23.29 48.87 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.791 -0.64 . . . . 75.540000000000006 111.53 -176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.401 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 82.6 m-85 -88.63 20.41 3.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.654 0.264 . . . . 74.519999999999996 111.57 -177.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -71.2 77.1 0.71 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.156 0.503 . . . . 62.340000000000003 110.876 178.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 166.67 -30.81 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.02 -0.991 . . . . 70.439999999999998 109.675 179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -78.38 151.21 32.94 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.678 -0.692 . . . . 74.450000000000003 111.539 -173.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.749 ' HG2' ' HB2' ' A' ' 9' ' ' ARG . 29.3 mt-10 -125.38 122.95 38.23 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.094 -0.957 . . . . 74.219999999999999 109.509 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -130.77 -178.68 15.57 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.726 -0.75 . . . . 71.219999999999999 112.472 -175.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 74.1 mt -102.07 135.94 42.77 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 120.764 0.316 . . . . 74.030000000000001 111.191 -177.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.404 HG21 ' CG2' ' A' ' 2' ' ' ILE . 62.0 t -75.66 111.09 11.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.937 0.399 . . . . 71.349999999999994 110.04 175.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -72.84 -41.39 64.85 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.659 0.742 . . . . 62.299999999999997 109.669 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 9.6 ptt180 -164.95 138.53 4.81 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 114.575 -1.193 . . . . 73.310000000000002 109.569 -174.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.507 HG13 HD21 ' A' ' 49' ' ' LEU . 60.3 t -95.21 139.77 18.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.396 -0.82 . . . . 51.329999999999998 109.77 176.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.549 ' HB3' ' HB2' ' A' ' 31' ' ' LYS . 6.0 t -130.43 63.29 1.57 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.475 -0.565 . . . . 62.530000000000001 109.475 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 16.25 81.89 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 125.291 1.436 . . . . 54.009999999999998 113.386 -178.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 119.99 -41.83 1.87 Allowed Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.673 -1.149 . . . . 70.230000000000004 110.672 -174.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.595 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 51.7 mmtt -109.78 167.35 10.22 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 122.76 0.424 . . . . 52.240000000000002 110.195 176.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -161.4 139.06 9.08 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.211 -0.45 . . . . 44.149999999999999 110.147 176.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.573 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -90.9 114.57 27.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.942 -0.392 . . . . 65.030000000000001 109.942 -179.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.481 HG21 HD21 ' A' ' 52' ' ' LEU . 42.2 t -99.21 120.29 48.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.893 0.378 . . . . 73.319999999999993 110.819 -177.182 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 35.9 tp -97.65 114.52 26.49 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.566 -0.531 . . . . 62.039999999999999 109.566 176.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -84.4 141.97 30.46 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.95 -0.568 . . . . 72.109999999999999 109.925 178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -135.49 113.94 11.62 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.924 -0.58 . . . . 72.200000000000003 109.648 -177.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -142.39 79.71 1.67 Allowed 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 121.062 0.458 . . . . 74.129999999999995 110.936 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.42 -104.04 2.12 Favored Glycine 0 N--CA 1.45 -0.416 0 CA-C-N 115.848 -0.615 . . . . 64.340000000000003 112.656 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -96.78 -16.58 20.75 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.665 0.745 . . . . 64.120000000000005 109.625 178.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 90.7 t90 -95.04 141.17 29.0 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.211 -0.904 . . . . 63.299999999999997 111.239 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -153.39 150.91 29.33 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 114.88 -1.055 . . . . 75.310000000000002 109.527 177.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.454 ' HE2' ' CG2' ' A' ' 45' ' ' VAL . 87.3 tttt -158.09 131.31 7.53 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.058 -0.519 . . . . 72.219999999999999 110.27 -175.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.454 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.9 tp -99.81 110.7 23.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.358 -0.383 . . . . 71.129999999999995 110.3 179.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.454 ' CG2' ' HE2' ' A' ' 43' ' ' LYS . 40.2 t -124.27 120.4 59.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.981 0.419 . . . . 64.530000000000001 110.425 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.573 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.2 m -75.88 130.01 37.87 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.206 0.527 . . . . 73.400000000000006 110.493 176.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -125.28 -171.06 2.28 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.504 -0.771 . . . . 54.340000000000003 108.979 176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.717 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 19.9 mtm180 -99.33 171.04 8.23 Favored 'General case' 0 C--N 1.316 -0.888 0 N-CA-C 109.466 -0.568 . . . . 74.109999999999999 109.466 173.132 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.507 HD21 HG13 ' A' ' 27' ' ' VAL . 75.3 mt -76.6 -30.99 57.18 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.014 0.435 . . . . 64.219999999999999 110.039 -178.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 9.6 p -71.58 -12.78 61.53 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.718 -0.674 . . . . 45.420000000000002 110.345 178.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.717 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 4.8 mm-40 -86.67 -14.68 41.89 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.13 -0.486 . . . . 71.519999999999996 110.744 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.704 HD13 HG21 ' A' ' 8' ' ' VAL . 79.7 mt -110.74 130.67 55.51 Favored 'General case' 0 N--CA 1.45 -0.463 0 CA-C-O 121.283 0.563 . . . . 72.230000000000004 112.403 -168.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -109.89 116.0 30.84 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.35 -0.841 . . . . 75.310000000000002 109.081 172.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.69 131.35 50.64 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.819 0.343 . . . . 72.109999999999999 110.485 177.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.592 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.7 t -80.54 173.08 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 N-CA-C 109.245 -0.65 . . . . 72.120000000000005 109.245 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.592 ' H ' HG12 ' A' ' 55' ' ' VAL . 62.9 pttt -67.17 142.53 97.05 Favored Pre-proline 0 N--CA 1.446 -0.658 0 N-CA-C 110.076 -0.342 . . . . 55.439999999999998 110.076 178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_exo -60.17 154.11 54.2 Favored 'Trans proline' 0 N--CA 1.461 -0.428 0 C-N-CA 122.407 2.071 . . . . 72.340000000000003 111.103 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.797 ' H ' HD12 ' A' ' 58' ' ' ILE . 1.8 mp -58.26 147.47 6.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.247 0.546 . . . . 75.140000000000001 109.926 -178.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.852 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.6 pt? -85.06 102.44 13.23 Favored 'General case' 0 C--N 1.314 -0.959 0 CA-C-N 115.556 -0.747 . . . . 72.200000000000003 110.665 -174.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.415 ' HB2' ' H ' ' A' ' 61' ' ' HIS . 30.7 mt-10 -111.27 -82.95 0.58 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.818 -0.628 . . . . 70.310000000000002 109.683 176.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.415 ' H ' ' HB2' ' A' ' 60' ' ' GLU . 81.2 m-70 -145.43 138.56 26.28 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.383 -0.826 . . . . 74.439999999999998 109.535 175.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 79.8 t60 -77.74 91.2 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.933 -0.395 . . . . 74.239999999999995 109.933 177.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 8.3 t-80 -68.58 142.62 55.12 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.057 -0.719 . . . . 73.420000000000002 109.057 178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 43.5 m170 -72.41 159.83 33.33 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.986 0.422 . . . . 53.43 111.459 -174.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 34.9 p80 -68.97 169.74 11.13 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.507 -0.769 . . . . 54.420000000000002 111.924 -176.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 49.0 t60 . . . . . 0 C--O 1.25 1.114 0 CA-C-N 115.044 -0.98 . . . . 74.319999999999993 110.208 176.479 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.8 ttm . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.963 0.411 . . . . 75.239999999999995 110.342 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.586 HG12 ' HB2' ' A' ' 54' ' ' ALA . 48.1 mt -122.33 138.23 53.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.976 -0.557 . . . . 71.010000000000005 109.796 179.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -119.64 153.08 54.14 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.056 -0.52 . . . . 73.239999999999995 110.753 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -64.17 130.81 28.28 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.619 2.213 . . . . 74.319999999999993 111.463 176.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 103.39 -13.1 54.8 Favored Glycine 0 N--CA 1.448 -0.52 0 C-N-CA 120.958 -0.639 . . . . 74.030000000000001 112.16 -177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.77 150.63 24.43 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.009 0.433 . . . . 64.0 111.232 -178.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.6 m -87.24 130.27 34.65 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.716 -0.674 . . . . 72.0 109.882 177.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.717 HG12 ' HA ' ' A' ' 54' ' ' ALA . 22.9 m -128.93 152.29 36.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.898 0.38 . . . . 73.409999999999997 110.601 -178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.429 ' HD2' ' OE2' ' A' ' 53' ' ' GLU . 44.7 ttm180 -110.46 138.05 47.35 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 109.246 -0.65 . . . . 73.120000000000005 109.246 175.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.412 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 47.5 t -76.25 113.36 15.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 120.907 0.384 . . . . 70.540000000000006 110.818 -179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 5.5 p -96.87 2.32 51.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.328 0.585 . . . . 65.299999999999997 110.577 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.1 t-20 -72.8 115.26 11.87 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.528 -0.76 . . . . 65.019999999999996 110.32 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.9 t -91.77 -8.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.422 0.63 . . . . 63.140000000000001 110.471 -176.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 21.1 t70 -65.37 -37.81 88.16 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.71 -0.677 . . . . 64.349999999999994 110.637 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.469 ' OD2' ' HD2' ' A' ' 17' ' ' TYR . 13.6 t70 -103.45 173.47 6.29 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.189 -0.46 . . . . 72.230000000000004 109.877 178.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 2.9 m -88.94 -12.1 42.55 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 111.713 0.264 . . . . 71.299999999999997 111.713 -172.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HD2' ' OD2' ' A' ' 15' ' ' ASP . 58.4 m-85 -79.27 30.84 0.22 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.071 0.462 . . . . 73.409999999999997 112.068 -178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.436 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 86.2 t80 -70.54 138.31 50.87 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.432 -0.581 . . . . 75.400000000000006 109.432 175.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 41.3 mtt180 70.59 18.96 6.3 Favored 'General case' 0 N--CA 1.471 0.576 0 O-C-N 123.506 0.504 . . . . 74.319999999999993 112.049 -178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -93.73 150.74 20.15 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.685 -0.406 . . . . 44.210000000000001 110.522 173.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -103.57 121.52 43.07 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.221 -0.9 . . . . 73.109999999999999 109.341 -176.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.84 162.84 23.86 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.508 -0.853 . . . . 63.109999999999999 112.318 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.428 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.6 tt -116.74 123.69 47.8 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.703 -0.48 . . . . 65.439999999999998 109.703 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.46 HG13 ' HB1' ' A' ' 32' ' ' ALA . 75.6 t -65.74 114.85 3.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.961 -0.563 . . . . 63.409999999999997 110.954 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 33.2 mm-40 -79.21 -35.46 41.67 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.366 0.603 . . . . 63.450000000000003 110.145 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -165.68 154.47 11.66 Favored 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.136 -0.938 . . . . 72.420000000000002 108.923 -178.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 66.2 t -110.75 126.36 68.09 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.126 0 CA-C-N 115.535 -0.757 . . . . 72.129999999999995 109.305 174.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 27.7 t -125.43 84.98 2.34 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.55 -0.296 . . . . 71.019999999999996 110.8 -177.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 63.8 m-20 40.59 77.97 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.45 0 O-C-N 124.263 0.977 . . . . 52.049999999999997 112.969 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.407 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 96.09 -29.9 9.36 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.586 -0.816 . . . . 71.340000000000003 112.804 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HB3' HG22 ' A' ' 46' ' ' THR . 41.4 mttt -109.71 163.82 13.13 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.995 0.426 . . . . 71.239999999999995 111.379 177.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 24' ' ' VAL . . . -143.7 137.14 27.98 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.67 -0.695 . . . . 71.319999999999993 109.93 176.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.592 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.82 105.34 14.64 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 109.961 -0.385 . . . . 71.129999999999995 109.961 -179.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.0 t -92.77 118.44 38.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.18 -0.463 . . . . 72.310000000000002 110.925 -176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.2 tp -93.34 118.79 31.71 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.638 -0.504 . . . . 73.420000000000002 109.638 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -86.76 147.35 25.88 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.941 -0.572 . . . . 74.239999999999995 109.93 178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tm-20 -135.54 119.99 18.03 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.988 -0.745 . . . . 71.230000000000004 108.988 -178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -138.97 42.26 2.1 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.565 0.697 . . . . 72.219999999999999 110.046 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.18 -102.54 2.42 Favored Glycine 0 N--CA 1.446 -0.677 0 CA-C-N 115.764 -0.653 . . . . 44.450000000000003 111.671 -178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -93.29 -32.87 14.15 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.211 0.529 . . . . 72.329999999999998 109.793 175.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 85.6 t90 -74.96 140.63 43.81 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.491 -0.777 . . . . 70.25 111.007 179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -144.9 165.62 27.62 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 114.66 -1.155 . . . . 74.040000000000006 108.77 177.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.4 tttp -164.7 137.93 4.88 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 110.144 -0.317 . . . . 70.109999999999999 110.144 -179.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.592 HD11 ' HB1' ' A' ' 33' ' ' ALA . 47.8 tp -109.16 109.24 20.16 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.809 0.338 . . . . 73.099999999999994 110.178 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -124.44 124.06 67.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-O 121.064 0.459 . . . . 74.0 110.265 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.422 HG22 ' HB3' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -87.33 111.13 20.76 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.393 0.616 . . . . 73.219999999999999 110.796 179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -108.78 178.1 4.58 Favored 'General case' 0 C--N 1.311 -1.066 0 CA-C-N 115.245 -0.889 . . . . 70.430000000000007 109.455 177.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.738 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 54.0 mtt85 -88.9 159.19 17.8 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 109.706 -0.479 . . . . 71.120000000000005 109.706 175.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 30' ' ' GLY . 94.0 mt -71.45 -26.91 62.92 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.343 0.592 . . . . 74.109999999999999 109.792 -176.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 p -80.0 -12.03 59.74 Favored 'General case' 0 N--CA 1.446 -0.67 0 CA-C-N 115.289 -0.869 . . . . 71.409999999999997 109.994 177.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.738 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.5 mt-10 -98.93 3.08 47.04 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.838 -0.619 . . . . 74.5 110.558 -179.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 mt -128.01 153.55 46.63 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.541 -0.754 . . . . 71.430000000000007 110.361 -178.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.429 ' OE2' ' HD2' ' A' ' 9' ' ' ARG . 11.7 pt-20 -118.28 123.14 44.68 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.28 -0.637 . . . . 74.219999999999999 109.28 170.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.717 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -78.5 123.86 27.51 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.319 -0.4 . . . . 73.329999999999998 110.03 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.495 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -86.37 164.7 2.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 N-CA-C 108.899 -0.778 . . . . 63.310000000000002 108.899 177.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.495 ' H ' HG12 ' A' ' 55' ' ' VAL . 34.0 ttpt 63.27 111.4 0.03 OUTLIER Pre-proline 0 C--N 1.329 -0.321 0 O-C-N 123.906 0.753 . . . . 75.439999999999998 110.495 -171.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -59.07 151.66 64.76 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 122.436 2.091 . . . . 73.340000000000003 111.92 178.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.81 HD12 ' H ' ' A' ' 58' ' ' ILE . 3.0 mp -63.33 158.96 3.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.501 0 N-CA-C 109.602 -0.518 . . . . 74.209999999999994 109.602 179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.815 ' HG ' ' H ' ' A' ' 60' ' ' GLU . 30.6 tp 73.0 -172.08 0.14 Allowed 'General case' 0 C--O 1.234 0.289 0 O-C-N 123.763 0.664 . . . . 71.519999999999996 109.384 -174.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.815 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 32.2 mt-10 -93.48 150.73 20.22 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 109.688 -0.486 . . . . 65.420000000000002 109.688 177.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 16.4 p-80 -48.62 126.75 12.31 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-O 121.191 0.519 . . . . 64.010000000000005 111.11 177.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.8 p80 -129.19 165.51 21.19 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.484 -0.78 . . . . 71.310000000000002 110.602 -173.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.21 114.08 13.3 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.286 -0.415 . . . . 64.450000000000003 110.975 -175.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -71.53 173.53 7.86 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.453 -0.34 . . . . 75.409999999999997 110.943 178.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -64.25 -64.68 0.82 Allowed 'General case' 0 N--CA 1.465 0.317 0 CA-C-O 121.299 0.571 . . . . 72.129999999999995 109.751 -177.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 . . . . . 0 C--O 1.249 1.039 0 N-CA-C 108.906 -0.776 . . . . 72.150000000000006 108.906 175.41 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.9 ptm . . . . . 0 N--CA 1.478 0.963 0 CA-C-O 121.058 0.456 . . . . 73.450000000000003 110.24 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.545 HG12 ' HB2' ' A' ' 54' ' ' ALA . 41.1 mt -108.93 143.94 18.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.234 0.54 . . . . 73.439999999999998 111.444 -173.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 89.8 m-85 -130.77 154.64 81.9 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.646 -0.706 . . . . 73.019999999999996 109.714 178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 23.0 Cg_exo -64.82 119.15 6.11 Favored 'Trans proline' 0 C--O 1.235 0.33 0 C-N-CA 122.354 2.036 . . . . 75.430000000000007 111.425 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 109.24 -3.83 31.4 Favored Glycine 0 N--CA 1.446 -0.673 0 CA-C-N 115.943 -0.571 . . . . 43.43 111.949 -175.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -91.15 153.77 19.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.855 0.359 . . . . 73.019999999999996 110.811 -179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.9 m -91.82 132.44 36.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.564 . . . . 72.420000000000002 110.29 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.4 m -125.64 160.97 31.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.0 0.428 . . . . 63.399999999999999 110.828 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt85 -124.81 130.59 52.69 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.884 -0.784 . . . . 72.230000000000004 108.884 178.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.52 ' HA ' HD23 ' A' ' 52' ' ' LEU . 51.2 t -68.73 108.81 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.155 0.503 . . . . 65.329999999999998 110.767 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 7.2 m -88.13 -17.98 29.81 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.484 -0.78 . . . . 72.0 110.416 -178.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.491 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 42.7 t30 -66.85 106.99 2.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.975 -0.557 . . . . 71.219999999999999 110.573 179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.22 -24.79 19.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.817 -0.629 . . . . 74.140000000000001 110.54 -176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -67.01 -27.09 67.14 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.362 -0.835 . . . . 71.140000000000001 111.189 -177.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.491 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 11.2 t70 -85.86 164.94 17.21 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.2 -0.455 . . . . 63.009999999999998 110.766 -176.221 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.5 m -82.65 -23.77 34.07 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.346 -0.388 . . . . 72.329999999999998 110.705 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -85.38 21.53 1.73 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.949 0.404 . . . . 72.209999999999994 111.026 -179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.477 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 29.9 t80 -63.19 133.04 53.66 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.032 -0.531 . . . . 73.329999999999998 110.268 178.354 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 62.8 mtt180 76.66 3.23 3.46 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 123.621 0.768 . . . . 72.340000000000003 112.22 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -84.5 157.21 21.38 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 120.885 0.374 . . . . 75.349999999999994 110.251 175.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -118.05 141.94 47.93 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.744 -0.662 . . . . 72.319999999999993 110.122 -177.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -157.55 165.19 33.38 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.551 -0.833 . . . . 51.229999999999997 111.793 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.0 mp -104.43 131.52 51.7 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 110.26 -0.274 . . . . 73.109999999999999 110.26 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.515 HG11 HG22 ' A' ' 27' ' ' VAL . 59.9 t -70.46 117.08 12.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 116.023 -0.535 . . . . 74.019999999999996 110.199 178.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.442 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 29.3 mm-40 -83.33 -31.7 26.68 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.496 0.665 . . . . 75.340000000000003 110.279 -177.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -158.18 128.55 6.17 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 114.96 -1.018 . . . . 73.329999999999998 110.373 -177.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.515 HG22 HG11 ' A' ' 24' ' ' VAL . 57.8 t -98.38 120.14 47.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 115.572 -0.74 . . . . 75.420000000000002 110.036 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 31.5 m -102.09 -178.86 3.83 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.053 -0.721 . . . . 74.310000000000002 109.053 176.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -77.18 81.93 3.68 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.342 0.592 . . . . 70.219999999999999 110.069 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.416 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 121.84 -31.24 5.04 Favored Glycine 0 C--N 1.318 -0.444 0 CA-C-N 115.364 -0.834 . . . . 74.109999999999999 112.447 175.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.407 ' HB3' HG22 ' A' ' 46' ' ' THR . 97.1 mttt -120.28 159.79 24.27 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 120.868 0.366 . . . . 52.350000000000001 111.262 -177.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.0 135.92 36.42 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.047 -0.524 . . . . 71.120000000000005 109.812 177.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -89.19 109.36 20.24 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.909 0.385 . . . . 32.549999999999997 110.263 -177.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.1 t -92.0 126.58 44.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.699 -0.682 . . . . 64.430000000000007 110.423 -177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.442 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 34.4 tp -90.79 123.61 34.49 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.917 -0.583 . . . . 65.209999999999994 110.666 179.472 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 88.6 m-85 -107.85 134.0 51.41 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 108.55 -0.907 . . . . 61.119999999999997 108.55 171.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -143.05 128.69 19.19 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.972 0.415 . . . . 72.120000000000005 110.392 -173.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -134.31 74.9 1.56 Allowed 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.415 -0.587 . . . . 60.439999999999998 109.415 -179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.34 -97.82 0.35 Allowed Glycine 0 N--CA 1.449 -0.452 0 CA-C-N 115.684 -0.689 . . . . 40.009999999999998 112.554 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -87.55 -22.5 24.79 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.266 0.555 . . . . 71.209999999999994 110.201 -179.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.446 ' HZ2' ' HD2' ' A' ' 43' ' ' LYS . 87.1 t90 -91.75 146.93 23.37 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.724 -0.671 . . . . 73.430000000000007 110.983 -177.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -150.27 159.07 44.71 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.442 -0.799 . . . . 63.149999999999999 110.408 179.44 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.446 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 11.9 mttm -163.88 133.49 4.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.688 -0.687 . . . . 31.449999999999999 110.828 173.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 50.7 tp -106.3 104.12 13.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.587 -0.523 . . . . 71.239999999999995 109.587 176.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.44 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 29.0 t -113.53 118.04 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.071 0.463 . . . . 62.43 110.411 -176.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.593 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.4 m -82.81 130.28 35.11 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.875 -0.602 . . . . 64.140000000000001 110.469 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.49 ' HB2' HD11 ' A' ' 52' ' ' LEU . 91.2 m-85 -123.13 178.97 4.85 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-N 115.607 -0.724 . . . . 55.399999999999999 109.062 177.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.519 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 57.7 mtp180 -96.63 162.83 13.28 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.048 0.451 . . . . 72.540000000000006 110.563 178.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.428 HD22 HD12 ' A' ' 2' ' ' ILE . 94.4 mt -76.3 -22.92 54.42 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.929 -0.578 . . . . 55.240000000000002 110.41 -173.514 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.8 p -85.76 -8.26 58.25 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.975 -0.557 . . . . 70.150000000000006 109.92 177.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 55.7 mt-10 -98.89 -8.31 25.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.931 -0.577 . . . . 64.420000000000002 111.125 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.52 HD23 ' HA ' ' A' ' 10' ' ' VAL . 57.1 mt -124.15 151.61 43.79 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.85 -0.614 . . . . 71.140000000000001 110.45 -177.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -113.66 147.97 37.17 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.203 -0.665 . . . . 74.439999999999998 109.203 170.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.545 ' HB2' HG12 ' A' ' 2' ' ' ILE . . . -89.27 126.9 35.7 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.043 0.449 . . . . 61.210000000000001 110.937 -177.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.762 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.9 t -100.38 -175.09 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.018 -1.105 . . . . 71.530000000000001 108.018 175.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.762 ' H ' HG12 ' A' ' 55' ' ' VAL . 86.5 tttt 70.31 109.29 0.03 OUTLIER Pre-proline 0 C--O 1.233 0.224 0 CA-C-O 121.322 0.582 . . . . 74.140000000000001 110.774 179.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.43 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 27.7 Cg_endo -61.86 142.37 93.15 Favored 'Trans proline' 0 N--CA 1.464 -0.211 0 C-N-CA 122.835 2.357 . . . . 64.030000000000001 112.867 -176.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.1 mt -71.7 159.51 5.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.823 -0.626 . . . . 72.329999999999998 109.52 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -85.71 113.03 21.58 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.999 0.428 . . . . 62.520000000000003 110.281 -177.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.447 ' CD ' ' H ' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -151.21 -171.01 3.82 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.269 -1.011 . . . . 62.329999999999998 108.269 174.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.447 ' H ' ' CD ' ' A' ' 60' ' ' GLU . 64.9 m80 -87.49 -72.9 0.5 Allowed 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.451 -0.574 . . . . 74.120000000000005 109.451 -179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -150.65 168.19 25.06 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.632 -0.713 . . . . 62.340000000000003 109.2 177.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 12.2 p-80 -103.65 157.61 16.94 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.618 -0.512 . . . . 53.420000000000002 109.618 177.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -86.06 156.67 20.31 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 116.226 -0.443 . . . . 71.329999999999998 110.378 -177.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.8 p-80 -65.37 155.28 35.86 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.793 -0.447 . . . . 55.109999999999999 109.793 176.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 31.7 m170 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.356 -0.831 . . . . 74.420000000000002 109.714 -179.101 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.865 0 CA-C-O 120.993 0.425 . . . . 61.530000000000001 110.353 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.4 mt -126.28 140.79 47.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.097 -0.501 . . . . 74.329999999999998 109.946 178.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -133.94 152.65 78.96 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.193 -0.458 . . . . 70.349999999999994 110.726 -177.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HG3' ' H ' ' A' ' 27' ' ' VAL . 24.1 Cg_exo -64.4 123.1 11.26 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.73 2.287 . . . . 70.340000000000003 111.565 176.015 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 113.58 -0.81 24.82 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 121.017 -0.611 . . . . 60.409999999999997 112.089 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -106.88 145.41 32.21 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.848 0.356 . . . . 70.040000000000006 111.043 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 5.8 m -84.93 131.18 34.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.757 -0.656 . . . . 73.209999999999994 110.021 176.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG12 ' HA ' ' A' ' 54' ' ' ALA . 32.7 m -129.46 150.85 35.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 120.778 0.323 . . . . 62.140000000000001 110.832 -178.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 9' ' ' ARG . 17.3 ttt85 -104.33 134.83 46.89 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.856 -0.424 . . . . 62.119999999999997 109.856 175.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HA ' HD23 ' A' ' 52' ' ' LEU . 49.0 t -60.9 114.51 1.17 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.284 -0.416 . . . . 75.129999999999995 110.131 177.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.4 m -98.05 -9.73 25.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.39 0.614 . . . . 73.400000000000006 110.184 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.714 ' HB2' ' HB2' ' A' ' 51' ' ' GLU . 36.0 t30 -74.25 113.89 11.97 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.385 -0.825 . . . . 74.239999999999995 110.556 178.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 21.7 t -69.46 -26.02 30.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.089 -0.505 . . . . 54.25 110.889 -178.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -66.64 -30.25 70.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.074 -0.512 . . . . 62.420000000000002 111.408 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -75.37 158.49 32.67 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.095 -0.502 . . . . 65.230000000000004 111.418 -174.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.2 m -90.42 -12.31 37.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.817 -0.628 . . . . 71.439999999999998 110.938 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 78.0 m-85 -98.51 21.4 11.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.751 0.31 . . . . 72.25 110.169 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.1 t80 -66.63 80.91 0.1 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.661 -0.7 . . . . 64.129999999999995 111.3 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 165.22 -27.82 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 114.728 -1.124 . . . . 75.349999999999994 109.206 177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -76.73 152.44 35.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.491 0.662 . . . . 75.25 111.854 -173.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -119.42 109.78 16.16 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 114.856 -1.065 . . . . 73.129999999999995 109.232 178.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.05 174.89 15.6 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 120.726 -0.75 . . . . 44.439999999999998 112.565 -173.39 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.428 HD22 ' HA ' ' A' ' 23' ' ' LEU . 1.2 tm? -102.38 126.54 49.43 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.592 -0.521 . . . . 54.420000000000002 109.592 -176.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.402 HG13 ' HB1' ' A' ' 32' ' ' ALA . 92.0 t -78.3 112.44 16.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 110.263 -0.273 . . . . 75.439999999999998 110.263 176.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -79.11 -34.39 43.47 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.956 0.407 . . . . 74.239999999999995 110.551 -179.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.3 ptp180 -164.01 134.63 4.34 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 115.899 -0.591 . . . . 74.120000000000005 110.41 -174.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.466 ' H ' ' HG3' ' A' ' 4' ' ' PRO . 96.9 t -91.58 123.3 43.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 CA-C-N 115.386 -0.825 . . . . 74.540000000000006 109.096 172.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.6 t -126.91 91.36 3.32 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.702 0.286 . . . . 64.099999999999994 110.765 -174.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 49.94 75.88 0.15 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.274 -0.875 . . . . 53.420000000000002 112.586 174.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.33 -20.99 6.42 Favored Glycine 0 CA--C 1.519 0.31 0 C-N-CA 121.06 -0.59 . . . . 43.109999999999999 113.404 176.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.597 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 55.8 mtpt -110.48 165.48 11.76 Favored 'General case' 0 N--CA 1.444 -0.738 0 O-C-N 122.767 -0.255 . . . . 73.200000000000003 110.607 179.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.491 ' HB2' HD21 ' A' ' 49' ' ' LEU . . . -142.79 141.25 31.64 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.647 -0.251 . . . . 72.030000000000001 110.48 178.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -92.14 107.8 19.47 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.578 -0.527 . . . . 70.109999999999999 109.578 -179.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 56.8 t -102.85 118.87 50.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.974 -0.557 . . . . 74.109999999999999 110.897 -175.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 44.0 tp -92.68 119.28 31.93 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 115.837 -0.619 . . . . 64.400000000000006 110.74 177.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.496 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 47.3 m-85 -89.59 134.12 34.28 Favored 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 107.594 -1.262 . . . . 71.549999999999997 107.594 169.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -149.38 124.39 10.02 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.934 -0.395 . . . . 72.120000000000005 109.934 -172.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.1 t30 -153.12 86.09 1.23 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.024 0.44 . . . . 54.229999999999997 110.667 176.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 75.7 -93.73 0.94 Allowed Glycine 0 N--CA 1.45 -0.424 0 CA-C-N 115.625 -0.716 . . . . 75.040000000000006 113.516 172.794 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -91.63 -21.97 20.53 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.869 0.366 . . . . 72.0 111.217 -176.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 64.0 t90 -111.07 143.5 41.7 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.315 0.578 . . . . 71.519999999999996 111.857 -172.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.496 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 4.2 p-10 -147.99 153.06 38.5 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 114.664 -1.153 . . . . 74.140000000000001 109.176 175.022 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HG3' HG23 ' A' ' 45' ' ' VAL . 57.1 tptt -160.39 111.98 1.93 Allowed 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.169 -0.469 . . . . 73.420000000000002 110.594 -178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -92.09 104.71 17.07 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.199 -0.455 . . . . 70.140000000000001 110.082 178.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.419 HG23 ' HG3' ' A' ' 43' ' ' LYS . 21.1 t -117.88 125.74 74.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.674 0 CA-C-O 120.957 0.408 . . . . 51.140000000000001 109.958 -179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.492 HG22 ' HE2' ' A' ' 31' ' ' LYS . 4.4 m -85.03 130.83 34.55 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.076 -0.511 . . . . 55.219999999999999 110.607 179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.725 ' HB2' HD11 ' A' ' 52' ' ' LEU . 88.1 m-85 -126.53 -175.27 3.34 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.684 -0.689 . . . . 70.230000000000004 109.772 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.882 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 15.8 mmt180 -88.91 161.33 16.73 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.8 -0.445 . . . . 73.549999999999997 109.8 174.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.491 HD21 ' HB2' ' A' ' 32' ' ' ALA . 94.0 mt -83.41 -27.03 29.87 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.56 0.695 . . . . 74.519999999999996 109.343 -179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.3 p -76.45 -10.17 59.2 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.066 -0.97 . . . . 74.549999999999997 110.8 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.882 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 19.1 pt-20 -117.22 16.57 14.88 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.367 -0.533 . . . . 73.450000000000003 111.278 178.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.725 HD11 ' HB2' ' A' ' 47' ' ' PHE . 95.8 mt -131.86 154.35 49.27 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.857 -0.611 . . . . 71.299999999999997 109.97 175.49 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -149.06 141.37 24.11 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.624 -0.51 . . . . 73.519999999999996 109.624 171.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.49 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.3 138.34 51.45 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.092 -0.504 . . . . 53.210000000000001 111.594 -175.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.567 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -86.15 171.08 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.544 -0.753 . . . . 64.140000000000001 109.057 177.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.567 ' H ' HG12 ' A' ' 55' ' ' VAL . 93.3 mttt -121.22 158.43 53.08 Favored Pre-proline 0 C--N 1.315 -0.902 0 CA-C-N 116.685 -0.234 . . . . 65.120000000000005 110.457 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -58.33 131.21 41.63 Favored 'Trans proline' 0 N--CA 1.458 -0.574 0 C-N-CA 122.087 1.858 . . . . 70.219999999999999 110.016 170.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.801 HD12 ' H ' ' A' ' 58' ' ' ILE . 3.0 mp -62.84 149.69 9.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.318 0.58 . . . . 74.329999999999998 109.833 -174.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.689 HD23 ' H ' ' A' ' 59' ' ' LEU . 2.0 pt? -111.47 146.3 37.48 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.411 -0.813 . . . . 75.400000000000006 109.728 -176.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -73.15 92.93 1.77 Allowed 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.311 0.577 . . . . 71.5 109.54 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 15.7 p-80 -84.12 116.28 22.82 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.392 -0.822 . . . . 75.530000000000001 109.965 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.543 ' O ' ' HD2' ' A' ' 64' ' ' HIS . 11.9 m-70 -95.11 158.53 15.42 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.768 -0.651 . . . . 74.109999999999999 111.164 -176.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.523 ' H ' ' CD2' ' A' ' 63' ' ' HIS . 5.9 p80 -66.23 102.3 0.82 Allowed 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.302 -0.863 . . . . 53.020000000000003 109.623 169.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.543 ' HD2' ' O ' ' A' ' 62' ' ' HIS . 4.2 p80 -142.33 80.46 1.71 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.7 0.762 . . . . 75.109999999999999 111.595 -177.053 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 13.1 m-70 -136.84 71.61 1.41 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.934 -0.575 . . . . 74.400000000000006 110.607 173.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 . . . . . 0 C--O 1.245 0.827 0 CA-C-O 118.599 -0.715 . . . . 73.510000000000005 109.367 177.36 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.3 ptt? . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 111.179 0.066 . . . . 63.450000000000003 111.179 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.9 mt 69.94 147.36 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 CA-C-O 121.281 0.563 . . . . 73.109999999999999 110.928 -178.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.401 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 55.0 m-85 -95.19 139.78 22.16 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-N 116.076 -0.511 . . . . 75.129999999999995 110.752 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 16.8 Cg_exo -67.67 137.94 43.76 Favored 'Trans proline' 0 N--CA 1.463 -0.314 0 C-N-CA 122.636 2.224 . . . . 73.519999999999996 111.458 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.22 4.37 64.58 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.844 -0.694 . . . . 72.209999999999994 111.799 -176.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.44 161.68 13.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.617 0.246 . . . . 70.150000000000006 110.446 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.6 m -87.43 131.26 34.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.091 -0.504 . . . . 75.140000000000001 110.239 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 18.3 m -130.69 150.29 34.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.993 0.425 . . . . 71.120000000000005 111.055 -178.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.448 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 36.9 ttp180 -117.41 142.22 47.39 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.754 -0.657 . . . . 73.239999999999995 109.366 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.443 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.8 t -77.86 105.86 7.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.742 -0.466 . . . . 72.430000000000007 109.742 177.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.4 m -89.52 -4.21 58.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.776 -0.647 . . . . 72.329999999999998 111.053 -177.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.613 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 58.0 t30 -69.38 102.86 1.85 Allowed 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 109.7 -0.482 . . . . 70.239999999999995 109.7 177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.524 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 22.4 t -63.03 -35.55 72.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.593 -0.73 . . . . 45.119999999999997 112.14 -171.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -78.96 -10.94 59.97 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.027 0.441 . . . . 71.010000000000005 111.597 -174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.613 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 5.6 t70 -84.4 160.37 20.63 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.012 -0.43 . . . . 72.239999999999995 110.7 -175.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.5 m -71.06 -32.37 69.05 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.068 0.461 . . . . 74.310000000000002 110.507 -179.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 91.2 m-85 -87.86 21.13 2.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.003 -0.544 . . . . 53.5 111.25 -176.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 32.9 t80 -59.27 132.25 53.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.02 0.438 . . . . 75.519999999999996 111.146 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 9.2 ttt-85 74.81 -3.8 2.51 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 114.924 -1.034 . . . . 65.329999999999998 111.917 175.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -77.78 149.87 34.4 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.652 -0.499 . . . . 63.43 109.652 175.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.448 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 37.1 mt-10 -125.34 136.2 53.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.991 -0.55 . . . . 70.040000000000006 110.726 -173.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -149.12 -171.24 17.62 Favored Glycine 0 N--CA 1.445 -0.759 0 N-CA-C 111.009 -0.836 . . . . 73.340000000000003 111.009 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.425 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 7.9 mp -112.85 150.8 31.21 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 117.431 0.616 . . . . 71.299999999999997 110.923 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.1 t -88.01 115.0 27.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.039 -0.528 . . . . 73.239999999999995 110.231 176.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 3.7 mp0 -79.58 -28.24 41.13 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.839 0.352 . . . . 75.209999999999994 110.71 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -170.28 133.73 1.13 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 72.420000000000002 110.665 -179.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.567 HG13 HD21 ' A' ' 49' ' ' LEU . 58.0 t -93.88 135.4 28.45 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-N 115.318 -0.855 . . . . 62.520000000000003 109.786 176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.7 t -107.34 -159.94 0.71 Allowed 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.929 -0.397 . . . . 73.409999999999997 109.929 -179.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -59.8 -33.83 72.25 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.525 0.678 . . . . 71.319999999999993 111.709 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.408 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . -155.16 -12.46 0.06 OUTLIER Glycine 0 C--N 1.31 -0.865 0 CA-C-N 114.791 -1.095 . . . . 54.43 112.319 178.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.481 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 63.8 mttp -104.27 172.09 6.98 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.844 0.354 . . . . 71.349999999999994 111.255 179.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.11 140.87 21.82 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.908 -0.587 . . . . 73.530000000000001 110.03 176.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -89.61 111.73 22.76 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.692 -0.484 . . . . 73.519999999999996 109.692 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.425 ' HA ' ' O ' ' A' ' 23' ' ' LEU . 40.1 t -104.17 122.77 57.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 120.844 0.354 . . . . 63.439999999999998 111.067 -176.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.6 tp -89.46 121.59 31.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.131 -0.486 . . . . 75.219999999999999 110.269 176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.453 ' CE2' ' HE2' ' A' ' 47' ' ' PHE . 96.4 m-85 -101.41 151.96 21.3 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.993 -0.549 . . . . 71.430000000000007 110.244 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -122.32 -63.46 1.28 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.891 -0.595 . . . . 75.439999999999998 110.168 -175.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 t30 67.08 -57.32 0.42 Allowed 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 123.538 0.735 . . . . 73.450000000000003 111.525 -177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' ASN . . . 158.35 102.55 0.19 Allowed Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 110.904 -0.878 . . . . 44.32 110.904 -178.322 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HB3' ' O ' ' A' ' 39' ' ' GLY . 24.9 t30 75.09 -40.59 0.44 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.422 0.689 . . . . 74.329999999999998 110.623 -177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 43.5 t90 -64.26 154.68 34.35 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.521 -0.763 . . . . 70.219999999999999 110.7 176.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -152.62 143.7 23.09 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.099 0.476 . . . . 74.340000000000003 109.882 176.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.3 tptm -168.22 125.25 1.08 Allowed 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 115.568 -0.742 . . . . 74.109999999999999 109.904 -175.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 40.6 tp -100.09 102.55 13.92 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.3 -0.63 . . . . 71.409999999999997 109.3 177.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 25.0 t -111.35 120.04 61.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.061 -0.518 . . . . 53.210000000000001 110.609 -174.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -72.23 129.25 38.0 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.942 -0.572 . . . . 72.400000000000006 110.269 176.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.453 ' HE2' ' CE2' ' A' ' 36' ' ' PHE . 45.2 m-85 -126.99 -174.37 3.13 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.938 -0.574 . . . . 72.230000000000004 109.542 175.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.567 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 33.5 mtt180 -103.93 162.13 13.39 Favored 'General case' 0 C--N 1.316 -0.848 0 N-CA-C 109.462 -0.57 . . . . 72.150000000000006 109.462 178.428 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.567 HD21 HG13 ' A' ' 27' ' ' VAL . 90.4 mt -73.06 -33.8 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.261 -0.427 . . . . 71.540000000000006 110.508 -175.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.0 m -73.44 -16.08 61.32 Favored 'General case' 0 N--CA 1.436 -1.157 0 CA-C-N 115.751 -0.659 . . . . 70.430000000000007 110.579 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.567 ' OE1' ' HB2' ' A' ' 48' ' ' ARG . 3.5 mp0 -89.95 -8.85 50.77 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.827 -0.624 . . . . 74.040000000000006 111.387 -178.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 83.3 mt -116.88 157.39 25.72 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.341 -0.391 . . . . 74.510000000000005 111.391 -174.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -130.54 148.42 52.34 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.045 -0.724 . . . . 74.010000000000005 109.045 171.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.37 121.73 21.84 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.995 0.426 . . . . 71.349999999999994 110.067 176.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.608 HG12 ' H ' ' A' ' 56' ' ' LYS . 12.4 t -76.05 170.33 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.194 -0.669 . . . . 72.409999999999997 109.194 177.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.608 ' H ' HG12 ' A' ' 55' ' ' VAL . 1.8 mppt? -107.37 128.98 24.93 Favored Pre-proline 0 C--N 1.308 -1.229 0 CA-C-N 115.732 -0.667 . . . . 61.32 109.378 -175.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_exo -52.06 138.51 53.12 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.525 2.15 . . . . 65.349999999999994 111.362 178.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.83 HD12 ' H ' ' A' ' 58' ' ' ILE . 1.4 mp -61.85 146.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.168 0.508 . . . . 74.030000000000001 109.693 -176.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.558 HD13 ' HD2' ' A' ' 61' ' ' HIS . 0.5 OUTLIER -148.02 -178.56 6.35 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.419 -0.81 . . . . 71.329999999999998 110.944 -170.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 7.8 tm-20 -109.24 115.2 29.55 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.065 0.459 . . . . 64.409999999999997 110.554 -175.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.558 ' HD2' HD13 ' A' ' 59' ' ' LEU . 55.6 m-70 -135.59 120.24 18.29 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.728 -0.669 . . . . 64.340000000000003 109.436 170.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.0 p-80 -66.85 130.91 44.7 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.983 0.42 . . . . 61.130000000000003 110.138 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -69.71 160.0 32.46 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.493 -0.776 . . . . 74.430000000000007 111.431 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -46.52 143.13 2.76 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 115.075 -0.966 . . . . 71.530000000000001 112.01 178.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -93.9 137.21 33.37 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.043 -0.526 . . . . 74.129999999999995 110.438 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 41.5 p-80 . . . . . 0 C--O 1.245 0.82 0 CA-C-O 118.51 -0.757 . . . . 73.209999999999994 110.295 178.604 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.1 ttm . . . . . 0 N--CA 1.476 0.872 0 CA-C-O 120.871 0.367 . . . . 70.230000000000004 110.599 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.451 ' O ' HG21 ' A' ' 27' ' ' VAL . 48.8 mt -125.34 140.96 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.847 -0.615 . . . . 74.450000000000003 109.341 176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.415 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 39.4 p90 -115.79 149.24 42.83 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-O 120.595 0.236 . . . . 74.420000000000002 110.98 -177.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 34.5 Cg_exo -62.13 142.79 93.33 Favored 'Trans proline' 0 C--N 1.343 0.254 0 C-N-CA 122.607 2.205 . . . . 64.25 111.744 176.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.58 -7.85 65.97 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.975 -0.631 . . . . 54.219999999999999 112.128 -177.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.1 143.6 26.98 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.929 0.395 . . . . 75.150000000000006 110.864 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.3 m -80.59 125.03 29.48 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.746 -0.661 . . . . 74.120000000000005 109.907 177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 17.6 m -130.1 148.22 33.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-O 121.314 0.578 . . . . 42.200000000000003 111.349 -177.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.9 ttp180 -111.76 133.85 53.71 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.285 -0.87 . . . . 62.43 109.3 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.424 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 46.3 t -80.08 101.17 4.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.576 -0.527 . . . . 64.219999999999999 109.576 176.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.6 m -103.31 13.7 33.19 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.895 -0.593 . . . . 64.450000000000003 110.526 -177.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.506 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 51.9 t30 -61.6 107.98 0.9 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 108.533 -0.914 . . . . 71.430000000000007 108.533 172.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 46.8 t -55.84 -47.04 80.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.024 -0.534 . . . . 74.120000000000005 112.298 -168.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -98.58 40.57 1.18 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.363 0.602 . . . . 71.530000000000001 110.537 -174.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.506 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 6.1 t70 -110.44 161.13 15.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.129 -0.487 . . . . 74.409999999999997 110.111 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.9 m -81.14 -23.17 38.48 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.34 0.591 . . . . 70.310000000000002 110.104 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' CD1' ' HZ ' ' A' ' 47' ' ' PHE . 73.7 m-85 -98.66 24.72 7.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.733 -0.667 . . . . 70.109999999999999 110.848 179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 46.0 t80 -62.44 127.88 33.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.954 -0.566 . . . . 74.349999999999994 110.023 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 17.4 mtp180 76.12 10.54 3.09 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 124.057 0.848 . . . . 71.230000000000004 112.308 -179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -87.66 148.26 24.88 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.425 -0.583 . . . . 71.549999999999997 109.425 171.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -128.73 142.48 50.99 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.702 -0.681 . . . . 63.350000000000001 110.401 -173.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -166.96 -169.03 30.03 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.82 -0.705 . . . . 53.409999999999997 111.709 -178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.9 mp -115.77 136.66 52.84 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.716 0.293 . . . . 72.219999999999999 110.914 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -64.36 122.91 16.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.043 -0.526 . . . . 52.340000000000003 109.654 174.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.426 ' HG3' HD13 ' A' ' 44' ' ' LEU . 31.2 mm-40 -89.4 -33.09 16.97 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.285 0.564 . . . . 71.140000000000001 110.177 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 5.0 ptm180 -169.03 136.55 1.88 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.289 -0.869 . . . . 74.450000000000003 110.204 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.651 HG12 ' H ' ' A' ' 29' ' ' ASP . 43.7 t -103.35 142.51 17.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.485 -0.78 . . . . 73.430000000000007 109.689 177.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.5 t -121.91 34.8 5.06 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.078 0.466 . . . . 73.549999999999997 109.868 179.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.651 ' H ' HG12 ' A' ' 27' ' ' VAL . 24.4 m-20 50.04 87.09 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 114.953 -1.021 . . . . 71.150000000000006 111.533 -177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 115.29 -46.26 1.19 Allowed Glycine 0 N--CA 1.448 -0.529 0 N-CA-C 110.842 -0.903 . . . . 53.109999999999999 110.842 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.677 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 30.5 mtpp -112.28 161.02 17.07 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 109.844 -0.428 . . . . 73.129999999999995 109.844 176.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -153.55 142.63 21.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.751 -0.204 . . . . 51.439999999999998 110.556 178.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.637 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -91.67 115.48 28.09 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.593 -0.521 . . . . 75.230000000000004 109.593 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.643 HG21 HD21 ' A' ' 52' ' ' LEU . 18.3 t -100.67 124.79 54.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.119 -0.491 . . . . 73.519999999999996 110.594 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.6 tp -94.92 107.29 19.31 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.579 -0.526 . . . . 73.200000000000003 109.579 176.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.497 ' HE2' ' HB ' ' A' ' 45' ' ' VAL . 81.4 m-85 -86.63 142.33 28.33 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 109.16 -0.682 . . . . 63.149999999999999 109.16 178.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -140.1 131.32 26.56 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.96 0.41 . . . . 71.510000000000005 110.449 -177.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.48 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 3.2 t-20 -141.14 91.07 2.37 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.52 -0.764 . . . . 63.43 108.951 176.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.66 -114.61 4.04 Favored Glycine 0 N--CA 1.448 -0.53 0 CA-C-N 115.651 -0.704 . . . . 54.439999999999998 111.774 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -89.87 -30.24 18.03 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.622 0.725 . . . . 71.349999999999994 109.079 178.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.48 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 65.8 t90 -72.27 138.9 47.75 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.994 -1.003 . . . . 75.239999999999995 111.556 -176.497 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.4 p30 -143.14 155.17 44.51 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 114.824 -1.08 . . . . 65.030000000000001 109.181 176.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.462 ' HD2' ' HZ2' ' A' ' 41' ' ' TRP . 76.4 tttt -153.97 120.18 5.41 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 116.458 -0.337 . . . . 71.439999999999998 110.516 -176.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.51 HD11 ' HB1' ' A' ' 33' ' ' ALA . 62.6 tp -93.88 110.4 22.06 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.994 0.426 . . . . 73.129999999999995 110.566 179.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.497 ' HB ' ' HE2' ' A' ' 36' ' ' PHE . 25.3 t -126.2 127.67 70.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 116.014 -0.539 . . . . 71.239999999999995 109.799 179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.637 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.5 m -83.26 133.0 35.01 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.247 0.546 . . . . 61.299999999999997 110.826 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.46 ' HZ ' ' CD1' ' A' ' 17' ' ' TYR . 55.7 m-85 -131.83 -160.15 1.02 Allowed 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.425 -0.807 . . . . 70.099999999999994 109.656 178.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.8 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 63.7 mtm180 -109.08 173.66 6.22 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.77 -0.455 . . . . 75.340000000000003 109.77 175.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.417 HD21 HG13 ' A' ' 27' ' ' VAL . 95.5 mt -81.45 -28.56 34.13 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.116 0.484 . . . . 72.409999999999997 109.912 -178.189 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.8 p -68.9 -17.86 64.03 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.675 -0.693 . . . . 55.219999999999999 110.178 176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.8 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.3 mm-40 -86.62 -13.07 46.74 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.865 -0.607 . . . . 73.109999999999999 110.622 -176.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.643 HD21 HG21 ' A' ' 34' ' ' VAL . 87.5 mt -112.73 140.93 47.09 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-N 116.05 -0.523 . . . . 73.209999999999994 112.144 -171.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -117.0 112.8 21.47 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.699 -0.682 . . . . 62.509999999999998 109.714 168.331 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.78 134.26 52.76 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.865 -0.421 . . . . 55.109999999999999 109.865 176.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.546 ' O ' ' HG2' ' A' ' 56' ' ' LYS . 2.1 t -80.3 157.76 4.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 N-CA-C 109.586 -0.524 . . . . 52.539999999999999 109.586 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 55' ' ' VAL . 12.9 pttm 55.65 146.88 0.05 OUTLIER Pre-proline 0 CA--C 1.54 0.567 0 C-N-CA 124.945 1.298 . . . . 73.329999999999998 112.739 -172.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -70.48 157.5 58.81 Favored 'Trans proline' 0 C--O 1.235 0.372 0 C-N-CA 122.439 2.092 . . . . 73.519999999999996 112.021 178.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.41 HG13 ' H ' ' A' ' 58' ' ' ILE . 3.1 mt -64.81 150.6 10.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.33 -0.619 . . . . 75.230000000000004 109.33 177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.535 HD11 ' HE2' ' A' ' 56' ' ' LYS . 5.3 mp -103.46 115.16 30.0 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 112.57 0.581 . . . . 71.129999999999995 112.57 -167.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 59.02 92.95 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.085 -0.961 . . . . 73.019999999999996 113.238 169.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 60.3 m80 -139.2 164.3 30.16 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.061 -0.518 . . . . 74.420000000000002 110.147 173.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -84.3 111.57 19.52 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.154 -0.684 . . . . 75.129999999999995 109.154 177.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 17.6 t-80 -127.26 134.29 50.08 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 116.005 -0.543 . . . . 75.299999999999997 110.089 -176.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.0 m-70 -65.99 120.02 12.39 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.269 -0.423 . . . . 73.540000000000006 109.964 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -73.38 133.76 43.87 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.268 -0.424 . . . . 63.420000000000002 110.957 -176.291 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 81.7 t60 . . . . . 0 C--O 1.243 0.739 0 N-CA-C 108.932 -0.766 . . . . 74.340000000000003 108.932 174.708 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' O ' ' HB ' ' A' ' 2' ' ' ILE . 17.3 tpt . . . . . 0 N--CA 1.481 1.108 0 CA-C-O 120.366 0.126 . . . . 72.25 110.889 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.582 HD12 HD22 ' A' ' 49' ' ' LEU . 72.7 mt 74.83 143.89 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.26 0 O-C-N 123.667 0.604 . . . . 74.409999999999997 110.18 -176.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 88.4 m-85 -131.16 146.09 60.55 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-N 116.309 -0.405 . . . . 73.310000000000002 110.639 -175.137 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -61.77 125.6 17.02 Favored 'Trans proline' 0 N--CA 1.461 -0.427 0 C-N-CA 122.54 2.16 . . . . 63.109999999999999 111.207 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 103.12 -3.0 47.57 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 121.051 -0.595 . . . . 62.310000000000002 112.026 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -103.38 154.94 18.86 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.74 0.305 . . . . 75.439999999999998 110.825 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.9 m -88.43 134.79 33.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.765 -0.652 . . . . 71.409999999999997 110.527 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG21 HD13 ' A' ' 52' ' ' LEU . 16.3 m -124.22 153.56 30.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-N 116.264 -0.426 . . . . 72.540000000000006 110.702 177.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.492 ' HD3' ' OE2' ' A' ' 53' ' ' GLU . 53.8 ttt180 -110.98 119.87 40.49 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.699 -0.682 . . . . 72.120000000000005 109.73 -178.049 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 25.8 t -76.15 98.88 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.005 0.431 . . . . 63.409999999999997 110.249 -179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 18.2 p -105.8 13.83 29.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 116.313 -0.403 . . . . 72.409999999999997 111.273 -178.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.579 ' HB3' ' HB2' ' A' ' 15' ' ' ASP . 54.3 t30 -62.8 112.65 2.63 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.061 -0.518 . . . . 41.25 109.671 176.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.523 ' HA ' ' CE2' ' A' ' 18' ' ' TYR . 23.5 t -69.54 -27.92 35.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.188 0.518 . . . . 63.32 111.411 -172.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -100.39 40.36 1.26 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.817 0.818 . . . . 51.009999999999998 109.395 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.579 ' HB2' ' HB3' ' A' ' 12' ' ' ASN . 3.7 t70 -119.47 -174.53 2.75 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.511 -0.768 . . . . 73.329999999999998 110.671 -179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 24.4 m -109.59 -28.85 8.66 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.967 -0.56 . . . . 75.409999999999997 110.241 179.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.446 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 92.6 m-85 -101.07 38.27 1.59 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.098 -0.501 . . . . 72.209999999999994 111.151 -176.616 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.678 ' CD1' ' HG3' ' A' ' 19' ' ' ARG . 10.1 t80 -59.35 126.3 27.09 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.742 -0.663 . . . . 75.409999999999997 110.263 178.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.678 ' HG3' ' CD1' ' A' ' 18' ' ' TYR . 87.1 mtt180 80.09 4.05 1.93 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.097 0.959 . . . . 72.510000000000005 112.681 177.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -83.71 149.09 26.7 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.067 0.46 . . . . 71.219999999999999 110.153 175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -125.29 125.46 43.57 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.606 -0.724 . . . . 71.409999999999997 110.221 -177.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.61 171.67 23.4 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.844 -0.693 . . . . 61.450000000000003 111.754 -178.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 9.6 mp -100.21 124.88 46.18 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 120.867 0.365 . . . . 74.510000000000005 110.976 -176.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 77.0 t -66.03 119.35 10.84 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.88 -0.6 . . . . 64.340000000000003 110.313 177.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 29.7 mm-40 -77.86 -36.71 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.3 0.571 . . . . 74.209999999999994 109.854 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -170.03 143.0 2.43 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.063 -0.971 . . . . 72.209999999999994 109.408 -178.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 46.6 t -98.22 92.85 2.97 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.605 -0.725 . . . . 75.219999999999999 109.373 174.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 30.8 p -103.54 114.12 28.15 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.277 -0.42 . . . . 64.239999999999995 111.12 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.9 t70 61.67 37.68 15.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.427 -0.806 . . . . 64.120000000000005 111.624 175.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.526 ' O ' ' HG ' ' A' ' 49' ' ' LEU . . . 81.44 6.14 89.44 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.609 -0.805 . . . . 34.149999999999999 112.772 176.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 35.2 mtmt -117.4 144.74 44.65 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 109.305 -0.628 . . . . 62.219999999999999 109.305 176.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -114.05 124.25 51.67 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.764 0.316 . . . . 75.120000000000005 111.113 -174.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.507 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -81.93 101.09 10.04 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 109.241 -0.652 . . . . 63.539999999999999 109.241 176.432 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 41.9 t -91.97 121.36 42.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-O 121.083 0.468 . . . . 71.129999999999995 110.874 -174.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.2 tp -91.33 126.74 36.51 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.8 -0.636 . . . . 63.119999999999997 110.493 179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -110.11 143.7 39.79 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.182 -0.463 . . . . 74.510000000000005 110.409 176.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -137.78 129.19 27.96 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.395 -0.821 . . . . 74.540000000000006 109.126 178.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -135.86 87.53 2.32 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.717 0.294 . . . . 71.129999999999995 110.291 179.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.18 -77.98 0.56 Allowed Glycine 0 N--CA 1.451 -0.313 0 CA-C-N 115.962 -0.563 . . . . 71.409999999999997 112.576 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -128.39 -4.79 5.41 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.737 0.78 . . . . 43.539999999999999 109.17 179.454 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.0 t90 -89.98 138.25 31.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.66 -0.7 . . . . 73.209999999999994 111.022 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.33 146.23 49.76 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.067 -0.969 . . . . 64.340000000000003 109.787 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -166.28 136.49 3.35 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.049 0.452 . . . . 72.219999999999999 111.156 176.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.507 HD11 ' HB1' ' A' ' 33' ' ' ALA . 54.0 tp -106.48 109.49 21.43 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.512 -0.767 . . . . 75.349999999999994 110.128 178.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 27.1 t -116.25 117.92 57.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 120.913 0.387 . . . . 72.239999999999995 110.293 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.454 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.3 m -78.6 127.94 32.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.062 0.458 . . . . 51.009999999999998 110.643 178.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -122.64 179.01 4.76 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-N 115.772 -0.649 . . . . 73.420000000000002 110.173 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.423 ' O ' ' HG ' ' A' ' 52' ' ' LEU . 2.2 mpt_? -98.77 154.83 17.7 Favored 'General case' 0 C--N 1.318 -0.778 0 N-CA-C 108.66 -0.867 . . . . 74.319999999999993 108.66 178.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.582 HD22 HD12 ' A' ' 2' ' ' ILE . 84.5 mt -72.82 -32.86 65.82 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.45 0.643 . . . . 64.209999999999994 109.388 -179.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 6.7 p -71.03 -12.21 61.4 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 114.994 -1.003 . . . . 61.439999999999998 110.764 176.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.419 ' HG2' ' HD3' ' A' ' 48' ' ' ARG . 2.9 mp0 -108.02 7.15 27.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.791 -0.641 . . . . 72.420000000000002 111.589 -178.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.488 HD13 HG21 ' A' ' 8' ' ' VAL . 93.0 mt -121.97 146.22 47.36 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.111 0.481 . . . . 73.140000000000001 111.591 -177.637 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.492 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 40.0 tt0 -102.48 108.43 19.74 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 108.838 -0.801 . . . . 40.340000000000003 108.838 174.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.36 124.11 22.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.181 -0.463 . . . . 51.210000000000001 110.015 178.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.8 t -78.65 170.69 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.234 -0.439 . . . . 65.519999999999996 109.827 -178.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.591 ' H ' HG12 ' A' ' 55' ' ' VAL . 21.6 pttp -73.67 144.88 83.82 Favored Pre-proline 0 C--N 1.32 -0.694 0 CA-C-N 115.998 -0.547 . . . . 72.230000000000004 110.339 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -63.68 130.21 27.29 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.075 1.85 . . . . 73.219999999999999 111.415 175.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.413 HG22 ' N ' ' A' ' 59' ' ' LEU . 9.3 mt -73.54 163.94 3.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.025 -0.534 . . . . 65.420000000000002 109.85 -177.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.413 ' N ' HG22 ' A' ' 58' ' ' ILE . 92.5 mt 71.31 39.89 0.9 Allowed 'General case' 0 C--O 1.236 0.352 0 O-C-N 123.554 0.534 . . . . 72.239999999999995 110.75 177.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -63.53 119.3 9.53 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.695 -0.684 . . . . 60.509999999999998 109.666 175.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -73.49 110.18 7.58 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.353 0.597 . . . . 75.230000000000004 111.282 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -84.23 103.37 13.36 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.091 -0.959 . . . . 65.450000000000003 110.457 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 18.9 t-160 55.5 73.07 0.44 Allowed 'General case' 0 N--CA 1.463 0.206 0 O-C-N 123.693 0.621 . . . . 74.230000000000004 110.621 177.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.3 t60 -146.56 103.37 3.66 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.705 -0.85 . . . . 65.109999999999999 108.705 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -74.77 96.94 3.15 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.218 -0.446 . . . . 63.32 111.197 -170.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.931 0 CA-C-N 115.591 -0.732 . . . . 51.119999999999997 109.655 174.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 120.885 0.374 . . . . 72.420000000000002 110.748 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.456 HD12 HD22 ' A' ' 49' ' ' LEU . 54.3 mt -92.16 148.29 4.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 115.817 -0.629 . . . . 74.319999999999993 109.342 175.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -124.08 146.62 51.85 Favored Pre-proline 0 C--N 1.326 -0.438 0 CA-C-O 120.438 0.161 . . . . 74.5 110.609 -179.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -55.97 127.79 27.53 Favored 'Trans proline' 0 C--N 1.343 0.268 0 C-N-CA 122.762 2.308 . . . . 75.549999999999997 111.902 176.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 105.84 0.29 39.24 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.834 -0.698 . . . . 54.219999999999999 112.187 -176.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -93.41 135.38 34.7 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.649 0.262 . . . . 64.329999999999998 110.48 177.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.8 m -83.12 125.07 31.1 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.591 -0.522 . . . . 44.109999999999999 109.591 176.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 54' ' ' ALA . 17.0 m -122.18 143.39 34.99 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.807 0 CA-C-N 116.221 -0.445 . . . . 71.329999999999998 111.014 -178.251 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 30.6 ttp180 -98.77 129.54 45.19 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.005 -0.543 . . . . 72.409999999999997 109.702 179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 56.7 t -61.84 120.94 9.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 110.078 -0.341 . . . . 74.450000000000003 110.078 178.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.402 HG22 ' O ' ' A' ' 11' ' ' THR . 17.9 m -116.29 8.85 14.36 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.681 0.753 . . . . 55.229999999999997 110.303 -178.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 49.1 t-20 -74.21 106.83 6.04 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.749 -0.834 . . . . 74.409999999999997 108.749 174.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -62.76 -21.89 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 112.846 0.684 . . . . 75.409999999999997 112.846 -174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -86.14 -32.12 21.47 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.027 0.442 . . . . 72.310000000000002 110.612 -179.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -65.19 158.24 26.63 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.656 -0.702 . . . . 70.340000000000003 111.824 -172.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.2 m -81.43 -24.19 37.04 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.46 -0.791 . . . . 63.25 111.279 -176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -92.68 21.2 5.69 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.395 -0.366 . . . . 74.239999999999995 110.61 -176.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.522 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 42.9 t80 -70.49 77.63 0.57 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.931 -0.577 . . . . 74.510000000000005 111.293 -176.696 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.522 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 9.7 ptp85 163.58 -22.36 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.59 1.156 . . . . 74.510000000000005 108.633 177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -77.98 154.73 31.28 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 115.35 -0.841 . . . . 74.450000000000003 111.224 -178.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -125.02 127.85 47.62 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.2 -0.909 . . . . 63.509999999999998 109.298 177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.96 168.17 21.43 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.529 -0.843 . . . . 73.409999999999997 112.228 -176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.8 mp -96.47 126.37 41.62 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-O 120.639 0.257 . . . . 73.5 110.473 -178.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.512 HG11 HG22 ' A' ' 27' ' ' VAL . 59.1 t -67.96 119.8 14.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-O 120.89 0.376 . . . . 74.209999999999994 110.132 177.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 25.9 mm-40 -86.05 -30.38 22.68 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.828 -0.623 . . . . 51.240000000000002 110.578 -178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.402 HH11 ' HD3' ' A' ' 26' ' ' ARG . 12.2 ptp180 -164.31 143.15 7.32 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.614 -0.721 . . . . 75.230000000000004 109.63 -178.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.512 HG22 HG11 ' A' ' 24' ' ' VAL . 40.0 t -114.69 142.33 27.9 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 CA-C-N 115.214 -0.903 . . . . 63.210000000000001 110.369 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 33.4 p -132.42 -175.56 3.79 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.658 -0.497 . . . . 54.119999999999997 109.658 176.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -77.74 75.35 4.29 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.316 0.579 . . . . 72.400000000000006 110.517 -178.423 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 123.43 -27.16 5.85 Favored Glycine 0 N--CA 1.446 -0.648 0 CA-C-N 115.536 -0.756 . . . . 72.230000000000004 112.586 175.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.633 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 47.7 mtmt -120.11 162.23 19.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 120.693 0.282 . . . . 74.109999999999999 111.34 -176.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -154.04 143.78 21.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.228 -0.442 . . . . 72.109999999999999 110.561 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.83 115.37 27.4 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.83 -0.433 . . . . 64.109999999999999 109.83 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -99.88 128.99 51.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.326 -0.397 . . . . 71.340000000000003 110.814 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.2 tp -102.34 120.06 39.86 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.058 -0.519 . . . . 73.430000000000007 110.934 179.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -104.9 146.37 29.11 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.841 -0.618 . . . . 73.519999999999996 109.532 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 18.3 tt0 -149.27 127.41 12.03 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.28 -0.267 . . . . 71.340000000000003 110.28 179.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -142.72 85.71 1.9 Allowed 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.666 -0.494 . . . . 54.219999999999999 109.666 175.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 71.0 -105.11 1.54 Allowed Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.602 -0.727 . . . . 62.200000000000003 112.159 -179.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -87.56 -32.17 19.51 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.204 0.525 . . . . 72.400000000000006 110.141 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 76.4 t90 -75.93 138.53 41.07 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.592 -0.731 . . . . 72.120000000000005 111.272 -178.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -143.11 155.99 44.71 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 114.824 -1.08 . . . . 71.450000000000003 108.813 175.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.602 ' HG3' HG23 ' A' ' 45' ' ' VAL . 41.9 tptt -155.94 108.8 2.66 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 120.664 -0.415 . . . . 73.540000000000006 111.247 -176.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 62.6 tp -99.23 109.57 22.21 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.389 -0.597 . . . . 71.140000000000001 109.389 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.602 HG23 ' HG3' ' A' ' 43' ' ' LYS . 46.1 t -130.28 131.99 65.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.783 0.325 . . . . 71.140000000000001 110.247 -178.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.527 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.7 OUTLIER -83.29 126.54 32.79 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.067 0.46 . . . . 71.230000000000004 110.682 177.155 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.8 m-85 -123.25 -170.34 2.1 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 108.765 -0.828 . . . . 74.510000000000005 108.765 177.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 1.06 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 66.2 mtt180 -95.03 176.96 6.04 Favored 'General case' 0 C--N 1.321 -0.67 0 N-CA-C 109.325 -0.621 . . . . 73.420000000000002 109.325 173.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.496 HD21 HG13 ' A' ' 27' ' ' VAL . 97.3 mt -84.1 -32.01 24.98 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.038 -0.727 . . . . 62.509999999999998 109.038 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 16.8 p -71.21 -19.63 62.36 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.087 -0.96 . . . . 62.149999999999999 110.862 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 1.06 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 3.0 mm-40 -85.54 -7.84 58.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 64.540000000000006 110.81 -175.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.584 HD13 HG21 ' A' ' 8' ' ' VAL . 73.4 mt -116.85 138.47 51.49 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.094 0.473 . . . . 73.109999999999999 111.751 -172.087 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -97.68 104.46 16.48 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.094 -1.076 . . . . 64.329999999999998 108.094 172.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.799 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -70.08 107.86 3.83 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.25 -0.432 . . . . 63.109999999999999 110.838 -176.339 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.509 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -88.48 169.25 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.877 -0.786 . . . . 72.099999999999994 108.877 177.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.509 ' H ' HG12 ' A' ' 55' ' ' VAL . 98.6 mttt -110.13 132.61 21.37 Favored Pre-proline 0 N--CA 1.439 -0.98 0 CA-C-N 116.501 -0.318 . . . . 72.219999999999999 110.363 -178.36 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 31.6 Cg_exo -59.23 143.26 99.82 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.542 2.161 . . . . 43.210000000000001 111.179 176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.799 HD12 ' H ' ' A' ' 58' ' ' ILE . 1.1 mp -64.33 144.8 14.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.705 -0.479 . . . . 62.310000000000002 109.705 -178.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' O ' HD12 ' A' ' 59' ' ' LEU . 2.7 pp -125.91 148.89 49.08 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.605 -0.725 . . . . 73.530000000000001 110.572 -176.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -95.17 165.16 12.54 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.643 -0.708 . . . . 73.319999999999993 111.493 -174.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 81.9 t60 -131.68 134.26 45.76 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.746 -0.661 . . . . 54.439999999999998 110.397 179.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -120.9 167.28 12.71 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.193 -0.458 . . . . 75.329999999999998 109.872 177.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 45.7 p-80 -135.8 145.63 46.71 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 110.148 -0.316 . . . . 74.120000000000005 110.148 177.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 4.6 t-80 -92.48 132.52 36.73 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.357 -0.609 . . . . 75.310000000000002 109.357 179.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 26.9 m80 -59.64 -83.38 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 111.859 0.318 . . . . 75.519999999999996 111.859 -174.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 C--O 1.245 0.839 0 CA-C-O 118.653 -0.689 . . . . 71.439999999999998 109.857 -178.018 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.476 0.839 0 CA-C-O 120.928 0.394 . . . . 73.340000000000003 110.448 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 63.6 mt -115.72 143.79 24.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.56 -0.745 . . . . 74.230000000000004 109.936 -178.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 94.5 m-85 -117.72 141.21 28.67 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-N 116.512 -0.313 . . . . 64.349999999999994 110.864 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_exo -62.6 137.2 62.8 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 122.492 2.128 . . . . 51.399999999999999 110.975 173.519 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 96.26 -11.89 66.99 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.904 -0.665 . . . . 55.219999999999999 112.018 -177.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.82 165.76 12.76 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.881 0.372 . . . . 72.340000000000003 110.706 178.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 20.0 m -93.31 138.95 31.18 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.092 -0.504 . . . . 74.400000000000006 110.21 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.568 HG21 HD13 ' A' ' 52' ' ' LEU . 6.7 m -130.65 148.06 33.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.925 0.393 . . . . 65.430000000000007 111.083 179.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.64 ' HG3' ' HG2' ' A' ' 21' ' ' GLU . 34.2 ttm180 -109.97 141.81 42.23 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.838 -0.619 . . . . 54.020000000000003 109.483 178.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.503 ' HB ' ' O ' ' A' ' 17' ' ' TYR . 55.4 t -79.54 110.56 15.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.007 0.432 . . . . 64.230000000000004 110.019 176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.8 m -91.29 -11.78 37.06 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.718 -0.674 . . . . 74.420000000000002 111.159 -177.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 43.5 t-20 -65.23 106.33 1.3 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.182 -0.463 . . . . 52.549999999999997 109.808 179.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.6 p -71.34 -24.16 23.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.625 -0.716 . . . . 75.230000000000004 111.375 -173.202 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.5 t70 -89.98 -8.13 52.39 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.867 -0.606 . . . . 72.319999999999993 110.759 -176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -86.05 165.22 16.83 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.919 0.39 . . . . 61.130000000000003 110.445 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.1 m -72.16 -35.96 69.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.178 -0.464 . . . . 42.0 111.893 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.503 ' O ' ' HB ' ' A' ' 10' ' ' VAL . 95.7 m-85 -94.97 27.97 2.94 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 121.096 0.474 . . . . 74.010000000000005 111.689 -172.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.478 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 45.5 t80 -61.86 130.97 48.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.026 -0.534 . . . . 64.439999999999998 110.038 174.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.478 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 38.6 mtm180 77.82 6.04 2.82 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.827 0.851 . . . . 72.140000000000001 111.833 -177.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -96.33 148.29 22.91 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.832 -0.433 . . . . 71.400000000000006 109.832 173.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.64 ' HG2' ' HG3' ' A' ' 9' ' ' ARG . 33.5 mt-10 -127.92 128.15 44.61 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.838 -0.619 . . . . 74.049999999999997 110.245 -175.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -131.49 -177.11 14.71 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.939 -0.648 . . . . 62.140000000000001 112.335 -176.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 49.4 tp -102.89 132.48 49.08 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.491 0.186 . . . . 75.209999999999994 110.555 -176.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.3 t -72.74 111.85 7.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 N-CA-C 110.153 -0.314 . . . . 74.129999999999995 110.153 175.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -78.08 -34.98 49.95 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.192 -0.67 . . . . 74.430000000000007 109.192 -178.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -175.28 136.59 0.37 Allowed 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 115.325 -0.852 . . . . 65.230000000000004 110.16 -178.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.8 t -102.9 108.56 24.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 108.645 -0.872 . . . . 71.209999999999994 108.645 172.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.5 t -152.47 142.62 22.35 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.523 -0.308 . . . . 53.420000000000002 111.056 -172.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 20.9 t70 66.79 18.95 10.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.457 -0.792 . . . . 62.329999999999998 111.386 172.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 94.06 -1.15 67.36 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.927 -0.654 . . . . 72.329999999999998 112.81 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 31' ' ' LYS . 26.2 mtmt -124.09 174.28 7.74 Favored 'General case' 0 N--CA 1.443 -0.781 0 C-N-CA 122.629 0.372 . . . . 72.450000000000003 110.118 -178.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.07 129.92 28.38 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.622 0.249 . . . . 65.209999999999994 110.446 178.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.705 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -86.52 115.01 23.73 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.705 -0.48 . . . . 42.210000000000001 109.705 -179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.444 HG21 HD21 ' A' ' 52' ' ' LEU . 55.9 t -98.53 119.09 46.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-O 121.285 0.564 . . . . 73.540000000000006 110.648 -177.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.6 tp -89.81 118.78 29.66 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.546 -0.752 . . . . 73.450000000000003 110.072 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -94.77 137.43 33.87 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.929 -0.767 . . . . 72.439999999999998 108.929 172.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -156.41 108.59 2.53 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.71 -0.848 . . . . 74.329999999999998 108.71 -174.073 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -136.89 100.88 4.42 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.957 -0.565 . . . . 54.240000000000002 110.84 -175.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.96 -77.81 0.41 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.583 -0.735 . . . . 72.209999999999994 112.471 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -127.27 -17.41 4.75 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.205 0.526 . . . . 40.229999999999997 110.385 -177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 48.2 t90 -88.76 138.24 31.59 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.786 -0.643 . . . . 75.150000000000006 111.683 -175.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -134.9 143.6 47.03 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.712 -1.131 . . . . 64.439999999999998 109.741 179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 61.3 tttp -167.61 120.45 0.92 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-O 120.919 0.39 . . . . 73.530000000000001 110.631 177.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.18 109.72 22.42 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.304 -0.407 . . . . 71.540000000000006 110.032 178.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 24.0 t -119.19 120.74 64.74 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.696 0 CA-C-N 116.229 -0.441 . . . . 74.25 109.97 179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.705 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.8 m -78.19 130.73 36.67 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-O 121.206 0.527 . . . . 74.299999999999997 109.673 177.691 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -123.17 180.0 4.49 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.477 -0.783 . . . . 75.510000000000005 109.746 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.493 ' HD3' ' OE2' ' A' ' 51' ' ' GLU . 73.4 mtp180 -94.62 161.65 14.11 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.738 -0.665 . . . . 75.120000000000005 109.565 177.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 91.1 mt -70.44 -26.44 63.65 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.108 -0.496 . . . . 64.530000000000001 110.064 -178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 13.8 m -76.2 -11.32 59.9 Favored 'General case' 0 N--CA 1.434 -1.258 0 CA-C-N 115.687 -0.688 . . . . 65.549999999999997 110.726 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.493 ' OE2' ' HD3' ' A' ' 48' ' ' ARG . 0.4 OUTLIER -85.02 -23.4 28.65 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.056 -0.52 . . . . 74.310000000000002 111.116 179.589 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.568 HD13 HG21 ' A' ' 8' ' ' VAL . 62.1 mt -115.79 144.7 43.61 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.331 0.493 . . . . 74.319999999999993 112.331 -168.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.415 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -111.85 140.92 46.1 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.783 -0.821 . . . . 75.540000000000006 108.783 167.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -77.49 115.43 17.25 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 110.145 -0.317 . . . . 54.240000000000002 110.145 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.623 HG12 ' H ' ' A' ' 56' ' ' LYS . 10.3 t -70.58 170.98 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.139 -0.689 . . . . 73.530000000000001 109.139 179.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.623 ' H ' HG12 ' A' ' 55' ' ' VAL . 50.2 mttp -82.98 150.44 61.61 Favored Pre-proline 0 C--N 1.312 -1.063 0 CA-C-N 115.996 -0.547 . . . . 72.219999999999999 110.129 -173.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.78 160.12 22.45 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.646 2.231 . . . . 73.049999999999997 112.42 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.64 HD12 ' H ' ' A' ' 58' ' ' ILE . 3.8 mp -77.38 155.05 5.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.677 -0.86 . . . . 70.25 108.677 178.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.4 mt -101.79 105.48 16.35 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 121.134 0.492 . . . . 74.329999999999998 111.179 -171.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -112.14 12.84 20.53 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.688 0.756 . . . . 72.25 109.685 177.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 28.9 m80 -136.59 169.37 17.82 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.892 -0.595 . . . . 74.0 111.085 -178.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 28.5 t-80 -61.75 138.64 58.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.374 -0.83 . . . . 64.239999999999995 110.401 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 25.1 p-80 -62.26 154.32 28.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.071 0.462 . . . . 65.150000000000006 111.159 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 24.7 m170 -106.64 170.47 7.92 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 109.273 -0.64 . . . . 70.019999999999996 109.273 178.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 29.8 m170 -98.94 160.52 14.21 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.791 0.329 . . . . 72.25 110.761 -179.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 33.5 m80 . . . . . 0 C--O 1.244 0.81 0 CA-C-O 118.649 -0.691 . . . . 75.209999999999994 109.436 177.701 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.055 0 CA-C-O 121.065 0.46 . . . . 72.530000000000001 110.767 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 52.5 mt -105.24 140.97 21.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.226 -0.443 . . . . 74.200000000000003 110.068 178.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -126.92 158.68 67.82 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.147 -0.479 . . . . 70.129999999999995 110.507 -177.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -67.71 128.79 18.58 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.543 2.162 . . . . 73.209999999999994 111.241 176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.497 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 94.11 27.2 12.59 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.555 -0.831 . . . . 64.030000000000001 111.646 -176.374 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -121.83 144.34 48.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.721 0.296 . . . . 72.109999999999999 110.778 178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.3 m -82.72 130.2 35.09 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.004 -0.544 . . . . 63.530000000000001 110.574 179.172 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 20.7 m -127.78 162.37 33.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.009 -0.541 . . . . 32.43 110.846 -179.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HB3' ' OE2' ' A' ' 53' ' ' GLU . 41.5 ttp180 -119.88 124.0 44.96 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.397 -0.819 . . . . 73.510000000000005 109.709 179.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.502 ' HA ' HD23 ' A' ' 52' ' ' LEU . 47.8 t -66.4 113.09 2.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.882 0.373 . . . . 73.409999999999997 110.65 -176.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . 0.412 ' OG1' ' HG3' ' A' ' 53' ' ' GLU . 0.2 OUTLIER -96.24 -11.41 26.06 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.961 -0.563 . . . . 61.109999999999999 111.007 -176.378 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 41.7 t30 -65.93 113.12 4.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.472 . . . . 63.100000000000001 110.288 178.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.98 -39.07 76.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.005 -0.543 . . . . 45.409999999999997 111.532 -174.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -85.59 34.53 0.59 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.903 0.859 . . . . 63.399999999999999 109.66 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.529 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 7.1 t70 -116.42 159.17 22.38 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.447 -0.797 . . . . 71.439999999999998 110.269 179.266 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.0 m -75.76 -31.31 59.47 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.191 0.519 . . . . 74.120000000000005 110.325 179.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -99.72 25.02 7.6 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.859 -0.609 . . . . 74.230000000000004 111.089 -174.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 18.4 t80 -58.39 128.88 39.36 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.769 -0.651 . . . . 64.010000000000005 111.126 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 74.2 mtp180 77.14 -8.41 1.69 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.138 0.975 . . . . 71.209999999999994 112.376 179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -80.39 158.03 26.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.018 0.437 . . . . 62.219999999999999 110.809 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -104.91 138.76 40.66 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.688 -0.687 . . . . 61.520000000000003 110.445 -175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -145.36 171.83 26.31 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.552 -0.619 . . . . 53.020000000000003 111.552 179.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.497 HD21 ' HA2' ' A' ' 5' ' ' GLY . 4.4 tt -120.08 122.54 41.29 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 117.062 0.431 . . . . 32.200000000000003 109.889 -177.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.545 HG11 HG22 ' A' ' 27' ' ' VAL . 39.5 t -69.21 122.73 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.912 0.387 . . . . 73.420000000000002 110.762 -179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.413 ' NE2' HD22 ' A' ' 23' ' ' LEU . 27.4 mm-40 -98.61 -30.78 12.29 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.914 -0.585 . . . . 75.439999999999998 110.752 -177.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 26' ' ' ARG . 19.0 ttt180 -146.61 118.92 8.36 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.572 -0.74 . . . . 74.329999999999998 109.903 -174.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.545 HG22 HG11 ' A' ' 24' ' ' VAL . 59.4 t -103.64 128.81 56.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 75.129999999999995 110.888 -179.242 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.9 t -106.42 -179.35 3.91 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.903 -0.777 . . . . 62.229999999999997 108.903 176.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -80.61 29.91 0.31 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.953 0.406 . . . . 71.299999999999997 111.099 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 168.0 -29.64 0.17 Allowed Glycine 0 N--CA 1.448 -0.512 0 CA-C-N 115.956 -0.566 . . . . 52.32 111.777 -178.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 65.5 mttm -105.06 164.92 11.44 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 120.58 0.229 . . . . 63.109999999999999 110.44 178.633 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -150.49 137.9 19.62 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.586 -0.279 . . . . 62.539999999999999 110.405 177.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -101.06 110.73 22.79 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.893 -0.41 . . . . 73.239999999999995 109.893 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 67.2 t -100.26 129.39 51.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 116.169 -0.468 . . . . 55.439999999999998 110.858 -176.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 37.6 tp -95.19 129.15 42.41 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.681 -0.69 . . . . 64.549999999999997 110.399 178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.4 m-85 -109.74 136.91 48.32 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 109.469 -0.567 . . . . 74.299999999999997 109.469 174.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -121.85 116.82 25.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.085 -0.507 . . . . 70.129999999999995 111.059 -174.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.427 ' HB3' ' HB3' ' A' ' 41' ' ' TRP . 17.2 t30 -110.2 -10.9 14.62 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.648 -0.706 . . . . 70.219999999999999 110.295 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.58 -71.98 0.22 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.899 -0.667 . . . . 53.5 111.545 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 22.9 t-20 -90.16 -18.89 24.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.602 0.715 . . . . 72.450000000000003 109.935 177.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.427 ' HB3' ' HB3' ' A' ' 38' ' ' ASN . 73.7 t90 -112.92 135.14 54.02 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.25 -0.886 . . . . 65.439999999999998 111.022 -178.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -134.43 149.06 50.74 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.039 -0.982 . . . . 71.25 109.256 178.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.588 ' HE2' HG22 ' A' ' 45' ' ' VAL . 88.5 tttt -165.14 119.06 1.25 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.934 0.397 . . . . 75.019999999999996 110.865 179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 39.6 tp -92.7 108.36 19.92 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.675 -0.693 . . . . 51.450000000000003 109.562 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.588 HG22 ' HE2' ' A' ' 43' ' ' LYS . 10.8 t -108.51 125.43 65.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 116.427 -0.351 . . . . 44.200000000000003 110.766 -176.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.8 m -85.17 130.76 34.54 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.405 0.621 . . . . 72.129999999999995 110.679 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -125.56 -164.55 1.31 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.252 -0.885 . . . . 64.030000000000001 108.838 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.844 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 86.6 mtm180 -106.37 162.6 13.54 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 109.285 -0.635 . . . . 70.530000000000001 109.285 171.747 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 84.1 mt -73.41 -25.15 60.42 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.101 0.477 . . . . 74.329999999999998 109.941 -178.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.7 p -82.48 -9.19 59.53 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.68 -0.691 . . . . 61.43 110.432 176.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.844 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 7.7 mm-40 -88.17 -12.96 42.42 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.274 0.559 . . . . 71.340000000000003 110.929 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 10' ' ' VAL . 27.2 mt -126.59 167.28 15.88 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.611 -0.722 . . . . 54.530000000000001 110.732 -173.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.58 ' OE2' ' HB3' ' A' ' 9' ' ' ARG . 0.1 OUTLIER -151.27 148.77 28.6 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.993 -0.743 . . . . 71.299999999999997 108.993 167.894 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -81.44 141.31 34.02 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.682 0.277 . . . . 55.439999999999998 110.631 -174.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.3 t -73.37 169.56 1.62 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 N-CA-C 108.784 -0.821 . . . . 74.010000000000005 108.784 177.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.51 ' H ' HG12 ' A' ' 55' ' ' VAL . 29.2 mtpp -75.62 135.07 72.0 Favored Pre-proline 0 C--N 1.314 -0.965 0 CA-C-N 116.66 -0.246 . . . . 54.130000000000003 110.652 -177.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 77.1 Cg_exo -50.52 119.58 5.3 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.165 1.91 . . . . 72.150000000000006 109.209 167.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.71 HD12 ' H ' ' A' ' 58' ' ' ILE . 0.5 OUTLIER -48.39 135.83 4.98 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 CA-C-O 121.998 0.904 . . . . 63.399999999999999 112.726 -164.01 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 4.8 tt -112.56 103.19 11.25 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-N 113.827 -1.533 . . . . 73.439999999999998 107.194 177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 9.2 tt0 -53.13 148.11 8.72 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 123.948 0.78 . . . . 73.510000000000005 111.367 -170.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -42.73 112.69 0.38 Allowed 'General case' 0 C--O 1.233 0.229 0 O-C-N 124.124 0.89 . . . . 74.409999999999997 112.366 -171.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 27.6 p-80 -69.6 148.39 49.44 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.909 -1.041 . . . . 73.140000000000001 110.506 177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -77.28 178.07 7.41 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.573 -0.739 . . . . 64.239999999999995 110.757 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -72.14 114.9 10.75 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.014 -0.736 . . . . 73.319999999999993 109.014 174.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -120.65 169.22 10.58 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.834 0.349 . . . . 72.439999999999998 110.779 -176.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 42.2 m80 . . . . . 0 C--O 1.244 0.766 0 N-CA-C 109.199 -0.667 . . . . 72.409999999999997 109.199 176.899 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.1 ptp . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 120.808 0.337 . . . . 75.329999999999998 110.661 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.746 HD12 HD22 ' A' ' 49' ' ' LEU . 48.9 mt -112.59 146.61 17.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.552 -0.536 . . . . 53.340000000000003 109.552 178.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -114.13 147.19 37.3 Favored Pre-proline 0 C--N 1.326 -0.435 0 CA-C-O 120.719 0.295 . . . . 44.539999999999999 111.173 -175.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -68.97 151.66 73.48 Favored 'Trans proline' 0 C--O 1.234 0.29 0 C-N-CA 122.738 2.292 . . . . 64.200000000000003 111.438 174.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 83.48 2.54 90.1 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.843 -0.694 . . . . 50.310000000000002 112.004 -178.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -101.91 153.02 20.24 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 120.773 0.32 . . . . 74.329999999999998 110.496 179.195 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.6 m -89.56 129.91 35.96 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.978 -0.556 . . . . 72.209999999999994 110.649 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG21 HD13 ' A' ' 52' ' ' LEU . 17.3 m -124.34 158.4 31.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-N 115.908 -0.587 . . . . 72.430000000000007 110.023 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.402 ' HB3' ' CG ' ' A' ' 53' ' ' GLU . 35.7 ttt180 -118.59 126.53 52.16 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.907 -0.405 . . . . 74.150000000000006 109.907 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.3 t -72.27 115.3 12.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.023 -0.535 . . . . 75.150000000000006 110.941 -174.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.0 m -100.36 -3.68 30.65 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.827 -0.624 . . . . 64.120000000000005 110.6 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.593 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 27.0 t-20 -64.94 113.67 4.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 63.229999999999997 110.042 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.3 t -78.08 -13.64 13.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 115.655 -0.702 . . . . 72.409999999999997 111.54 -173.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -76.59 -48.89 17.77 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 111.967 0.358 . . . . 74.25 111.967 -176.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -79.98 161.43 25.47 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.063 0.458 . . . . 71.329999999999998 110.97 -174.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -62.92 -30.49 71.59 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.502 -0.772 . . . . 64.019999999999996 112.605 179.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -80.91 24.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.286 0.476 . . . . 73.420000000000002 112.286 -175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 50.7 t80 -64.99 127.88 33.42 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.14 -0.482 . . . . 74.219999999999999 109.795 172.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.463 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 35.7 mtm180 74.72 27.15 1.31 Allowed 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 123.288 0.635 . . . . 70.430000000000007 111.892 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.42 152.87 24.11 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.954 -0.387 . . . . 73.5 109.954 172.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -102.96 142.18 34.49 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.581 -0.526 . . . . 73.420000000000002 109.581 176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.45 ' HA3' ' CG1' ' A' ' 34' ' ' VAL . . . -144.24 170.0 26.15 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.719 -0.753 . . . . 73.25 112.067 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 34.8 tp -109.91 123.04 48.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.647 0.26 . . . . 73.319999999999993 110.577 -178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.44 HG11 HG22 ' A' ' 27' ' ' VAL . 52.2 t -68.32 115.42 6.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.413 0 CA-C-N 116.535 -0.302 . . . . 60.509999999999998 110.52 178.332 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 28.4 mm-40 -81.48 -33.08 32.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.138 0.494 . . . . 75.299999999999997 110.463 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.454 ' HD2' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -169.38 143.6 2.89 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 108.643 -0.873 . . . . 73.439999999999998 108.643 177.444 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.44 HG22 HG11 ' A' ' 24' ' ' VAL . 23.6 t -99.14 135.59 33.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.071 0 CA-C-N 115.69 -0.686 . . . . 63.009999999999998 110.332 -178.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.524 ' HB3' ' HB3' ' A' ' 31' ' ' LYS . 8.5 t -104.89 -176.19 3.01 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 108.695 -0.854 . . . . 73.349999999999994 108.695 178.06 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -82.39 77.69 9.14 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.495 0.664 . . . . 71.209999999999994 110.081 -178.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.87 3.24 39.64 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.039 -0.982 . . . . 71.25 111.84 -179.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.541 ' HG2' HG22 ' A' ' 46' ' ' THR . 27.7 ttmt -141.5 172.88 12.08 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.903 -0.777 . . . . 65.150000000000006 108.903 -176.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -164.8 143.73 6.85 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.479 0.18 . . . . 53.530000000000001 110.887 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.632 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.19 119.07 32.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.785 0.326 . . . . 72.140000000000001 110.276 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.478 HG21 HD21 ' A' ' 52' ' ' LEU . 39.9 t -100.82 124.65 54.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.996 -0.547 . . . . 53.509999999999998 111.028 -176.029 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 33.5 tp -96.44 121.59 38.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.129 -0.487 . . . . 62.25 110.295 177.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.3 m-85 -96.75 137.23 36.14 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 108.655 -0.869 . . . . 74.540000000000006 108.655 173.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -141.47 114.51 8.61 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 109.823 -0.436 . . . . 64.310000000000002 109.823 -171.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.411 ' HB3' ' HE3' ' A' ' 41' ' ' TRP . 29.4 t-20 -137.04 90.31 2.52 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.215 0.531 . . . . 60.200000000000003 111.157 -178.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 72.13 -90.7 0.52 Allowed Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.46 -0.791 . . . . 62.030000000000001 112.833 175.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -115.0 -16.23 11.68 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.348 0.594 . . . . 75.209999999999994 109.943 -178.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.411 ' HE3' ' HB3' ' A' ' 38' ' ' ASN . 66.9 t90 -94.28 144.07 25.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.691 -0.686 . . . . 72.329999999999998 110.682 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -148.2 158.29 43.99 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.368 -0.833 . . . . 72.230000000000004 110.018 177.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -159.58 132.11 6.65 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.957 -0.565 . . . . 74.150000000000006 110.132 178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.411 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.0 tp -103.92 109.44 21.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.311 -0.404 . . . . 62.329999999999998 110.301 178.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 43.0 t -120.59 124.47 72.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.353 -0.385 . . . . 62.509999999999998 110.307 179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.632 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.3 m -81.12 132.65 35.37 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-O 121.267 0.556 . . . . 53.43 110.755 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 78.1 m-85 -129.61 177.89 6.89 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 108.82 -0.808 . . . . 73.239999999999995 108.82 176.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.547 ' HB2' ' OE1' ' A' ' 51' ' ' GLU . 0.5 OUTLIER -97.61 178.11 5.28 Favored 'General case' 0 C--N 1.317 -0.819 0 C-N-CA 120.816 -0.354 . . . . 64.340000000000003 110.265 179.457 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.746 HD22 HD12 ' A' ' 2' ' ' ILE . 68.8 mt -78.56 -25.96 45.5 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.195 0.521 . . . . 64.140000000000001 110.02 -175.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 2.7 p -76.3 -17.5 59.41 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.581 -0.736 . . . . 62.399999999999999 109.996 174.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.593 ' HG3' ' HB2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -86.44 -18.84 30.69 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.1 -0.955 . . . . 63.399999999999999 110.835 -178.202 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.478 HD21 HG21 ' A' ' 34' ' ' VAL . 55.6 mt -122.65 122.63 39.26 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.957 -0.565 . . . . 73.409999999999997 111.202 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.402 ' CG ' ' HB3' ' A' ' 9' ' ' ARG . 12.8 pt-20 -88.34 118.26 27.83 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.114 -0.698 . . . . 73.209999999999994 109.114 172.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.432 ' HA ' HG12 ' A' ' 8' ' ' VAL . . . -75.11 106.29 6.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.977 -0.556 . . . . 71.540000000000006 109.967 179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.504 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.1 t -74.84 168.87 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.684 -0.689 . . . . 71.310000000000002 110.107 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.504 ' H ' HG12 ' A' ' 55' ' ' VAL . 49.2 pttt -78.13 148.99 75.75 Favored Pre-proline 0 C--N 1.317 -0.838 0 CA-C-N 115.918 -0.583 . . . . 73.329999999999998 109.808 179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.94 163.97 26.43 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.332 2.021 . . . . 70.109999999999999 112.059 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.415 HG22 ' H ' ' A' ' 59' ' ' LEU . 12.4 mm -65.65 165.67 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 108.698 -0.852 . . . . 74.25 108.698 176.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' H ' HG22 ' A' ' 58' ' ' ILE . 76.2 mt -70.66 75.95 0.59 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.201 0.524 . . . . 74.420000000000002 112.365 -173.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -92.81 130.85 38.29 Favored 'General case' 0 N--CA 1.445 -0.693 0 N-CA-C 108.187 -1.042 . . . . 55.229999999999997 108.187 168.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -80.55 65.81 5.83 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.657 0.741 . . . . 72.219999999999999 111.453 -174.239 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . 0.51 ' O ' ' HB2' ' A' ' 63' ' ' HIS . 18.0 t60 -95.7 162.22 13.7 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 107.589 -1.263 . . . . 73.450000000000003 107.589 174.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.51 ' HB2' ' O ' ' A' ' 62' ' ' HIS . 41.6 m-70 72.36 108.2 0.07 Allowed 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.074 0.464 . . . . 55.210000000000001 109.984 -173.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 25.0 t60 -83.16 -39.66 20.74 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.268 -0.424 . . . . 74.25 110.826 -175.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 69.59 138.46 0.04 OUTLIER 'General case' 0 N--CA 1.466 0.372 0 O-C-N 123.998 0.811 . . . . 71.209999999999994 110.617 -174.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.278 -0.868 . . . . 55.32 109.958 177.747 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.051 0.453 . . . . 74.0 111.413 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.464 HD12 HD22 ' A' ' 49' ' ' LEU . 57.9 mt -127.16 142.89 42.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 108.585 -0.895 . . . . 72.340000000000003 108.585 173.166 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.403 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 97.6 m-85 -127.85 145.55 55.52 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 120.75 0.31 . . . . 61.43 111.281 -175.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 3' ' ' PHE . 35.6 Cg_exo -59.86 142.91 99.49 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.092 2.528 . . . . 64.230000000000004 112.313 179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.25 6.08 63.23 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.846 -0.692 . . . . 62.219999999999999 112.312 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -112.72 157.52 21.2 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.669 0.271 . . . . 53.009999999999998 110.305 177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.2 m -92.03 130.55 37.74 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.323 -0.399 . . . . 64.329999999999998 110.45 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 m -123.63 142.94 38.53 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.074 -0.512 . . . . 75.209999999999994 110.154 177.15 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 25.8 ttp180 -102.18 125.44 48.87 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.954 -0.566 . . . . 72.140000000000001 110.047 -178.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 57.6 t -62.64 115.85 2.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.684 -0.689 . . . . 64.540000000000006 110.406 -178.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 4.5 m -105.69 10.52 32.81 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.763 -0.653 . . . . 73.140000000000001 110.319 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.9 m120 -58.0 109.71 0.79 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.93 -0.577 . . . . 71.409999999999997 109.979 175.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.37 -35.41 62.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.011 -0.54 . . . . 75.120000000000005 112.141 -169.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -99.89 -2.61 34.38 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 121.394 0.616 . . . . 63.450000000000003 111.018 -173.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.98 165.61 16.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.256 -0.429 . . . . 72.540000000000006 110.263 -178.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 22.9 m -84.82 -27.29 26.89 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.268 -0.424 . . . . 72.239999999999995 110.84 -177.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -87.95 24.67 1.73 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.085 0.469 . . . . 73.299999999999997 111.16 -177.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.49 ' O ' ' HB2' ' A' ' 19' ' ' ARG . 53.6 t80 -63.12 136.81 57.99 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.733 -0.667 . . . . 72.540000000000006 110.027 176.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.49 ' HB2' ' O ' ' A' ' 18' ' ' TYR . 40.3 mtm180 82.44 -10.91 1.04 Allowed 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 123.802 0.841 . . . . 63.229999999999997 112.251 178.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 36.0 m-85 -72.92 150.64 42.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.834 0.35 . . . . 73.420000000000002 110.398 177.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -117.62 133.38 56.02 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 116.13 -0.486 . . . . 73.439999999999998 110.235 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -134.68 172.97 21.7 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.583 -0.818 . . . . 73.230000000000004 112.484 -177.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 46.6 tp -101.47 125.96 48.19 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.422 -0.214 . . . . 74.019999999999996 110.422 -176.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 44.6 t -67.87 115.17 5.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 110.133 -0.321 . . . . 75.120000000000005 110.133 177.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.436 ' HG3' HD13 ' A' ' 44' ' ' LEU . 27.6 mm-40 -87.35 -35.81 18.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.959 -0.564 . . . . 74.5 110.418 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 17.9 ptp180 -166.81 148.87 6.29 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.692 -0.686 . . . . 74.530000000000001 109.574 -177.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.424 HG21 ' O ' ' A' ' 2' ' ' ILE . 44.4 t -105.4 140.93 21.92 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.334 -0.848 . . . . 73.310000000000002 109.755 177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 8.1 t -129.3 -162.27 1.19 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 109.859 -0.423 . . . . 72.420000000000002 109.859 -178.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -72.42 86.85 1.15 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.235 0.541 . . . . 75.230000000000004 110.139 -177.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.64 5.67 86.32 Favored Glycine 0 C--N 1.317 -0.509 0 CA-C-N 114.739 -1.119 . . . . 73.010000000000005 111.854 177.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 36.7 mtmm -129.41 166.25 19.93 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 122.625 0.37 . . . . 71.25 110.637 -177.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.2 141.88 24.52 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 116.268 -0.423 . . . . 62.219999999999999 110.242 177.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.468 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -89.71 108.48 19.71 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.971 -0.381 . . . . 73.25 109.971 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.9 t -95.6 122.42 47.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 116.126 -0.488 . . . . 74.109999999999999 110.609 -177.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 36.0 tp -96.63 120.09 36.32 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.074 -0.512 . . . . 75.230000000000004 110.553 177.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.666 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 95.9 m-85 -93.44 141.62 28.25 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 108.82 -0.807 . . . . 73.120000000000005 108.82 171.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -140.72 133.21 28.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.263 -0.426 . . . . 33.219999999999999 110.028 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -147.44 70.79 1.18 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.172 0.51 . . . . 71.209999999999994 110.127 176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 79.54 -88.02 1.22 Allowed Glycine 0 N--CA 1.453 -0.225 0 CA-C-N 115.653 -0.703 . . . . 54.149999999999999 112.441 178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -104.53 -20.81 13.57 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.394 0.616 . . . . 51.109999999999999 109.878 178.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 73.7 t90 -81.69 132.01 35.28 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.261 -0.881 . . . . 75.510000000000005 111.394 -177.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -128.93 152.57 48.42 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 114.458 -1.246 . . . . 72.540000000000006 109.346 178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.666 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 54.5 tttp -157.73 100.92 1.79 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.517 -0.311 . . . . 62.420000000000002 110.224 178.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.468 HD11 ' HB1' ' A' ' 33' ' ' ALA . 56.5 tp -95.15 106.32 18.32 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.387 -0.369 . . . . 74.340000000000003 110.324 178.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.526 HG23 ' HG2' ' A' ' 43' ' ' LYS . 54.8 t -126.33 126.46 69.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-N 116.195 -0.457 . . . . 52.240000000000002 110.487 -178.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 2.1 m -77.65 131.8 37.92 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.1 -0.5 . . . . 62.340000000000003 110.347 177.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -124.44 -174.59 3.05 Favored 'General case' 0 C--N 1.316 -0.883 0 N-CA-C 109.134 -0.691 . . . . 65.5 109.134 176.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.605 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 9.4 mtt180 -102.28 164.1 11.87 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.723 0.297 . . . . 54.530000000000001 110.31 179.16 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.464 HD22 HD12 ' A' ' 2' ' ' ILE . 91.7 mt -78.64 -20.89 49.27 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.269 0.556 . . . . 75.150000000000006 110.378 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 3.5 p -88.53 -16.49 32.5 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.65 -0.704 . . . . 34.229999999999997 110.102 175.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.605 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 12.3 mm-40 -93.55 -4.18 51.42 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.561 -0.745 . . . . 62.020000000000003 110.347 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 96.9 mt -121.58 158.74 27.89 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.786 -0.643 . . . . 72.019999999999996 110.768 -179.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -139.63 123.84 17.92 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.457 -0.572 . . . . 62.219999999999999 109.457 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.37 132.04 51.25 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.852 0.358 . . . . 63.530000000000001 110.697 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.831 HG12 ' H ' ' A' ' 56' ' ' LYS . 1.8 t -103.15 -169.78 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.154 -0.476 . . . . 64.319999999999993 110.166 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.831 ' H ' HG12 ' A' ' 55' ' ' VAL . 18.5 ptpt -63.48 153.67 81.95 Favored Pre-proline 0 C--N 1.321 -0.658 0 CA-C-N 115.712 -0.677 . . . . 53.210000000000001 111.929 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 56' ' ' LYS . 2.8 Cg_exo -77.57 164.04 28.79 Favored 'Trans proline' 0 N--CA 1.457 -0.638 0 C-N-CA 122.684 2.256 . . . . 65.109999999999999 109.613 163.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.49 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.6 mp -75.65 161.7 4.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 N-CA-C 109.23 -0.656 . . . . 72.099999999999994 109.23 -178.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.887 ' HG ' ' H ' ' A' ' 60' ' ' GLU . 19.4 tp 68.58 -169.83 0.18 Allowed 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.602 0.761 . . . . 72.319999999999993 110.157 -174.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.887 ' H ' ' HG ' ' A' ' 59' ' ' LEU . 41.8 tt0 -60.75 113.55 2.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 122.508 0.323 . . . . 74.0 110.75 179.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -80.5 121.29 25.58 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 109.482 -0.562 . . . . 64.540000000000006 109.482 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 68.0 m80 -91.44 136.81 32.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.981 -0.554 . . . . 73.540000000000006 111.178 -174.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -67.28 151.03 48.22 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.372 -0.831 . . . . 64.010000000000005 109.84 -178.611 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -58.04 146.69 31.99 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.161 0.505 . . . . 62.340000000000003 111.447 -178.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 78.3 m80 -96.29 -165.94 1.35 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.517 -0.765 . . . . 73.109999999999999 110.999 -175.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 89.3 m-70 . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.564 -0.731 . . . . 75.420000000000002 110.136 -179.993 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 57.0 ttp . . . . . 0 N--CA 1.478 0.967 0 CA-C-O 120.843 0.354 . . . . 73.0 110.514 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.673 HD12 HD22 ' A' ' 49' ' ' LEU . 56.8 mt -130.24 142.84 42.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.703 -0.48 . . . . 70.010000000000005 109.703 178.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -129.36 147.82 66.69 Favored Pre-proline 0 C--N 1.326 -0.444 0 CA-C-N 116.308 -0.405 . . . . 51.109999999999999 110.519 -178.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_exo -60.6 129.77 30.73 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 122.613 2.209 . . . . 73.120000000000005 111.209 175.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 111.82 -7.18 27.67 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 121.115 -0.564 . . . . 61.530000000000001 111.829 -175.482 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -89.54 147.27 24.05 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.612 0.244 . . . . 64.439999999999998 110.617 177.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 8.8 m -89.31 132.71 34.8 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.335 -0.393 . . . . 75.349999999999994 110.381 179.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.642 HG21 HD13 ' A' ' 52' ' ' LEU . 12.0 m -133.61 149.27 30.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 120.935 0.398 . . . . 73.129999999999995 111.552 -176.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 60.4 ttp180 -114.96 135.83 53.78 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.776 -0.647 . . . . 43.240000000000002 109.695 176.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.3 t -75.2 106.15 4.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 109.927 -0.397 . . . . 64.140000000000001 109.927 178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 2.9 m -90.97 -5.97 54.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 120.756 0.312 . . . . 63.030000000000001 111.48 -174.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -65.68 111.37 3.16 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.309 -0.626 . . . . 73.340000000000003 109.309 176.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.477 ' HA ' ' CD1' ' A' ' 18' ' ' TYR . 3.0 t -80.78 -1.14 4.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 121.395 0.617 . . . . 54.32 111.033 -173.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -101.35 -22.99 14.45 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.99 -0.55 . . . . 73.209999999999994 110.673 179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -74.72 158.03 34.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.528 0.68 . . . . 72.430000000000007 111.964 -170.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 31.1 m -65.31 -32.6 74.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.979 -1.009 . . . . 72.120000000000005 111.555 179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 91.5 m-85 -101.4 30.62 4.13 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.289 -0.414 . . . . 64.209999999999994 111.232 -177.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.477 ' CD1' ' HA ' ' A' ' 13' ' ' VAL . 25.0 t80 -55.37 138.16 46.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.906 0.384 . . . . 75.540000000000006 111.699 179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 20.8 ptt180 56.08 18.3 3.11 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.239 1.416 . . . . 70.209999999999994 113.276 176.25 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -85.27 151.27 24.18 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 108.786 -0.82 . . . . 74.420000000000002 108.786 167.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -121.19 130.16 53.57 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 116.006 -0.543 . . . . 72.439999999999998 110.067 -176.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.16 -174.67 16.62 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.522 -0.847 . . . . 32.439999999999998 112.384 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 17.1 tp -113.1 132.81 55.29 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 110.336 -0.246 . . . . 74.530000000000001 110.336 -177.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.1 t -69.51 114.48 6.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 110.043 -0.354 . . . . 74.349999999999994 110.043 176.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.443 ' HG3' HD13 ' A' ' 44' ' ' LEU . 28.6 mm-40 -79.11 -35.3 42.49 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.145 0.498 . . . . 73.510000000000005 110.366 -179.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 16.6 ptt180 -172.24 146.24 1.84 Allowed 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.366 -0.834 . . . . 74.230000000000004 109.259 -175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.8 t -109.76 128.44 65.84 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.021 0 CA-C-N 115.327 -0.851 . . . . 73.219999999999999 110.17 178.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 10.5 t -106.63 67.87 0.73 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.492 -0.558 . . . . 50.119999999999997 109.492 176.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 36.4 t70 68.85 -72.34 0.1 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 114.9 -1.046 . . . . 54.119999999999997 112.531 176.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.55 -9.76 20.73 Favored Glycine 0 C--N 1.303 -1.286 0 CA-C-N 115.257 -0.883 . . . . 35.409999999999997 113.022 -176.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -124.28 170.35 10.86 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 110.2 -0.296 . . . . 53.119999999999997 110.2 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -149.72 149.1 30.07 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.532 0.206 . . . . 65.099999999999994 110.973 -179.507 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.571 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -96.16 117.07 30.01 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.731 -0.47 . . . . 53.420000000000002 109.731 177.033 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 37.2 t -100.36 120.94 50.51 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 120.974 0.416 . . . . 65.439999999999998 110.85 -176.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 34.8 tp -93.69 115.72 28.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.018 -0.537 . . . . 75.230000000000004 109.912 176.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.0 m-85 -91.75 144.73 25.21 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 115.959 -0.564 . . . . 62.020000000000003 109.508 177.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.87 112.37 7.11 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 109.693 -0.484 . . . . 74.040000000000006 109.693 -176.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -130.73 79.68 1.91 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.106 -0.497 . . . . 52.140000000000001 110.262 -178.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 69.49 -90.58 0.3 Allowed Glycine 0 N--CA 1.451 -0.309 0 CA-C-N 116.055 -0.52 . . . . 73.329999999999998 112.672 176.04 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -100.73 -22.38 14.91 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.421 0.629 . . . . 62.329999999999998 110.1 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 80.9 t90 -92.16 144.49 25.37 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.401 -0.818 . . . . 65.349999999999994 110.978 -176.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -149.69 153.59 37.2 Favored 'General case' 0 C--N 1.316 -0.862 0 CA-C-N 115.076 -0.965 . . . . 71.430000000000007 109.266 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.437 ' HG3' HG23 ' A' ' 45' ' ' VAL . 24.2 tptm -162.53 128.43 3.42 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.409 -0.359 . . . . 72.140000000000001 110.82 -175.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.571 HD11 ' HB1' ' A' ' 33' ' ' ALA . 63.8 tp -98.12 112.03 24.14 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.184 -0.462 . . . . 73.209999999999994 109.959 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.437 HG23 ' HG3' ' A' ' 43' ' ' LYS . 42.0 t -126.53 125.81 67.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 120.839 0.352 . . . . 74.109999999999999 110.483 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 7.5 m -73.68 140.4 46.04 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.189 0.519 . . . . 71.540000000000006 110.844 176.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 65.8 m-85 -137.0 -176.06 4.25 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.259 -0.882 . . . . 72.439999999999998 109.262 176.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.849 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 98.9 mtt180 -91.39 -179.28 5.35 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.099 -0.704 . . . . 72.310000000000002 109.099 170.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.673 HD22 HD12 ' A' ' 2' ' ' ILE . 87.0 mt -87.25 -33.03 19.43 Favored 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 108.951 -0.759 . . . . 74.409999999999997 108.951 177.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 28.8 m -70.63 -14.41 62.47 Favored 'General case' 0 N--CA 1.437 -1.112 0 CA-C-N 115.57 -0.741 . . . . 75.420000000000002 111.106 176.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.849 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 11.1 mm-40 -80.53 -18.71 47.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.204 0.526 . . . . 74.340000000000003 110.591 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.642 HD13 HG21 ' A' ' 8' ' ' VAL . 38.8 mt -115.68 157.38 24.32 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.618 -0.719 . . . . 74.5 111.325 -172.776 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -124.84 146.6 49.19 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 108.7 -0.852 . . . . 74.150000000000006 108.7 169.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.87 123.57 26.46 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 120.761 0.315 . . . . 52.119999999999997 110.238 179.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.453 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.8 t -79.44 162.27 3.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 108.947 -0.76 . . . . 64.319999999999993 108.947 177.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.453 ' H ' HG12 ' A' ' 55' ' ' VAL . 0.5 OUTLIER -102.4 126.17 33.99 Favored Pre-proline 0 C--N 1.31 -1.125 0 CA-C-N 115.847 -0.615 . . . . 75.439999999999998 109.754 -173.572 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 56' ' ' LYS . 9.7 Cg_endo -52.96 130.6 38.62 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.666 2.244 . . . . 73.209999999999994 111.277 177.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.4 mt -66.09 150.25 11.01 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-O 121.153 0.501 . . . . 75.420000000000002 109.959 -177.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 21.2 tp -132.45 162.51 30.99 Favored 'General case' 0 C--N 1.312 -1.022 0 N-CA-C 108.425 -0.954 . . . . 73.099999999999994 108.425 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -77.35 66.43 3.11 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.623 0.725 . . . . 75.120000000000005 111.28 -175.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 56.2 m-70 -133.62 147.77 51.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.943 -1.026 . . . . 72.120000000000005 108.787 173.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 6.2 p-80 -96.96 11.65 35.24 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 120.812 -0.355 . . . . 71.209999999999994 111.158 -177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 34.3 m80 55.75 -158.35 0.23 Allowed 'General case' 0 N--CA 1.466 0.367 0 O-C-N 123.559 0.537 . . . . 61.009999999999998 110.957 178.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 3.1 t60 -155.55 90.42 1.24 Allowed 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.591 -0.522 . . . . 54.329999999999998 109.591 174.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 55.6 m80 -99.29 158.05 15.97 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.13 0.49 . . . . 71.329999999999998 111.36 -176.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 23.8 t60 . . . . . 0 C--N 1.321 -0.674 0 CA-C-O 118.232 -0.889 . . . . 72.239999999999995 108.772 172.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 tpt . . . . . 0 N--CA 1.483 1.188 0 CA-C-O 120.357 0.122 . . . . 74.319999999999993 111.116 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 60.3 mt 77.11 133.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 CA-C-O 121.44 0.638 . . . . 74.209999999999994 110.421 -175.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -146.17 162.56 34.54 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.177 -0.92 . . . . 71.299999999999997 109.533 -176.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -59.47 113.11 1.47 Allowed 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.181 1.921 . . . . 72.230000000000004 111.098 174.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 117.11 -9.58 15.51 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.798 -0.715 . . . . 44.420000000000002 111.983 -175.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -88.95 147.12 24.49 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 63.340000000000003 110.433 179.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.0 m -89.89 132.58 35.22 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.116 -0.493 . . . . 64.219999999999999 110.158 178.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.417 HG21 HD13 ' A' ' 52' ' ' LEU . 16.4 m -127.7 152.59 35.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.954 0.407 . . . . 62.450000000000003 110.736 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HB3' ' HG3' ' A' ' 53' ' ' GLU . 43.5 ttm180 -110.06 129.28 55.71 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 109.032 -0.729 . . . . 65.109999999999999 109.032 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.8 t -75.36 101.39 2.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-O 121.085 0.469 . . . . 63.130000000000003 110.915 -175.695 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.3 m -79.76 -12.45 59.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.607 -0.724 . . . . 64.439999999999998 109.573 176.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -68.6 107.42 2.95 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.28 -0.873 . . . . 71.010000000000005 110.125 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.4 p -89.94 -13.61 9.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 115.757 -0.656 . . . . 64.430000000000007 110.601 -179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.69 -36.17 82.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.418 -0.81 . . . . 72.5 110.47 178.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -80.99 -174.91 5.11 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.937 -0.574 . . . . 73.010000000000005 109.874 177.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.3 m -93.92 -21.13 19.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.085 0.469 . . . . 65.150000000000006 110.807 -176.045 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.534 ' OH ' ' HG3' ' A' ' 43' ' ' LYS . 54.2 m-85 -90.25 40.49 1.01 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.099 -0.5 . . . . 74.340000000000003 111.329 -177.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.537 ' O ' ' HG2' ' A' ' 19' ' ' ARG . 29.7 t80 -57.65 132.46 53.33 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.813 -0.631 . . . . 73.340000000000003 111.096 177.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.537 ' HG2' ' O ' ' A' ' 18' ' ' TYR . 36.2 ptt180 59.84 14.93 4.51 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.147 1.379 . . . . 71.329999999999998 112.77 176.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 26.3 m-85 -80.22 156.57 26.83 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.858 0.361 . . . . 73.439999999999998 110.106 174.009 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -118.73 117.66 29.51 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.106 -0.497 . . . . 74.219999999999999 109.901 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.6 176.47 17.92 Favored Glycine 0 N--CA 1.449 -0.474 0 C-N-CA 120.615 -0.803 . . . . 71.099999999999994 112.478 -174.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 26.7 tp -107.95 123.18 48.25 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 120.586 0.232 . . . . 73.040000000000006 110.383 -176.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.419 HG11 HG22 ' A' ' 27' ' ' VAL . 58.0 t -67.56 122.09 18.01 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.934 0.397 . . . . 71.340000000000003 110.007 177.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . 0.461 ' HG2' ' HB2' ' A' ' 35' ' ' LEU . 24.9 mm-40 -91.49 -27.56 18.17 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.976 -0.557 . . . . 61.32 111.005 -177.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 10.4 ptt180 -168.2 135.5 2.13 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.389 -0.823 . . . . 73.040000000000006 109.938 -179.55 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.419 HG22 HG11 ' A' ' 24' ' ' VAL . 42.5 t -104.06 150.36 7.28 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 115.256 -0.884 . . . . 62.5 110.086 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.2 p -138.85 -177.63 4.96 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.3 -0.63 . . . . 54.109999999999999 109.3 175.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -76.44 80.43 3.16 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.595 0.712 . . . . 71.140000000000001 110.759 -177.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.41 -24.58 9.1 Favored Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 114.809 -1.087 . . . . 61.020000000000003 112.025 175.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -118.82 157.83 26.82 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 120.556 0.217 . . . . 64.120000000000005 111.161 -176.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -148.06 138.43 22.85 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.347 -0.388 . . . . 63.25 110.163 177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.464 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -95.0 112.15 23.88 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 110.125 -0.324 . . . . 61.420000000000002 110.125 -178.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.4 t -97.9 124.52 50.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.06 -0.518 . . . . 73.219999999999999 110.586 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.461 ' HB2' ' HG2' ' A' ' 25' ' ' GLN . 33.8 tp -93.53 119.79 33.01 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.007 -0.542 . . . . 64.319999999999993 110.467 179.119 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -100.46 141.06 33.83 Favored 'General case' 0 C--N 1.314 -0.958 0 N-CA-C 108.95 -0.759 . . . . 61.329999999999998 108.95 172.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -139.03 141.08 38.27 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-N 116.549 -0.296 . . . . 65.420000000000002 110.37 -175.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -153.8 76.49 1.07 Allowed 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.239 -0.652 . . . . 74.319999999999993 109.239 174.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 70.94 -110.08 3.11 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.6 -0.727 . . . . 44.310000000000002 111.877 -178.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -84.37 -15.83 44.98 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.885 0.374 . . . . 75.239999999999995 110.736 178.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.0 t90 -87.16 142.78 27.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.363 0.602 . . . . 73.439999999999998 110.582 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -147.31 163.35 36.69 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 114.919 -1.037 . . . . 72.510000000000005 109.45 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.557 ' HD2' ' CG2' ' A' ' 45' ' ' VAL . 4.3 tmtp? -166.5 109.23 0.73 Allowed 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 116.33 -0.396 . . . . 73.409999999999997 110.221 179.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 48.9 tp -96.34 104.05 15.99 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.764 -0.458 . . . . 75.329999999999998 109.764 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.557 ' CG2' ' HD2' ' A' ' 43' ' ' LYS . 17.9 t -111.95 126.37 69.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.277 -0.42 . . . . 60.5 110.251 -176.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 1.6 m -85.68 120.28 26.94 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.328 0.585 . . . . 42.109999999999999 109.815 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 71.5 m-85 -112.42 -168.32 1.3 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 115.402 -0.817 . . . . 74.510000000000005 109.106 178.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.95 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 55.3 mmt-85 -105.63 160.45 15.18 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.187 -0.672 . . . . 64.409999999999997 109.187 173.235 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.2 mt -71.07 -27.86 63.93 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.254 0.549 . . . . 74.040000000000006 110.035 -177.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 33.2 p -75.43 -22.47 57.33 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.477 -0.783 . . . . 50.240000000000002 110.305 175.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.95 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 20.6 mm-40 -88.28 -5.38 58.39 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.0 -0.545 . . . . 70.010000000000005 111.378 -173.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.417 HD13 HG21 ' A' ' 8' ' ' VAL . 72.5 mt -120.02 143.04 48.28 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.059 -0.519 . . . . 71.030000000000001 110.263 -178.327 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.574 ' HG3' ' HB3' ' A' ' 9' ' ' ARG . 9.7 pt-20 -107.59 130.66 54.87 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.183 -0.673 . . . . 52.149999999999999 109.183 172.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.99 124.64 24.83 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 116.34 -0.391 . . . . 75.209999999999994 110.093 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.53 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.9 t -83.01 168.14 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 108.849 -0.797 . . . . 64.219999999999999 108.849 177.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.53 ' H ' HG12 ' A' ' 55' ' ' VAL . 11.0 mptt -88.13 132.99 38.0 Favored Pre-proline 0 C--N 1.314 -0.978 0 N-CA-C 109.715 -0.476 . . . . 72.0 109.715 -176.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -71.04 177.97 5.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.349 2.032 . . . . 72.329999999999998 112.015 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 6.5 mt -67.31 152.86 9.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.257 -0.646 . . . . 74.230000000000004 109.257 178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.9 mt -83.86 104.35 13.88 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.047 0.451 . . . . 52.530000000000001 111.116 -175.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.664 ' HB3' ' HB2' ' A' ' 63' ' ' HIS . 1.2 tm-20 -60.11 121.2 11.3 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 107.878 -1.156 . . . . 73.319999999999993 107.878 171.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 62.8 m80 -64.94 -26.43 68.3 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 112.912 0.708 . . . . 75.439999999999998 112.912 -167.124 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 58.9 m80 -100.27 8.34 43.81 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.819 0.342 . . . . 75.219999999999999 110.778 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . 0.664 ' HB2' ' HB3' ' A' ' 60' ' ' GLU . 27.2 t60 -82.58 115.41 21.53 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.209 -0.45 . . . . 72.0 110.138 179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.9 m80 -90.17 176.38 6.78 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.205 0.526 . . . . 54.310000000000002 110.784 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 34.6 p80 -125.21 162.18 25.25 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.939 -0.573 . . . . 64.200000000000003 109.553 175.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 9.3 p80 . . . . . 0 C--O 1.246 0.888 0 N-CA-C 109.101 -0.703 . . . . 72.25 109.101 175.195 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.1 ptp . . . . . 0 N--CA 1.479 1.008 0 N-CA-C 109.866 -0.42 . . . . 64.230000000000004 109.866 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.71 ' HB ' HD22 ' A' ' 49' ' ' LEU . 59.7 mt -87.14 144.28 9.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.14 0.495 . . . . 72.409999999999997 111.856 -174.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 84.6 m-85 -135.83 155.88 77.66 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 115.306 -0.861 . . . . 73.120000000000005 109.448 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -63.72 132.38 34.92 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.063 1.842 . . . . 74.25 111.59 176.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 100.52 -7.54 58.02 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.98 -0.628 . . . . 63.329999999999998 112.216 -177.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -94.81 147.31 23.49 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.754 0.312 . . . . 72.109999999999999 111.15 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 11.8 m -87.02 126.15 34.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.837 -0.62 . . . . 74.519999999999996 110.068 177.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.428 HG21 HD13 ' A' ' 52' ' ' LEU . 21.0 m -124.97 148.16 29.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-O 121.211 0.529 . . . . 72.420000000000002 110.973 -177.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 21' ' ' GLU . 23.5 ttp180 -111.05 132.41 54.26 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.46 -0.791 . . . . 73.030000000000001 109.682 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.1 t -77.08 100.1 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 110.362 -179.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 3.8 p -102.06 7.26 41.21 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.216 0.532 . . . . 75.420000000000002 111.176 177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.459 ' ND2' ' HB2' ' A' ' 15' ' ' ASP . 48.1 t30 -71.93 100.12 2.38 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.55 -0.75 . . . . 74.129999999999995 109.549 175.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -60.95 -30.18 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 115.685 -0.688 . . . . 72.540000000000006 111.984 -171.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -80.66 -7.43 59.3 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.019 0.438 . . . . 75.400000000000006 111.637 -175.258 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.459 ' HB2' ' ND2' ' A' ' 12' ' ' ASN . 18.3 t70 -87.92 162.09 17.1 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 122.048 -0.408 . . . . 73.200000000000003 111.277 -175.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 5.7 m -77.05 -26.63 53.81 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.083 -0.508 . . . . 72.340000000000003 111.696 -177.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' OH ' ' HE2' ' A' ' 43' ' ' LYS . 89.9 m-85 -106.91 28.89 7.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.894 0.378 . . . . 73.239999999999995 111.265 -176.463 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.425 ' O ' ' HB3' ' A' ' 19' ' ' ARG . 20.2 t80 -68.88 82.2 0.3 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.796 -0.638 . . . . 64.5 110.408 175.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . 0.425 ' HB3' ' O ' ' A' ' 18' ' ' TYR . 25.9 ptt180 169.91 -27.06 0.0 OUTLIER 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.376 -0.829 . . . . 73.430000000000007 110.421 178.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 52.1 m-85 -88.61 158.4 18.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.291 0.567 . . . . 74.239999999999995 112.013 -176.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 9' ' ' ARG . 81.4 mt-10 -125.8 134.16 51.78 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.183 -0.917 . . . . 72.299999999999997 108.962 178.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -142.61 178.45 21.05 Favored Glycine 0 C--O 1.229 -0.207 0 C-N-CA 120.373 -0.918 . . . . 73.239999999999995 112.335 -174.453 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 8.1 mp -111.94 129.69 56.09 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 116.943 0.372 . . . . 61.32 110.388 -178.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.569 HG21 ' CG2' ' A' ' 2' ' ' ILE . 74.4 t -68.31 124.83 24.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.295 -0.412 . . . . 73.140000000000001 110.764 179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -93.63 -29.17 15.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.067 -0.515 . . . . 73.0 110.82 -178.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.401 HH11 ' HD2' ' A' ' 26' ' ' ARG . 11.3 ptm180 -165.3 133.06 3.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.509 -0.769 . . . . 73.329999999999998 110.689 -174.1 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.511 HG12 ' H ' ' A' ' 29' ' ' ASP . 96.5 t -97.4 131.54 44.04 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.554 -0.748 . . . . 75.329999999999998 109.057 173.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.2 t -116.06 36.37 4.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.17 0.51 . . . . 72.129999999999995 109.996 -176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.511 ' H ' HG12 ' A' ' 27' ' ' VAL . 10.5 m-20 63.0 99.85 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.032 -0.985 . . . . 70.329999999999998 111.706 -179.812 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.98 -32.02 3.87 Favored Glycine 0 N--CA 1.451 -0.319 0 CA-C-N 115.873 -0.603 . . . . 73.439999999999998 111.64 -177.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 23.3 ttmt -118.62 165.24 14.2 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.062 -0.718 . . . . 64.109999999999999 109.062 179.664 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -157.97 146.02 18.73 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 116.513 -0.312 . . . . 53.229999999999997 110.676 -179.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 46' ' ' THR . . . -94.54 114.34 26.3 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.823 -0.436 . . . . 74.540000000000006 109.823 -179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.0 t -94.58 125.66 47.15 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 115.877 -0.601 . . . . 63.25 110.408 -177.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 30.0 tp -98.14 110.77 23.29 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.911 -0.586 . . . . 43.340000000000003 110.39 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.682 ' HB2' ' HB3' ' A' ' 43' ' ' LYS . 78.6 m-85 -91.66 142.87 27.14 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 108.66 -0.866 . . . . 73.310000000000002 108.66 173.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.427 ' HA ' ' O ' ' A' ' 41' ' ' TRP . 3.8 tm-20 -155.77 126.59 6.93 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 109.168 -0.678 . . . . 73.299999999999997 109.168 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.4 t-20 -153.56 102.91 2.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.2 -0.454 . . . . 72.530000000000001 110.627 -179.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.6 -84.93 1.18 Allowed Glycine 0 N--CA 1.448 -0.509 0 CA-C-N 115.823 -0.626 . . . . 63.119999999999997 112.398 177.017 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -129.39 -4.9 4.82 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.509 0.671 . . . . 51.130000000000003 109.95 -177.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.472 ' CZ2' ' HB2' ' A' ' 43' ' ' LYS . 35.3 t90 -100.38 135.97 41.0 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.764 -0.653 . . . . 72.319999999999993 112.251 -173.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -121.2 144.12 48.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.764 -1.107 . . . . 74.439999999999998 109.154 176.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.682 ' HB3' ' HB2' ' A' ' 36' ' ' PHE . 44.9 tptt -146.76 110.39 4.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.585 0.231 . . . . 63.439999999999998 110.431 178.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . . . . . . . . . 37.9 tp -106.74 105.46 15.51 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.843 0.354 . . . . 73.540000000000006 110.087 177.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.415 HG23 ' HG3' ' A' ' 43' ' ' LYS . 24.7 t -127.98 133.03 68.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 116.088 -0.505 . . . . 71.439999999999998 110.018 -178.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.448 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 0.2 OUTLIER -85.07 122.88 29.92 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 120.972 0.415 . . . . 71.230000000000004 111.206 -179.271 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -122.91 175.67 6.44 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.765 -0.828 . . . . 73.340000000000003 108.765 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.851 ' HB2' ' HG3' ' A' ' 51' ' ' GLU . 63.6 mtt180 -89.11 165.11 14.71 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.256 0.55 . . . . 72.319999999999993 110.589 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.71 HD22 ' HB ' ' A' ' 2' ' ' ILE . 96.5 mt -79.53 -24.78 41.95 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.497 -0.774 . . . . 74.109999999999999 110.139 -175.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 20.1 t -91.63 -5.98 52.97 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.603 -0.726 . . . . 64.040000000000006 110.101 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.851 ' HG3' ' HB2' ' A' ' 48' ' ' ARG . 52.8 mt-10 -92.73 -9.38 40.88 Favored 'General case' 0 N--CA 1.465 0.296 0 C-N-CA 120.64 -0.424 . . . . 70.340000000000003 111.91 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.58 ' HB2' HD11 ' A' ' 2' ' ' ILE . 44.5 mt -120.66 163.78 17.52 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.559 -0.291 . . . . 73.120000000000005 110.694 -174.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 22.8 pt-20 -123.57 155.09 38.29 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 109.891 -0.411 . . . . 73.030000000000001 109.891 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -95.6 125.06 39.93 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.863 0.363 . . . . 73.030000000000001 110.955 -176.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.525 HG12 ' H ' ' A' ' 56' ' ' LYS . 2.4 t -82.95 170.05 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 108.8 -0.815 . . . . 74.099999999999994 108.8 177.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.525 ' H ' HG12 ' A' ' 55' ' ' VAL . 19.1 tptm -103.23 121.68 47.94 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.176 -0.305 . . . . 63.140000000000001 110.176 -176.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_exo -57.3 152.5 45.7 Favored 'Trans proline' 0 C--O 1.235 0.356 0 C-N-CA 123.074 2.516 . . . . 52.200000000000003 112.394 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.417 ' H ' HG13 ' A' ' 58' ' ' ILE . 6.7 mt -63.69 156.74 4.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.923 -0.581 . . . . 70.530000000000001 110.15 -179.492 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.71 HD23 ' H ' ' A' ' 59' ' ' LEU . 1.9 pt? -110.29 -172.39 2.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 116.153 -0.476 . . . . 71.319999999999993 110.276 -178.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . 0.492 ' CD ' ' H ' ' A' ' 60' ' ' GLU . 0.6 OUTLIER -98.27 45.59 1.01 Allowed 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.013 0.375 . . . . 63.43 112.013 -174.306 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 70.42 -1.43 2.51 Favored 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 123.216 0.607 . . . . 64.400000000000006 111.883 175.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -59.76 -32.22 70.38 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 111.856 0.317 . . . . 72.329999999999998 111.856 -174.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 39.6 m80 62.91 101.69 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.453 0 O-C-N 123.675 0.61 . . . . 74.439999999999998 110.589 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -102.48 -66.63 0.92 Allowed 'General case' 0 C--N 1.32 -0.691 0 C-N-CA 120.75 -0.38 . . . . 75.25 110.287 -176.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 63.91 113.54 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.416 0 O-C-N 123.78 0.675 . . . . 73.219999999999999 110.541 -178.39 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 6.3 p80 . . . . . 0 C--O 1.249 1.053 0 CA-C-O 118.168 -0.92 . . . . 74.239999999999995 110.188 -179.506 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 111.515 0.191 . . . . 73.420000000000002 111.515 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 61.9 mt -87.41 139.66 17.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 108.8 -0.815 . . . . 75.319999999999993 108.8 171.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -118.93 154.83 53.21 Favored Pre-proline 0 C--N 1.318 -0.791 0 CA-C-O 120.68 0.276 . . . . 65.439999999999998 110.899 -175.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.64 ' HB3' ' HA ' ' A' ' 26' ' ' ARG . 15.8 Cg_endo -59.82 126.03 19.34 Favored 'Trans proline' 0 N--CA 1.461 -0.435 0 C-N-CA 122.366 2.044 . . . . 71.040000000000006 111.214 174.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.569 ' HA2' HD21 ' A' ' 23' ' ' LEU . . . 108.78 -7.48 33.61 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.623 -0.799 . . . . 45.340000000000003 111.811 -175.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -92.57 152.73 19.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.731 0.3 . . . . 71.0 110.715 178.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.2 m -95.32 130.46 42.08 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.968 -0.56 . . . . 61.329999999999998 110.117 178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG21 HD13 ' A' ' 52' ' ' LEU . 21.6 m -124.52 155.8 32.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 120.908 0.385 . . . . 73.140000000000001 111.395 -177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 9' ' ' ARG . 19.2 ttt180 -122.8 121.32 35.99 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.581 -0.736 . . . . 73.310000000000002 109.372 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 52.1 t -60.99 116.02 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.846 0.355 . . . . 54.399999999999999 111.238 -175.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' THR . . . . . . . . . . . . . 12.7 m -90.74 -28.32 18.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.854 -0.612 . . . . 62.439999999999998 111.514 -177.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 50.3 t-20 -63.44 111.92 2.53 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 110.031 -0.359 . . . . 75.019999999999996 110.031 -178.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.482 ' HA ' ' CG ' ' A' ' 18' ' ' TYR . 30.5 t -72.81 -26.26 23.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 CA-C-O 121.175 0.512 . . . . 73.239999999999995 111.515 -173.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.47 -15.39 55.18 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.907 -0.588 . . . . 65.340000000000003 111.281 -174.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -77.03 160.16 29.33 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.093 0.473 . . . . 54.399999999999999 111.3 -176.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.3 m -66.88 -38.69 86.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.739 -0.664 . . . . 75.540000000000006 111.637 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 71.5 m-85 -99.61 26.8 5.81 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.897 0.379 . . . . 71.109999999999999 111.345 -174.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.482 ' CG ' ' HA ' ' A' ' 13' ' ' VAL . 37.4 t80 -57.98 140.51 52.14 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.048 -0.524 . . . . 74.549999999999997 110.86 175.438 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ARG . . . . . . . . . . . . . 29.4 ttt180 73.87 9.5 4.76 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.405 -0.816 . . . . 75.409999999999997 111.485 174.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -102.58 153.04 20.48 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 109.896 -0.409 . . . . 74.510000000000005 109.896 173.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -113.88 139.38 49.23 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.119 -0.491 . . . . 62.420000000000002 110.181 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -144.53 175.92 23.99 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.815 -0.707 . . . . 53.350000000000001 112.228 -178.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.569 HD21 ' HA2' ' A' ' 5' ' ' GLY . 6.8 tt -112.6 124.95 53.69 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 110.112 -0.329 . . . . 74.420000000000002 110.112 -177.474 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.5 t -65.54 117.31 6.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.222 -0.445 . . . . 62.299999999999997 110.804 -179.816 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 31.1 mm-40 -78.09 -36.13 48.51 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.987 -0.552 . . . . 64.299999999999997 110.161 179.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.64 ' HA ' ' HB3' ' A' ' 4' ' ' PRO . 30.5 ptt180 -170.8 145.98 2.51 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.695 -0.684 . . . . 62.0 109.954 -179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.608 HG13 HD21 ' A' ' 49' ' ' LEU . 89.7 t -106.76 121.52 59.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.988 0 CA-C-N 115.279 -0.873 . . . . 62.329999999999998 109.302 172.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 63.4 m -155.29 139.31 16.4 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.726 -0.215 . . . . 61.350000000000001 110.873 -177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 67.67 15.29 9.69 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 115.799 -0.637 . . . . 64.209999999999994 111.474 173.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.98 2.7 71.2 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.709 -0.758 . . . . 54.43 111.907 -177.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 48' ' ' ARG . 61.2 mtpt -115.31 163.05 16.26 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 110.182 -0.303 . . . . 62.219999999999999 110.182 178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -136.25 125.87 25.37 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.256 -0.429 . . . . 42.450000000000003 110.048 179.567 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.728 ' HB1' HD11 ' A' ' 44' ' ' LEU . . . -83.38 113.12 20.52 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.891 -0.411 . . . . 71.299999999999997 109.891 -178.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 50.5 t -98.18 119.65 46.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.914 0.387 . . . . 71.420000000000002 111.238 -176.138 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 28.7 tp -94.1 108.79 20.6 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.945 -0.571 . . . . 74.340000000000003 109.685 174.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.459 ' O ' ' HA ' ' A' ' 42' ' ' ASP . 96.6 m-85 -80.36 141.36 35.46 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 109.284 -0.636 . . . . 63.509999999999998 109.284 175.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -139.24 124.37 18.94 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.194 -0.457 . . . . 61.43 110.488 -175.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -128.85 86.3 2.43 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.125 -0.489 . . . . 60.210000000000001 109.916 178.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 66.81 -95.34 0.27 Allowed Glycine 0 N--CA 1.452 -0.289 0 N-CA-C 111.205 -0.758 . . . . 71.519999999999996 111.205 -177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.3 t-20 -122.37 87.77 2.81 Favored 'General case' 0 CA--C 1.504 -0.79 0 CA-C-O 122.529 1.156 . . . . 74.420000000000002 108.554 172.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . . . . . . . . . 89.5 t90 178.8 138.46 0.09 Allowed 'General case' 0 C--N 1.292 -1.909 0 CA-C-N 112.283 -2.235 . . . . 74.540000000000006 109.463 -176.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.459 ' HA ' ' O ' ' A' ' 36' ' ' PHE . 3.6 p30 -137.03 152.71 50.41 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-N 115.489 -0.778 . . . . 74.099999999999994 110.558 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.424 ' HG3' HG23 ' A' ' 45' ' ' VAL . 17.1 tppt? -156.56 107.14 2.37 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 115.303 -0.862 . . . . 73.420000000000002 110.044 177.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LEU . . . . . 0.728 HD11 ' HB1' ' A' ' 33' ' ' ALA . 57.4 tp -89.21 110.86 21.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.169 -0.469 . . . . 71.200000000000003 110.716 179.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.424 HG23 ' HG3' ' A' ' 43' ' ' LYS . 34.8 t -125.65 120.73 58.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.213 -0.662 . . . . 65.540000000000006 109.213 175.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.598 ' HA ' ' HA ' ' A' ' 33' ' ' ALA . 3.0 m -81.41 130.93 35.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.282 0.563 . . . . 71.439999999999998 111.067 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.471 ' HB2' HD11 ' A' ' 52' ' ' LEU . 81.9 m-85 -124.53 -167.27 1.63 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.19 -0.914 . . . . 72.140000000000001 109.038 177.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.722 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 65.2 mtt-85 -110.24 162.81 14.25 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.885 -0.413 . . . . 65.349999999999994 109.885 175.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.608 HD21 HG13 ' A' ' 27' ' ' VAL . 3.6 mm? -66.4 -33.29 75.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.429 0.633 . . . . 63.25 109.999 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.7 p -78.16 -6.38 54.61 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.514 -0.766 . . . . 64.329999999999998 110.573 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.722 ' HG2' ' HB2' ' A' ' 48' ' ' ARG . 15.4 mm-40 -94.13 -15.57 24.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.078 -0.51 . . . . 62.420000000000002 111.001 178.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.471 HD11 ' HB2' ' A' ' 47' ' ' PHE . 29.4 mt -127.79 150.07 49.98 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.066 -0.515 . . . . 74.109999999999999 111.645 -171.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -121.25 143.45 49.15 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.655 -0.868 . . . . 75.209999999999994 108.655 169.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -79.18 136.37 37.08 Favored 'General case' 0 C--N 1.319 -0.731 0 C-N-CA 120.958 -0.297 . . . . 53.240000000000002 110.246 -178.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.532 HG12 ' H ' ' A' ' 56' ' ' LYS . 3.0 t -67.27 164.17 2.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 109.534 -0.543 . . . . 34.350000000000001 109.534 179.037 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.532 ' H ' HG12 ' A' ' 55' ' ' VAL . 87.6 tttt -130.53 137.02 29.89 Favored Pre-proline 0 C--N 1.314 -0.967 0 CA-C-N 116.168 -0.469 . . . . 72.010000000000005 110.439 -169.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.74 135.76 57.45 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 122.693 2.262 . . . . 61.140000000000001 111.359 174.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.23 152.48 5.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.237 0.541 . . . . 64.219999999999999 111.097 -174.159 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -123.32 144.93 49.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.644 -0.707 . . . . 53.119999999999997 110.028 -178.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.28 164.18 15.72 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.175 -0.676 . . . . 74.409999999999997 109.175 -179.719 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -63.96 131.47 47.75 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.943 0.401 . . . . 73.400000000000006 110.969 -176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -152.85 157.36 40.61 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.828 -0.624 . . . . 64.109999999999999 110.121 -177.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 63.87 -153.56 0.31 Allowed 'General case' 0 CA--C 1.534 0.347 0 O-C-N 123.596 0.56 . . . . 75.019999999999996 109.756 -179.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.7 t-80 73.93 -29.03 0.19 Allowed 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.249 0.62 . . . . 64.230000000000004 111.979 176.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -59.82 -40.36 88.19 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.174 0.512 . . . . 72.530000000000001 110.079 173.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' HIS . . . . . . . . . . . . . 15.6 p80 . . . . . 0 C--O 1.244 0.782 0 CA-C-N 115.327 -0.851 . . . . 71.109999999999999 108.762 175.227 . . . . . . . . 0 0 . 1 stop_ save_